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ABSTRACT 
In 2011, the European Food Safety Authority (EFSA) received a mandate from the Food Safety Authority of 
Ireland (FSAI) to review the available scientific data on the prevalence of each food allergy in Europe, to derive 
threshold concentrations for each allergen in foods when possible, and to review the analytical methods available 
for the detection/quantification of food allergens. This report presents the findings of a series of systematic 
reviews of the literature related to these aims. Systematic searches of relevant bibliographic databases and the 
grey literature were conducted, studies were selected for inclusion according to pre-specified criteria, relevant 
data was extracted from all included studies, and the quality of included studies assessed. The first systematic 
review examined the literature on the prevalence of food allergy (IgE-mediated and non-IgE mediated) in 
different regions of the World and in individual European countries for different age groups in relation to each of 
the following food allergens: milk/dairy, eggs, cereals, peanuts, nuts, celery, crustaceans, fish, molluscs, soy, 
lupin, mustard and sesame. For each of these allergens changes in prevalence trends over time were also 
examined. Additionally, emerging food allergens in different European countries were identified. Of the 7333 
articles identified by the searches, data from 92 studies was included, 52 of which reported on studies conducted 
within Europe. The second systematic review examined the effects of food processing on the allergenicity of 
foods in relation to each of the following food allergens: milk/dairy, eggs, cereals, peanuts, nuts, celery, 
crustaceans, fish, molluscs, soy, lupin, mustard and sesame. From 1040 articles identified by the searches, 25 
studies were included in this review. The final systematic review examined the evidence regarding the new 
analytical methods available to analyse/detect the food allergens considered in the previous systematic reviews 
in processed foods. From 1475 articles identified by the searches, 84 studies were included.  
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SUMMARY 
In 2011, the European Food Safety Authority (EFSA) received a mandate from the Food Safety 
Authority of Ireland (FSAI) to review the available scientific data on the prevalence of each food 
allergy in Europe, to derive threshold concentrations for each allergen in foods when possible, and to 
review the analytical methods available for the detection/quantification of food allergens. Hence, 
EFSA commissioned this research project, the objectives of which were to carry out a series of 
systematic reviews of the literature reviews. This project followed systematic review methodology: 
systematic searches of relevant bibliographic databases and the grey literature were conducted; studies 
were selected for inclusion according to pre-specified criteria; relevant data was extracted from all 
included studies; and the quality of included studies assessed. 
The first systematic review examined the literature on the prevalence of food allergy (IgE-mediated 
and non-IgE mediated) in different regions of the World and in individual European countries for 
different age groups in relation to each of the following food allergens: milk/dairy, eggs, cereals, 
peanuts, nuts, celery, crustaceans, fish, molluscs, soy, lupin, mustard and sesame. For each of these 
allergens changes in prevalence trends over time were also examined. Additionally, emerging food 
allergens in different European countries were identified.  
Of the 7333 articles identified by the searches, 92 articles were included in this systematic review, 52 
of which reported on studies conducted within Europe, presenting data for the following countries: 
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Sweden, Italy, Netherlands, 
Norway, Portugal, Spain, Sweden, Turkey, United Kingdom and Estonia. In the included studies, the 
prevalence of food allergy was assessed using a variety of methods of diagnosis, and prevalence data 
has been presented in this report accordingly. Fifty-seven studies utilised questionnaire or interview 
methods to assess the prevalence of either self-reported allergy and/or clinician-diagnosed allergy. 
Twenty-five studies presented data on sensitisation to foods, measured by either skin prick testing 
and/or serum-specific IgE testing. Some studies (27) combined information from self-reports of 
adverse reactions with the results of skin prick or serum-specific IgE testing to present the prevalence 
of allergy to a specific food. Only 21 of the included studies utilised food challenges to determine the 
prevalence of food allergy. Of the included studies, 55 were considered to have utilised a method of 
diagnosis at high risk of bias, 11 used a sampling method considered to be at high risk of bias (the 
sampling method was unclear in 16 studies) and seven failed to consider reasons for non-response 
and/or explore withdrawal/loss-to-follow-up (for 69 studies this was unclear). Worldwide milk/dairy 
was the most common allergen examined (by 40 European studies and 29 non-European), followed by 
egg (35 European studies, 26 non-European), fish/shellfish/molluscs (34 European studies, 27 non-
European) and peanut (27 European studies, 26 non-European). The least examined allergens were 
celery (four European studies, one non-European), mustard (one European study) and lupin (no 
studies).  
Although some allergens were widely studied, such as milk, peanut and fish/shellfish/molluscs, the 
systematic review revealed that there are many gaps in the evidence base for the prevalence of 
allergies to some individual foods (e.g. lupin and celery). Moreover, there are gaps in the evidence 
base related to the prevalence of food allergies in specific age groups and countries. An important 
issue is that many studies focus on the prevalence of self-reported rather than challenge-proven food 
allergy. Even in studies utilising food challenges there was a huge variety in the approach taken, which 
hinders comparisons across allergens, age groups and countries. For example, in many studies aspects 
of the challenge protocol were unclear and several studies utilising food challenges did so as part of an 
algorithm drawing upon other information (e.g. sensitisation data, symptom reports) to diagnose food 
allergy and such algorithms differed between studies. Time trends are particularly difficult to describe 
based upon the current evidence base given the lack of studies utilising similar methodologies with 
comparable age groups in the same country. 
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The second systematic review examined the effects of food processing on the allergenicity of foods in 
relation to each of the following food allergens: milk/dairy, eggs, cereals, peanuts, nuts, celery, 
crustaceans, fish, molluscs, soy, lupin, mustard and sesame. This review was concerned with studies 
that used food challenges to assess changes in the allergenicity of foods processed using a wide variety 
of methods. From 1040 articles identified by the searches, 25 studies were included in this review. The 
included studies investigated the allergenicity of the following reported allergens: celery (one study), 
wheat (one study), egg (six studies), hazelnut (two studies), milk and dairy (14 studies) and peanut oil 
(one study).   
The majority of studies focussed on the effect of heat; commonly boiling, roasting or baking. The 
exceptions were the studies investigating hydrolysis and fractioning of milk for infant milk formulas 
and one study investigating the effect of maturation time for cheese production for those with allergy 
to the additive lysozyme (from egg) or milk allergens. There were no included studies investigating 
the effect of using egg or milk as fining agents within the wine making industry. Additionally, 
although a large number of studies were carried out on peanut allergy no studies were identified that 
challenged participants with two forms of peanut, for example raw and roasted. However, we did find 
one study that investigated the allergenicity of crude versus refined peanut oil. 
Most studies utilized a cross-over design where each participant underwent challenge to two forms of 
the food. The order in which the participants were allocated to the challenge with each type of food 
was determined randomly for only a small proportion of studies. The remaining cross-over studies 
used a non-random order, usually because the participants were challenged to the food considered 
least allergenic first since the studies were designed to investigate whether a diet including extensively 
heated egg or milk could lead to increased tolerance rather than the effect of processing on 
allergenicity. In all cases, data was extracted only for those participants who were challenge positive 
to one or more of the forms of the food being examined. Studies did not tend to include a high 
proportion of participants with severe allergy. In the large majority of studies that carried out a double-
blind placebo-controlled food challenge the challenge procedure (for example the method of masking 
(and its validity), the method of generating the random sequence, the ratio of active to placebo 
challenge and the way in which the sequence was concealed from the participants and the study 
personnel) was not clearly reported. 
The evidence suggests that the allergenicity of foods can be altered by food processing. However, 
although there are trends for certain foods, for example, that extensive heating of egg, milk, celery, 
and to some extent hazelnut, reduces allergenicity, this reduction will not be experienced by all people 
with that allergy. The included studies were small and not representative of the wider allergic 
population. More high quality research is required to determine if certain types of processing increase 
allergenicity, especially for foods such as peanut where this is suggested by the in vitro research 
evidence.  It would be useful to identify groups of people more likely to tolerate certain types of 
processed foods, so that more specific diagnostic challenges can be accessed and lead to individualised 
management strategies. 
The final systematic review examined the evidence regarding the new analytical methods available to 
analyse/detect the food allergens considered in the previous systematic reviews in processed foods. 
The review set out to include studies investigating extraction and detection of the food/proteins in a 
food matrix of relevance to the real world setting.  Studies investigating food matrixes spiked with 
allergen were included. From 1475 articles identified by the searches, 84 studies were included.  
This review revealed that there are a large number of studies that have investigated the effectiveness of 
assays for detecting allergens in foods published since 2004. The foods with the most research 
conducted was tree nuts, followed by peanut, milk and dairy and egg. For most allergens there are tests 
developed that can detect down to 10µg/ml. However the food matrix used could affect the 
performance of the extraction processes and assays. There was variability in the types of experiments 
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carried out, the format and statistical analysis of the data presented and in specific techniques such as 
the method of spiking and in the source of extracts used to validate the assay in the studies retrieved 
for this review. In a large proportion of studies there was a potential high risk of bias for at least one 
item. There are a range of criteria that could be used to validate assays and ensure that there is 
consistent quality control across institutions. We focused on the accuracy as determined by the 
percentage recovery of a spiked sample and the limit of detection of each allergen within a suitable 
food matrix; this is just one aspect of quality control. The limit of detection reported by some of these 
studies showed that the values reported by manufacturers are not always achieved in practice. Reasons 
for variation could be the type of matrix used, for example manufacturers may report the sensitivity of 
the assay when the allergen standard is diluted in assay buffer rather than being within a complex food 
matrix. Before funding or adopting an assay and extraction procedure  it is recommended that all key 
quality and validation data are reviewed in accordance with the relevant standards and that  each 
laboratory carry out their own validation experiments to assess the performance of the assay within 
their specific context.  The organisations providing guidance for quality assurance are discussed. 
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BACKGROUND  
In 2011, the European Food Safety Authority (EFSA) received a mandate from the Food Safety 
Authority of Ireland (FSAI) to review the available scientific data on the prevalence of each food 
allergy in Europe, to derive threshold concentrations for each allergen in foods when possible, and to 
review the analytical methods available for the detection/quantification of food allergens. In order to 
address this mandate, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) will  
update its opinion, published in 2004
2
, relating to the evaluation of allergenic foods for labelling 
purposes which provides the scientific basis for the identification of foods, food components and food 
ingredients which may trigger allergic reactions in susceptible individuals, as well as an overview on 
the prevalence of food allergy, on the setting of threshold concentrations/minimal eliciting doses for 
individual food allergens, and on the analytical methods for the detection/quantification of these food 
allergens in raw and processed foods. 
 
OBJECTIVES  
The objectives of the contract resulting from the present procurement procedure are the collection, 
collation and analysis of published and unpublished data related to:  
1. The prevalence of food allergy (IgE-mediated and non-IgE mediated) in different regions of 
the World (e.g. North America, Canada, Australia and New Zealand) and primarily in 
individual European countries for different age groups in relation to each of the following 
food allergens: milk/dairy, eggs, cereals, peanuts, nuts, celery, crustaceans, fish, molluscs, 
soy, lupin, mustard and sesame.  
2. The natural history of food allergy to each allergen listed above (changes in prevalence and/or 
severity with age) and on changes in prevalence trends over time at a population level, 
whenever available.  
3. The most prevalent (emerging) food allergies in different European countries (i.e. food 
allergens other than those listed above) and changes in sensitisation patterns where known or 
emerging. 
4. The effects of food processing on the allergenicity of foods in relation to each of the following 
food allergens: milk/dairy, eggs, cereals, peanuts, nuts, celery, crustaceans, fish, molluscs, 
soy, lupin, mustard and sesame; and on the new analytical methods available to analyse/detect 
these food allergens in processed foods. 
To achieve these objectives the contractor should carry out comprehensive literature searches to 
identify and retrieve all related information/data published in peer-reviewed journals and should make 
reasonable efforts to identify and retrieve unpublished data.  The data retrieved should be further 
analysed following well-accepted methodologies and criteria in order to identify relevant scientific 
data. The information should be transferred in a concise way to EFSA including the full list of 
references used for each single food allergen. References not considered pertinent should be listed and 
a reasoning why these references were not considered pertinent should be provided, in both raw and 
processed foods. 
 
                                                     
2
  EFSA (European Food Safety Authority), 2004. Opinion of the Scientific Panel on Dietetic Products, Nutrition and 
Allergies on a request from the Commission relating to the evaluation of allergenic foods for labelling purposes. The EFSA 
Journal 32, 1-197 
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TERMS OF REFERENCE 
This contract was awarded by EFSA to: University of Portsmouth 
Contractor: Dr Elizabeth Bartle, University of Portsmouth Higher Education Corporation 
Contract title: Literature searches and reviews related to the prevalence of food allergy in Europe.  
Contract number: CFT/EFSA/NUTRI/2012/02 
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INTRODUCTION AND OBJECTIVES 
In order to address the four objectives we have brought together a team of academics with expertise in 
the field of food allergy research and systematic reviews. The overall approach was a series of 
systematic reviews of the literature, using the following stages: 
Stage 1. Conduct a comprehensive and systematic search of the (published and 
unpublished) literature to identify all potentially relevant studies.  
Stage 2. Screen all identified studies against pre-specified eligibility criteria for their 
relevance to the objective.  
Stage 3. For all included studies, extract data relevant to the objective (using pre-specified 
data collection forms).  
Stage 4. For all included studies, assess the validity of the findings (using pre-specified 
quality assessment criteria).  
Stage 5. Synthesise the results of the included studies (as appropriate) and present the 
characteristics and findings.  
 
These literature reviews would adhere to the nomenclature for food allergy as specified by the World 
Allergy Organisation and so will not include non-allergic food hypersensitivity (i.e. where 
immunologic mechanisms have not been implicated).  
The objectives are to carry out systematic literature reviews:  
1. on the prevalence of food allergy (IgE-mediated and non-IgE mediated) in different regions of 
the World (e.g. North America,  Canada,  Australia and  New Zealand) and primarily in 
individual European countries for different age groups in relation to each of the following 
food allergens: milk/dairy, eggs, cereals, peanuts, nuts, celery, crustaceans, fish, molluscs, 
soy, lupin, mustard and sesame;   
2. and for each allergen listed above to present changes in prevalence trends over time at a 
population level for specific age groups, whenever available;  
3. to identify emerging food allergens in different European countries (i.e. food allergens other 
than those listed above, where there is a significantly high prevalence) and present the 
prevalence and changes in prevalence with time, whenever available; 
4. (4a) on the effects of food processing on the allergenicity of foods in relation to each of the 
following food allergens: milk/dairy, eggs, cereals, peanuts, nuts, celery, crustaceans, fish, 
molluscs, soy, lupin, mustard and sesame; 
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5. (4b) on the new analytical methods available to analyse/detect these food allergens in 
processed foods. 
The methods and the results for objectives 1-3 are reported in the same section as they share the same 
search strategy. The methods and the results for objectives 4a and 4b are presented separately as the 
search strategies and the assessment criteria are distinct. 
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1. THE PREVALENCE OF FOOD ALLERGY IN DIFFERENT REGIONS OF THE WORLD AND 
INDIVIDUAL EUROPEAN COUNTRIES (OBJECTIVES 1-3) 
1.1. Materials and Methods 
1.1.1. Literature search strategy 
1.1.1.1. Bibliographic databases and grey literature searching 
We searched the following databases: Web of Science including Social Science Citation Index 
Expanded (1970-present), Social Sciences Citation Index (1970-present), Conference Proceedings 
Citation Index Science (1990-present), Book Citation Index Science (2005-present), and PubMed.  
Searches of conference proceedings were carried out using the Conference Proceedings Citations 
Index in which studies reported in the proceedings of a comprehensive range of allergy conferences 
(including the World Allergy Congress, the Annual meeting of the American Academy of Asthma, 
Allergy and Immunology and the Congress of the European Academy of Allergy and Clinical 
Immunology) can be identified.  
Grey literature was sought via direct contact with a list of topic experts and examination of the lists of 
awards made by known funders of research in the field (see Box 1). To ensure thoroughness, a 
snowball approach was taken, whereby the experts were asked whether they knew of any others 
working in fields directly related to the objectives whom we should contact. 
Box 1. Topic experts and known funders of research in the field. 
Dr Katie Allen Dr Scott Sicherer 
Professor S Hasan Arshad Dr Bodo Niggemann 
Professor Peter Burney Professor Ulrich Wahn 
Dr Kirsten Beyer Professor Jonathan Hourihane 
Professor Gideon Lack Dr Graham Roberts 
Dr Montserrat Fernandez Rivas  Professor Susan Prescott 
Professor Hugh Sampson  
1.1.1.2. Search terms and Boolean operators 
Specific search strategies were tailored for the requirements of each database. In order to identify all 
relevant articles, no language or date restrictions were employed and searches were not limited by 
study type. The team evaluated the sensitivity of the search strategy by checking that the search results 
included studies on this topic known by experts within the field. 
In PubMed the terms were searched for in the title and abstract fields and using MeSH terms where 
appropriate. In Web of Science the terms were searched for in the „Topic Search‟ field (which includes 
title, abstract and keywords). Within groups of terms the terms were combined using OR, the groups 
of terms themselves were then combined in the following manner: #1 AND #2 AND #3. 
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Table 1.1:  Search terms for the prevalence of food allergy (objectives 1, 2 and 3) 
Topics Search terms
3
 Search terms for PubMed Search terms for Web of Science 
Group 1. 
Prevalence  
   
Prevalence Prevalence, point prevalence prevalence[Tiab] OR “point prevalence”[Tiab] OR 
prevalence[MeSH Terms] 
prevalence OR “point prevalence” 
Incidence Incidence, cumulative incidence incidence[Tiab] OR “cumulative incidence”[Tiab] OR 
incidence[MeSH Terms] 
incidence OR “cumulative incidence” 
Natural history Natural history “natural history”[tiab] OR ((change[tiab] OR 
changes[tiab]) AND (severity[tiab] OR prevalence[tiab]) 
AND time[tiab]) 
“natural history” OR ((change OR changes) 
AND (severity OR prevalence) AND time) 
Group 2. Food  food[Tiab] food 
Milk and dairy Milk, lactose, dairy, butter, cream, infant 
formula, cheese, yoghurt, petit filous, 
casein, whey 
milk[Tiab] OR milk[MeSH Terms] OR lactose[MeSH 
Terms] OR lactose[Tiab] OR dairy[Tiab] OR 
butter[Tiab] OR cream[Tiab] OR “infant formula”[Tiab] 
OR cheese[Tiab] OR yoghurt[Tiab] OR “petit 
filous”[Tiab] OR casein[Tiab] OR whey[Tiab] 
milk OR lactose OR dairy OR butter OR 
cream OR “infant formula” OR cheese OR 
yoghurt OR “petit filous” OR casein OR 
whey 
Egg Egg, eggs egg[Tiab] OR eggs[Tiab] egg OR eggs 
Cereals Cereal, gluten, wheat, rye, barley, oats, 
spelt, kamut 
cereals[MeSH Terms] OR cereal[Tiab] OR cereals[Tiab] 
OR glutens[MeSH Terms] OR glutens[Tiab] OR 
gluten[Tiab] OR wheat[Tiab] OR rye[Tiab] OR barley[ 
Tiab] OR oats [Tiab] OR oat[Tiab] OR spelt[Tiab] OR 
kamut[Tiab] 
cereal OR cereals OR gluten OR glutens OR 
wheat OR rye OR barley OR oats OR oat 
OR spelt OR kamut 
Peanut Peanut, arachis peanut[Tiab] OR arachis[Tiab] peanut OR arachis 
                                                     
3
 As indicated in technical offer and updated in light of kick-off meeting (e.g. expanded the range of terms included for specific types of fish and shellfish) 
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Topics Search terms
3
 Search terms for PubMed Search terms for Web of Science 
Nuts Nut, almond, hazelnut, walnut, cashew, 
pecan, macadamia, pistachio, beechnut, 
filbert, tree nuts 
nuts[MeSH Terms] OR nuts[Tiab] OR nut[Tiab] OR 
almond[Tiab] OR almonds[Tiab] OR hazelnut[ Tiab] OR 
hazelnuts[Tiab] OR walnut[Tiab] OR walnuts[Tiab] OR 
cashew[Tiab] OR cashews[Tiab] OR pecan[Tiab] OR 
pecans[Tiab] OR macadamia[Tiab] OR 
macadamias[Tiab] OR pistachio[Tiab] OR 
pistachios[Tiab] OR beechnut[Tiab] OR beechnuts[Tiab] 
OR filbert[Tiab] OR filberts[Tiab] 
nuts OR nut OR almond OR almonds OR 
hazelnut OR hazelnuts OR walnut OR 
walnuts OR cashew OR cashews OR pecan 
OR pecans OR macadamia OR macadamias 
OR pistachio OR pistachios OR beechnut 
OR beechnuts OR filbert OR filberts 
Celery Celery celery[tiab] celery 
Crustaceans Crustacean, crab, lobster, shrimp, prawn, 
crayfish, shellfish, langoustine 
crustacean[MeSH Terms] OR crustacea[Tiab] OR 
crustacean[Tiab] OR crustaceans[Tiab] OR crab[Tiab] 
OR crabs[Tiab] OR lobster[Tiab] OR lobsters[Tiab] OR 
shrimp[Tiab] OR shrimps[Tiab] OR prawn[Tiab] OR 
prawns[Tiab] OR crayfish[Tiab] OR shellfish[MeSH 
Terms] OR shellfish[Tiab] OR langoustine[Tiab] OR 
langoustines[Tiab] 
crustacea OR crustacean OR crustaceans OR 
crab OR crabs OR lobster OR lobsters OR 
shrimp OR shrimps OR prawn OR prawns 
OR crayfish OR shellfish OR langoustine 
OR langoustines 
Fish Fish, pollock, carp, cod, mackerel, 
salmon, tuna, shark, sea bass, swordfish, 
hake, sole, megrim, sardines, halibut, 
anchovy, catfish, trout 
fishes[MeSH Terms] OR fish[Tiab] OR pollock[Tiab] 
OR carp[Tiab] OR cod[Tiab] OR mackerel[Tiab] OR 
salmon[Tiab] OR tuna[Tiab] OR shark[tiab] OR “sea 
bass”[tiab] OR swordfish[tiab] OR hake[tiab] OR 
sole[tiab] OR megrim[tiab] OR sardine[tiab] OR 
sardines[tiab] OR halibut[tiab] OR anchovy[tiab] OR 
anchovies[tiab] OR catfish[tiab] OR trout[tiab] 
fish OR pollock OR carp OR cod OR 
mackerel OR salmon OR tuna OR shark OR 
“sea bass” OR swordfish OR hake OR sole 
OR megrim OR sardine OR sardines OR 
halibut OR anchovy OR anchovies OR 
catfish OR trout 
Molluscs Mollusc, oyster, snail, squid, mussels, 
clams, abalone, octopus, scallop 
mollusca[MeSH Terms] OR mollusc[Tiab] OR 
molluscs[Tiab] OR oyster[Tiab] OR oysters[Tiab] OR 
snail [Tiab] OR snails[Tiab] OR squid[Tiab] OR 
mussel[Tiab] OR mussels[Tiab] OR clam[Tiab] OR 
clams[Tiab] OR abalone[tiab] OR octopus[tiab] OR 
scallop[tiab] OR scallops[tiab] 
mollusc OR molluscs OR oyster OR oysters 
OR snail  OR snails OR squid OR mussel 
OR mussels OR clam OR clams OR abalone 
OR octopus OR scallop OR scallops 
Soy Soy, soya, soybean soy[Tiab] OR soybeans[MeSH Terms] OR 
soybean[Tiab] OR soybeans[Tiab] OR soya[Tiab] 
soy OR soybean OR soybeans OR soya 
Lupin Lupin, lupinus-albus lupinus[MeSH Terms] OR lupin[Tiab] lupin 
Mustard Mustard "mustard plant"[MeSH Terms] OR mustard[Tiab] mustard 
University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506                                   18 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food 
Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the 
rights of the authors. 
Topics Search terms
3
 Search terms for PubMed Search terms for Web of Science 
Sesame Sesame sesamum[MeSH Terms] OR "sesame"[Tiab] sesame 
Group 3. Allergy    
Allergy Hypersensitivity, allergy, immunology, 
sensitivity, intolerance, anaphylaxis, 
adverse reaction 
hypersensitivity[MeSH Terms] OR 
hypersensitivity[Tiab] OR allergy[Tiab] OR "allergy and 
immunology"[MeSH Terms] or immunology[Tiab] OR 
sensitivity[Tiab] OR intolerance[Tiab] OR 
anaphylaxis[MeSH Terms] OR anaphylaxis [Tiab] OR 
“adverse reaction”[Tiab] 
hypersensitivity OR allergy OR immunology 
OR sensitivity OR intolerance OR 
anaphylaxis  OR “adverse reaction” 
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1.1.1.3. Management of search results 
Search results were managed using reference management software (EndNote) and duplicates 
removed. Search results were then imported into EPPI Reviewer 4 (systematic review software) prior 
to screening for relevance. English language versions of articles were obtained via the British 
Library‟s document supply service (the British Library holds more than 500,000 articles translated 
into English). Where articles were not available, translation services were used. Searches were 
updated prior to data analysis/synthesis. 
1.1.1.4. Specific search strategy for identifying articles related to the prevalence of emerging 
allergens 
It was anticipated that many of the articles which report the prevalence of food allergy to common 
allergens such as peanut and milk, would do so in the context of a larger study that screened 
participants for adverse reactions to a number of (or, in some cases, to any) foods. Hence, for such 
studies data was presented for allergens other than those listed in Objective 1. These studies were 
identified by the search strategy outlined in Section 1.1.1.2. Nevertheless, there may also be some 
smaller studies which have specifically explored the prevalence of allergens that have the potential to 
be „emerging‟. Hence, within the main search strategy the term „food‟ was included to identify articles 
which might be reporting the prevalence of allergy to foods other than those specifically listed in 
Objective 1.  
1.1.1.5. Specific search strategy for identifying the clinical reactivity to emerging allergens 
For the key emerging allergens identified, we have also reported information on clinical reactivity and 
reports of severe reactions. If available, this was sourced from challenge data provided within the 
relevant articles. However, if no challenge data was presented in the prevalence studies (i.e. they 
present sensitivity data only) we searched for smaller observational studies, particularly case reports 
of anaphylaxis.  
1.1.1.6. Specific search strategy for identifying the prevalence of allergy to any food 
In addition to the key objectives, we also sought to summarise the prevalence of allergies to any food. 
Since this was not part of the original objectives, only those studies already included in the review 
were identified for screening.   
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Table 1.2:  Search terms to identify articles related to the clinical reactivity of emerging allergens 
Topics Search terms
4







Anaphylaxis[MeSH Terms] OR 
anaphylaxis[Tiab] OR 
asthma[Tiab] OR oedema[Tiab] 
OR odema[Tiab]  
Anaphylaxis OR asthma 




This will be a list of 
emerging food allergens 
identified for objective 3 
(with specific search 
terms as described in 
Table 1.1). 
The search terms provided will be 
adapted for use in PubMed. 
The search terms 
provided will be adapted 







hypersensitivity[MeSH Terms] OR 
hypersensitivity[Tiab] OR 
allergy[Tiab] OR "allergy and 





allergy OR immunology 
OR sensitivity OR 
intolerance OR 
anaphylaxis  OR “adverse 
reaction” 
Group 4.  
Case reports 
Case report, case study, 
case history 
“case report”[Tiab] OR “case 
study”[Tiab] OR “case 
history”[Tiab] OR “case 
reports”[MeSH] 
“case report” OR “case 
study” OR “case history” 
1.1.2. Study selection general approach 
All identified articles were screened for inclusion in the review as follows. Firstly, the titles and 
abstracts of all identified articles were screened for potential relevance by one review author (a team 
approach was taken whereby references were divided amongst the review team for screening). At this 
stage, articles were excluded if, for example, they were obviously unrelated to the topic of the review 
(e.g. Diagnostic value of D-dimer in outpatients with suspected deep venous thrombosis receiving oral 
anticoagulation); the sample was inappropriate for the scope of the review (e.g. Prevalence of soy 
protein hypersensitivity in cow's milk protein-sensitive children in Korea) or because they did not 
present primary research (e.g. Gastrointestinal allergy to food: a review). An inclusive approach was 
taken, whereby if the review author was unsure of the potential relevance of an article it was marked 
as „potentially eligible‟. The full-text of all potentially eligible studies was then retrieved and assessed 
against the criteria outlined in section 1.1.3. If the review author was unsure about the eligibility of 
the paper for inclusion in the review, the paper was discussed with another review author. Reasons for 
exclusion were recorded.  
1.1.3. Study selection specific approach: objectives 1-3 
1.1.3.1. Types of studies 
We have included population-based cross-sectional studies and cohort studies examining the 
prevalence of food allergy (IgE-mediated and non-IgE mediated). To be included all studies must 
have presented an identifiable point (or period) in time at which the prevalence of food allergy was 
measured.  
                                                     
4 As indicated in technical offer and updated in light of kick-off meeting 
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1.1.3.2. Types of participants 
We included participants of all age groups from any country. Studies that did not present region or 
country-specific data were excluded from the review. Studies must have been population based, using 
either a fixed cohort or an appropriate sampling strategy. Studies conducted in a clinical setting (e.g. a 
survey of the prevalence of specific food allergies in current patients at an allergy clinic) or in selected 
patient groups (e.g. measuring the prevalence of food allergy in patients with asthma) were excluded 
since they do not provide information about the general prevalence of food allergies.  
1.1.3.3. Types of outcome measure 
Objectives 1 and 2 are interested in one outcome - the prevalence of food allergies (IgE and/or non-
IgE mediated) to any one of the following allergens: milk/dairy, eggs, cereals, peanuts, nuts, celery, 
crustaceans, fish, molluscs, soy, lupin, mustard and sesame. Objective 3 is interested in the prevalence 
of food allergies to emerging allergens. Hence, all studies reporting the prevalence of food allergies to 
specific allergens were eligible for inclusion in the review. 
Studies employing at least one of the following methods of diagnosis to determine the prevalence of 
allergies to one or more of the above food allergens were eligible for inclusion in the review for 
Objectives 1-3: 
 Self-reported food allergy 
 Clinical history of adverse reactions to foods and positive SPT (for IgE-mediated food 
allergy) 
 Clinical history of adverse reactions to foods and positive serum-specific IgE (for IgE-
mediated food allergy) 
 Clinical history of adverse reactions to foods and positive food challenge (open or double-
blind placebo-controlled: for IgE and non-IgE mediated food allergy, allowing for delayed 
reactions in the case of non-IgE mediated food allergy) 
Studies which presented data regarding sensitisation as determined by the following methods were 
also eligible for inclusion in the review for Objective 1: 
 Positive SPT 
 Positive serum-specific IgE 
Studies that did not present separate prevalence data for individual allergens were excluded from the 
review.  
1.1.4. Study selection specific approach for identifying the prevalence of allergy to any food 
All included studies were screened for the inclusion of data for the prevalence of allergy to any food. 
The methods and outcome measures used to identify this data needed to meet the criteria outlined for 
Objectives 1-3 (Section 1.1.3) to be eligible for inclusion in the review.  
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1.1.5. Data collection general approach 
As described in the technical offer, data extraction and management was facilitated by the EPPI 
Reviewer software (EPPI Centre, 2011), which has been developed to aid the management of 
systematic reviews. The software facilitates the following activities: reference management, study 
classification/screening, data extraction and retrieval, collaborative working (i.e. allocation of 
screening and comparison of screening decisions), data analysis and reporting.  
As has been piloted for articles related to the prevalence of peanut allergy, we used data collection 
forms developed in EPPI Reviewer to extract relevant data for objectives 1-3 according to 
predetermined criteria. The following was extracted for all included studies: 
1. General information: Authors‟ contact details, research funder, year(s) study conducted, 
country/countries in which conducted. 
2. Methods: Study design (cross-sectional or cohort study, and for cohort studies additional 
information regarding at what ages articles have reported), type of food allergy considered 
(IgE mediated, non-IgE mediated or both), food(s) assessed (including potential emerging 
allergens), method of diagnosis (to include additional information with regard to the 
procedure, e.g. whether extracts or prick-to-prick method has been used for skin prick 
testing), sampling strategy (e.g. local or general population, random or non-random) and 
sample characteristics (e.g. age group, ethnic background, response rate, withdrawal). 
3. Outcomes [for ease of reporting, this data has been recorded in a Microsoft Excel spread 
sheet]: Information on reported outcomes and relevant data (percentage prevalence, raw data 
and confidence intervals; presented by allergen, year of study, method of diagnosis and age). 
Additional information was collected if reported by a study, as follows: 
 Where a study has reported the prevalence of sensitisation to a food (indicated by either a 
positive skin prick test or serum-specific IgE test), and where relevant (e.g. in the case of 
wheat and grass) and reported by the study, data was recorded regarding cross-reactivity. 
Where such data was relevant but not reported, this was also recorded. 
 Objective 3 (emerging allergens): Where studies have been sought which provide evidence 
regarding the clinical reactivity of emerging allergens, information regarding the nature of 
reactions reported was extracted. This included information regarding the symptoms of the 
reaction, the time between ingestion and reaction and the treatment required.  
Where there was ambiguity in the reporting of results, all efforts were made within the given 
timeframe to contact the study authors to provide additional information.  
Upon completion of data collection, those studies included in the review were exported from EPPI 
Reviewer into EndNote reference management software. Where available in electronic format (and 
when compliant with copyright and data sharing rules), the full-text of articles not currently accessible 
within EFSA‟s current subscriptions have been provided within the EndNote file. 
1.1.6.  Data collection specific approach for emerging allergens (Objective 3) 
Objective 3 is interested in the prevalence of allergies (IgE and/or non-IgE mediated) to any emerging 
allergens. Emerging allergens have been defined as any allergen other than: milk/dairy, eggs, cereals, 
peanuts, nuts, celery, crustaceans, fish, molluscs, soy, lupin, mustard and sesame that has either 
increasing prevalence or was reported to have a significant prevalence in at least one country in 
Europe.  
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It was anticipated that articles which report the prevalence of food allergy to common allergens such 
as peanut and milk, do so in the context of a larger study which has screened participants for adverse 
reactions to a number of (or, in some cases, to any) foods. Hence, for such studies data has often been 
presented for allergens other than those listed in Objective 1. Additional studies may also have been 
identified which have examined the prevalence of less common allergens that have the potential to be 
defined as „emerging‟. Data from such studies have been included. All studies have been screened on 
the criteria outlined in Section 1.1.3. and data has been collected in accordance with section 1.1.4. 
Prevalence data has been extracted for all foods reported in a report of a study, in order to identify 
those allergens which may be considered „emerging‟. 
1.1.7. Data collection specific approach for allergy to any food  
In addition to the key objectives, data has also been collected and reported related to the prevalence of 
allergies to any food. This data was collected only from, and in the same manner as, the studies 
included within the systematic reviews conducted for objectives 1-3.  
1.1.8. Assessing the quality of included studies 
Studies were assessed as being at low or high risk of bias on the basis of three quality criteria (Table 
1.3). The first related to the risk of bias of the diagnostic method employed by the study. In studies 
utilising more than one method of diagnosis, the risk of bias of the highest quality method was judged. 
The second criterion related to the method of sampling, in particular, whether the sample utilised the 
whole population (for example, all consecutive births), a random sample or a non-random sample. 
The third criterion related to whether the study had explored the reasons for non-response (in cross-
sectional studies) or withdrawal/loss o follow-up (in cohort studies). 




Diagnostic method Sampling strategy: method Reasons for non-response or 
withdrawal/loss to follow-up 
Low risk of bias  Food challenges (open 
or double-blind) with or 
without clinical history 
 Sensitisation (skin prick 
test and/or serum-
specific IgE) with 
clinical history 
 Whole population 
 Random 
Yes 
High risk of 
bias 
 Sensitisation (skin prick 
test and/or serum 
specific IgE) without 
clinical history 
 Clinical history alone 
 Clinician diagnosed 
 Self-report 
 Non-random No 
1.1.9. Data synthesis and presentation 
1.1.9.1. General approach 
Our general approach to the synthesis of data was as follows. For all objectives a narrative approach 
was taken, presenting data in tables reporting the mean and, where possible, the confidence intervals. 
Confidence intervals were calculated for proportions using Wilson‟s correction for continuity. Where 
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raw data was not presented in the article, confidence intervals have been presented as per the article or 
marked „unknown‟ if not reported. 
Europe has been defined geographically rather than by membership of the European Union. Key 
characteristics of the included studies have been presented (Table 1.4) , including (but not limited to) 
information about study design (e.g. cohort study), country studied, allergens assessed and the method 
of diagnosis. Information has also been presented regarding the quality of the evidence (Table 1.6).  
1.1.9.2. Objectives 1 and 3 
As described in the technical offer, in addition to the approach described above, for Objective 1 and 3, 
for each allergen we have presented a table which maps the data (percentage prevalence and 95% 
confidence intervals, where possible) according to country and then by age (this has been grouped 
however is meaningful dependent upon the approach taken by the included studies). The prevalence 
data has been presented by method of diagnosis, and information has also been included on the year, 
country and age group for which data is being presented, and on whether the study assessed IgE-
mediated allergy, non-IgE-mediated allergy or both (it is important to note that this was assessed 
across the whole study rather than by individual food; where a study provides only self-report data 
and has not distinguished between symptoms typical of either IgE and non-IgE mediated reactions 
this has been classified as examining both IgE and non-IgE mediated allergies although it has been 
noted that the presence or absence of IgE was not tested for). Data has additionally been narratively 
reported for the prevalence of allergy to any food both across Europe and for countries outside of 
Europe. 
1.1.9.3. Objective 2 
In addition to the general approach, for each listed allergen (milk/dairy, eggs, cereals, peanuts, nuts, 
celery, crustaceans, fish, molluscs, soy, lupin, mustard and sesame) we have provided a narrative 
summary of changes in prevalence over time. We have discussed this by country and age group. 
1.2. Results 
1.2.1. Results of the search 
After removal of duplicates 7323 references were identified with a further ten papers identified 
through the expert panel thereby totalling 7333. Of these 7145 were excluded based on the title and 
abstract. The full-text was obtained for 187 references (the full text could not be obtained for Wang 
1990). After full text screening a further 99 studies were excluded.  The flow chart and the reasons for 
exclusion are outlined in Figure 1.1. One of the most common reasons for exclusion was that the 
article reported data that was reproduced in another included paper, for example a conference abstract 
subsequently presented in a full journal article or a report of a subset of a population that was reported 
in full in another paper. Another reason for exclusion was that the study utilised an unsuitable design 
such as case-control or a case series within a clinic setting as the samples would not be representative 
of the general population.  The excluded studies are presented in Table 1.33. After screening the full 
text 89 studies were included in the final systematic review (Figure 1.1). 
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Figure 1.1.:  Flowchart of search results and screening for all studies. 
 
1.2.2. Included studies 
We included 92 articles, 52 of which were conducted within Europe. Of these, five were based in 
Denmark, one in Estonia, three in Finland, three in France, three in Germany, two in Greece, one in 
Hungary, one in Iceland and Sweden combined, two in Italy, one in the Netherlands, two in Norway, 
one in Portugal, one in Spain, four in Sweden, six in Turkey, thirteen in the United Kingdom, and 
lastly one in Estonia (Table 1.4). 
Of the 40 studies conducted outside of Europe, one was conducted in West Africa (Ghana), ten in 
Eastern Asia (China, Korea, Hong Kong, Japan, and Taiwan), one in South-Central Asia (India), four 
in South-East Asia (Philippines, Singapore, Thailand), two in the Middle East (Israel, United Arab 
Emirates), 18 in North America (Canada, USA), one in North-West South America (Colombia) and 
three in Australia. The key characteristics of these studies are shown for each country in alphabetical 
order (Table 1.4)   
Screened on title and abstract = 
7333
*Note that studies only needed to meet one of these criteria to be excluded and 
were not considered against any subsequent criteria. Criteria are presented in the 
order in which they were considered.
Results from database searches = 
9807
Main reason
Study design = 21
Topic = 18
Unidentifiable time point = 4
Unidentifiable age group = 0
Unidentifiable location = 0
Inappropriate sample = 18
Unidentifiable allergen = 1
Inappropriate method of diagnosis 
= 1
Data not presented by individual 
allergen = 13
Linked records (i.e. data presented 
more fully in an alternative paper) 
= 22
Cannot obtain study record = 1
Duplicates removed = 2484
Excluded = 7145
Potentially eligible = 188
Excluded = 99Screened on full-text = 188
Included = 89
Additional papers identified (e.g. 
from contact with expert panel) = 
10 
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The majority of studies (66) employed a cross-sectional design and 25 used a cohort design. Further 
information about the included studies are presented in a series of tables.The method of identifying 
food allergy is outlined in Table 1.4 and additional tables provide further information about the 
method utilised for questionnaire or interview based approaches (Table 1.7), sensitisation testing 
(Table 1.8), and food challenge (Table 1.9).  Some studies presented the findings for more than one 
method of identification enabling comparison of methods as exemplified by Schafer 2001 in 
Germany, Mustafayev 2010 in Turkey, Venter 2006 and Nicolaou 2010 in the UK and Woods 2002 in 
Australia.  Many studies reported using a combination of methods within an algorithm; almost 
without exception this two or three step process was applied to food challenges where only those who 
either self-reported food allergy in a questionnaire or who had a positive clinical history were 
challenged.  
Questionnaire or interview methods for assessing suspected food allergy were presented in 57 studies. 
The sensitivity and specificity of these questionnaire-based methods was not available for some of the 
studies (for example, Murrugo 2008 used a ten item questionnaire with no reference to validation) 
whereas some studies used tools that had undergone some pretesting (such as Ben Shoshan 2010, 
Sicherer 1999, 2002 and 2010 and others such as Martinez-Gimeno 2000 who used tools that had 
undergone rigorous validation ref http://isaac.auckland.ac.nz/, Table 1.7). Although we provide data 
under the headings self-reported, clinician diagnosed and clinical history it should be noted that there 
is overlap between these identification methods as some self-report questionnaires include questions 
on „do you have doctor diagnosed allergies‟ and some of the „clinical histories‟ were collected using a 
structured format questionnaire. 
The IgE sensitisation of the entire study population was assessed using skin prick test for 19 studies 
and serum specific IgE in eight.  In total 25 studies used either or both methods.  Rates of sensitisation 
were consistently higher than rates of prevalence of food allergy. For example,  Woods (2002) tested 
sensitisation to milk using a skin prick test and found sensitisation of 0.7% (95% CI: 0.2-2.1),  but 
when this was combined with clinical history the rate was 0.0% (95% CI: 0.0-1.0); when testing for 
peanut sensitisation using SPT, Grundy 2002 reported a rate of 3.3% (95% CI: 2.4-4.5), but this fell to 
0.7% (95% CI: 0.3-1.3) upon food challenge. Although sensitisation to food allergens has poor 
specificity for food allergy this measure does allow for comparisons between countries and over time.  
 
Twenty-seven studies reported data on the prevalence of food allergy as determined by combining 
sensitisation data from the whole study population with self-reports of allergy, for example Tariq 
1996, Orhan 2009 and Ostblom 2008a. In contrast, oral food challenges were usually carried out on a 
subset of the study population who reported allergy to a particular food or foods (via a questionnaire 
or clinical interview) and/or were sensitised to a specific food allergen (determined by SPT or SIgE). 
It is important to note, however, that in the majority of studies utilising food challenges, a subset of 
participants (typically individuals with a convincing clinical history of severe reactions, and clear 
elevated specific IgE and or skin prick test) were not challenged since it is unethical to do so. This 
aligns with the management of patients in practice, and these individuals were typically considered to 
be allergic and, for prevalence calculations, had been counted alongside those who experienced a 
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Table 1.4:  Key characteristics of included studies 
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• Positive skin 
prick test with 
clinical history 



















Finland 7, 27, 47 
and 67 
year olds 
Main list:  
Cereals (Wheat), Eggs, 
Fish (cod), Milk,  
 





















IgE-  only 
 




























IgE-  only 
 























Cereals (wheat), Eggs, 
Fish, Milk/dairy, Tree nuts 
Additional food(s) 
Apple, Chocolate, Citrus, 
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Sample characteristics  
Age  Mean 
(SD) 





















• Positive skin 
prick test with 
clinical history 

















Eggs, Milk/dairy, Peanuts 































Eggs, Milk/dairy (milk and 
milk products) 
Additional food(s): 
Additives and colourings, 
Artificial colourings and e-
























Eggs, Milk/dairy, Soy 
Tree nuts, Peanuts 
Additional food(s): 
Fruit and/or Vegetables 





















Cereals (Wheat), Eggs, 
Fish, Milk/dairy, Peanuts, 
Soy 
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Sample characteristics  
Age  Mean 
(SD) 




















Eggs, Fish, Milk/dairy, 
Peanuts, Soy, Tree nuts 
Additional food(s): 
Apple, Banana, Carrot,  
Cherry, Chicken, 
Chocolate, Lemon, Orange, 
Pea, Plum, Tomato 
IgE-  only 
 
• Self report 
• Positive skin 

































IgE-  only 
 
































IgE-  only 
 














months (±  
2.5) 
 





















Eggs, Milk/dairy, Peanuts 
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Sample characteristics  
Age  Mean 
(SD) 




d visits at 
6-12 
months, 























• Positive skin 





























Molluscs, (squid, mollusc 
not specified) 
Additional food(s) 
Ant eggs, Beef, Chocolate, 
Coconut, Insect 
1.2.3. IgE-  only 
 
• Self-report 




























Crustaceans, Eggs, Fish, 
Milk/dairy, Peanuts, Tree 
nuts 
Additional food(s): 
Beef, Chocolate, Citrus 
Fruit and/or Vegetables, 
Both IgE 
and non-
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Sample characteristics  
Age  Mean 
(SD) 
Age (Range) Sample 
size 
 

















Crustaceans (shrimp), Eggs 
(egg white), Milk/dairy, 
Peanuts 

































Additives and colourings, 
Alcohol, Fruit and/or 
vegetables, Meat, Seafood 
Both IgE 
and non-

























































IgE only   
 
• Self-report 
• Positive skin 
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Sample characteristics  
Age  Mean 
(SD) 

















IgE-  only 
 



































Eggs, Fish, Milk/dairy 
Cow's milk,  Peanuts,  
Tree nuts (pistachio, 
walnut, hazelnut) 
IgE-  only 
 
• Self-report 



























IgE-  only 
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Sample characteristics  
Age  Mean 
(SD) 




















Eggs, Fish, Milk/dairy 
Peanuts, Soy 
Additional food(s): 
Apple, Avocado, Banana, 
Beans, Carrot, Cassava, 
Coconut, Cocoyam, Corn, 
Kontomire, Mango, Melon, 
Millet, Okro, Orange, Palm 
nut, Pawpaw, Pineapple, 
Potato, Nutmeg, Rice, 



































Eggs, Fish, Milk/dairy 
(cow‟s milk), Peanuts, Soy 
Additional food(s): 
Apple, Banana, Beef, 
Buckwheat, Chicken, 




























Eggs, Fish, Milk/dairy, 
Peanuts, Tree nuts 
(hazelnut, walnut) 
Additional food(s): 
Banana, Beef, Black 
Pepper, Chickpea, Cocoa, 
 IgE only 
 
• Self-report 
• Positive skin 
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Sample characteristics  
Age  Mean 
(SD) 
Age (Range) Sample 
size 
 





















































Cereals (wheat), Eggs 
(egg white), Fish (cod),  
Milk/dairy, Peanuts, Soy 
Additional food(s): 
Banana, Chocolate, Citrus, 
Pea, Stone fruit 
Both IgE 
and non-




































Fish, Milk/dairy, Peanuts, 
Soy, Tree nuts 
Both IgE 
and non-


































Cereals (wheat),  
Crustaceans (shrimp), 
Eggs, Fish (codfish),  
Milk/dairy, Peanuts, Soy 
Additional food(s): 
Additives and colourings 
Fruit and/or V  egetables 
Both IgE 
and non-
IgE   
 
















Group 1: 3 
years, 
Group 2: 
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Sample characteristics  
Age  Mean 
(SD) 


























Eggs, Fish (cod) 
Milk/dairy, Molluscs, 
(octopus), Peanuts, Soy 
Additional food(s): 
Additives and colourings 
Both IgE 
and non-






































Crustaceans (shellfish),  
Eggs, Fish, Milk/dairy, 
Peanuts, Tree nuts 
Additional food(s): 
Additives and colourings 
Both IgE 
and non-
IgE   
 
• Self-report 



























Cereals (wheat, barley, rye, 
oat, maize, rice, 
millet/buckwheat) Eggs, 
Fish, Milk/dairy, Peanuts, 
Tree nuts 
Additional food(s): 
Chocolate, Citrus,  
Fruit and/or vegetables, 
Apple, Pear, Cherry, 
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Sample characteristics  
Age  Mean 
(SD) 


















Eggs, Fish, Milk/dairy, 






























Eggs (egg white), Fish 
Milk/dairy, Peanuts,  
Tree nuts (hazelnut) 
IgE-  only 
 




































Eggs, Fish (cod), 
Milk/dairy, Peanuts, 
Sesame, Soy, Tree nuts 
(cashew, almond, walnut, 
hazelnut, brazil nut, pecan) 
IgE-  only 
 












































IgE   
 







(±  0.89) 
Group 2: 
8.71 years 
(±  1.41) 
 
9-13 years 196 
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Sample characteristics  
Age  Mean 
(SD) 

















IgE   
• Self-report 
















Eggs, Fish, Milk/dairy, 
Molluscs, Soy 
Additional food(s): 
Beef, Chicken, Corn, 
Mushroom, Pork, Rice, 
Seafood, Tomato 
IgG  Other 46.57± 7.91 
years 











































- 6 years 
 
Main list: 
Crustaceans (shrimp),  
Eggs (egg yolk and egg 
white), Fish, Milk/dairy, 

































IgE   
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Sample characteristics  
Age  Mean 
(SD) 























Celery, Cereals (flour), 
Crustaceans (crab), 
Eggs, Fish, Milk/dairy 
Peanuts, Soy, Tree nuts 
Additional food(s): 
Additives and colourings, 
Citrus, Fruit and/or 
vegetables, Meat, Pork, 
Seafood, Spices, Herbs  




IgE   
 
• Self-report 






female had a 
median age 




















IgE   
• Self-report 





















































Peanuts, Tree nuts 
 



























Peanuts, Tree nuts 





























Not reported All ages 
 
4336  
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Sample characteristics  
Age  Mean 
(SD) 




















Peanuts, Sesame, Tree nuts 
 




























Cereals (wheat), Eggs, 
Fish, Milk/dairy, Peanuts, 
Sesame, Soy, Tree nuts 
Additional food(s): 































Peanuts, Tree nuts 
Peanut, Hazelnut, Cashew 
 
IgE only   
 
• Self report 
• Positive skin 
prick test with 
clinical history 






















Celery, Cereals (wheat) 
Crustaceans, Eggs, Fish 
Milk/dairy, Molluscs 
(oyster), Mustard, Peanuts, 
Sesame,  















University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506               46 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food 
Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the 
rights of the authors. 















Sample characteristics  
Age  Mean 
(SD) 
Age (Range) Sample 
size 
 
Apple, Banana, Carrot, 
Cherry, Chocolate, Fruits, 
Garlic, Kiwi, Melon, 

























IgE   
 
• Self-report 































Cereals (wheat, corn), 
Eggs, Fish, Milk/dairy, 
Peanuts, Sesame 
Additional food(s): 





IgE   
 
• Positive skin 

























Crustaceans, Eggs, Fish, 
Milk/dairy, Peanuts, Soy, 
Tree nuts 
Additional food(s): 
Additives and colourings, 
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Sample characteristics  
Age  Mean 
(SD) 




















(goat, cheese, casein) 
Molluscs (clam, squid, 
oyster. scallop, abalone, 
pacific squid, octopus), 
Tree nuts, Pistachio 
Additional food(s): 
Cacao, Fruits, Litchi, 
Garlic, Grape, Melon, 
Onion 



























Cereals (wheat products, 
bread/plain cereal), Eggs, 
Milk/dairy (milk, cheese, 
yoghurt, ice cream), 
Peanuts (Including peanut 
butter and coconut) 
Additional food(s): 
Additives and colourings, 
Alcohol, Chocolate, 
Fats/Oils, Fruits Dried, 
High fat foods, Meat and 
Poultry, Processed meats, 
Restaurant/takeaway 
meals, Sauces, Seafood, 
Spices, 
Herbs, Condiments, Sugar, 
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Sample characteristics  
Age  Mean 
(SD) 


































• Positive skin 
prick test with 
clinical history 























Crustaceans (shrimp, crab), 
Eggs, Fish, Milk/dairy, 














































Cereals, Crustaceans, Eggs, 
Fish, Milk/dairy, Soy  
Additional food(s): 
Additives and colourings, 
Alcohol, Caffeine, Cheese, 
Chocolate, Citrus, Fruit 





























7-13 years Main list: 
Cereals, Wheat, Eggs 
Additional food(s): 
Chocolate, Fruits, shellfish 
Both IgE 
and non-
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Sample characteristics  
Age  Mean 
(SD) 


















Celery, Cereals (barley, 
wheat, rye, flour, oat 
meal), Crustaceans 
(crab), Eggs (hen), Fish 
(herring, mackerel), 
Milk/dairy (cow‟s milk), 
Molluscs (mussels), 
Peanuts, Sesame, Soy, Tree 
nuts (hazelnut, walnut) 
Additional food(s): 
Apple, Apricot, Carob 
Carrot, Cherry, Grape, 
Guar gum, Nectarine,  
Peach, Pear, Plum, 




IgE   
 
• Positive skin 
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Table 1.5:   Study designs of included studies 
Study ID Study design Cross-sectional: utilising 
existing survey 
Cohort: reported 





Target age group or age at 
recruitment and follow up 
Al-Hammadi (2010) Cross-sectional 
study 
No N/A N/A 6-9 years 
Altintas (1995) Cross-sectional 
study 
No N/A N/A Newborn 
Arbes (2005) Cross-sectional 
study 
No N/A N/A All ages 




Babu (2008) Cross-sectional 
study 
No N/A N/A 5-60 years 





N/A N/A Elderly people mean age of 
77 years 
Ben-Shoshan (2009) Cross-sectional 
study 
No N/A N/A 5-9 years 
Ben-Shoshan (2010) Cross-sectional 
study 
 
No N/A N/A All ages 
Bjornsson (1996) Cross-sectional 
study 
 
Yes - European 
Community Respiratory 
Health Survey 1991-1992 
N/A N/A 20-44 years 
 
Bock (1987) Cohort study N/A Multiple time points Fort Collins 
Youth Centre 
Birth- 3years 
Branum (2009) Cross-sectional 
study 
Yes - NHANES 2005-2006 N/A N/A < 18 years 
Brugman (1998) Cross-sectional   study No N/A N/A 2, 4 and 7 or 8 primary school 
and 2
nd
 yr of secondary school 
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Study ID Study design Cross-sectional: utilising 
existing survey 
Cohort: reported 





Target age group or age at 
recruitment and follow up 
Chen (2011) Cross-sectional 
study 
No N/A N/A <12 months 
Chen (2012) Cross-sectional 
study 
No N/A N/A 0-2years 
Connett (2012) Cross-sectional 
study 
No N/A N/A 14-16 years 
Dalal (2002) Cross-sectional 
study 
No N/A N/A 0-2years 
Eggesbo (1999) Cohort study 
 








Birth, 12,18,24 months 
Eller (2009) Cohort study 
 




Birth, 3, 6, 9, 12, 18, 36, 72 
months 
Emmett (1999) Cross-sectional 
study 
No N/A N/A ≥15 years 
Falcao (2004) Cross-sectional 
study 
No  N/A N/A >39 years 
 
Frongia (2005) Cross-sectional study Yes - linked to ICONA 2003 N/A N/A 12-24 months 
Gelincik (2008) Cross-sectional 
study 
No N/A N/A ≥18 years 
Gerrard (1973) Cross-sectional 
study 
No N/A N/A 6-36 months 
Greenhawt (2009) Cross-sectional 
study 
No N/A N/A 18> years 
Grundy (2002) Cohort study 
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Study ID Study design Cross-sectional: utilising 
existing survey 
Cohort: reported 





Target age group or age at 
recruitment and follow up 
Gupta (2011) Cross-sectional 
study 
No N/A N/A <18 years 
Haahtela (1980) Cross-sectional 
study 
No N/A N/A 15-17 years 





Hourihane (2007) Cross-sectional 
study 
No N/A N/A 3-6 years 
Hu (2010) Cross-sectional 
study 
Yes - repeated 1999 
methodology in 2009 
N/A N/A 0-24 months 
 
Julge (2001) Cohort study 
 






6 months, 1, 2 and 5 years 
 
Kagan (2003) Cross-sectional 
study 
No N/A N/A 5-9 years 




N/A N/A 1,2,3 and 6 years 
 







Keet (2012) Cross-sectional 
study 
Yes - NHANES 2005-2006 N/A N/A 1-21 years 
Kilgallen (1996) Cross-sectional 
study 
No N/A N/A 0-48 months 
Kim (2011) Cohort study 
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Study ID Study design Cross-sectional: utilising 
existing survey 
Cohort: reported 





Target age group or age at 
recruitment and follow up 
Centre 
2006-2007 
Krause (2002) Cross-sectional 
study 
No N/A N/A 7-15 years 

















No N/A N/A 8-18months 
Kumar (2011) Cohort study 
 
N/A Single time point Boston birth 
Cohort 
2 years 








N/A N/A 3-7 years 




N/A N/A 2-7 years 
 
Liu (2010) Cross-sectional 
study 
Yes - NHANES 2005-2006 N/A N/A All ages 
 











Yes - Extension of the 
International Study of 
Asthma and Allergy in 
Children (ISAAC) 
N/A N/A 6-13 years 
 




N/A N/A Adults 
 
Mortz (2005) Cohort study N/A Single time point TOACS 14 years 
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Study ID Study design Cross-sectional: utilising 
existing survey 
Cohort: reported 





Target age group or age at 
recruitment and follow up 
  1995-1996 
 
 




N/A N/A 10-11 years 
 
Nicolaou (2010) Cohort study 
 












N/A N/A 5-16 years 
 
Oh (2004) Cross-sectional 
study 
 
No N/A N/A 2 age groups, 6-12 year olds 
and 12-15 year olds 




N/A N/A 6-9 years 
 
Osborne (2011) Cohort study 
 




Ostblom (2008a) Cohort study 
 





Ostblom (2008b) Cohort study 
 




1, 2, 4 and 8 years (same 
cohort) 
Osterballe (2005) Cohort study 
 





Group 1: 3 years, Group 2: 
<3 years, Group 3: Children 
> 3 years, Group 4: Adults 
Osterballe (2009) Cohort study 
 




Pereira (2005) Cohort study 
2 birth cohorts used: 
1991-1992 and 
1987-1988 
N/A Single time point 
 
Isle of Wight 
2002-2003 
Birth cohort 1991-1992 – 
11years 
Birth cohort 1987-1988 - 15 
years 
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Study ID Study design Cross-sectional: utilising 
existing survey 
Cohort: reported 





Target age group or age at 
recruitment and follow up 




N/A N/A 1-4 years 
 




N/A N/A 2-14 years 
 
Ro (2012) Cohort study 
 





Roberts (2005) Cohort study 
 








N/A N/A 9-13 years 
 





Sai (2011) Cross-sectional study 
 
No N/A N/A Not reported 




N/A N/A Not reported 




N/A N/A 3 months- 6 years 
 





N/A N/A 5-7 years 
 
Schafer (2001) Cross-sectional 
study 
No N/A N/A 25-74 years 
 





Shek (2010) Cross-sectional No N/A N/A 4-6 years, 14-16 years 
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Study ID Study design Cross-sectional: utilising 
existing survey 
Cohort: reported 





Target age group or age at 








N/A N/A All ages 
 





N/A N/A All ages 
 





N/A N/A All ages 





N/A N/A All ages 
 





N/A N/A All ages 
 




N/A N/A 4 years 
 




N/A N/A 5-17 years 
 
Venter (2006) Cohort study 
 
N/A Single time point Isle of 
Wight 
1997-1998 
6 year olds 
 
Venter (2008) Cohort study 
 










N/A N/A ≥18 years 
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Study ID Study design Cross-sectional: utilising 
existing survey 
Cohort: reported 





Target age group or age at 
recruitment and follow up 






N/A N/A 6-8 years 
 
Woods (1998) Cross-sectional 
study 
No N/A N/A 20-44 years 
Woods (2002) Cohort study 
 
N/A Multiple time 
points 
ECRHS Not reported 
 




N/A N/A All ages 
 
Young (1994) Cross-sectional 
study 
No N/A N/A Not reported 
 




N/A N/A 7-13 years 




N/A N/A All 
 
 
                                                     
5
 Although suggests  a cohort study it appears to be a cross sectional study in which there were stages of detection, i.e, questionnaire which led to further testing 
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1.2.4. Quality of included studies 
Table 1.6. presents the quality assessment for all included studies.  
Table 1.6:   Quality assessment of all studies 
Study ID (1) Method of diagnosis (2) Sampling strategy: 
method 






High risk of bias Low risk of bias Unclear 
Altintas (1995) High risk of bias Low risk of bias Unclear 
Arbes (2005) High risk of bias Unclear Low risk of bias 
Arshad (2001) High risk of bias Low risk of bias Low risk of bias 
Babu (2008) Low risk of bias Low risk of bias Unclear 
Bakos (2006) High risk of bias High risk of bias Low risk of bias 
Ben-Shoshan 
(2009) 
Low risk of bias Low risk of bias Unclear 
Ben-Shoshan 
(2010) 
High risk of bias Low risk of bias Unclear 
Bjornsson (1996) High risk of bias Low risk of bias Unclear 
Bock (1987) Low risk of bias Low risk of bias High risk of bias 
Branum (2009) High risk of bias Low risk of bias Unclear 
Brugman (1998) High risk of bias Unclear Unclear 
Chen (2011) Low risk of bias Low risk of bias Unclear 
Chen (2012) Low risk of bias Low risk of bias Unclear 
Connett (2012) High risk of bias Low risk of bias Unclear 
Dalal (2002) Low risk of bias Unclear Unclear 
Eggesbo (1999) High risk of bias Low risk of bias Unclear 
Eller (2009) Low risk of bias Low risk of bias High risk of bias 
Emmett (1999) High risk of bias Unclear Unclear 
Falcao (2004) High risk of bias Low risk of bias Unclear 
Frongia (2005) High risk of bias Low risk of bias Low risk of bias 
Gelincik (2008) Low risk of bias Low risk of bias Unclear 
Gerrard (1973) High risk of bias High risk of bias Low risk of bias 
Greenhawt (2009) High risk of bias Low risk of bias Unclear 
Grundy (2002) Low risk of bias Low risk of bias Unclear 
Gupta (2011) High risk of bias Low risk of bias Unclear 
Haahtela (1980) High risk of bias Low risk of bias Low risk of bias 
Host (2002) Low risk of bias Low risk of bais Unclear 
Hourihane (2007) Low risk of bias Low risk of bias Unclear 
Hu (2010) Low risk of bias Low risk of bias Unclear 
Julge (2001) High risk of bias Low risk of bias Low risk of bias 
Kagan (2003) Low risk of bias Low risk of bias High risk of bias 
Kajosaari (1982) Low risk of bias Low risk of bias Unclear 
Katz (2010) Low risk of bias Low risk of bias High risk of bias 
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Study ID (1) Method of diagnosis (2) Sampling strategy: 
method 




Keet (2012) High risk of bias Low risk of bias Unclear 
Kilgallen (1996) High risk of bias Unclear Unclear 
Kim (2011) High risk of bias Unclear Unclear 
Krause (2002) Low risk of bias Low risk of bias Unclear 
Kristjansson 
(1999) 
Low risk of bias High risk of bias Unclear 
Kucukosmanoglu 
(2008a) 
High risk of bias Unclear Unclear 
Kucukosmanoglu 
(2008b) 
Low risk of bias High risk of bias Unclear 
Kumar (2011) High risk of bias High risk of bias Unclear 
Lack (2003) Low risk of bias Low risk of bias Unclear 
Lao-araya (2012) Low risk of bias Low risk of bias Unclear 
Leung (2009) High risk of bias Low risk of bias Unclear 
Liu (2010) High risk of bias Low risk of bias Unclear 
Marrugo (2008) High risk of bias Low risk of bias Unclear 
Martinez-Gimeno 
(2000) 
High risk of bias Low risk of bias Unclear 
Morita (2012) Low risk of bias High risk of bias Unclear 
Mortz (2005) Low risk of bias Unclear Unclear 
Mustafayev 
(2012) 
Low risk of bias Unclear Unclear 
Nicolaou (2010) Low risk of bias Low risk of bias Unclear 
Obeng (2011) High risk of bias Unclear Unclear 
Oh (2004) High risk of bias Low risk of bias Unclear 
Orhan (2009) Low risk of bias Low risk of bias Unclear 
Osborne (2011) High risk of bias High risk of bias Unclear 
Ostblom (2008a) Low risk of bias Unclear Unclear 
Ostblom (2008b) High risk of bias Unclear Unclear 
Osterballe (2005) Low risk of bias Low risk of bias Unclear 
Osterballe (2009) High risk of bias Low risk of bias Unclear 
Pereira (2005) High risk of bias Low risk of bias Low risk of bias 
Pyrhonen (2009) High risk of bias Low risk of bias Unclear 
Rance (2005) High risk of bias Low risk of bias Unclear 
Ro (2012) High risk of bias Unclear Unclear 
Roberts (2005) High risk of bias Low risk of bias Unclear 
Ronchetti (2008) High risk of bias Low risk of bias Unclear 
Saarinen (1999)  High risk of bias High risk of bias 
Sai (2011) Low risk of bias Low risk of bias Unclear 
Sakellariou 
(2008) 
High risk of bias Unclear Unclear 
Santadusit (2005) High risk of bias Low risk of bias Unclear 
Schafer (1999) High risk of bias High risk of bias Unclear 
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Study ID (1) Method of diagnosis (2) Sampling strategy: 
method 




Schafer (2001) High risk of bias Low risk of bias Unclear 
Schrander (1993) Low risk of bias Low risk of bias Low risk of bias 
Shek (2010) High risk of bias Low risk of bias Unclear 
Sicherer (1999) High risk of bias Low risk of bias Low risk of bias 
Sicherer (2003) High risk of bias Low risk of bias Low risk of bias 
Sicherer (2004) High risk of bias Low risk of bias Low risk of bias 
Sicherer (2010) High risk of bias Low risk of bias Unclear 
Soller (2012) High risk of bias Low risk of bias High risk of bias 
Tariq (1996) Low risk of bias Low risk of bias Low risk of bias 
Touraine (2002) High risk of bias High risk of bias Unclear 
Venter (2006) Low risk of bias Low risk of bias Low risk of bias 
Venter (2008) Low risk of bias Low risk of bias Unclear 
Vierk (2007) High risk of bias Low risk of bias Low risk of bias 
Wan (2012) Low risk of bias Unclear Unclear 
Woods (1998) High risk of bias Low risk of bias Unclear 
Woods (2002) Low risk of bias High risk of bias Unclear 
Wu (2012) High risk of bias Low risk of bias Unclear 
Young (1994) High risk of bias Low risk of bias High risk of bias 
Zannikos (2008) High risk of bias Unclear Unclear 
Zuberbier (2004) Low risk of bias Low risk of bias Unclear 
(1) Low risk of bias = food challenges (open or double-blind) with or without clinical history or sensitisation (skin prick test 
and/or serum-specific IgE) with clinical history; High risk of bias = Sensitisation (skin prick test and/or serum specific 
IgE) without clinical history, clinical history alone, clinician diagnosed or self-report.  
(2) Low risk of bias = whole population, random; High risk of bias = non-random. 
(3) Low risk of bias = reasons for non-response or withdrawal/loss to follow-up explored; High risk of bias = reasons for 
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1.2.5. Further information about diagnostic procedures employed by all studies 
Table 1.7:   Further information about questionnaire-based methods employed by studies 
Study ID Self-report Clinician diagnosed Clinical history 
Al- Hammadi (2010) Not applicable Questions regarding allergic disease and atopic 
family history were asked through a 
questionnaire for parents to complete. A child 
was considered to have food allergy or other 
allergic illness only if it was diagnosed by a 
physician. 
Not applicable 
Altintas (1995) Not applicable The diagnosis of cow‟s milk allergy was based 
on a) the presence of symptoms in response to a 
diet containing cow‟s milk, b) the disappearance 
of symptoms upon withdrawal of cow‟s milk, 
and c) at least two positive milk challenges. 
Not applicable 
Babu (2008) A detailed case history was taken based on a 
structured questionnaire containing information 
regarding demographics, age at onset of disease 
and the present allergic status. In addition type 
of complaints, allergy to other foods and/or 
pollens and insects, and duration of onset of 
allergic symptoms after ingestion of the 
offending food were taken. 
Not applicable Not applicable 
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Study ID Self-report Clinician diagnosed Clinical history 
Ben-Shoshan (2010) A  standardised questionnaire developed 
previously by Sicherer et al (1999; 2004) to 
determine the general population prevalence of 
peanut, tree nut, fish, and shellfish allergy in the 
United States, and modified it to incorporate 
questions regarding sesame allergy 
Confirmed allergy only if one of the following 
was fulfilled: a) Convincing history of an IgE-
mediated reaction attributed to food and 
physician confirmation of a positive SPT, serum 
food-specific IgE >0.35 kU/L or a positive food 
challenge. b) Never exposed to the food or had 
an uncertain history of an IgE-mediated reaction 
and physician confirmation of a positive SPT 
and a food-specific IgE above previously 
published thresholds (i.e., >15 kU/L for peanut 
and tree nut and >20 kU/L for fish) or a positive 
SPT and a positive food challenge or a positive 
food challenge alone 
A convincing history of an IgE-mediated 
reaction to a specific food was defined as a 
minimum of 2 mild signs/symptoms or 1 
moderate or 1 severe sign/symptom that was 
likely IgE-mediated and occurred within 120 
minutes after ingestion or contact (or inhalation 
in the case of fish and shellfish). Reactions were 
classified as mild, moderate or severe based on 
the same criteria outlined for Ben-Shoshan 
2010. 
Bock (1987) At each visit to the clinic, parents were asked to 
complete a dietary questionnaire that inquired 
about the infant‟s current diet and whether any 
adverse reactions to foods had been noted. The 
parents were also asked about any restrictions 
on the child‟s diet. 
Not applicable Not applicable 
Brugman (1998) A questionnaire on food hypersensitivity was 
mailed to parents. Once completed this was then 
checked by the school physician or nurse, where 
some aspects of the child‟s health were added 
based on school records of absence, medicinal 
use, medical treatment and overall health 
evaluation. 
Not applicable Not applicable 
Chen (2011) Not applicable Not applicable Information collected by questionnaire about 
medical history of adverse reactions to foods 
and risk factors, such as delivery, feeding 
pattern, family history of allergy, and other 
allergic co-morbidities 
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Study ID Self-report Clinician diagnosed Clinical history 
Dalal (2002) Not applicable Not applicable Information was obtained from patient medical 
records at the family health centre, and from the 
family health centre staff, including nurses and 
dieticians. 
Eggesbo (1999) The parents of infants were asked to complete a 
self-administrered questionnaire on the 
maternity ward. Further information was 
collected by postal questionnaire every 6 
months until the child reached the age of two. 
The operational definition of the outcome, 
parentally perceived reactions to food, was 
based on the question „does the child react to 
any food items?‟. Possible symptoms were 
listed for parents to mark of what symptoms the 
child had experienced. 
Not applicable Not applicable 
Emmett (1999) Identification of food allergies suffered within 
the household. 
Not applicable Questions on source of diagnosis, doctor 
consultation, number of reactions, age at first 
reaction, type of contact with peanuts causing 
the reactions, amount of peanuts taken, 
symptoms occurring, medication taken, and 
hospitalisation if necessary 
Falcoa (2004) Participants completed a large questionnaire as 
part of an on-going health and nutrition survey 
of residents of Porto. 
Not applicable Not applicable 
Frongia (2005) Not applicable An interview with the parents of the children 
was carried out with a healthcare professional, 
guided by a questionnaire. Food allergy was 
only included when it had been diagnosed by a 
doctor. 
Not applicable 
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Study ID Self-report Clinician diagnosed Clinical history 
Gelinick (2008) An initial screening questionnaire contained two 
questions relating to foods, those who disclosed 
food-related complaints were called once more 
and a similar questionnaire was repeated. Those 
suspected of having a food allergy were invited 
for a personal investigation at the clinic. 
Not applicable Not applicable 
Gerrard (1973) Not applicable Not applicable Case histories were obtained by a nurse and 
included the following data: the age, marital 
status and ethnic origin of the parents; the 
prevalence in parents and siblings of a history of 
eczema, hay fever, urticaria, recurrent 
bronchitis, allergies to food/drugs, enuresis and 
recurrent headaches; and the attitudes of parents 
and siblings to milk. Additional medical records 
and follow up examinations were taken at each 
age. 
Greenhawt (2009) Questions asked about the occurence of a 
specific allergic reaction, the symptoms and 
foods attrituable to the reaction, emergency 
medications maintained. 
Not applicable Not applicable 
Grundy (2002) Parents of children completed a questionnaire 
asking information about past and current atopic 
symptoms on the basis of the ISAAC 
questionnaire. 
Not applicable Not applicable 
Gupta (2011) Not applicable Not applicable A convincing food allergy based on self report 
in conjunction with one or more of the 
following reaction symptoms: anaphylaxis, 
angioedema, coughing, other oropharyngeal 
symptoms, eczema, flushing, hives, low blood 
pressure, pruritus, trouble breathing, vomiting, 
or wheezing. A confirmed food allergy also 
included report of physician-diagnosis with 
serum-specific immunoglobulin E testing, skin 
prick testing, or an oral food challenge 
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Study ID Self-report Clinician diagnosed Clinical history 
Host (2002) Not applicable Not applicable The diagnosis of  CMPA/CMPI was established 
by the following, generally accepted, criteria; 
definite disappearance of symptoms after each 
of two dietary eliminations of cow‟s milk and 
cow‟s milk products; recurrence of identical 
symptoms after one challenge; exclusion of 
lactose intolerance and coincidental infection 
Kajosaari (1982) Information was obtained from the mothers by 
questionnaire. The family history of atopy, the 
child‟s possible atopic symptoms and signs, 
duration of breast feeding, and the introduction 
age for fish, citrus and eggs were recorded. The 
history was confirmed and checked by 
telephone interviews whenever symptoms or 
signs of atopy were suspected. 
Not applicable Not applicable 
Katz (2010) Initial contact made by telephone interview in 
95.8% infants and by questionnaire for the 
remaining 4.2% 
Not applicable Sixty-six infants were given diagnoses of IgE-
cow‟s milk allergy, forty-eight fulfilled all 
criteria, including suggestive history of an 
immediate response, a positive SPT response, 
and a positive challenge result to cow‟s milk 
protein. Common symptoms of IgE-mediated 
cow‟s milk allergy were cutaneous reactions, 
including urticarias, angioedema and pruritus, 
followed by gastrointestinal and respiratory 
symptoms. 
Kilgallen (1996) An interview-assisted questionnaire was 
designed for use with parents. It contained four 
sections and covered the presence or absence of 
perceived food allergy, symptoms, foods 
implicated and infant feeding history. 
Not applicable Not applicable 
Kim (2011) Not applicable Food allergy was defined as a convincing 
history of reproducible symptoms within 2 
hours after ingestion of single food 
Not applicable 
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Study ID Self-report Clinician diagnosed Clinical history 
Kristjansson (1999) A questionnaire was designed based on a 
questionnaire developed by the Allergology 
section of the Swedish Paediatric Association. It 
included 17 questions relating to the duration of 
breast feeding, food habits, symptoms relating 
to adverse food reactions, other manifestations 
of allergy and family atopic history. 
Not applicable Not applicable 
Lack (2003) Not applicable Not applicable Children identified up to 38 months old having 
peanut allergy, based on responses to questions 
about food avoidance and reactions to particular 
foods. Affected children were also identified 
from responses to questions on the 
questionnaire regarding previous 
hospitalizations and clinical investigations 
Lao-araya (2012) Parents were asked about the child‟s 
demographics, number of siblings, feeding 
history during infancy and the child‟s and 
family history of atopic disease. 
Not applicable Not applicable 
Leung (2009) Parents were asked about the occurrence and 
frequency of any AFR (adverse food reaction) 
in their children. 'Current' symptoms referred to 
symptoms in the past 12 months, whereas 'AFR 
ever' was defined as suffering from AFR in the 
subjects' life time 
Not applicable Not applicable 
Marrugo (2008) Questions were asked about personal data and 
occupation and personal history of atopic 
disease. 
Not applicable Not applicable 
Martinez-Gimeno 
(2000) 
Extension of the International Study of Asthma 
and Allergy in Children (ISAAC study) 
questionnaire. 
Not applicable Not applicable 
Morita (2012) Participants were screened for wheat allergy by 
a questionnaire-based examination. 
Not applicable Not applicable 
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Study ID Self-report Clinician diagnosed Clinical history 
Mustafayev (2012) Any person answering yes to the question „did 
your child have any allergic complaint after any 
food intake within the last year‟ was contacted 
via telephone by a paediatrician trained in food 
allergy. 
Not applicable Not applicable 
Obeng (2011) The questionnaire included questions from the 
EuroPrevall study on the symptoms of adverse 
reactions to food (www.europrevall.org) 
Not applicable Not applicable 
Oh (2004) The Korean version of the ISAAC questionnaire 
was administered to the parents of the children 
and to the student themselves in middle schools. 
Not applicable Not applicable 
Orhan (2009) Questionnaire asking „Has your child ever had 
an adverse reaction to any food within two 
hours following consumption?‟. If the parent 
responded 'yes' then a further series of questions 
were asked to gain information about the 
reaction. 
Not applicable Not applicable 
Ostblom (2008a) Any of the following parentally reported 
symptoms related to ingestion of a certain food 
were defined as food allergy: asthma, itchy eyes 
and/or runny nose, oedema of lips/eyes, 
urticaria, eczema or vomiting/diarrhoea 
Not applicable Not applicable 
Ostblom (2008b) Parents asked to report on any reactions to foods 
experienced by their child 
Parental report of doctor diagnosed food allergy Not applicable 
Osterballe (2009) A questionnaire with the main question: 'do you 
suspect hypersensitivity to foods and/or drinks?' 
Not applicable Not applicable 
Pereira (2005) Questionnaires were completed by the parent 
and child and where a current adverse reaction 
to any food was stated, they were asked to 
describe the symptoms that they experienced. 
Not applicable Not applicable 
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Study ID Self-report Clinician diagnosed Clinical history 
Pyrhonen (2009) The baseline questionnaire asked structured 
questions about the child‟s background and food 
allergy or hypersensitivity. Parents were asked 
to indicate, per food, whether they never 
perceived symptoms, never tasted the foods, 
parents perceived allergy, physician diagnosed 
allergy, symptoms occurred in last 12 months 
and symptoms occurred more than 12 months 
ago. 
The definition of food allergy and food 
hypersensitivity was based on a diagnosis 
reached by a physician. 
Not applicable 
Rance (2005) A standard, anonymous questionnaire asked 
„Has your child ever had an allergic reaction to 
food?‟ If  „Yes‟ parents were asked  additional 
questions about clinical and treatment data and 
the results of allergy tests. 
Not applicable Not applicable 
Saarinen (1999) For the first 8 weeks mothers asked to record 
daily feeding regime and return the records. 
Also completed a questionnaire on parental 
atopy. 
Not applicable Not applicable 
Sakellariou (2208) A survey was conducted in the context of 
EUROPREVALL. 
Not applicable Not applicable 
Santadusit (2005) A 16-item food allergy questionnaire was 
answered by parents. Families reporting adverse 
food reactions were invited to participate in 
further diagnostic investigations. 
Not applicable Not applicable 
Schafer (2001) A computer-assisted standardised interview 
asked whether participants had allergic reactions 
to foods and if so the type of reaction was 
recorded in detail. The reported reactions were 
catergorised according to reaction site, 
furthermore history and doctor‟s diagnosis were 
recorded. 
Not applicable Not applicable 
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Study ID Self-report Clinician diagnosed Clinical history 
Schrander (1993 A standard form was used by the four health 
care doctors for entering data concerning family 
history, symptoms and dietary interventions. 
Not applicable Family history regarding atopic disease as well 
as possible food intolerance in first and second 
degree relatives was recorded. When present for 
more than two weeks the following complaints 
were considered suspect for the presence of 
cow‟s milk protein intolerance: Symptoms, 
gastrointestinal, respiratory and cutaneous 
manifestations. Symptoms crying/colic were 
considered when present for more than two 
hours per day. 
Shek (2010) Survey conducted using a structured 
questionnaire used in the US population 
(Sicherer et al. 2003). 
 
Not applicable Reactions considered convincing if organ 
systems were affected and symptoms were 
typical of allergic reactions (skin: hives and 
angioedema; respiratory system: trouble 
breathing, wheezing, and throat tightness; 
gastrointestinal system: vomiting and diarrhoea) 
occurring within 2 hours of ingestion. 
Sicherer (1999) Not applicable Not applicable Telephone script with computerized algorithms. 
Reactions considered “convincing” if organ 
systems were affected and symptoms typical of  
allergic reactions (skin system: hives and 
angioedema; respiratory system: trouble 
breathing, wheezing, throat tightness; 
gastrointestinal system: vomiting and diarrhoea) 
occurring within 1 hour of ingestion 
Sicherer (2004) Not applicable Not applicable Telephone script with computerized algorithms. 
Screening questions, to identify individuals, 
additional questions administered depending on 
responses and included those regarding, severe 
reactions, lifetime recurrence, seafood related 
medical history. Algorithms categorised people 
into no allergy, physician diagnosed (self 
reported), convincing allergy (levels 1-4) and 
probable allergy (levels 1-3). 
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Study ID Self-report Clinician diagnosed Clinical history 
Sicherer (2010) Not applicable Not applicable As reported for Sicherer et al. (1999) 
Soller (2012) A cross-sectional telephone interview asked if 
anyone in the household had a food allergy, and 
to which foods. 
Not applicable Not applicable 
Tariq (1996) Data was obtained on feeding, atopic disease, 
family history, parental smoking. Exposure to 
pets, housing conditions, and current illness 
from records. Questions about eating nuts were 
asked only at age 4 years. 
Not applicable Not applicable 
Touraine (2002) Questionnaire distributed to schools for parents 
to answer. The questionnaire asked „Does your 
child have a food allergy?‟. If answered yes, 
further information was gathered about the 
types of symptoms, and the presence of allergies 
to pollen, house dust mites and mould. Also 
asked about family atopic disease and any 
treatment received. 
Not applicable Not applicable 
Venter (2006) Parents completed a questionnaire, asking 'Does 
your child currently have a problem with any of 
the following foods? Milk, egg, peanut, tree 
nuts (e.g. almond, brazil), wheat, fish, sesame 
and other. If yes to any of the above foods, can 
you describe the problem‟ 
Not applicable Not applicable 
Woods (1998) Participants completed detailed second phase 
ECRHS questionnaire administered by a trained 
interviewer. The questionnaire covered 
respiratory symptoms during the last 12 months, 
history of asthma, home and work environment, 
allergic symptoms, smoking, demographics, 
medications and dietary information. 
Not applicable Not applicable 
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Study ID Self-report Clinician diagnosed Clinical history 
Woods (2002) Four questions relating to diet were asked in the 
ECRHS questionnaire. The first three gathered 
information on the amount of convenience-type 
food and drinks consumed, the fourth asked 
whether responders had ever suffered from any 
illness/trouble from food ingestion. 
Not applicable Not applicable 
Wu (2012) Not applicable Self-administered questionnaire. Six reviewed 
and analysed questionnaire descriptions of 
symptoms and records of physicians‟ 
evaluations to distinguish food allergy from 
non-immunologic adverse food reactions. Cases 
diagnosed by clinicians and confirmed by 
positive laboratory tests were enrolled as 
definite cases. If symptoms occurred within 
minutes diagnosis was presumed to be food 
allergy on the basis of type I immediate 
hypersensitivity reaction. Non-allergic food 
hypersensitivity was usually characterized by a 
delayed reaction, occurring hours or even days 
after eating certain food. Allergic reactions did 
not depend on the amount of ingested food, 
whereas food intolerance worsened as more 
food was consumed. 
Not applicable 
Young (1994) Questions were about perceived connection 
between food ingestion and allergic symptoms. 
Not applicable Not applicable 
Zannikos (2008) A survey was conducted in the context of 
EUROPREVALL. 
Not applicable Not applicable 
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Table 1.8:   Further information about skin-prick test and serum-specific IgE testing performed by studies 




Time to read 
response 







Arbes (2005) Wheal with mean 
diameter >3mm 






Only house dust mite, 








Arshad (2001) Wheal with mean 
diameter >3mm 







were used when 




Histamine (0.1%) in 
phosphate buffered 
saline and physiologic 















extracts, EE and EC, 
along with controls 
(positive: histamine 
dihydrochloride 
equivalent to 1 mg/mL 
histamine base, and 
Not reported 
 
Cut-off value twofold 
higher readings than 
those of normal 
subjects. Only those 
SPT positive tested 
ELISA 
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Time to read 
response 








glycerinated PBS) were 
used for SPT 





Lofarma, Milan, Italy 
Not reported 
 


















convincing or uncertain 
history  having  a 
negative SPT response 
with commercial 
extract, test repeated 
with crude extract (i.e., 
peanut butter) 
Not reported Peanut specific IgE 
>15 kU/L  those never 
or rarely ingested 
peanut or had an 
uncertain history 
Peanut-specific IgE 
>0.35 kU/L for those 




Bjornsson (1996) Not applicable Not applicable Not applicable Not applicable 
 
> 0.35 kU/L for single 
allergens, only those  
with a positive reaction 
to the panel (fx5) were 
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Time to read 
response 







Branum (2009) Not applicable Not applicable Not applicable Not applicable 
 
The range of detectable 
serum IgE levels was 




Chen (2011) Wheal with mean 
diameter >3mm 










































Unclear Not reported Not applicable Not applicable 
Haahtela (1980) Not reported >15 minutes Not reported Not reported Not applicable Not reported 
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Time to read 
response 




















Detection level was 0.5 
standardised units per 
ml (SU/mL) 
corresponding to 
approx 0.09 paper 
RAST  units (PRU) 
Magic Lite 
 
Kagan (2003) Wheal with mean 
diameter >3mm 






SPT performed by 
standard technique. 
Lots of glycerinated 
extract from the same 
manufacturer used 
throughout the study.  
Prick-to-prick 
When SPT response 
was negative and 
clinical history 
convincing or 
uncertain, SPT was 





>15 kU/L assumed 




Katz (2010) Wheal with mean 
diameter >3mm 
20 minutes SPTs were done to CMP, 
soy, a negative control, 
and histamine (1mg/mL; 
ALK-Abello, Port 
Washington, NY) 
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Time to read 
response 







Keet (2012) Not applicable Not applicable Not applicable Not applicable 
 
A specific IgE level of 
at least 0.35 kU/L to 





Krause (2002) Not applicable Not applicable Not applicable Not applicable 
 
 
The cut off for a 
positive reaction was 
set at ≥0.7 kU/L 
Pharmacia CAP 
 











































Kumar (2011) Not applicable Not applicable Not applicable Not applicable 
 
Sensitisation defined as 
sIgE ≥ 0.35 kUA/L at 
2-year visit for egg 
white, cow‟s milk, 
peanut, soy, shrimp, 
walnut, wheat, and cod.  
Number of food 
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Time to read 
response 







subject was categorised 
as 0 (reference) 1 or 2 
or >= 3 foods. Peanut 
sIgE levels were 
dichotomised at >= 5 
kUA/L, a level 
associated with greater 
likelihood of clinical 
reactivity among 
children 1 to 5 years. 
Milk and egg sIgE 
levels were 
dichotomised as 5 and 
2 kUA/L, respectively, 
corresponding to 95th 
percentile positive 
predictive values for 
children <= 2 years of 
age. These cut off 
points, rather than 
those for children > 5 
years of age (15 kVA/L 
for milk and 7 kUA/L 
for egg) were chosen 
due to the ages of 
children in the cohort. 
For assessment of cut 
off points, the control 
group included all 
children with levels 
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Time to read 
response 







below the cut off points 






Skin testing was 
performed with peanut 
(concentration, 1:20 








Liu (2010) Not applicable Not applicable Not applicable Not applicable 
 
The following 95% 
predictive levels have 
been proposed, based 
on positive predictive 
values for clinical 
reactivity: egg, 7 kU/L; 
milk, 15 kU/L; and 
peanut, 14 kU/L.1 
Clinical studies 
determined that 95% 
predictive levels differ 
for young children (i.e., 
<2 years old): egg, 2 
kU/L14; milk, 5 
kU/L.15 There is a lack 
of data correlating 
outcomes of allergy for 
shrimp with IgE levels, 
and thus no well 
established IgE cut off 




University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506              79 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety 
Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output 
adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the 
authors. 




Time to read 
response 








shrimp was treated in 
accordance with the 
typical patterns 
described, using a 
threshold of 5 kU/L.  





Wheat and bread 
extract 




Mortz (2005) Not applicable Not applicable Not applicable Not applicable 
 
A serum level > 0.35 
kU/l (corresponding to 
class 1) for specific IgE 
was considered positive 
CAP FEIA 
 








Not reported Pharmacia CAP 
 
Nicolaou (2010) Wheal with mean 
diameter >3mm 









sIgE ≥0.2 kUa/L ImmunoCAP 
 






SPT carried out with 
commercially available 
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Time to read 
response 










Sensitisation to fresh 
fruits or vegetables or 
beef was tested using 
prick-to-prick testing 






Not reported Not applicable 
 
Not applicable 
Ostblom (2008a) Not applicable Not applicable Not applicable Not applicable 
 
An IgE antibody level 
≥0.35 kUA/L was 
considered positive. 
Serum samples  scoring 
positive for fx5® were 
further analyzed 
towards the individual 




Osterballe (2005) Wheal with mean 
diameter >3mm 






Skin prick test was 
performed by the 
prick-prick technique 
using a selected panel 
of fresh unprocessed 
foods 
 
Yes, and reported both 
primary allergy (allergy 
independent of pollen 
sensitisation) and 
secondary allergy 
(reactions to pollen related 
fruit and vegetables in 
pollen sensitised 
Measurable specific 
IgE was classified as a 
positive test result (ML 
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Time to read 
response 














Skin prick test was 
performed with the 
suspected food (fresh 
unprocessed foods) 
 
Primary food allergy 
defined as being 
independent of pollen 
sensitisation, whereas 
secondary food allergy was 
defined as reactions to 
pollen related fruits and 
vegetables in pollen 
allergic patients. Food 
allergy included both 













Wheat and grass cross-
reactivity in 72/80 15 year 





Ro (2012) Wheal with mean 
diameter >3mm 






SPT allergen extracts 







For SPTs to milk, 
Not reported 
 
The reference value for 
total IgE in two-year-
old children, specified 
by the manufacturer, 
was 0–45 kU/L. The 
detection limit for sIgE 
tests was 0.1 kU/L.  
Concentrations of 0.35 
kU/L or above were 
regarded as positive 
Immulite 2000 
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Time to read 
response 








skimmed milk was 
used.  
 






Not reported, although 
recognised as a potential 















Serum studies are 
mentioned in the 
methodology however 
no raw data has been 
presented 
Not reported 





















Not applicable Not applicable 























explored between grass 
and wheat. If a participant 
tested positive to wheat 
and grass but ate wheat 
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Time to read 
response 











to a predefined panel of 
foods (milk, egg, 
wheat, cod fish, peanut 
and sesame) and to 
additional foods 
reported to be a 
problem. 
Prick-to-prick 
In the case of fruits and 
vegetables, prick-to-
prick testing to the 
fresh product was 
conducted 
defined as cross-reactivity 
and not reported as wheat 
allergy/sensitisation 
 
Venter (2008) Wheal with mean 
diameter >3mm 





Wan (2012) Not applicable Not applicable Not applicable Not applicable Not reported ImmunoCAP 
RAST 
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Table 1.9:   Further information about food challenge procedures performed by studies 
Study ID Time-frame for 
monitoring reactions 
 
Active and placebo 
food carriers 
Dosing schedule Method of determining 
positive test 




Ben-Shoshan (2009) See Kagan 2003 
 
See Kagan 2003 
 
See Kagan 2003 
 
See Kagan 2003 
 
See Kagan 2003 
 
See Kagan 2003 
Bock (1987) Not reported Not reported Initial amount given 
was less than parents 
thought would 
produce a reaction, 
amounts then 
increased until a 
reaction was produced 
Not reported Not reported Not reported 
 





challenge; a drop of 
ordinary formula/milk 
was put on the lips at 
first. If no reaction 
after 20 min, the dose 
increased stepwise 
(1.0, 2.0, 5.0, 10, 20, 
40, 80–120/150 ml). 
In the egg challenge, 
boiled egg was used, 
and 1/16 of 
yolk/white (depending 
on the SPT or history, 
or else started with 
yolk then followed by 
white) were the 
starting dose and the 
amount doubled every 
20 min (1/16, 1/8, 1/4, 
1/2)  
Observed for at least 2h after 
last dose. Parents reported any 
symptoms occurring within 
the 3 days after challenge. 
Food allergy confirmed if 
evidence of an unequivocal 
allergic reaction i.e. urticaria, 
angioedema, vomiting, 
diarrhoea, acute eczema flare 
up, or respiratory and 
cardiovascular symptoms 
during the challenge 
procedure. Parents of those 
demonstrating no reactions on 
test day were asked to the 
research paediatrician by 
phone daily for 3 days, if 
suspicious reactions were 
reported, the child should 
return to  hospital immediately  
Highest dose 
administered was 
the normal daily 
intake of the 
food in question, 
adjusted for the 
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Study ID Time-frame for 
monitoring reactions 
 
Active and placebo 
food carriers 
Dosing schedule Method of determining 
positive test 




Chen (2012) 2 hours 
 
Not reported Not reported Not reported Not reported Not reported 
Eller (2009) Not reported, although 
did classify late 
reactions as those >2 
hours and monitored 






cow‟s milk and hen's 
egg, all masked as 
previously described 
(see Osterballe, 
2005). Vehicle foods 















performed in all 
children 3 years 







years of age 
 
Gelincik (2008) 2-12 hours depending 
on patient history 
Peppermint oil, pure 
cacao powder, cereal 
flakes, wheat flour, 
lemon juice, honey, 
sugar, mashed potato, 
milkshake, rice-
pudding, carob, 
cinnamon and various 
vegetables 
Not reported Not reported Not reported Not reported 
Grundy (2002) Observed for 15 
minutes for any 
symptoms, if no 
reaction an oral 




of peanut butter 
spread on bread or a 
flapjack biscuit that 
contained peanut 
were given 
Offered a portion 
containing 0.25 g of 
peanut, then 0.5 g, 1 
g, 2 g, and 4.25 g 
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Study ID Time-frame for 
monitoring reactions 
 
Active and placebo 
food carriers 
Dosing schedule Method of determining 
positive test 




Host (2002) Varied within in age 
groups 
Not reported Not reported Not reported Not reported Not reported 
Hourihane (2007) 30 minutes 
 
Peanut flour-based 
biscuits, prepared in 
Southampton by an 
experienced dietician 
(K.E.C.G.) 
1 mg, 10 mg, 100 mg, 
1 g, and 5 g 
 
Identification of an objective 
allergic reaction with clinical 
signs or completion of the full 
challenge with no such signs 






Hu (2010) 2 hours Not reported 0.5, 1.0, 2.0, 5.0, 10, 20, 
40, 80, 100, 150 mL 
Respiratory rate, heart rate, 





Kagan (2003) 15-30 minutes 
 
Peanut flakes served 
as the source of 
peanut, and cracker 
crumbs served as the 
placebo. The peanut 
and placebo were 
disguised with either 
applesauce or grape 




with 10 mg of either 
peanut or placebo, if 
tolerated, the dose 
was increased to 25 
mg, 50 mg, 100 mg, 
250 mg, 500mg, 1 g, 
and 2.5 g  
 
A challenge was considered 
positive if at least 2 of the 
mild manifestations described 
previously as characterizing a 
convincing clinical history 
(i.e.; involving only pruritus, 
urticaria, flushing, or 
rhinoconjunctivitis) or at least 
1 of the moderate (i.e. 
involving angioedema, throat 
tightness, gastrointestinal 
complaints, or breathing 
difficulties (other than 
wheeze)) or severe 
manifestations occurred 
If 2.5 g of peanut 








Kajosaari (1982) Not reported Not reported Not reported Not reported Not reported Not reported 
Katz (2010) 2 weeks Not reported Increasing doses of 
Materna infant formula, 
1:10 diluted formula 
1.0mL (2.7mg of CMP) 
up to 120mL (3.24g of 
Not reported Not reported Not reported 
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Study ID Time-frame for 
monitoring reactions 
 
Active and placebo 
food carriers 
Dosing schedule Method of determining 
positive test 




CMP) every 30 minutes 
Kucukosmanoglu 
(2008b) 
Min 4 hours 
 
Not reported Not reported Not reported Not reported Not reported 




Use of graded doses 
until a reaction or 8 g 
of dry-weight 





8g of dry-weight 
equivalent, 
followed by an 
open challenge 
with a peanut 
butter sandwich 




Lao-araya (2012) Min 4hours 
 
Not reported Not reported Not reported Not reported Not reported 
Mortz (2005) 2 hours Chocolate bar 0.16, 0.32, 1.28, 2.56, 
5.12, 10.24, 30.50g 
Followed EAACI guidelines 50g Not reported 
Mustafayev (2012) 20 minute intervals Not reported Not reported Not reported Not reported Not reported 
Nicolaou (2010) 30 minute intervals 
for open challenges. 
DBPCFC lasted 8 
hours (including the 
2-hour observation 
period after the 
administration of the 
final dose) 
 
Peanut concealed in 
brownies for open 
challenges 
10 mg, 100 mg, 1 g, 
and 5 g peanut protein 
for open and DBPC 
challenges 
 
Challenge was considered 
positive after development of 
at least 2 objective signs i.e. 
skin rash, sneezing, vomiting, 

















Orhan (2009) Negative DBPCFCs 
were followed by 
open challenges. 
Duration between a 
A wide variety of 
foods were used to 
mask the active 
doses. All active and 
15 minutes 
 
DBPCFC were considered 
positive if a single or a 
combination of the clinical 
reactions, including cutaneous 
The titrated 





University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506              88 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety 
Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output 
adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the 
authors. 
Study ID Time-frame for 
monitoring reactions 
 
Active and placebo 
food carriers 
Dosing schedule Method of determining 
positive test 





and open challenge 
was 2 hours. In the 
open challenge, 
patients received a 
larger quantity of food 
(a meal-size portion 
for age) 
 
placebo foods were 
as similar as possible 
in colour, flavour-
taste, consistency, 
and texture so as not 
to be differentiated 
by the patients 
(eruption, itching, rash, 
swelling), nasal (sneezing, 
itching, secretion, blockage), 
ocular (redness, itching, 
secretion), bronchial (cough, 
wheezing, shortness of 
breath), gastrointestinal 
(vomiting, diarrhoea), 
laryngeal (difficulty in 
swallowing, difficulty in 
speaking), cardiovascular 
(tachycardia, hypotension), 
and other (sweating, pallor, 





corn was of the 
same magnitude: 
0.1, 0.3, 0.6, 1.5, 
2.5, 5, and 15 g, 
in total 25 g of 
the respective 
food. The dose 
steps for cow‟s 
milk were 5, 10, 
40, 75, and 150 
mL, in total 280 
mL; 0.1, 0.3, 0.6, 
1.5, 2.5, 5, 15, 
and 25 g for 
hen‟s egg, kiwi 
fruit, banana, 
and tomato, in 
total 50 g; 1, 2, 
5, 7, and 10 g for 
cocoa, in total 25 
g; 1, 2, 7, 15, 25, 
and 50 g for beef 
and fish, in total 
100 g; and 0.1, 
0.3, 0.6, 1.5, 2.5, 
and 5 g for black 





The dose interval was 
15 minutes. A positive 
Codfish, hazelnut, 
peanut and walnut 
The titrated doses of 




but appears to be 
The open 
controlled 
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Study ID Time-frame for 
monitoring reactions 
 
Active and placebo 
food carriers 
Dosing schedule Method of determining 
positive test 




challenge was divided 
into immediate or late 
reactions. The 
immediate reactions 
were defined as a 
reaction taking place 
within 2 h after the 
last dose 
administered, whereas 
late reactions occurred 
between 2 and 24 h 
after the last dose. All 
participants with a 
positive outcome in 
food challenge were 
examined for late 
reactions by telephone 




clinical examination  
 
were masked in 
chocolate bars with 
basic ingredients of 
margarine, dark 
chocolate, salt, icing 
sugar, oat grains, soy 
flour, oat flour and 
mint. Cow‟s milk and 
hen‟s egg were 
masked in a coloured 
cup (with top) with 
basic ingredients of 
sugar, cocoa, vanilla 
sugar and oat drink 
(placebo).Challenge 
with additives 
comprised the same 
type of candy as 








250, 1000, 2000, 
4000, 8000 and 
23,750 mg of codfish, 
in total 39 g, whereas 
the doses used for 
hazelnut, peanut and 
walnut challenges 
were of the same 
magnitude: 80, 160, 
640, 1280, 2560, 5120 
and 15,200 mg, in 
total 25 g of the 
respective food. The 
titrated doses of cow‟s 
milk were: 5, 10, 40, 
80 and 160 g of fresh 
cow‟s milk, in total 
295 ml, whereas the 
dose steps for hen‟s 
egg were 11, 44, 250, 
500, 1000, 2500, 5000 
and 40,000 mg of 
pasteurized whole-egg 
(49,305 mg, approx 
one egg). OCFC were 
performed with the 
following dose steps: 
0.5, 1, 2, 4, 8, 16 and 
32 g 
for all foods 
except additives, 
for which total 
dose on 90 g 
wine gum in 
children and 160 







in all children <3 







than 3 yr of age 
 
Osterballe (2009) A positive challenge 
was divided into 
immediate or late 
Codfish and peanut 
were masked in 
chocolate bars with 
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Study ID Time-frame for 
monitoring reactions 
 
Active and placebo 
food carriers 
Dosing schedule Method of determining 
positive test 






were defined as a 
reaction taking place 
within 2 h after the 
last dose 
administered, whereas 
late reactions occurred 
between 2 and 24 h 
after the last dose of 
the food had been 
administered. All 
participants with a 
positive immediate 
reaction after food 
challenge were 
examined for late 
reactions by telephone 
interview and reported 
symptoms were 
subsequently 
evaluated by clinical 
examination 
 
basic ingredients of 
margarine, dark 
chocolate, salt, icing 
sugar, oat grains, soy 
flour, oat flour and 
mint. Cow's milk and 
hen's egg were 
masked in a coloured 
cup (with top) with 
basic ingredients of 
sugar, cocoa, vanilla 
sugar and oat drink 
(placebo). Hen's egg 
challenge was 
performed with fresh 
pasteurized whole-








dose steps: 0.5, 
1, 2, 4, 8, 16, 32 
g, in total 63.5 g 





the same type of 
wine gum 
(containing 
natural dyes) as 
suspected by the 
participants and 
a total dose of 
160 g wine gum 
was given.  The 
titrated doses of 
codfish were: 
125, 250, 1000, 
2000, 4000, 
8000, 23,750 mg 
of codfish, in 
total 39 g, 
whereas the 
doses used for 
peanut and soy 
challenges were 






















milk, hen's egg, 





University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506              91 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety 
Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output 
adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the 
authors. 
Study ID Time-frame for 
monitoring reactions 
 
Active and placebo 
food carriers 
Dosing schedule Method of determining 
positive test 





160, 640, 1280, 
2560, 5120, 
15,200 mg, in 
total 25 g of 
peanut or soy. 
The titrated 
doses of cow's 
milk were: 5, 10, 
40, 80, 160 g of 
fresh cow's milk, 
in total 295 ml. 
Dose steps for 
Hen's egg were 
11, 44, 250, 500, 
1000, 2500, 







Saarinen (1999) Initially infants were 
fed cow‟s milk 
formula every 30 to 
60 minutes. All those 
without symptoms 
were examined for 
delayed symptoms 5 
days after challenge 
test. 
Not reported Cow‟s milk formula 
was given in 
quantities of 1,10,50 
and 100 ml at 
intervals of 30 to 60 
minutes 
Challenge was considered 
positive if one or more of the 
following symptoms appeared; 
urticaria, exanthema, atopic 
dermatitis, vomiting, 
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Study ID Time-frame for 
monitoring reactions 
 
Active and placebo 
food carriers 
Dosing schedule Method of determining 
positive test 




Schrander (1993) Not reported Not reported Challenges in patients 
with gastrointestinal 
symptoms were done 
with full amounts of 
milk.  In children with 
an increased risk of 
anaphylaxis were 
performed with 
increasing amounts of 
milk. 5, 10, 30. 50, 100 
ml. 
A positive challenge was 
defined as the recurrence of the 
patients original complaints.  
Two positive elimination 
challenge tests after exclusion of 
lactose intolerance were 
consider diagnostic for cow‟s 
milk protein intolerance 
100 ml Not reported 
Venter (2006) 1 day in hospital for 
immediate and 1 week 




Not reported Not reported Not reported One-day 
challenge 
protocols were 
based on the 
consumption of 
the equivalent of 
8-10g of dried 






parent was asked 
to give the child 
further doses of 
the food at 
home. One week 
challenges were 
based on normal 
daily 
Not reported 
University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506              93 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety 
Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output 
adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the 
authors. 
Study ID Time-frame for 
monitoring reactions 
 
Active and placebo 
food carriers 
Dosing schedule Method of determining 
positive test 





the specific age 
group 
Zuberbier (2004) Not reported On one day a range 
of food additives 
known to cause non-
allergic intolerance 
reactions were given 
in 13 capsules, on 
another day the same 
number of capsules 
filled with mannit 
and silcium dioxide 
were given as a 
placebo 
Not reported Not reported Not reported Food items were 




cereal flakes and 
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1.2.6. Results for Prevalence with age in different countries and regions 
1.2.6.1. Celery allergy prevalence across Europe 
Four studies reported the prevalence of celery allergy in a European country. These studies were 
published between 2001 and 2006 and reported prevalence data from France, Germany and Hungary. 
The studies assessed the prevalence of celery allergy in those aged 5 years or more. 
Self reported celery allergy was presented in only one study, which found that 5.5% (95% CI: 4.3-
7.1%) of 5 -17 year olds in France reported a problem with eating celery (Touraine 2002). Two 
studies performed SPT to celery and reported rates of sensitisation of 9.1% (95% CI: not reported) in 
adults in Germany (Schafer 2001), 11.1% (95% CI: 3.6-27.0%) in adults in Hungary (Bakos 2006) 
declining to 3.7% (95% CI: 1.2-9.7%) in elderly people in Hungary (Bakos 2006). One study (Bakos 
2006) also assessed serum SIgE levels to celery in Hungarian adults and the elderly and reported 
sensitisation rates of 2.8% (95% CI: 0.2-16.2%) and 9.2% (95% CI: 4.7-16.6%) respectively (Bakos 
et al, 2006). One population-based study reported the prevalence of celery allergy based on a positive 
SPT and clinical history as 3.5% (95% CI: 2.9-4.2%) (Zuberbier 2004).  
Aside from the self-report data, for which it is not clear whether the researchers detected delayed 
reactions to celery, the only study to assess the prevalence of allergy, rather than sensitisation, to 
celery appears to be detecting IgE-mediated allergies (since they have used skin prisk testing in 
combination with a positive clinical history). The majority of studies, however, assessed sensitisation 
to celery rather than allergy. Furthermore, there were no studies that reported the prevalence of celery 
allergy based on open or double blind food challenge. 
1.2.6.2. Celery allergy prevalence of different regions of the world 
Only one study investigating the prevalence of celery allergy could be identified in other regions of 
the world. A study conducted in Taiwan found that 1.8% (95% CI: 1.1-2.9%) of 6-8 year olds in 
Taiwan suffer from celery allergy based on positive serum SIgE level and a good clinical history 
(Wan 2012). Hence, at present only IgE mediated allergy has been investigated. 
1.2.6.3. Cereals allergy prevalence across Europe 
The prevalence data for cereal allergy was derived from 13 countries (22 studies), including Denmark, 
Finland, France, Germany, Greece, Greenland, Hungary, Iceland, Italy, Norway, Sweden, Turkey and 
the UK. The data was published from 1980 to 2009 and the age range of the participants ranged from 
birth – 97 years. The majority of the studies focused on wheat allergy, but a number of studies also 
reported data on rye, barley, oat, corn or mixed grains. 
 
Mixed grains 
Three studies presented the prevalence rates of self reported allergy to mixed grains or cereals. The 
rates reported ranged between 0.2% (95% CI: 0.1-0.5%) in 18 month olds in Norway (Eggesbo 1999) 
to 2.3% (95% CI: 1.5-3.7%) in one year olds in Finland (Pyrhonen 2009). Pyrhonen 2009 also report 
rates of clinician diagnosed cereal allergy at 1.1% (95% CI: 0.5-2.1%) of one year olds, 0.9% (95% 
CI: 0.4-1.9%) of 2 year olds and 2% of 3 (95% CI: 0.9-2.9%) and 4 (95% CI: 1.2-3.2%) year olds. All 
of these studies examined IgE and non-IgE mediated allergy, although only two of the three studies 
tested for the presence or absence of IgE; Eggesbo 1999 presented self-reported allergy and did not 
attempt to distinguish between IgE or non-IgE mediated reactions. 
 
Rye, Barley and oatmeal 
One study reported data on rye/barley allergy, one study reported on rye allergy only and one more on 
barley and oatmeal allergy. Self reported allergy to rye/barley ranged between 1.3 (95% CI: 0.7-2.4%) 
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– 1.8% (95%CI:1.1-3.1%). Clinician diagnosed rye/barley allergy was reported for 1.3% (95% CI: 
0.7-2.4%) of one year olds, 1.8% (95% CI: 1.0-3%) of 2 year olds, 2% (95% CI: 1.2-3.4%) of 3 year 
olds and 2.7% (95%CI:1.7-4.1%) of 4 year olds (Pyrhonen 2009). One study (Zuberbier 2004) 
diagnosed food allergy in Germany based upon a positive skin prick test and clinical history and 
reported the following prevalence rates: barley allergy in 2.2% (95% CI: 1.7-2.8%), rye allergy in 
1.2% (95% CI: 0.8-1.6%) and oatmeal allergy in 1.2% (95% CI: 0.9-1.7%). The study presenting the 
prevalence of self-reported allergy did not attempt to distinguish between IgE or non-IgE mediated 
reactions. Pryhonen 2009 also reported prevalence rates that included both IgE and non-IgE-mediated 
allergy. The diagnostic methods utilised by Zuberbier 2004 detected IgE-mediated allergy only. 
 
Corn 
Two studies looked at the prevalence of corn allergy. A study conducted in Turkey (Orhan 2009) 
found that only 0.1% (95% CI: 0.0 - 0.4) of the study population of 6-9 year olds reported allergy to 
corn all of whom were sensitised to it. However, in all cases corn allergy was not confirmed by 
DBPCFC (95%CI:0-0.2%). This study detected IgE-mediated allergy only. In the UK, corn allergy 
was confirmed by DBPCFC in 0.1% (95%CI: 0.0-0.8%) of 1, 2 and 3 year old children, in a study that 




Two studies reported prevalence rates of reactions to “flour” where the type of flour was unspecified, 
both of which were conducted in Germany. Schafer 2001 found that 0.7% of their study population 
(95%CI: not reported) reported symptoms upon ingestion of flour (which may have been either IgE or 
non-IgE mediated).  Examining IgE and non-IgE mediated allergy separately, Zuberbier 2004 




Twenty studies assessed the prevalence of self-reported wheat allergy/gluten sensitivity. The lowest 
rates of self-reported wheat allergy were presented for a group of 7-13 year olds in Greece (0.2% 
(95% CI: 0.0-0.5%)) (Zannikos 2008). The highest rates were reported by a Finnish study of 1-year-
olds (2.1% (95% CI: 1.3-3.4%)) (Pyrhonen 2009). Clinician-diagnosed wheat allergy was reported by 
two studies. Prevalence rates of clinician-diagnosed wheat allergy were reported to be 0.3% (95% CI: 
0.1-0.6%) of 1 year olds and 8 year olds in Sweden (Ostblom 2008b). A higher rate (3.4% (95% CI: 
2.3-5%)) was reported for a group of 4 years olds in Finland (Pyrhonen 2009). 
 
Sensitisation to wheat, as measured by SPT, was reported in seven studies and, as measured by 
specific IgE, in four studies. The lowest rate of sensitisation (determined via SPT) was 0% (95% CI: 
0-0.6%) reported for 1 and 3 year olds in the UK (Venter 2008). The highest rate, 13.9% (95% CI: 
5.2-30.3%), was reported by a Hungarian study of 20-69 year olds (Bakos 2006). Only three studies 
reported prevalence of wheat allergy based on a positive SPT and clinical history. Based on this 
method of diagnosis, the lowest prevalence of wheat allergy was reported in a group of 18 month-old 
children in Sweden (0% (95% CI: 0-1.4%)) and Iceland 0% (95% CI: 0-1.5%)) (Kristjansson 1999) 
and the highest rate,  1.2% (95% CI: 0.9-1.7%), was reported for all ages in Germany (Zuberbier 
2004) . Only one study (Ostblom 2008b) reported a prevalence rate based on positive specific IgE 
levels and clinical history. Using this method in a Swedish population, the prevalence rate was 1.3% 
(95% CI: 1.0-1.9%) of 4 year olds (Ostblom 2008b). In the only study to combine clinical history with 
a positive OFC/DBPCFC outcome, Osterballe 2005 did not identify a single confirmed case of wheat 
allergy in any age group. 
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A number of studies used other methods of diagnosing wheat allergy. Using atopy patch tests in an 
Italian population, Ronchetti 2008 reported the prevalence of wheat allergy to be 5.6% (95% CI; 3.0-
10.1%) of 13 year olds and 6% (95% CI: 3.2-10.7%) of 9 year olds. Using a combination of history 
and SPT and/or OFC and DBPCFC, the prevalence of wheat allergy was 0.4% (95% CI: 0.1-1.2%) in 
one year olds, 0.3% (95% CI: 0.1-1.1) in two year olds, 0.2% (95% CI: 0.0-0.9%) in 3 year olds and 
0.3% (95% CI: 0-1.0%) in six year olds in the United Kingdom (Venter 2008; Venter 2006). Of the 
studies that assessed the prevalence of wheat/gluten allergy in Europe, 17 assessed both IgE and non-
IgE mediated wheat/gluten allergy (although four of these did not perform any tests to determine the 
presence or absence of IgE) and four IgE-mediated allergy only.  
1.2.6.4. Cereals allergy prevalence in different regions of the world 
A number of studies (N=14) have looked into cereal allergy outside of the EU. Studies were 
conducted in Australia, Canada, China, Ghana, Japan, Korea, Thailand, United Arab Emirates, and the 
United States. 
 
Corn and Millet 
One study looked at IgE-mediated cereal allergy in 5-16 year olds in Ghana and found reported 
allergy to corn in 0.2% (95% CI: not reported) of children and millet in 0.1% (95% CI: not reported) 
(Obeng 2011). In the United States, one study reported a prevalence rate for corn allergy (both IgE 




Nine studies looked at the reported prevalence of wheat allergy. The lowest rates were reported by a 
study conducted in Korea in a group of 6-12 year old children (0% (95%CI:0.0-0.1%)) (Oh 2004). 
The highest rate was found in the United States, where 2.3% (95% CI: 1.3-4.2%) of the adult study 
population reported having wheat allergy (Greenhawt 2009). One study, conducted in the United 
States, looked at the prevalence of a reported clinical diagnosis of wheat allergy across different age 
groups (Gupta 2011). The prevalence ranged between 0.3% for both 0-2 year olds (95% CI: 0.1-0.5) 
and 14-17 year olds (95% CI: 0.2-0.4). Two studies presented prevalence rates for clinician diagnosed 
wheat allergy. These were 0.1% (95% CI: 0-0.5%) for a group of 0-12 month olds in Korea (Kim 
2011) and 0.5% (95% CI: 0.1-2.0%) for a group of 6-9 year olds in the United Arab Emirates (Al-
Hammadi 2006).  
 
Three studies measured the prevalence of sensitization to wheat by either SPT (n=2) or serum specific 
IgE levels (n=1). In an Australian adult population, the prevalence of sensitization to wheat was found 
to be 2.2% (95% CI: 1.1 - 4.1) (Woods 2002). A study conducted in 0-24 month olds in China in 1999 
and 2009 reported wheat sensitisation rates (assessed by SPT) of 0.3% (95% CI: 0.0-2.1%) and 0.5% 
(95%CI:0.1-2.1%) respectively (Hu 2010). The prevalence of sensitisation to wheat in a group of 0-12 
month olds in Japan, as determined by positive serum specific IgE levels, was 1.4% (95%CI: not 
reported) (Morita 2012).  
 
Two studies used a positive SPT/specific IgE level in combination with clinical history to estimate the 
prevalence of wheat allergy. These studies reported prevalence rates of between 0% (95% CI: 0.0-
0.1%) for Australian adults (Woods 2002) and 0.2% (95% CI: 0.0-0.9%) for Japanese adults (Morita 
2012). A higher prevalence rate (1.2% (95% CI: 1.0-1.4%)) was reported by a Chinese study which 
utilised IgG levels to diagnose wheat allergy (Sai 2011). In the United States the prevalence of wheat 
allergy in 0-3 year olds has been found to be 0.2% (95% CI: 0-1.3%) when using food challenges 
(Bock 1987). Also in the United States, self-reports of clinician diagnosed wheat allergy yielded a 
prevalence rate of 0.5% (95% CI: 0.3-0.8%) (Vierk 2007). 
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The minority of adverse reactions to wheat are considered to be IgE-mediated. Of the studies 
reporting the prevalence of wheat allergy outside of Europe, five assessed IgE-mediated allergy only, 
nine considered both IgE and non-IgE mediated allergy (of which seven did not perform tests to 
determine the presence or absence of IgE) and one assessed IgG-mediated allergy. 
1.2.6.5. Egg allergy prevalence across Europe 
The prevalence of egg allergy has been assessed in 17 countries (35 studies), including Denmark, 
Estonia, Finland, France, Germany, Greece, Greenland, Hungary, Iceland, Ireland, Italy, Norway, 
Portugal, Spain, Sweden, Turkey and the UK. The included studies were published between 1980 and 
2012 and the age range of the participants ranged from birth – 97 years. 
 
None of the included studies reported prevalence rates for egg allergy based on self-report or clinical 
history. Three studies focussed on clinician diagnosed egg allergy with the lowest prevalence figures 
seen in 8 year olds from Sweden (1.6% (95% CI: 1.2-2.1)) (Ostblom 2008) and the highest in 4 year 
olds from Finland (3.9% (95%CI:2.7-5.5%)) (Pyrhonen 2009).  
 
Eleven studies reported sensitisation rates based on skin prick test results and six on specific IgE 
levels. In the younger cohorts (0-3 years old), sensitisation rates as determined by SPT ranged from 
1.3% (95% CI: 0.7-2.3%)(Venter 2008) to 5.2% (95% CI :not reported) (Julge 2001). In this age 
group, rates determined by sIgE ranged between 4.2% (95% CI: not reported) (Julge 2001) and 20.6% 
(95% CI: not reported) (Julge 2001). In children older than 3 years, sensitisation rates as determined 
by SPT ranged from 0% (95% CI: not reported) (Julge 2001; Roncetti 2008) to 2.8% (95% CI: 1.9-
3.9%) (Schafer 1999), and as determined by sIgE, from 0.4% (95% CI: 0.1-1.1%) (Krause 2002) to as 
high as 22.7% (95% CI: not reported) (Julge 2001). Sensitisation rates in adults ranged between 0.4% 
(95%: not reported) (Schafer 2001) and 1.9% (95% CI: not reported) (Schafer 2001) when SPTs were 
utilised. When sensitisation in adults was determined via sIgE testing to egg yolk, sensitisation rates 
were 0% (95% CI: 0-12%) in ages 20-69 years and 60-97 years (Bakos 2006).When the sIgE to egg 
white was tested, sensitisation rates were reported to be 2.8% (95% CI: 0.2-16.2%) in ages 20-69 
years and 2.8% (95% CI: 0.7-8.4%) in ages 60 – 97 years (Bakos 2006).  
 
Four studies based egg allergy prevalence rates on a good clinical history plus a positive SPT, and 
reported rates ranging from 0.1% (95% CI: 0-0.1%) in 18 year olds in Turkey (Gelincik 2008) to 
1.5% (95% CI: 0.6 – 3.7%) in 18 month olds in Sweden (Kristjansson et al. 1999). Two studies based 
egg allergy prevalence rates on a good clinical history plus a positive serum specific IgE result. One 
was conducted in Sweden and reported the prevalence of egg allergy to be 0.6% (95% CI: 0.3-1.0%) 
(Ostblom 2008a). The other found the prevalence of egg allergy in Turkey to be 0.1% (95% CI: 0.0-
0.1%)(Gelinicik 2008). 
 
Several studies utilised food challenges (four used open food challenges and four DBPCFC), in 
combination with clinical history, to diagnose egg allergy. Based on open food challenge and a good 
clinical history the highest prevalence rate was 2.6% (95% CI: not reported) in 18 month old children 
in Denmark (Eller 2009). In contrast, based on DBPCFC and history the highest prevalence rate 
reported was 1.6% (95% CI: 0.1-3.4%) (Osterballe 2005) in 3 year old children also from Denmark. 
Five studies combined a variety of methods to determine egg allergy prevalence. Of these, the highest 
reported prevalence of egg allergy was a very high rate of 10.2% (95% CI: 6.5-15.5%) diagnosed 
using the atopy patch test in 13 year old children (Ronchetti 2008).      
Egg allergy is classically considered as an IgE mediated food allergy. We tried to understand from the 
included studies if the symptoms related to egg were considered IgE or non-IgE mediated. In Europe, 
24 studies covered both IgE and non-IgE medidated food allergies. Apart from the study by Venter et 
al.which clearly indicate the presence of IgE and non-IgE mediated egg allergy, it is very difficult to 
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tell from the other papers if the egg allergy per se was IgE or non-IgE mediated or both. In fact 11 of 
the studies who indicated that they studied both IgE and non-IgE mediated allergies, did not perform 
any tests to determine the presence or absence of IgE. Ten studies focussed on IgE mediated egg 
allergy.                            
1.2.6.6. Egg allergy prevalence in different regions of the world 
A number of studies outside of Europe have looked at the prevalence rates of egg allergy. The 
countries studies include Australia, Canada, China, Colombia, Ghana, Hong Kong, Israel, Korea, 
Taiwan, Thailand, United Arab Emirates and the USA. The studies were reported between 1998 and 
2012 and included participants of all ages.  
Twelve studies looked into the self-reported prevalence of egg allergy. The lowest prevalence rate, 
0.1% (95% CI: not reported), was reported in 5-16 year olds from Ghana (Obeng 2011). The highest 
prevalence, 1.6% (95% CI: 0.7%-3.2%), was reported in a group of US adults (Greenhawt 2009). Two 
studies reported prevalence based on a reported clinical history of egg allergy ranging from 0.4% 
(95% CI: 0.3 – 0.5%) in 14-17 years olds in the US to 1.3% (95% CI: 0.9 – 1.7%)   in 3-5 year olds 
(Gupta et al. 2011). Only three studies focussed on clinician diagnosed egg allergy with the lowest 
prevalence figures seen in adults from Taiwan (0.3% (95% CI: 0.2-0. 4%)) (Wu 2012) and the highest 
in 6-9 year olds from the UAE (3% (95%CI:1.8-5.7%)) (Al-Hammadi 2010).  
Four studies reported sensitisation rates based on skin prick test results and four as determined by 
specific IgE levels. High rates of sensitisation to egg, as measured by SPT, are reported with, for 
example, a sensitisation rate of 11.8% (95% CI: 10.6-13.0) in 12-15 month olds in Australia (Osborne 
2011) and 16.2% (95% CI: 12.8-20.4%) in 0-24 month olds in China (Hu 2010). Sensitisation rates as 
measured by serum specific IgE levels ranged between 2.1% (95% CI: not reported) in 20-39 year 
olds in the US (Liu 2010) and 21% (95% CI: 18.7-23.6%) in 6 months – 6 year olds in the US (Kumar 
2011). 
Only two studies based egg prevalence rates on a good clinical history plus a positive SPT. Dalal 
2002 found a prevalence for egg allergy of 0.5% (95% CI: 0.3-0.6%) in 0-2 year olds in Israel and 
Woods 2002 reported a rate of 0.2% (95% CI: 0.0-1.4%) in 26-50 year olds in Australia. No study 
based egg allergy prevalence rates on a good clinical history plus a positive serum specific IgE result 
or a positive DBPCFC and a good clinical history. However, three studies based a diagnosis of egg 
allergy on a positive OFC plus history. Chen 2011 reported egg allergy prevalence rates of 0.5% in 0-
12 month olds in China. A different study in the same country reported prevalence rates of 2.9% (95% 
CI: 1.4-5.6%) in 0-24 month olds in 1999 and 5% (95% CI: 3.2-7.7%) in 0-24 month olds in 2009 (Hu 
2010). Osborne 2011 reported a prevalence of 9% (95% CI: 7.9-10.0) in 12-15 months olds in 
Australia. 
Five studies utilised other methods to diagnose egg allergy. The methodologies varied widely from 
using a combination of history, sensitisation status and/or food challenges, to less credible methods 
such as IgG levels. Many studies conducted on egg allergy outside of Europe utilised questionnaire 
based methods to determine the prevalence of egg allergy, which in some cases focussed on IgE 
mediated allergy, but did not confirm a history of immediate type symptoms with specific IgE or SPT. 
Only three studies reported on IgE and non-IgE mediated egg allergy, and one of these studies did not 
determine the presence of IgE, with 20 studies reporting on IgE mediated food allergies and 8 of these 
not testing for the presence of IgE. One study used IgG testing. 
1.2.6.7. Fish and Shellfish prevalence across Europe 
There were 34 studies which looked at the prevalence of fish and shellfish allergies in Europe (the 
countries studied were Denmark, Finland, France, Germany, Greece, Greenland, Hungary, Iceland, 
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Norway, Portugal, Spain, Sweden, The Netherlands, Turkey and the United Kingdom). Data was 
published between 1980 and 2012. The prevalence of seafood allergy was assessed in participants 
from 6 months to 97 years. Prevalence rates based on self-reported allergy were presented in 22 
studies; sensitisation rates were assessed in eight studies using skin prick tests and five studies using 
serum SIgE tests; sensitisation plus clinical history was obtained in four studies and seven studies 
adopted open and/or double blind food challenges.  
IgE-mediated allergy was considered in 11 studies (Arshad 2001; Bakos 2006; Bjornsson 1996; 
Haahtela 1980; Kajosaari 1982; Krause 2002; Kristjansson 1999; Mustafayev 2012; Orhan 2009; Ro 
2012; Roberts 2005). The methods adopted by these studies included skin prick and specific IgE tests 
to assess sensitisation, and food challenges and/or self-reported allergy where only IgE-associated 
symptoms were considered a positive indication of allergy. In the remaining 23 studies both IgE-
mediated and non-IgE mediated allergy were included in the reported prevalence figures. 
The highest self-reported prevalence of fish allergy was found in Finland, with 7% (95% CI: not 
reported) (Kajosaari 1982) of parents of 1 year olds reporting that their child had an adverse reaction 
to fish. A similar prevalence rate, 6.9% (95% CI: 6.2-7.6%) (Martinez-Gimeno 2000), was found in 6-
13 year olds in a Spanish population. The lowest rate was found in Denmark where only 0.2 % (95% 
CI: 0-1%) (Osterballe 2009) of 22 year olds reported an adverse reaction to fish, however this study 
only asked about an allergy to cod, and so the neglect of other fish species could account for the low 
prevalence. Studies reporting prevalence of clinician diagnosed allergy or a diagnosis based on 
clinical history of fish allergy ranged from 0.2% (95% CI: 0-0.9%) (Pyrhonen 2009) of 1 year olds in 
Finland and 0.2% (95% CI: 0.1-0.4%) (Ostblom 2008 b) of 1 year olds in Sweden to 1.0% (95% CI: 
0.5-2.0%) (Pyrhonen 2009) of 4 and 5 year olds in Finland.  
Looking at sensitisation, the highest prevalence of fish sensitisation as detected by skin prick tests was 
seen in Finland, with 2.7% (95% CI: 1.7-4.2%) (Haahtela 1980) of 15-17 year olds being sensitised. 
The lowest rates were found in the UK where 0% (95% CI: 0-0.3%) (Roberts 2005) of 7 year olds had 
a positive skin prick test to cod, and in Hungary where 0% (95% CI: 0-4.2%) (Bakos2006) of 60-97 
year olds showed sensitisation to cod on a SIgE test. When sensitisation plus a convincing clinical 
history was obtained, the highest rate for fish allergy was 0.6% (95% CI: 0.1-2.5%) 
(Kristjansson,1999) was reported in Iceland at 18 months of age. The lowest rate was found in Turkey 
in 0.2% (95% CI: 0.1-0.5%) of 6-9 year olds (Orhan 2009). Four of the studies that adopted open 
and/or double-blind food challenges to diagnose fish allergy reported 0% prevalence to fish, however 
one study in a Finnish population found a prevalence of 1% (95% CI: not reported) of 6 year olds 
(Kajosaari,1982). 
With regard to crustacean allergy, the prevalence of self-reported crustacean-related adverse food 
reactions ranged from 0.3% (95%CI: 0.1-1.0%) of 11 year olds in the UK (Pereira, 2005) to 5.5% 
(95%CI: 4.3-7.1%)   of 5-17 year olds in France (Touraine, 2002). Sensitisation rates for crustacean 
allergy were similar in Germany 1.9% (95% CI: not reported) based on skin prick tests (Schafer, 
2001) and Hungary 1.8% (95% CI: 0.3-7.1%)) based on SIgE testing (Bakos 2006. Only one study, 
conducted in Denmark, reported challenge proven prevalence data for crustacean allergy, which found 
a prevalence of 0% (95% CI: 0.0-2.0%) in 0-22 year olds and 0.3% (95% CI: 0.1-1.0%) in individuals 
22 years or older (Osterballe, 2005). 
Where mollusc allergy is concerned, only three studies collected data on self-reported mollusc-related 
adverse reactions in Europe, with the highest prevalence reported in France where 1.5% (95% CI: 0.9-
2.4%) of 5-17 year olds reported an allergy to oysters (Touraine 2002) and the lowest prevalence in 
Denmark, with only 0.4% (95% CI: 0.1-1.1%) of 22 year olds self-reporting an allergy to octopus 
(Osterballe 2009). Prevalence of allergy to mollusc, as diagnosed using positive SPT and convincing 
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clinical history, was presented by only one study, conducted in Germany, which reported a prevalence 
of 0% (95% CI: 0.0-0.2) for mussel allergy (Zuberbier 2004). There were no studies in Europe that 
adopted food challenges to confirm mollusc allergy. 
1.2.6.8. Fish and Shellfish prevalence in different regions of the world 
Twenty-seven studies looked at the prevalence of fish and shellfish allergy across the rest of the 
world. Two studies have been conducted in Australia, one in Canada, three in China, one in 
Colombia, one in Ghana, one in Hong Kong, one in Israel, two in Korea, eight in South-East Asia, 
two in Taiwan, one in the United Emirates, and the rest of the studies were all conducted in the USA. 
Data was published between 1998 and 2012 with participant ages ranging from 0- 83 years of age. 
Self-reported allergy was presented in 16 studies, 10 studies combined clinical history with a clinician 
diagnosed seafood allergy, seven studies measured sensitisation rates, with a further three studies also 
taking into account a convincing clinical history as well as sensitisation. Only two studies adopted 
food challenges to confirm suspected allergy. 
IgE-mediated allergy was considered in 11 studies (Ben-Shoshan 2009; Branum 2009; Chen 2011; 
Dalal 2002; Greenhawt 2009; Kim 2011; Lao-araya 2012; Liu 2010; Osborne 2011; Wan 2012; 
Woods 2002). The methods adopted by these studies included skin prick and specific IgE tests to 
assess sensitisation, and food challenges and/or self-reported allergy where only IgE-associated 
symptoms were considered a positive indication of allergy. In the remaining 16 studies both IgE-
mediated and non-IgE mediated allergy were included in the reported prevalence figures. 
The highest prevalence of self-reported fish-related adverse reactions was seen in adults in the United 
States (2.7% (95%CI:1.6-4.7%)) (Greenhawt 2009) compared with 0.6% (95% CI: 0.4-0.8) (Ben-
Shoshan 2010) of adults in Canada. In children in Canada, 0.2% (95% CI: 0.0-0.4%) (Ben-Shoshan 
2010) self-reported a fish allergy, which lowered to 0% (95% CI: not reported) (Ben-Shoshan 2010) 
confirmed with a clinician diagnosed fish allergy. The highest prevalence of clinician diagnosed fish 
allergy in Non-European countries is 2.8% (95% CI: 1.5-5.1%) (Al-Hammadi 2010) seen in 6-9 year 
olds in the United Arab Emirates; the lowest prevalence rates were reported in 0-2 year olds in Israel 
(0% (95% CI: 0-0.1%) (Dalal 2002) and 0-5 year olds in the United States (0% (95% CI: 0.0-0.5%) 
(Sicherer 2004).  
Two studies measured sensitisation, reporting prevalence ranges from 0.2% (95% CI: 0.0-1.3%) 
(Chen 2011) in 0-12 month olds to 0.8 % (95% CI: 0.2-2.5%) (Hu 2010) of 0-2 year olds both in 
China. In Israel, 0% (95% CI: 0.0-0.1%) (Dalal 2002) prevalence of fish allergy was found in 0-2 year 
olds when a convincing clinical history plus sensitisation was the method of diagnosis. Open food 
challenges were performed in 3-7 year olds in Thailand, revealing a 0.2% (95% CI: 0.0-1.4%) 
prevalence of allergy to fish (Lao-araya, 2012). 
With regard to shellfish allergy, self-reported shellfish allergy varied from a very low rate of 0.1% 
(95% CI: not reported) in 5-16 year olds in Ghana (Obeng 2011) to a very high rate of 24.5% (95% 
CI: not reported) in adults in China (Sai 2011). The lowest prevalence for clinician diagnosed 
shellfish allergy was 0.1% (95% CI: 0.0-0.1%) (Ben-Shoshan 2010), for under 18 year olds in 
Canada, and the highest prevalence based on a convincing clinical history was seen in Singapore, with 
5.2% (95% CI: 4.5-6.1%)  of 14-16 year olds suggesting a positive shellfish allergy (Shek 2010). 
Based on a positive skin prick test, crustacean sensitisation was 0% (95% CI: 0-1.6%) in 0-2 year olds 
from China (Hu 2010) compared with 17.3% (95% CI: 15.1-19.8%) of Taiwanese 6-8 year olds 
sensitised to lobster, determined using serum specific IgE testing (Wan 2012). Despite the large 
number of studies looking at the prevalence of shellfish allergy based on self reports of adverse 
reactions, convincing clinical history and a clinician diagnosis, only one study was found to perform 
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open food challenges to crustaceans, reporting a prevalence between 0.2% (95% CI: 0.0-1.4%) for 
crab and 0.9 (95% CI: 0.3-2.4%) for shrimp in 3-7 year olds in Thailand (Lao-araya 2012).  
Self-reported mollusc allergy was found to be 0.2% (95% CI: 0.0-1.4) for 3-7 year olds in Thailand 
(Lao-Araya 2012). In Taiwan, mollusc allergy defined by a clinician diagnosis varied from 0.1% 
(95% CI: 0.0-0.8) in under 3 year olds to 1.5% (95% CI: 1.3-1.7) in adults (Wu 2012). Sensitisation, 
as determined by serum-specific IgE testing, has been reported for 6-8 year old children in Taiwan for 
scallop (24.9% (95% CI: 22.2-27.7%)) and abalone (25.1% (95% CI: 22.4-27.9%)) sensitised to 
mollusc (abalone) (Wan 2012). There were no studies conducted outside of Europe reporting data on 
challenge proven mollusc allergy. 
Six studies reported seafood allergy, which one can only presume to include both fish and shellfish 
allergy, with the highest prevalence rate found in Colombia with 4% (95% CI: 3.3-4.7%) of all ages 
self-reporting an allergy (Marrugo 2008). The lowest prevalence was seen in Korea, with 0.4% (95% 
CI: 0.3-0.4%) of 6-12 year olds self-reporting a seafood allergy (Oh 2004). In addition, one study 
from China reported high prevalence of allergy to fish 11.2% (95% CI: 10.7-11.8%) crab 24.5% (95% 
CI: 23.8-25.3%) and shrimp 10.0% (95% CI: 9.5-10.6%) (Sai 2011) however data was calculated by 
IgG measurements, which do not report allergy. Furthermore, it was not clear how the clinical history 
was taken. Hence, caution should be taken when interpreting these findings.  
1.2.6.9. Fruit allergy prevalence across Europe 
A large number of studies (n=14) reported on fruit and in some cases vegetable allergies. Within 
Europe, the countries where the studies were performed include: Denmark, Finland, France, Germany, 
Greece, Hungary, Iceland, Norway, Portugal, Spain, Sweden, The Netherlands, Turkey and the UK. 
The data was published from 1982 to 2012 and the age range of the participants ranged from birth – 
97 years. 
 
A large variety of fruits have been studied including: a mixture of fruit and vegetables (n=13), apple 
(n=5), citrus/orange fruits (n=11), strawberry (n=6), kiwi (n=3), pear (n=3), apricot (n=1) , cherry 
(n=2) , grape (n=2), nectarine (n=1), peach (n=4), plum (n=2), banana (n=8), and pineapple (n=1). A 
number of these fruits have been implicated in Oral Allergy Syndrome (pear, apple, cherry and peach) 
and banana has been shown to cross react with latex, although this is outside the remit of this report. 
 
The highest rate of citrus fruit allergy, 11% (95%CI: not reported), was reported using a self-report 
method in a sample of 3 year old children in Finland (Kajosaari 1982). In the same study, using open 
food challenges, the prevalence of citrus fruit allergy was 2% (95%CI: not reported) in 6 year old 
children. This was the only study to use food challenges to diagnose citrus fruit allergy in a paediatric 
sample). Only two studies used food challenges, reporting a prevalence of 2% (95% CI: not reported) 
in 6 year olds in Finland (Kajosaari 1982) and 0% (95% CI: 0.0-0.1%) of adults in Turkey (Gelincik 
2008). 
 
Strawberry allergy was examined in six studies. Similar to the pattern for citrus fruits, the highest 
rates were presented for young children in Finland: 7% (95% CI: not reported) at age 1,  4% at age 2 
and 7% at age 3 years, however all were measured using self-report methods (Kajosaari 1982). Lower 
rates of self-reported strawberry allergy were reported for adults in Turkey (0.7% (95% CI: 0.5-
0.8%)), which translated to a 0% (95% CI: 0.0-0.1%) prevalence when diagnosis was made using 
DBPCFC (Gelincik 2008). Similarly low rates 0% (95% CI: 0.0-0.2%) were reported in children in 
Turkey using DBPCFC (Orhan 2009). 
 
Kiwi fruit, which is sometimes cited as the “15
th
” major allergen was found to have a 0.8% (95% CI: 
0.5-1.0%) allergy prevalence in a sample children in France, using a self report method (Rance 2005). 
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The only other studies examining kiwi allergy prevalence were both conducted with children in 
Turkey. One study identified the prevalence of self-reported kiwi allergy as 0.3% (95% CI: 0.1-0.6%) 
decreasing to 0.1 % (95% CI: 0-0.4%) when a DBPCFC method was employed (Orhan 2009). More 
recently, a prevalence of 0.1% (95% CI: 0.0-0.8%) was also found using open food challenges 
(Mustafayev 2012). 
 
It is difficult to truly distinguish IgE mediated from non-IgE mediated food allergies or even chemical 
intolerances in fruit induced reactions.  Nineteen studies in Europe report to have studied both IgE and 
non-IgE mediated reactions but only ten of these reported to have performed SPT or specific IgE tests 
and it was not clear if these tests have been performed to the fruit in question. Only two studies have 
reported IgE mediated reactions and both have utilised SPT/specific IgE testing, but it was once again 
not clear if these tests have been carried out the fruit in question. 
1.2.6.10. Fruit allergy prevalence in different regions of the world 
There were a total of 16 studies conducted in countries outside Europe that reported fruit allergy 
prevalence rates. The countries where the studies were performed include Australia, Canada, China, 
Colombia, Ghana, Hong Kong, Israel, Korea, Taiwan, United Arab Emirates and the United States. 
The data was published from 1987 to 2012 and the age range of the participants ranged from birth – 
44 years. 
 
In addition to the fruits that were reported as allergens in Europe (orange, apple, banana, pineapple, 
peach, grape, kiwi, strawberry and “fruits” not specified), additional fruit allergies were reported in 
these non-European countries. These were pawpaw, mango and melon in Ghana (Obeng 2011); 
mango, melon and litchi in Taiwan (Wu 2012), “fruit juice” in USA (Bock 1987) and “dried fruit” in 
Australia (Woods 1998). Conversely, cherry, plum and apricot were reported as causing adverse 
reactions in Europe, but not in countries outside. 
 
Food challenges were rarely used, with the majority of studies reliant on self-report methods. The 
highest prevalence rate was 10.8% (95% CI: 8.3-14%), which was reported to fruit juice in a study of 
one year old children in the United States (Bock 1987), which converted to a 7.9% (95% CI: 5.7-
10.8%) rate of “probable or convincing allergy” using a combination of SPT, sIgE, clinical history 
and food challenge. Indeed, this study was the only one to use food challenges as a method of 
diagnosis. Skin prick testing was only used by two further studies; Chen 2011 (orange) and Dalal 
2002 (strawberry) and sIgE by one study (Wan 2012) (lychee, melon and grape), perhaps reflecting 
the lack of valid diagnostic tests available for fruit allergens. 
 
As with the studies from Europe, it is very difficult to say with certainty if the fruit-related reactions 
were IgE mediated or not. Three studies reported on both IgE and non-IgE mediated reactions, but 
only one study tested for the presence of IgE and it is not clear if the test were performed to the 
particular fruit. Thirteen studies reported on IgE mediated reactions but only five of these tested 
SPT/Specific IgE, once again it was not clear if the reactions were IgE mediated or not. 
1.2.6.11. Milk/dairy allergy prevalence across Europe 
In total, forty studies looked at the prevalence of cow‟s milk allergy in Europe. The studies were from 
Denmark, Estonia, France, Finland, Germany, Greenland, Hungary, Iceland, Ireland, Italy, Norway, 
Portugal, Spain, Sweden, The Netherlands, Turkey and the United Kingdom. Data was published 
between the years 1982 and 2012 and included all age groups. 
 
Twenty-two studies reported prevalence rates based on self (or parentally) reported allergy. The 
highest self-reported rate of cow‟s milk allergy was 21% (95% CI: 19.9-22.1%), in a large Spanish 
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study of 6-13 year old children (Martinez-Gimeno 2000). The lowest rate of parentally reported cow‟s 
milk allergy was 0% (95% CI: 0-6.1%) in Ireland (Kilgallen 1996), however this was in a study of 
infants aged 0-6 months, which is an age at which symptoms may not yet have fully manifested. The 
same study reported a 0% (95% CI: 0-3.1%) prevalence of parentally reported allergy to yoghurt at 
age 24-36 months old. The lowest self-reported prevalence was found in a large study of adults in 
Turkey (0.2% (95%CI: 0.2-0.4%)) (Gelinicik 2008). 
 
Seventeen studies reported sensitisation rates; seven using sIgE, ten using SPT only and three using 
both SPT and sIgE.  The highest rate of positive sIgE was 25.8% (95% CI: not reported) in 2 year old 
children in Estonia (Julge 2001), although very surprisingly 0% (95% CI: not reported) of this sample 
had positive skin prick tests, which was the lowest reported level of positive SPT overall. The lowest 
rate of positive sIgE in adults was 1.0 (95% CI: 0.0–5.5) (Isolauri 2004). The lowest rate of positive 
sIgE in children was 0.5% (95% CI: 0.2-1.2%) in a study of children aged 5-18 years from Greenland 
(Krause 2002). The highest rate of positive SPT in adults was 14.7% (95% CI: 8.9-23.0%) in Hungary 
(Bakos 2006) and in children 3.9% (95%CI: 2.9-5.2%), in a study of German children aged 5-6 years 
(Schafer 1999).  
 
Prevalence of milk/dairy allergy as determined by sensitisation (SPT or specific IgE) plus clinical 
history was reported in six studies.  The only study to do so in an adult population reported a rate of 
0.1% (95%CI:0.0-0.3%) based on SPT and history (Zuberbier 2004). A prevalence of 0.2% (95% CI: 
0.0-0.8%) was reported in 8-18 month old infants in Turkey using specific IgE testing and history 
(Kucukosmanoglu 2008b). One study assessed the prevalence in older children, aged 4 years old, 
finding a prevalence of 1.8% (95% CI: 1.3-2.4%) (using specific IgE testing and history) in Sweden 
(Ostblom 2008a).  
  
Twelve studies used either open or double blind food challenges. The highest rates of challenge-
proven cow‟s milk allergy was 2.3% (95% CI: 1.5-3.3%) in a Dutch study of infants (Schrander 
1993). The lowest prevalence rate reported was 0.0% (95% CI: 0.0-4.2%), in a study of <3 year old 
children in Denmark (Osterballe 2005). In an adult population from Turkey, one study reported a 
prevalence of 0.0% (95%CI: 0-0.4%) using history and DBPCFC (Gelincik 2008). The highest rate in 
adults was 0.2% (95% CI: 0.1-1.0%) in a study conducted in Denmark (Osterballe 2005). One study 
used atopy patch testing (Ronchetti 2008) and reported a prevalence rate of 4.1 % (95% CI: 1.9-8.2%) 
in 13 year old children. 
 
Milk allergy is by far the most difficult food allergy to classify in terms of IgE and non-IgE mediated 
symptoms. It is the clinically most complex food allergy seen in young children with many of them 
suffering from both IgE and non-IgE mediated symptoms. Twenty-nine studies reported symptoms of 
both IgE and non-IgE mediated cow‟s milk allergy with only 14 studies confirming the presence of 
IgE by SPT or specific IgE testing. Nine studies reported rates of IgE mediated cow‟s milk allergy 
only and these studies have all utilised SPT or specific IgE tests. 
1.2.6.12. Milk/dairy allergy prevalence in different regions of the world 
Twenty-nine studies looked at the prevalence of cow‟s milk allergy outside Europe. This included 
studies from Australia, Canada, China, Colombia, Ghana, Hong Kong, Israel, Korea, Taiwan, 
Thailand, United Arab Emirates and United States of America. Data was published between the years 
1973 and 2012 and included all age groups. 
 
Fourteen studies reported prevalence rates based on self (or parentally) reported allergy. The highest 
rates in children and adults were both reported in studies from the USA; 13.1 % (95% CI: 10.3-
16.6%) for a group of one year olds (Bock 1987) and 10.5% (95%CI: 8.1-13.6%) in a study of adults 
(Greenhawt 2009). The lowest parentally reported prevalence rate was 0.2% (95% CI: not reported) in 
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a study of 5-16 year old children in Ghana (Obeng 2011).The lowest self reported rate in adults was 
1.9% (95% CI: 1.56-2.21%) in a Canadian study (Soller 2012). 
 
Eight studies reported sensitisation rates; four using sIgE and four using SPT. No studies measured 
both sIgE and SPT.  A study conducted in the US reported the highest rate of positive sIgE in adults 
(4.9% (95% CI: not reported)) and children (22% (95% CI: not reported)) (Liu 2010).  The only study 
that measured SPT in adults (Woods 2002), reported a sensitisation rate of 0.7% (95% CI: 0.2-2.1%). 
In children, the lowest sensitisation rate using SPT was 2.7% (95% CI: 1.5-4.7%) in China (Chen 
2011) and the highest 6.5% (95%CI: 4.4-9.6%), also in China (Hu 2010). 
 
Sensitisation plus clinical history was reported as a method of diagnosis in only three studies, the first 
of which reported a 0% (95% CI: 0-1.0%) prevalence rate in a sample of adults in Australia. A similar 
prevalence, 0.3% (95% CI: 0.2-0.5%), was reported by a study of children aged 0-2 years old in Israel 
(Dalal 2002). A study of children aged 6-8 years in Taiwan reported much higher prevalence rates of 
between 6.2-14.5% using sIgE plus clinical history (Wan 2012). 
 
Three studies used open food challenges to determine the prevalence of milk/dairy allergy. A study of 
3-7 year olds in Thailand reported the lowest prevalence rate, 0% (95% CI: 0-1.1%), of confirmed 
milk allergy (Lao-araya 2012). The other two studies (Hu 2010, Chen 2011) were both conducted in 
infants in China and reported prevalence rates of 3.5% (95% CI: 2-5.9%) and 1.3% (95% CI: 0.5-
2.9%) respectively. 
 
Bock 1987 reported a prevalence of 5% (95% CI: 3.3-7.4%) in one year old children using a 
combination of history, SPT and oral food challenge to determine a diagnosis of “probable or 
confirmed” food allergy. Similarly, Chen 2012 reported a prevalence of 3.5% (95% CI: 2.2-5.4%) in 
children under 2 years old in China, using a combination of clinical history and/or SPT and/or oral 
food challenge and/or elimination diet. A study of 0-2 year old children in Israel reported a lower 
prevalence rate of 1.1% (95% CI: 0.9 – 1.2), also using a combined method of a clear history, SPT 
and/or food challenge (Katz 2010).One study used IgG tests to diagnosis cow‟s milk allergy, reporting 
a very high prevalence rate of 24.5% (95% CI: 23.8-25.3%) in adults in China (Sai 2011), although as 
noted before prevalence data from IgG testing should be interpreted with caution.  
 
The picture of IgE vs. Non-IgE mediated cow‟s milk allergy is very different in the rest of the world 
than what is reported in Europe. Twenty one studies reported on IgE mediated cow‟s milk allergy, 
with eight studies not confirming the presence of IgE by appropriate tests. Only five studies reported 
on symptoms of both IgE and non-IgE mediated cow‟s milk allergy and three of these did not test for 
the presence of IgE. One study used IgG tests for diagnosis. 
1.2.6.13. Mustard allergy prevalence across Europe 
There was only one study which examined the prevalence of allergy to mustard. This was conducted 
in a French population of 5-17 year olds, 3% (95% CI: 2.1-4.3%) of which self-reported adverse 
reactions to mustard (no distinction was made between likely IgE or non-IgE mediated reactions; 
Touraine 2002). 
1.2.6.14. Mustard allergy prevalence in different regions of the world 
There were no studies on mustard allergy in other regions of the world. 
1.2.6.15. Peanut allergy prevalence across Europe 
The peanut allergy prevalence data was derived from 11 countries, including Denmark, France, 
Germany, Greenland, Hungary, Iceland, Norway, Sweden, The Netherlands, Turkey and the UK. The 
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data was published from 1996 to 2012 and the age range of the participants ranged from birth – 97 
years.  
 
Fifteen studies looked into the self-reported prevalence of peanut allergy. The lowest prevalence rate, 
0% (95% CI: 0-1.5%) was reported in 18 month olds from Iceland (Kristjansson 1998). The highest 
was reported for a group of 15-17 year olds from France ((15% (95%CI:13-17.3%)) (Touraine 2002). 
Two studies, both conducted in the UK, reported prevalence based on a clinical history of peanut 
allergy. This ranged from 0.2% in 0-14 year olds (Emmett 1999) to 0.4% in 4-6 year olds (Lack 2003) 
to 0.5% in those older than 15 years (Emmett 1999). Only one study focussed on clinician diagnosed 
peanut allergy with the lowest prevalence figures seen in 1 year olds from Sweden (0.2% (95% CI: 
0.1-0.4)) (Ostblom 2008) and the highest from 8 year olds in the same study (4% (95%CI:3.4-4.8)) 
(Ostblom 2008).  
 
Thirteen studies reported prevalence of peanut sensitisation based on skin prick test results and seven 
determined by serum-specific IgE levels. In the younger cohorts (0-3 years old), the rates of positive 
SPT ranged from 0.4% (95% CI: 0.0-1.2%) (Venter 2008) to 2.8% (95% CI: 1.5-5.3%) (Ro 2012). In 
the older children (>3 years) positive SPT results ranged from 0.7% (95% CI: 0.5-1.0%) (Mustafayev 
2012) to 5.1% (95% CI: 3.8-6.8%) (Nicolaou 2010). In adults, the sensitisation rates determined by 
positive SPT were between 6.4% (95% CI: 2.8-13.2%)(Bakos 2006) and 6.8%  (95% CI:not reported) 
(Schafer 2001). Similarly, for specific IgE levels, in the younger cohorts (0-3 years old) only one 
study from Norway determined specific IgE levels in younger children reporting a rate of sensitisation 
of 3.4% (95% CI: 1.9 – 6%) (Ro 2012). In the older children (>3 years) prevalence of sensitisation to 
peanut ranged between 2.6 % (95% CI: 1.8 – 3.8%) (Krause 2002) and 12.2% (95% CI: 9.7 – 15.2%) 
(Nicolaou). In adults sensitisation rates to peanut were reported between 0% (95% CI: 0 – 12.0%) 
(Bakos 2006) and 3.1% (95% CI: 2.3 – 4.2%) (Bjornsson 1996).  
 
Six studies based peanut allergy prevalence rates on a good clinical history plus a positive SPT. The 
prevalence rates determined using this method ranged from 0.0% in 18 month olds in Iceland (95% 
CI: 0-1.5%) (Kristjansson 1999) and 18 years olds in Turkey (95% CI: 0.0 – 0.1%) (Gelincik 2008) to 
0.6 (95% CI: 0.4-1.0%) in a whole population in Germany (Zuberbier 2004). Only one study based 
peanut allergy prevalence rates on a good clinical history plus a positive serum specific IgE result. 
This study was conducted in Sweden and found a prevalence of 2.4% (95% CI: 1.9-3.1%) (Ostblom 
2008a) 
 
Five studies used open food challenge and a good clinical history and eight studies used a good 
clinical history plus DBPCFC to diagnose peanut allergy. Based on OFC and a good clinical history 
the highest prevalence rate was 1.4% (95% CI: 0.9-2.3%) reported in 3-4 year olds children (Grundy 
2002) and based on DBPCFC and history the highest prevalence rate reported was 2.8% (95% CI: 
1.8-3.8%) in 3-6 year old children (Hourihane 2007). Both of these studies were conducted in the UK. 
Four studies utilised a good clinical history plus positive SPT, and/or a positive food challenge (either 
OFC or DBPCFC) to determine prevalence rates. The highest rate was reported by Nicolaou 2010 in 8 
year old children as 1.9% (95%CI:1.2-2.9%).                                                                          
 
Peanut allergy is classically considered to be an IgE-mediated allergy. Of the studies examining the 
prevalence of peanut allergy in Europe, 15 assessed both IgE and non-IgE mediated peanut allergy 
(although in two of these studies, they did not perform tests to determine the presence or absence of 
IgE) and 13 IgE-mediated allergy only. 
1.2.6.16. Peanut allergy prevalence in different regions of the world 
A number of studies outside of Europe have looked at the prevalence rates of peanut allergy. The 
countries included Australia, Canada, China, Ghana, Hong Kong, Israel, Korea, Philippines, 
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Singapore, Taiwan, United Emirates and the USA. The studies were published between 1987 and 
2012 and included all ages.  
 
Nine studies looked into the self-reported prevalence of peanut allergy. The lowest prevalence rate 
(0.1% (95% CI: 0.1-0.2%)) was reported in 12 – 15 year olds from Korea (Oh 2004) and the highest 
in an adult group from the US (8.4% (95% CI: 6.2%-11.2%)) (Greenhawt 2009). Seven studies, 
mostly questionnaire based studies from the US and Canada, reported prevalence based on a reported 
clinical history (in some cases with reported history of a clinician diagnosis) of peanut allergy ranging 
from 0.1% (95% CI: 0.0 – 0.2%) in 0-2 years olds in Israel (Dalal 2002) to 2.8% (95% CI: 2.3 – 
3.4%) in 3-5 year olds in the US (Gupta et al. 2011). Only three studies focussed on clinician 
diagnosed peanut allergy with the lowest prevalence figures reported in a study of adults from Canada 
(0.3% (95%CI:0.18-0.34)) (Ben-Shoshan 2010) and the highest in a study of 6-9 year olds from the 
UAE (2.3% (95%CI:1.1-4.4)) (Al-Hammadi 2010).  
 
Five studies reported data on skin prick test results and four studies determined specific IgE levels. In 
the younger cohorts (0-3 years old), the rates of positive SPT ranged from 0.3% (95% CI: 0.0-2.1%) 
(Hu 2010) to 6.4% (95% CI: 5.5-7.3%) (Osborne 2011). Woods 2002 reported figures of 5.7% (95% 
CI: 3.8-8.3%) in adults in Australia and Arbes 2005 a figure of 8.6% (95% CI: 8.1-9.2%) in all ages in 
the US, indicating the lack of studies of using SPT data in countries outside of Europe. Different age 
cut-offs were used to describe sensitisation rates to peanut allergens measured by specific IgE levels, 
but Kumar 2011 report a very high sensitisation rate of 13.5% (95% CI: 11.6-15.7%) in children 
under 6 years in the US. The highest reported sensitisation rates in adults were 8.7% (95% CI: not 
reported) in 20 – 39 year olds in the US (Liu 2010). This study also reported a sensitisation rate of 
7.6% (95%CI:not reported) for all ages (Liu 2010). 
 
Only two studies based peanut prevalence rates on a good clinical history plus a positive SPT. Dalal 
2002 found no peanut allergy in 0-2 year olds in Israel and Woods 2002 reported a rate of 0.4% (95% 
CI: 0.1-1.8%) in 26-50 year olds in Australia. In the only study outside of Europe to utilise food 
challenges to assess the prevalence of peanut allergy Osborne 2011 2.9% (95% CI: 2.2-3.5) of 12-15 
month olds had peanut allergy, based on open food challenges. Four studies utilised other methods to 
diagnose peanut allergy. These studies have used varied methodologies which makes them difficult to 
compare, but the prevalence rates reported range between 0.3% in an elderly US population (Liu 
2010)  up to 2.7% (95% CI: not reported) in 6-19 year olds in the US. 
 
Peanut allergy is classically considered to be an IgE-mediated allergy. Of the studies examining the 
prevalence of peanut allergy outside of Europe, two assessed both IgE and non-IgE mediated peanut 
allergy. The remainder of the studies assessed IgE-mediated allergy only, although of these nine did 
not utilise SPT or SIgE to determine the presence or absence of IgE and one did not clearly define 
how they determined that the allergy was IgE-mediated. 
1.2.6.17. Sesame allergy prevalence across Europe 
Studies looking at the prevalence of sesame allergy in Europe were from four countries: France, 
Germany, Hungary and the United Kingdom. Eight studies from Europe were reported between 1999 
and 2008 and all ages were studied. 
 
Self-reported sesame allergy was investigated in three studies, with the highest prevalence seen in 
France where 1.5% (95% CI: 0.9-2.4%) of 5-17 year olds self-reported an adverse reaction (Touraine 
2002). The lowest rate was found in the United Kingdom where, across all age groups, 0% (95% CI: 
0.0-0.1%) self-reported sesame allergy (Emmett 1999).  Sensitisation to sesame measured by SPT was 
reported in four studies. Roberts 1999 reported the lowest rate of sensitisation, 0.1% (95% CI: 0.0-
0.5%), in 7-year-old children in the UK and Venter 2008 the highest, 1.4% (95% CI: 0.7-2.7%), in 3 
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year olds also from the UK. Only one study determined specific IgE levels to sesame and found 0% 
(95% CI: 0.0-4.2%) of the 60-97 year olds in Hungary investigated were sensitised (Bakos 2006).  In 
Germany, a population based study reported prevalence rates based on a positive skin prick test plus a 
convincing clinical history of 2.2% (95% CI: 1.7-2.7%) (Zuberbier 2004). In the United Kingdom, 
two studies challenged those with suspected sesame allergy reporting prevalence of between 0.1% 
(95% CI: 0.0-0.8%) in 6 year olds (Venter 2006) and 0.6% (95% CI: 0.2-1.4%) in 3 year olds (Venter 
2008). Pereira 2005 performed a DBCPCFC to sesame in a 15-year old on the IOW, who did not have 
a positive result (not shown in table). 
 
For those studies examining the prevalence of sesame allergy in Europe, six looked at both IgE and 
non-IgE mediated allergy (one of which did not utilise SPT or SIgE to determine the presence or 
absence of IgE) and two IgE-mediated allergy only. 
1.2.6.18. Sesame allergy prevalence in different regions of the world 
Only four studies that investigated the prevalence of sesame allergy could be identified in other 
regions of the world, these were from Australia, Canada, Israel and the United States. Studies were 
reported between 2002 and 2011 and all ages were studied. Self reported sesame allergy was 
investigated in a Canadian study, with the highest prevalence reported in children under the age of 18 
years 0.2% (95% CI: 0.0-0.4%) (Ben-Shoshan 2010) and the lowest rate in adults 0.1% (95% CI: 0.0-
0.1%) (Ben-Shoshan 2010). Sensitisation (determined by skin prick test) to sesame was observed in 
1.6% (95% CI: 1.2-2.1%) of 12-15 month olds in Australia (Osborne 2011).  Three studies looked at a 
clinical history of sesame allergy and reported figures ranging from 0% (95% CI: 0.0-0.1%) in the US 
(Sicherer 2010) to 0.2% (95% CI: 0.0-0.4%) in Canada (Ben-Shoshan 2010) and 0.2% (95% CI: 0.1-
0.3%) in Israel (Dalal 2002). Two studies reported prevalence rates for sesame allergy based on open 
food challenges, with a study conducted in the UK reporting prevalence rates of 0.6% (95% CI: 0.2-
1.4) in 3 year olds and 0.1% (95% CI: 0-0.8) in 6 year olds (Venter 2008), and a study conducted in 
Australia reporting a rate of 0.7% (95% CI: 0.4-1.0) in 12-15 month olds (Osborne 2011). For those 
studies examining the prevalence of sesame allergy outside of Europe, two looked at both IgE and 
non-IgE mediated allergy (one of which did not utilise SPT or SIgE to determine the presence or 
absence of IgE) and two IgE-mediated allergy only. 
1.2.6.19. Soya allergy prevalence across Europe 
There were 15 studies that looked at soya allergy prevalence across Europe. The countries included 
Denmark, Germany, Hungary, Iceland, Sweden, The Netherlands and the United Kingdom. The data 
was reported from 1994 to 2008 and all ages were included.  
 
Eight studies reported prevalence based on self-reported soya allergy with the highest prevalence 
reported by a study conducted in Sweden in 4 year olds (1.2%, 95% CI: 0.8-1.7%) (Ostblom 2008a) 
and the lowest prevalence reported by a study conducted in the United Kingdom, with 0% (95% CI: 
0.0-0.1%) of those older than 15 years self-reporting an adverse reaction to soya (Emmett 1999). Only 
one study reported the prevalence of clinician diagnosed soya allergy, which found the following 
prevalence rates: 0.2% (95% CI: 0.1-0.4%) in 1 year olds and 0.8% (95% CI: 0.5-1.2%) in 4 and 8 
year olds in Sweden (Ostblom 2008a). 
 
Four studies reported sensitisation data based on a positive skin prick test with the highest 
sensitisation rate reported by a Hungarian study of 20-69 year olds (8.3%, 95% CI: 2.2-23.6%) (Bakos 
2006) and the lowest in a group of 7 year olds from the United Kingdom, with only 0.2% (95% CI: 
0.0-0.7%) having a positive skin prick test to soya. Four studies used serum-SIgE tests and reported 
sensitisation rates ranging from 2.1% (95% CI: 1.4-3.0%) in a group of 20-44 year olds in Sweden 
(Bjornsson 1996) to 3.7% (95% CI: 1.2-9.7%) in 60-97 year olds in Hungary (Bakos 2006). When a 
University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506    108 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
convincing history was combined with sensitisation, prevalence of soya allergy ranged from 0% (95% 
CI: 0.0-1.4%) in 18 month olds in Sweden (Kristjansson 1999) to 1.6% (95% CI: 1.1-2.1%) of 4 year 
olds, also in Sweden (Ostblom 2008a). Only one study performed a double-blind placebo-controlled 
food challenge, reporting 0% prevalence to soya in 0-22 year olds (Osterballe 2009). For those studies 
examining the prevalence of soya allergy in Europe, ten looked at both IgE and non-IgE mediated 
allergy (two of which did not utilise SPT or SIgE to determine the presence or absence of IgE) and 
five IgE-mediated allergy only. 
1.2.6.20. Soya allergy prevalence in different regions of the world 
There were 13 studies conducted in Canada, China, Ghana, Israel, Korea, Taiwan, Thailand and the 
United States. The data was published from 1987 to 2012 and all ages were included. Seven studies 
presented data for self-reported adverse reactions to soya with the lowest rate found in Korea; 
affecting in 0.1% (95% CI: 0.1-0.2%) of 12-15 year olds (Oh 2004). The highest rate was reported by 
Bock 1987, with 2.7% (95% CI: 1.2-4.2%) of 0-3 year olds in the United States reporting soya 
allergy. Four studies reported the prevalence of soya allergy based on clinical history and/or clinician 
diagnosis soya allergy with 0% (95% CI: 0.0-0.2%) of 0-2 year olds in Israel (Dalal 2002) and 0.6% 
(95% CI: 0.4-0.8%) of 11- 13 year olds in the United States (Gupta 2011) diagnosed with soya 
allergy. One study reported sensitisation based on skin prick test data, with sensitisation rates varying 
from 0.5% (95% CI: 0.1-2.1%) in 0-2 year olds in 2009 to 1% (95% CI: 0.3-3.1%) of 0-2 year olds in 
1999 (Hu 2010). One study combined clinical history and sensitisation reporting a prevalence of soya 
allergy of 0% (95% CI: 0.0-0.1%) in 0-2 year olds in Israel (Dalal 2002). No studies outside of 
Europe used food challenges to confirm soya allergy. One study measured IgG levels reporting a 
prevalence of 7.2% (95% CI: 6.6-7.7%) of adults in China (Sai, 2010) however caution should be 
applied to these results as IgG is not a true and accurate measure of food allergy. For those studies 
examining the prevalence of soya allergy outside of Europe, 11 looked at both IgE and non-IgE 
mediated allergy (seven of which did not utilise SPT or SIgE to determine the presence or absence of 
IgE), four IgE-mediated allergy only and one IgG-mediated only. 
1.2.6.21. Tree Nuts allergy prevalence across Europe 
The tree nut prevalence data was derived from 11 countries, including Finland, Germany, Greenland, 
Hungary, Iceland, Norway, Spain, Sweden, The Netherlands, Turkey and the UK. The data was 
published from 1982 to 2009 and all ages were included. The discussion will divide the results into all 
nuts- unspecified, hazelnuts, walnuts, almond, pistachio nuts, brazil nuts, cashew nuts and pecan nuts. 
 
All nuts unspecified 
Studies where the particular nut(s) studied were not reported have mainly focussed on self-reported 
“nut” allergy. The lowest rate of self-reported nut allergy was in Turkey amongst a group of adult 
respondents (0.1% (95% CI: 0-0.6%) (Gelincik 2008) and the highest rates were reported in Spain 
amongst 6-13 year olds (6.9% (95% CI: 6.2-7.6%)) (Martinez-Gimeno 2000).  
 
Only one study (conducted in Sweden) reported results based on SPT and a clinical history, which 
found that no parents reported their 18 month old to have a “nut” allergy (Kristjansson 1999). In 
addition, one study looked at clinician diagnosed nut allergy and found that 0.1% (95% CI: 0-0.6) of 
one year olds, 0% (95% CI: 0-0.6%) of two year olds, 0.5% (95%CI: 0.2-1.4%) of three year olds and 
0.4% (95% CI: 0.1-1.2%) of four year olds in Finland suffered from a “nut” allergy (Pyrhonen 2009). 
For those studies examining the prevalence of unspecified tree nut allergy in Europe, all ten looked at 
both IgE and non-IgE mediated allergy, six of which did not utilise SPT or SIgE to determine the 
presence or absence of IgE. 
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Hazelnuts 
Nine studies have examined the prevalence of hazelnut allergy. The lowest rate of reported hazelnut 
allergy was amongst 6-9 year olds in Turkey (0.3% (95% CI: 0.1-0.6%)) (Orhan 2006) and the highest 
rates amongst 10-11 year olds, also in Turkey (1.5% (95%CI:1.2-1.8%)) (Mustayev 2012). 
Sensitisation to hazelnut was tested by using SPT in five studies, with the lowest rates reported by 
Roberts 2005 in a 7-year-old cohort in the UK (0.1% (95%CI:0-0.5%)) and the highest in a group of  
of 25-74 year olds in Germany (11.3% (95% CI: not reported)) (Schafer 2001). Only one study 
measured specific IgEs to hazelnut in an adult and elderly population in Hungary and found rates of 
0.0% – 9.7% with the highest figures seen in the 60 – 97 year group (Bakos 2006). When prevalence 
rates were determined by combining SPT and a good clinical history (four studies), the lowest rates 
were reported for those older than 18 years in Turkey (0% (95% CI: 0-0.1%)) (Gelincik 2008) and the 
highest rates in Germany in a whole population (5.9% (95% CI: 5.1-6.8%), Zuberbier 2004). Utilising 
a good clinical history, positive SPT and/or a positive OFC/DBPCFC, Venter 2008 found that 0.1% 
(95% CI: 0.0-0.2%) of 3 year olds suffer from a hazelnut allergy in the UK. For those studies 
examining the prevalence of hazelnut allergy in Europe, four looked at both IgE and non-IgE 
mediated allergy and five IgE-mediated allergy only. 
 
Walnut allergy 
Only six studies in Europe investigated self-reported rates of adverse symptoms to walnut, 
sensitisation to walnut or prevalence of walnut allergy. In terms of sensitisation, Roberts 2005 found 
that 0.5% (95% CI: 0.3-1%) of 7 year olds in the UK have a positive SPT to walnut (Roberts 2005). 
Bakos 2006 found that 3.7% (95% CI: 1.2-9.7%) of 60 – 97 year olds in Hungary showed 
sensitisation to walnut measured by specific IgE levels (Bakos 2006). A study conducted in Germany 
found that 1.4% (95% CI: 1.1-1.8%) of respondents were diagnosed with a walnut allergy based on 
history and SPT and 1.0% (95% CI: 0.7-1.4%) based on history and a positive DBPCFC outcome 
(Zuberbier 2004).  
 
Three studies from Turkey investigated walnut allergy. Orhan 2009 found that, in a group of 6-9 year 
olds, 0.3% (95% CI: 0.1-0.6%) reported a problem on ingestion of walnut, 0.1% (95% CI: 0.0-0.3%) 
were diagnosed with a walnut allergy based on a good clinical history and positive SPT, and 0.0% 
(95% CI: 0-0.2%) were diagnosed based on DBPCFC and a good clinical history. A further study 
found that 1.2% (95% CI: 1.0-1.5%) of 10 -11 year olds in Turkey reported a problem on ingestion of 
walnut and reported prevalence of 0.4% (95% CI: 0.1-1.2%) based on an OFC and a good clinical 
history (Mustayev 2012). Gelincik 2008 reported that 0.1% (95% CI: 0.1-1.2%) of adults suffered 
from walnut allergy based on DBPCFC outcome and a good clinical history (Gelincik 2008). For 
those studies examining the prevalence of walnut allergy in Europe, two looked at both IgE and non-
IgE mediated allergy and four IgE-mediated allergy only. 
 
Almond 
Five studies in Europe investigated almond allergy. Ostblom 2008a reported that 3.8% (95% CI: 3.1-
4.7%) of 4 year olds in Sweden reported problems with almond. In terms of sensitisation, Venter 2008 
determined that 0.3% (95% CI: 0.0-1.2%) of 3 year olds in the United Kingdom had a positive SPT to 
almond and that 0.2% (95% CI: 0.0-0.9%) of 3 year olds had either a positive SPT with a good 
clinical history and/or a positive OFC/DBPCFC outcome. Also in the UK Roberts 2005 found that 
0.5% (95% CI: 0.2-0.9%) of 7 year olds are sensitised to walnut. Bakos 2009 found that no 60-97 year 
olds in Hungary had positive specific IgE levels to almond. Furthermore, in a study conducted in 
Iceland and Sweden, the prevalence rates for almond allergy in 18 months old were reported to be 0% 
(95% CI: 0-1.4%) and 0% (95%CI:0-1.5%) respectively based on skin prick test and history 
(Kristjansson 1999). For those studies examining the prevalence of almond allergy in Europe, three 
looked at both IgE and non-IgE mediated allergy and two IgE-mediated allergy only. 
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Pistachio 
Only one study in Europe investigated pistachio allergy which reported that 0.8 % (95% CI: 0.6-
1.1%) of 10-11 year olds in Turkey reported a problem on ingestion of pistachio (Musatayev 2012). 
This study examined IgE-mediated allergy only. 
 
Pecan 
Pecan allergy was only reported in one study in Europe, indicating that 0.2% (95% CI: 0.0-0.5%) of 




Sensitisation and allergy to brazil nut was reported in only two, UK-based, studies, one of which 
examined both IgE and non-IgE mediated allergy and the other IgE-mediated allergy. In younger 
children Venter 2008 reported 0.3% (95% CI: 0.0-1.2%) of 3 year olds and 0.2% (95% CI: 0.0-0.9%) 
of 3 year olds to be sensitised to brazil nut. In older children, Roberts 2005 found that 0.5% (95% CI: 
0.3-1%) of 7-year-olds in the UK are sensitised to brazil nut. 
 
Cashew 
Three studies from the UK (one of which examined both IgE and non-IgE mediated allergy and the 
other two IgE-mediated allergy) found that 0.2% (95% CI: 0.0-1.0)  of 3 year olds (Venter 2008), 
0.1% (95% CI: 0.0-0.2%) of 4 year olds (Tarik 1996) and 0.4% (95% CI: 0.2-0.8%) of 7-year olds 
(Roberts 2005) are sensitised to cashew nut. One study confirmed cashew nut allergy by food 
challenge in 0.1% (95% CI: 0.0-0.2%) of 3 year olds (Venter 2008).  
1.2.6.22. Tree Nuts allergy prevalence in different regions of the world 
Nine studies conducted in non-European countries investigated tree nut allergies with the majority of 
studies coming from the US and Canada. The studies were published between 1997 and 2008 and 
included all ages.  
 
All nuts unspecified  
Self-reported allergy to “nuts” was reported in three studies. The lowest rates were reported in 22 – 44 
year olds in Australia (0.6% (95% CI: 0.2-1.6%) (Woods 1998) and the highest rates reported in 4-6 
year olds in Singapore (4.7% (95% CI: 4.1-5.4%)) (Shek 2010). Prevalence of “nut” allergy based on 
clinical history was reported in four studies with the lowest rates from the US in those under 18 years 
old (0.2% (95% CI: 0.1-0.3%)) (Sicherer 1997, Sicherer 2002) and the highest in those over 18 years 
old (1.6% (95% CI: 1.4-1.9%)) (Sicherer 1997). One study from Korea reported the prevalence of 
clinician diagnosed nut allergy in 0-12 months old children to be 0.7% (95% CI: 0.3-1.4%) (Kim 
2011). For those studies examining the prevalence of unspecified tree nut allergy outside of Europe, 
two looked at both IgE and non-IgE mediated allergy and four IgE-mediated allergy only (although 
two did not test for the presence or absence of IgE). 
 
Pistachio allergy 
Only one study conducted outside of Europe reported (IgE mediated) prevalence to a particular tree 
nut. Wan 2012 reported that 2.2% (95% CI: 1.4-3.3%) of 6-8 year old Taiwanese children suffer from 
pistachio allergy based on history and a positive specific IgE level. 
1.2.6.23. All other foods, allergy prevalence across Europe 
Unsurprisingly, allergies to numerous less common foods have been reported in the literature in a 
wide number of countries, both in and outside Europe and at all ages. In Europe, 27 studies looked at 
the prevalence of allergy to “other foods”. The less common food allergens that were reported 
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included (but were not limited to): vegetables, such as peas, tomato, spinach, eggplant and carrot, in 
addition to chocolate, garlic, honey, pork, black pepper, pickle, cocoa, potato, sugar, chicken and 
beef.  Generic terms such as “colourings” “additives “junk food” and “soft drinks” were also reported 
as allergens in the titles of journal articles. The majority of such studies used self-report methods to 
determine prevalence. SPT plus clinical history was used by only two studies reporting prevalence of 
allergies to carob, carrageen and guar gum in adults in Germany (all < 1%) (Zuberbier 2004) and to 
pea of 0% (95% CI: 0.0-1.5%) in 18 month old infants in Iceland (Kristjansson 1999).  
 
Only seven studies used food challenges when reporting prevalence rates (Gelincik 2008; Mustafayev 
2012; Orhan 2009; Osterballe 2005; Venter 2006; Venter 2008; Zuberbier 2004). It is difficult and 
perhaps illogical to combine and summarise these studies due to the heterogenity of the allergens and 
populations studied. However, with the exception of Zuberbier 2004, who reported a 1.8% (95% CI: 
1.4-2.4%) prevalence of challenge proven allergy to “vegetables” (n = 3156), the other six studies all 
reported prevalence rates of less than 0.5%. For those studies examining the prevalence of other food 
allergies in Europe, 25 looked at both IgE and non-IgE mediated allergy (11 of which did not test for 
the presence or absence of IgE) and three IgE-mediated allergy only. 
1.2.6.24. All other foods, allergy prevalence in different regions of the world 
Outside of Europe, 16 studies looked at the prevalence of allergy to “other foods“. The studies were 
conducted in Australia, Canada, China, Colombia, Ghana, Hong Kong, India, Israel, Korea, Taiwan, 
Thailand, United Arab Emirates and the United States. Unusual allergens that were reported in 
countries outside of Europe that were not reported in Europe included cassava, cocoyam, sorghum 
and okra in Ghana (Obeng 2011); perilla seeds and buckwheat in Korea (Kim 2011; Oh 2004); duck 
in Thailand (Santadusit 2005); and monosodium glutamate in Australia (Woods 1998). The majority 
of the studies relied on self-report measures as a means of diagnosis, with none of the studies using 
food challenges. Sai (2011) used IgG as a measure of food allergy, and Leung (2009) reported self-
reported clinician-diagnosed prevalence of allergy to several foods. For those studies examining the 
prevalence of other food allergies outside of Europe, three looked at both IgE and non-IgE mediated 
allergy (one of which did not test for the presence or absence of IgE), twelve IgE-mediated allergy 
only (seven of which did not test for the presence or absence of IgE) and one IgG-mediated allergy 
only. 
1.2.6.25. Prevalence of allergy to any food across Europe 
We have reviewed all the included European studies in our systematic review to identify those studies 
which have reported on rates of diagnosed food allergy based on objective measures including 
clinician diagnosed food allergy/good clinical history plus supporting test or those who had either an 
open (OFC) or double blind placebo controlled food challenges (DBPCFC). We were able to identify 
a total of eight studies carried out in Denmark, Finland, Germany, United Kingdom and Turkey. 
 
Denmark 
Eller 2009 investigated food allergy in Danish children aged 0-6 years and reported that 3.6% of 
children suffered from any food allergy by 6 years based on OFC or DBPCFC (95% CI: 2.3 – 5.4%). 
Self-reported FA to any food by the age of 6 years was 11.6% (95% CI: 9.2-14.5). The main foods 
implicated were milk, egg and peanut. Osterballe 2005 reported OFC/DBPCFC confirmed FHS in 
young adults in Denmark as 1.7% (95% CI: 1.1 – 2.95%). Self-reported FHS was 19.6% (95% CI: 
17.0-22.4). The most common allergenic food was peanut followed by additives, shrimp, codfish, 
cow's milk, octopus and soy. 
 
Looking at young children (0-3 year olds), older siblings and parents of the young children, 
OFC/DBPCFC-confirmed FHS was 2.4% (95% CI: 1.8-3.2) in the whole population studied and 1.6% 
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(95% CI: 0.9-2.6) in the children (Osterballe 2005).  Breaking the point prevalence figures into 
specific age groups the data was: 2.3% (95% CI: 1.3-4.0) at the age of 3 years, 0.0% (95% CI: 0.0-
3.3) in those under 3 years, 1.0% (95% CI: 0.3-2.9) in those children over 3 years and 3.2% (95% CI: 
2.3-4.5) in the adults. The point prevalence of reported FHS in this study was:  13.0% (95% CI: 11.6-
14.7) in all of those studied, 14.1% (95% CI: 12.0-16.5) in the adults and 11.9% (95% CI: 10.0-14.1) 
in children of all ages. The most common allergenic foods were hen's egg affecting the children 3 




Zuberbier 2004 conducted a whole population study in the Germany. The point prevalence of adverse 
reactions to food confirmed by DBPCFC tests in the Berlin population as a mean of all age groups 
was 3.6% (95% CI: 3.0-4.2%) and 3.7% in the adult population (18-79 years, 95% CI: 3.1-4.4%). 
Two and a half percent were IgE-mediated and 1.1% non-IgE-mediated. In the children (0-17 years), 
the prevalence of all FHS was 4.2%;  IgE-mediated was 3.5% (95% CI: 2.4-5.1%) and non-IgE-
mediated was 0.7% (95% CI: 0.3-1.6%). Foods most commonly identified by oral challenges were 
apple, hazelnut, soy, kiwi, carrot and wheat. The self-reported lifetime prevalence of any adverse 
reaction to food in the Berlin population (mean age 41 years) was 34.9%.  
 
Turkey 
Gelincik 2008 reported FHS based on DBPCFC in adults (>18 years) in Turkey as 0.1% (95% CI: 
0.05– 0.18). Adding those with non-allergic FA, the figures were 0.3% (95% CI: 0.2 – 0.4).  The 
foods most commonly implicated in the reactions were tomato, cocoa and egg. The lifetime 
prevalence or self-reported FA and NAFA of all ages reported in the paper was 9.5% (95% CI: 8.9-
10.0). Orhan 2009 reported DBPCFC confirmed FA in 6-9 year old Turkish children as 0.8% (95% 
CI: 0.5 – 1.1).  Using a positive SPT and a clear history as the diagnostic end point, the recorded 
prevalence was 1.8% (95% CI: 1.3-2.3). The most common allergenic foods were beef, cow's milk, 
cocoa, egg and kiwi. Self-reported food allergy in this group was 5.7% (95% CI: 4.8-6.6). In another 
study focusing on IgE-mediated FA only, Mustayev 2012 reported a prevalence rate of 0.1% (9/6963; 
95% CI: 0.1-0.3) in adolescents in Turkey. The most common foods involved in allergic reactions 
were walnut and beef, followed by egg, peanut, spinach, kiwi, cheese, hazelnut and peach. A total of 
2.2% (152/6963; 95% CI 1.9-2.6) of parents reported a food related problem. 
 
United Kingdom 
Pereira 2005 studied 11 and 15 year old children in the UK. In the 11 year old cohort FHS confirmed 
by DBPCFC was 0.1% (95% CI: 0-0.7%) and OFC-confirmed FHS: 1.0% (95% CI: 0.5-2.0%). In the 
15 year old cohort, DBPCFC-confirmed FHS was 0.5% (95% CI: 0.2-1.4%) and OFC-confirmed FHS 
1.1% (95% CI: 0.5-2.1%). Using a positive SPT and/or a good clinical history or a positive food 
challenge as diagnostic end point, the figures were (at 11 years) 2.3% (95% CI: 1.5-3.6) based on a 
clear clinical history and/or OFC or 1.4% (0.8-2.5) based and/or a clear clinical history or DBPCFC. 
At 15 years, based on a clear clinical history and/or OFC, the rates were 2.2% (95% CI: 1.4-3.6) or 
2.1% (95% CI: 1.3-3.4) based on a clear clinical history and/or DBPCFC. Among the 11-year-olds, 
the foods most commonly implicated in FHS were peanuts, tree nuts, egg, milk, shell fish, gluten, 
green beans, cheese, kiwi, tomato, and additives. Among the 15-year-olds, the foods implicated were 
peanut, tree nuts, gluten, wheat, shellfish, egg, milk, and additives. Self-reported rates of FHS were 
11.6% (95% CI: 9.5-14.1%) at 11 years and 12.4% (95% CI: 10.3-15.0%) at 15 years. 
Venter et al studied a birth cohort age 1-3 years and a separate cohort at the age of 6 years. The 
prevalence of FHS defined by a positive OFC was 2.8% (95% CI: 1.9-4.1) at 1 year, 1.0% (95% CI: 
0.6-2.0) at two years and 0.8% (95% CI: 0.4-1.6) at 3 years. FHS diagnosed using a positive DBPCFC 
was 1.3% (95% CI: 0.8-2.3) at one year, 0.1% (95% CI: 0.0-0.7) at two years and 0.0% at 3 years. 
Using a clear clinical history and/or a positive OFC/DBPCFC as diagnostic end point the figures were 
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for OFC: 3.0% (95% CI: 2.1-4.3) at one year, 2.5% (95% CI: 1.5-3.7) at two years and 3.0% (95% Ci: 
2.1-4.4) at 3 years. For DBPCFC this was 2.7% (95% CI: 1.8-3.9) at one year, 2.1% (95% CI: 1.3-3.3) 
at two years and 2.9% (95% CI: 2.0-4.2) at 3 years. Using open food challenge and a good clinical 
history, the cumulative incidence of FHS was 6.0% (95% CI: 4.6-7.7). Based on DBPCFC and a good 
clinical history, the cumulative incidence was 5.0% (95% CI: 3.7-6.5). Overall, 33.7% of parents 
reported a food-related problem. The main foods implicated in the allergic reactions were milk, egg 
and peanut. 
  
Looking at different group of children recruited at 6 years of age, based on open food challenge 
and/or suggestive history and skin tests, the prevalence of FHS was 2.5% (95% CI: 1.5-3.8). Based on 
double-blind challenges, a clinical diagnosis or suggestive history and positive skin tests, the 
prevalence was 1.6% (95% CI: 0.9-2.7). Self-reported prevalence of FHS was 11.8% (95% CI: 9.6-
14.2) in this cohort. Milk, peanut and wheat were the key food allergens amongst those with positive 
challenges. 
1.2.6.26. Prevalence of allergy to any food in different regions of the world 
Very few studies outside of Europe used food challenge outcome as the final diagnostic point to 
determine the prevalence of food allergy. Looking at the studies we have identified from our 
systematic review a total  4 studies have reported on overall food allergy based on food challenge. 
 
China 
Chen 2011 studied the prevalence of FA in 0-1 year old children in Chongqing, China and found an 
overall prevalence of challenge-proven FA of 3.8% in infants (95% CI: 2.5-5.9%). The main foods 
implicated were egg and milk. Among the parents, 9.3% (46/ 497; 95% CI: 6.9-12.2) reported that 
their child had adverse food reactions. Looking at the prevalence of FA in 0-2 year olds, Chen 2012 
reported an overall prevalence of challenge-proven FA of 5.9% (95% CI: 4.9-7.2%). The most 
common food allergy was to egg, but cow‟s milk, shrimp and fish were also common allergens. Hu 
2010 reported on FA in 1999 and 2009 in China and reported that food allergy prevalence increased 
significantly from 3.5% (11/314; 95% CI: 1.9-6.4) in 1999 to 7.7% (31/401; 95% CI: 5.4-10.9) in 
2009 (p= 0.017). The main foods implicated were egg and milk and the rates did not change over the 
10 year period. Reported rates of FA was 13.7% (43/314; 95% CI: 10.2-18.1) in 1999 and 16.7% 
(67/401; 95% CI: 13.3-20.8) in 2009. 
Thailand 
The study by Lao-araya 2012 focused on IgE mediated food allergy only. The prevalence of IgE-
mediated FA confirmed by OFC was 1.1% (95% CI: 0.4-3.0). The five main allergens reported were 
shrimp, cow's milk, fish, chicken eggs, and ant eggs. Forty-two children (9.3%; 42/452; 95% CI: 6.9-
12.4) were reported to have FA.  
United States 
The study reported by Bock 1987 is one of the first papers reporting FHS based on oral food 
challenge outside of Europe and the only one ever from the US. Bock 1987 showed that of the 501 
children enrolled into the study, 37 (7.7%; 95%CI: 5.6-10.6) were diagnosed with FHS by means of 
either OFC or DBPCFC. However, 27.7% (95% CI: 23.8-32.0) were thought to have symptoms 
produced during food ingestion, due to parental reported problems. The most common foods 
implicated in the allergic reactions were egg and milk. 
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Table 1.10:   Celery allergy prevalence in European countries by age group 
Study ID Country Year(s) 
of study 
Age group Allergen Type of food 
allergy 
Questionnaire-based methods Sensitisation Sensitisation with clinical history Food challenge with clinical 
history 
Other 
Self-reported Clinical history Clinician-
diagnosed 














5-17 years celery/carrot 
Both IgE and 
non-IgE 
mediated (no 












0-80+ years celery 
Both IgE and 
non-IgE 
mediated 




- - - - 
Schafer (2001) Germany 
1997-
1998 
25-74 years celery 
Both IgE and 
non-IgE 
mediated 






- - - - - - 
Bakos (2006) Hungary 
2002-
2004 
20-69 years celery 
IgE mediated 











- - - - - 
Bakos (2006) Hungary 
2002-
2004 
60-97 years celery 
IgE mediated 











- - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
 
Table 1.11:   Celery allergy prevalence in non-European countries by age group 
Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy 
Questionnaire-based methods Sensitisation Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Wan (2012) Taiwan Not Reported 6-8 years celery IgE mediated 
only 
- - - - - - 1.8 
(1.1-2.9) 
n=1010 
- - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
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Table 1.12:     Cereals allergy prevalence in European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Osterballe 
(2005) 
Denmark 2000-2001 < 3 years wheat 
Both IgE and 
non-IgE 
mediated 












Denmark 2000-2001 3 years wheat 
Both IgE and 
non-IgE 
mediated 













Denmark 2000-2001 3-22 years wheat 
Both IgE and 
non-IgE 
mediated 
- - - - - - - - 
0  
(0 - 2)  
n=301 
0  




Denmark 2001-2002 22 years wheat 






(0.4 - 1.8)  
n=843 
- - - - - - - - - 
Osterballe 
(2005) 
Denmark 2000-2001 >22 years wheat 
Both IgE and 
non-IgE 
mediated 













Finland 2001-2009 1 year barley/rye 
Both IgE and 
non-IgE 
mediated (no 










(0.7 - 2.4)  
n=853 
- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 2 years barley/rye 
Both IgE and 
non-IgE 
mediated (no 












- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 3 years barley/rye 
Both IgE and 
non-IgE 
mediated (no 












- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 4 years barley/rye 
Both IgE and 
non-IgE 
mediated (no 










(1.7 - 4.1)  
n=819 
- - - - - - - 
Pyrhonen 
(2009) 





Both IgE and 
non-IgE 
mediated (no 










(0.5 - 2.1)  
n=853 
- - - - - - - 
Pyrhonen 
(2009) 





Both IgE and 
non-IgE 
mediated (no 












- - - - - - - 
Pyrhonen 
(2009) 





Both IgE and 
non-IgE 
mediated (no 










(0.9 - 2.9)  
n=784 
- - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Pyrhonen 
(2009) 





Both IgE and 
non-IgE 
mediated (no 












- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 1 year wheat 
Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 1 year wheat 
Both IgE and 
non-IgE 
mediated (no 










(0.9 - 2.8)  
n=853 
- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 2 years wheat 
Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 2 years wheat 
Both IgE and 
non-IgE 
mediated (no 
SPT or SIgE) 
2
†









- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 3 years wheat 
Both IgE and 
non-IgE 
mediated (no 










- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 4 years wheat 
Both IgE and 
non-IgE 
mediated (no 










- - - - - - - 
Touraine 
(2002) 
France 2000-2001 5-17 years wheat 
Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years barley 
Both IgE and 
non-IgE 
mediated 




- - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years flour 
Both IgE and 
non-IgE 
mediated 







Schafer (2001) Germany 1997-1998 25-74 years flour 








- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years oatmeal 
Both IgE and 
non-IgE 
mediated 




- - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years rye flour 
Both IgE and 
non-IgE 
mediated 




- - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years wheat 
Both IgE and 
non-IgE 
mediated 




- - - - 
Schafer (2001) Germany 1997-1998 25-74 years wheat 
Both IgE and 
non-IgE 
mediated 






- - - - - - 
Zannikos 
(2008) 
Greece 2007 7-13 years wheat 
Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Krause (2002) Greenland 1998 5-18 years wheat 
IgE mediated 






- - - - - 
Bakos (2006) Hungary 2002-2004 20-69 years rye 
IgE mediated 











- - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years rye flour 
IgE mediated 











- - - - - 
Bakos (2006) Hungary 2002-2004 20-69 years wheat 
IgE mediated 











- - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years wheat 
IgE mediated 











- - - - - 
Kristjansson 
(1999) 
Iceland 1994 18 months cereals 














- - - - 
Ronchetti 
(2008) 
Italy 2005 - 2006 9 years wheat 
Both IgE and 
non-IgE 
mediated 














Italy 2005 - 2006 13 years wheat 
Both IgE and 
non-IgE 
mediated 












Eggesbo (1999) Norway 1993-1995 1 year cereals 






- - - - - - - - - 
Eggesbo (1999) Norway 1993-1995 18 months cereals 






- - - - - - - - - 
Eggesbo (1999) Norway 1993-1995 2 years cereals 






- - - - - - - - - 
Kristjansson 
(1999) 
Sweden 1994 18 months cereals 














- - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Ostblom (2008 
b) 
Sweden 1995-2004 1 year wheat 














- - - - - - - 
Ostblom (2008 
b) 
Sweden 1996-1998 2 years wheat 














- - - - - - - 
Ostblom (2008 
b) 
Sweden 1998-2000 4 years wheat 














- - - - - - - 
Ostblom (2008 
a) 
Sweden 1999-2000 4 years wheat 


















- - - 
Ostblom 
 (2008 b) 
Sweden 2002-2004 8 years wheat 














- - - - - - - 
Bjornsson 
(1996) 
Sweden 1991-1992 20-44 years wheat 
IgE mediated 






- - - - - 





(0.0 - 0.4)  
n=2739 
















2001-2005 3 years corn 
Both IgE and 
non-IgE 
mediated 















2001-2005 1 year corn flour 
Both IgE and 
non-IgE 
mediated 















2001-2005 2 years corn flour 
Both IgE and 
non-IgE 
mediated 















2001-2005 1 year gluten 
Both IgE and 
non-IgE 
mediated 









2001-2005 2 years gluten 
Both IgE and 
non-IgE 
mediated 









2001-2005 3 years gluten 
Both IgE and 
non-IgE 
mediated 









2001-2005 1 year wheat 
Both IgE and 
non-IgE 
mediated 















2001-2005 2 years wheat 
Both IgE and 
non-IgE 
mediated 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 





















2001-2005 3 years wheat 
Both IgE and 
non-IgE 
mediated 















1993-1994 4 years wheat 
IgE mediated 




(0.1- 1)  
n=981 




2003-2004 6 years wheat 























2002-2003 11 years  wheat 


















2002-2003 15 years wheat 


















nr All ages wheat 












1995-1996 15 + years wheat/gluten 








- - - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
 
Table 1.13:   Cereals allergy prevalence in non-European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 

















- - - - 








- - - - - - - - - 
Soller (2012) Canada 2008-2009 <18 years wheat “likely” IgE 
mediated (no 




- - - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Soller (2012) Canada 2008-2009 >18 years wheat “likely” IgE 
mediated (no 




- - - - - - - - - 
Hu (2010) China 1999 0-24 months wheat IgE mediated 
only 





- - - - - - 
Hu (2010) China 2009 0-24 months wheat IgE mediated 
only 





- - - - - - 
Sai (2011) China 2008-2009 adults wheat IgG mediated 
only 










- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 




















- - - 
Kim (2011) Korea 2006-2007 0-12 months wheat IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Oh (2004) Korea 2000 6-12 years wheat IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 12-15 years wheat IgE mediated 







- - - - - - - - - 
Lao-araya 
(2012) 














2006 6-9 years wheat IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Gupta (2011) United States 2009-2010 0-2 years wheat IgE mediated 
(no SPT or 
SIgE) 
- 0.3  
(0.1-0.5)  
n=5429 
- - - - - - - - 
Bock (1987) United States 1980-1984 0-3 years wheat Both IgE and 
non-IgE 











Gupta (2011) United States 2009-2010 3-5 years wheat IgE mediated 
(no SPT or 
SIgE) 
- 0.5  
(0.3-0.7)  
n=5910 
- - - - - - - - 
Gupta (2011) United States 2009-2010 6-10 years wheat IgE mediated 
(no SPT or 
SIgE) 
- 0.4  
(0.3-0.5)  
n=9911 
- - - - - - - - 
Gupta (2011) United States 2009-2010 11-13 years wheat IgE mediated 
(no SPT or 
SIgE) 
- 0.7  
(0.5-0.9)  
n=6716 
- - - - - - - - 
Gupta (2011) United States 2009-2010 14-17 years wheat IgE mediated 
(no SPT or 
SIgE) 
- 0.3  
(0.2-0.4)  
n=10514 
- - - - - - - - 
Greenhawt 
(2009) 
United States nr 18 years+ wheat IgE mediated 







- - - - - - - - - 
Gupta (2011) United States 2009-2010 All ages wheat IgE mediated 
(no SPT or 
SIgE) 
- 0.4  
(0.3-0.5)  
n=3339 
- - - - - - - - 
Vierk (2007) United States 2001 18 years + wheat/gluten IgE mediated 













† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
 
Table 1.14:   Egg allergy prevalence in European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy 
Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Eller (2009) Denmark 1999-2000 3 months egg Both Ige and 
non-IgE 
mediated 




Eller (2009) Denmark 1999-2000 6 months egg Both Ige and 
non-IgE 
mediated 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy 
Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Eller (2009) Denmark 1999-2000 9 months egg Both Ige and 
non-IgE 
mediated 




Eller (2009) Denmark 1999-2000 1 year egg Both Ige and 
non-IgE 
mediated 




Eller (2009) Denmark 2000-2001 18 months egg Both Ige and 
non-IgE 
mediated 






Denmark 2000-2001 < 3 years egg Both Ige and 
non-IgE 
mediated 










Denmark 2000-2001 3 years egg Both Ige and 
non-IgE 
mediated 
- - - - - - - - 1.6 
†
 
(0.1 - 3.4)  
n=486 
2.9  
(1.7 - 4.9)  
n=486 
Eller (2009) Denmark 2001-2002 3 years egg Both Ige and 
non-IgE 
mediated 




Eller (2009) Denmark 2004-2005 6 years egg Both Ige and 
non-IgE 
mediated 






Denmark 2000-2001 3-22 years egg Both Ige and 
non-IgE 
mediated 
- - - - - - - - 0 
†
 















(0.4 - 1.9)  
n=843 





Denmark 2000-2001 >22 years egg Both Ige and 
non-IgE 
mediated 
- - - - - - - - 0.1 
†
 





(0 - 1)  
n=936 
Julge (2001) Estonia 1993-1999 6 months egg white IgE mediated 
only 






- - - - - 
Julge (2001) Estonia 1993-1999 1 year egg white IgE mediated 
only 






- - - - - 
Julge (2001) Estonia 1993-1999 2 years egg white IgE mediated 
only 






- - - - - 
Julge (2001) Estonia 1993-1999 5 years egg white IgE mediated 
only 






- - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 1 year egg Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 1 year egg Both IgE and 
non-IgE 
mediated (no 









(1.1 - 3.1)  
n=853 
- - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy 
Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Kajosaari 
(1982) 
Finland 1980-1981 2 years egg Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 2 years egg Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 3 years egg Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 3 years egg Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 4 years egg Both IgE and 
non-IgE 
mediated (no 









(2.7 - 5.5)  
n=819 
- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 6 years egg Both IgE and 
non-IgE 
mediated (no 








Rance (2005) France 2002 2-14 years egg Both IgE and 
non-IgE 
mediated (no 




(0.6 - 1.3)  
n=2716 
- - - - - - - - - 
Touraine 
(2002) 
France 2000-2001 5-17 years egg Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years egg Both IgE and 
non IgE 
mediated 
- - - - - 0.2 
(0.1-0.5)  
n=3156 



















- - - - - - 
Schafer (1999) Germany 1994 5-6 years egg Both IgE and 
non IgE 
mediated 





- - - - - - 
Sakellariou 
(2008) 
Greece 2007 20-54 years egg Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Zannikos 
(2008) 
Greece 2007 7-13 years egg Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506      124 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published 
complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights 
of the authors. 
Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy 
Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Krause (2002) Greenland 1998 5-18 years egg IgE mediated 
only 





- - - - - 
Bakos (2006) Hungary 2002-2004 20-69 years egg white IgE mediated 
only 










- - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years egg white IgE mediated 
only 










- - - - - 
Bakos (2006) Hungary 2002-2004 20-69 years egg yolk IgE mediated 
only 










- - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years egg yolk IgE mediated 
only 










- - - - - 
Kristjanson 
(1999) 













- - - - 
Kilgallen 
(1996) 
Ireland nr 0-6 months egg Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 12-24 months egg Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 24-36 months egg Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 36-48 months egg Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 6-12 months egg Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Frongia (2005) Italy 2003 12-24 months egg Both IgE and 
non-IgE 
mediated (no 
SPT or SIgE) 





- - - - - - - 
Ronchetti 
(2008) 
Italy 2005 - 2006 9 years egg Both IgE and 
non-IgE 
mediated 












Italy 2005 - 2006 13 years egg Both IgE and 
non-IgE 
mediated 
















- - - - - - - - - 
University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506      125 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published 
complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights 
of the authors. 
Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy 
Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 






- - - - - - - - - 






- - - - - - - - - 
Ro (2012) Norway 2002-2006 2 years egg IgE mediated 
only 
- - - 2.8  
†
 





(8.3 - 15.3)  
n=352 
- - - - - 
Falcao (2004) Portugal nr >39 years egg Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Martinez-
Gimeno (2000) 
Spain nr 6-13 years egg Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Ostblom (2008 
b) 













- - - - - - - 
Kristjanrson 
(1999) 













- - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Ostblom  
(2008 a) 
















- - - 
Ostblom  
(2008 b) 













- - - - - - - 
Bjornnson 
(1996) 
Sweden 1991-1992 20-44 years egg IgE mediated 
only 





- - - - - 
Kucukosmanogl
u (2008 a) 
Turkey 2002-2004 8-18 months egg IgE mediated 
only 





- - - - - - 





(1.4 - 2.5)  
n=2739 
- - - - 0.9 
†
 
(0.6 - 1.4)  
n=2739 
- - 0.1 
†
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy 
Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Mustafayev 
(2012) 
Turkey 2010 10-11 years egg white IgE mediated 
only 





- - - - - - 
Venter (2008) United 
Kingdom 
2001-2005 1 year egg Both IgE and 
non-IgE 
mediated 










Venter (2008) United 
Kingdom 
2001-2005 2 years egg Both IgE and 
non-IgE 
mediated 










Venter (2008) United 
Kingdom 
2001-2005 3 years egg Both IgE and 
non-IgE 
mediated 










Arshad (2001) United 
Kingdom 
1993-1994 4 years egg IgE mediated 
only 
- - - 0.8 
†
 
(0.4 - 2)  
n=980 
- - - - - - 
Venter (2006) United 
Kingdom 








- - 0.9 
†
 
(0.4 - 2)  
n=700 





Roberts (2005) United 
Kingdom 
1998-2000 7 years egg IgE mediated 
only 
- - - 0.4 
†
 
(0.3 - 0.6)  
n=5066 
- - - - - - 
Pereira (2005) United 
Kingdom 













- - - - - - 
Emmett (1999) United 
Kingdom 
1995-1996 15 + years egg Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Pereira (2005) United 
Kingdom 













- - - - - - 
Young (1994) United 
Kingdom 








- - - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
 
Table 1.15:   Egg allergy prevalence in non-European countries by age group 
Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Osborne Australia 2007-2010 12-15 months egg (raw) IgE mediated - - - 11.8  - - - 9# - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 












- - - - - - - - - 

















- - - - 
Soller (2012) Canada 2008-2009 <18 years egg “Likely” IgE 
mediated (no 




- - - - - - - - - 
Soller (2012) Canada 2008-2009 >18 years egg “Likely” IgE 
mediated (no 




- - - - - - - - - 
Chen (2011) China 2009 0-12 months egg IgE mediated 
only 











Hu (2010) China 1999 0-24 months egg IgE mediated 
only 











Hu (2010) China 2009 0-24 months egg IgE mediated 
only 











Sai (2011) China 2008-2009 adults egg IgG mediated 
only 





Chen (2012) China 
(Chongqing) 
2009-2010 0-2 years egg Both IgE and 
non-IgE 
mediated 





Chen (2012) China 
(Hangzhou) 
2009-2010 0-2 years egg Both IgE and 
non-IgE 
mediated 





Chen (2012) China 
(Zhuhai) 
2009-2010 0-2 years egg Both IgE and 
non-IgE 
mediated 







Colombia nr All ages egg Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 





- - - - - - - - - 
Leung (2009) Hong Kong 2006-2007 2-7 years egg IgE mediated 
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Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 





(0.6 - 1.0)  
n=9070 





- - - - 
Kim (2011) Korea 2006-2007 0-12 months egg IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Oh (2004) Korea 2000 6-12 years egg IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 12-15 years egg IgE mediated 







- - - - - - - - - 
Wu (2012) Taiwan 2004 <3 years egg IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 4-18 years egg IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 >19 years egg IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Lao-araya 
(2012) 







- - - - - - - - - 
Santadusit 
(2005) 
Thailand nr 6 months – 6 
years 





(0.2 - 1.7)  
n=656 
- - - - - - - - - 
Santadusit 
(2005) 
Thailand Nr 6 months – 6 
years 





(0.4 - 2.1)  
n=656 







2006 6-9 years egg IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Branum 
(2009) 




- - - - 6.7  
(nr)  
n=nr 
- - - - - 
Gupta (2011) United States 2009-2010 0-2 years egg IgE mediated 
(no SPT or 
SIgE) 
- 1  
(0.7-1.3)  
n=5429 
- - - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Kumar (2011) United States 2011  6 months - 6 
years 
egg IgE mediated 
only 





- - - - - 
Liu (2010) United States 2005-2006 1-5 years egg IgE mediated 
only 
- - - - 13.9  
(nr)  
n=909 
- - - - 1.8  
(nr)  
n=nr 
Keet (2012) United States 2005-2006 1-21 years egg IgE mediated 
only 
- - - - 6  
(nr)  
n=3550 
- - - - - 
Gupta (2011) United States 2009-2010 3-5 years egg IgE mediated 
(no SPT or 
SIgE) 
- 1.3  
(0.9-1.7)  
n=5910 
- - - - - - - - 
Gupta (2011) United States 2009-2010 6-10 years egg IgE mediated 
(no SPT or 
SIgE) 
- 0.8  
(0.6-1.1)  
n=9911 
- - - - - - - - 
Liu (2010) United States 2005-2006 6-19 years egg IgE mediated 
only 
- - - - 4.1  
(nr)  
n=2869 
- - - - 0.1  
(nr)  
n=nr 
Gupta (2011) United States 2009-2010 11-13 years egg IgE mediated 
(no SPT or 
SIgE) 
- 0.5  
(0.4-0.8)  
n=6716 
- - - - - - - - 
Gupta (2011) United States 2009-2010 14-17 years egg IgE mediated 
(no SPT or 
SIgE) 
- 0.4  
(0.3-0.5)  
n=10514 
- - - - - - - - 
Vierk (2007) United States 2001 18 years + egg IgE mediated 














United States nr 18 years+ egg IgE mediated 







- - - - - - - - - 
Liu (2010) United States 2005-2006 20-39 years egg IgE mediated 
only 
- - - - 2.1  
(nr)  
n=1672 
- - - - 0.1  
(nr)  
n=nr 
Liu (2010) United States 2005-2006 40-59 years egg IgE mediated 
only 
- - - - 3.8  
(nr)  
n=1361 
- - - - 0.2  
(nr)  
n=nr 
Liu (2010) United States 2005-2006 60+ years egg IgE mediated 
only 
- - - - 3.9  
(nr)  
n=1392 
- - - - 0.6  
(nr)  
n=nr 
Liu (2010) United States 2005-2006 All ages egg IgE mediated 
only 
- - - - 3.9  
(nr)  
n=8203 
- - - - 0.2  
(nr)  
n=nr 
Gupta (2011) United States 2009-2010 All ages egg IgE mediated 
(no SPT or 
SIgE) 
- 0.8  
(0.7-0.9)  
n=3339 
- - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
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Table 1.16:   Fish and Shellfish allergy prevalence in European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Osterballe 
(2005) 
Denmark 2000-2001 < 3 years crustaceans 
(shrimp) 
Both IgE and 
non-IgE 
mediated 










Denmark 2000-2001 3 years crustaceans 
(shrimp) 
Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0 
†
 









Denmark 2000-2001 3-22 years crustaceans 
(shrimp) 
Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0 
†
 









Denmark 2001-2002 22 years crustaceans 
(shrimp) 






(1.2 - 3.3)  
n=843 





Denmark 2000-2001 >22 years crustaceans 
(shrimp) 
Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0.3 
†
 









Denmark 2000-2001 < 3 years Fish (cod) Both IgE and 
non-IgE 
mediated 










Denmark 2000-2001 3 years Fish (cod) Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0 
†
 









Denmark 2000-2001 3-22 years Fish (cod) Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0 
†
 















(0 - 1)  
n=843 





Denmark 2000-2001 >22 years Fish (cod) Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0.2 
†
 









Denmark 2001-2002 22 years mollusc 
(octopus) 






(0.1 - 1.1)  
n=843 





Finland 1980-1981 1 year fish Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 1 year fish Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Kajosaari 
(1982) 
Finland 1980-1981 2 years fish Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 2 years fish Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 3 years fish Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 3 years fish Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 4 years fish Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 6 years fish Both IgE and 
non-IgE 
mediated (no 










Finland nr 15-17 years fish IgE mediated 
only 





- - - - - - 
Touraine 
(2002) 
France 2000-2001 5-17 years crustaceans Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Rance (2005) France 2002 2-14 years crustaceans 
(shrimp) 
Both IgE and 
non-IgE 
mediated (no 




(0.3 - 0.9)  
n=2716 
- - - - - - - - - 
Rance (2005) France 2002 2-14 years fish Both IgE and 
non-IgE 
mediated (no 




(0.4 - 1.1)  
n=2716 
- - - - - - - - - 
Touraine 
(2002) 
France 2000-2001 5-17 years fish Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Touraine 
(2002) 
France 2000-2001 5-17 years mollusc 
(oyster) 
Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years crustaceans 
(crab) 
Both IgE and 
non-IgE 
mediated 
- - - - - 0.3  
(0.2-0.6)  
n=3156 
- - - - 
University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506      132 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published 
complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights 
of the authors. 
Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Schafer (2001) Germany 1997-1998 25-74 years crustaceans 
(crab) 
Both IgE and 
non-IgE 
mediated 





- - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years fish (herring) Both IgE and 
non-IgE 
mediated 
- - - - - 0.1  
(0.0-0.4)  
n=3156 
- - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years fish (mackerel) Both IgE and 
non-IgE 
mediated 
- - - - - 0.1  
(0.0-0.3)  
n=3156 
- - - - 
Schafer (2001) Germany 1997-1998 25-74 years fish (mackerel) Both IgE and 
non-IgE 
mediated 





- - - - - - 








- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years mollusc 
(mussels) 
Both IgE and 
non-IgE 
mediated 
- - - - - 0.0  
(0.0-0.2)  
n=3156 
- - - - 
Zannikos 
(2008) 
Greece 2007 7-13 years fish Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
Sakellariou 
(2008) 
Greece 2007 20-54 years fish Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Zannikos 
(2008) 
Greece 2007 7-13 years shellfish Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
Krause (2002) Greenland 1998 5-18 years fish IgE mediated 
only 





- - - - - 




- - - - - - - - - - 









- - - - - 
Bakos (2006) Hungary 2002-2004 20-69 years fish (cod) IgE mediated 
only 
- - - - - - - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years fish (cod) IgE mediated 
only 





- - - - - 
Kristjansson 
(1999) 













- - - - 
Kristjansson 
(1999) 








- - - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 






- - - - - - - - - 






- - - - - - - - - 






- - - - - - - - - 
Ro (2012) Norway 2002-2006 2 years fish IgE mediated 
only 
- - - 0.3 
†
 





(0.4 - 3.1)  
n=352 
- - - - - 
Falcao (2004) Portugal nr >39 years fish Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Falcao (2004) Portugal nr >39 years Molluscs Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Martinez-
Gimeno (2000) 
Spain nr 6-13 years fish Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Kristjansson 
(1999) 













- - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Bjornsson 
(1996) 
Sweden 1991-1992 20-44 years fish IgE mediated 
only 





- - - - - 
Ostblom  
(2008 a) 
















- - - 
Kristjansson 
(1999) 








- - - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 






















1993- 1994 4-15 years fish/crustacean Both IgE and 
non-IgE (no 






- - - - - - - - - 





(0.2 - 1)  
n=2739 
- - - - 0.2 
†
 
(0.1 - 0.5)  
n=2739 
- - 0 
†
 












- - - - - - - - - 
Gelincik (2008) Turkey nr 18 years + fish Both Ige and 
non-IgE 
mediated 




















Pereira (2005) United 
Kingdom 
2002-2003 11 year olds crustaceans 
(prawn) 








- - - - - - - - - 
Pereira (2005) United 
Kingdom 
2002-2003 15 year olds crustaceans 
(prawn) 








- - - - - - - - - 
Pereira (2005) United 
Kingdom 













- - - - - - 
Pereira (2005) United 
Kingdom 













- - - - - - 
Emmett (1999) United 
Kingdom 








- - - - - - - - - 
Venter (2008) United 
Kingdom 
2001-2005 1 year fish (cod) Both IgE and 
non-IgE 
mediated  










Venter (2008) United 
Kingdom 
2001-2005 2 years fish (cod) Both IgE and 
non-IgE 
mediated 










Venter (2008) United 
Kingdom 
2001-2005 3 years fish (cod) Both IgE and 
non-IgE 
mediated 










Arshad (2001) United 
Kingdom 
1993-1994 4 years fish (cod) IgE mediated 
only 
- - - 0.7 
†
 
(0.3 - 2)  
n=981 
- - - - - - 
Venter (2006) United 
Kingdom 


















Roberts (2005) United 
Kingdom 
1998-2000 7 years fish (cod) IgE mediated 
only 
- - - 0 
†
 
(0 - 0.3)  
n=2061 
- - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Young (1994) United 
Kingdom 








- - - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
 
Table 1.17:   Fish and Shellfish allergy prevalence in non-European countries by age group 
Study ID Country Year(s) of 
study  
Age group Allergen  Tyoe of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 



















- - - - 








- - - - - - - - - 
Osborne (2011) Australia 2007-2010 12-15 months shellfish  - - - 0.4  
(0.2-0.7)  
n=2375 
- - - - - - 
Ben-Shoshan 
(2010) 
















- - - - - - - 
Ben-Shoshan 
(2010) 
















- - - - - - - 
Ben-Shoshan 
(2010) 
















- - - - - - - 
Ben-Shoshan 
(2010) 
















- - - - - - - 









- - - - - - 









- - - - - - 









- - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Tyoe of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 





















Chen (2011) China 2009 0-12 months fish IgE mediated 
only 





- - - - - - 
Hu (2010) China 1999 0-24 months fish IgE mediated 
only 





- - - - - - 
Hu (2010) China 2009 0-24 months fish IgE mediated 
only 





- - - - - - 
Sai (2011) China 2008-2009 adults fish IgG mediated 
only 







Colombia nr All ages seafood Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 







- - - - - - - - - 





- - - - - - - - - 
Leung (2009) Hong Kong 2006-2007 2-7 years crustaceans IgE mediated 












Leung (2009) Hong Kong 2006-2007 2-7 years fish IgE mediated 

















(0 - 0.1)  
n=9070 
- - - 0 
†
 
(0 - 0.1)  
n=9070 
- - - - 
Oh (2004) Korea 2000 6-12 years fish IgE mediated 





(0.6 - 0.8)  
n=27425 
- - - - - - - - - 
Oh (2004) Korea 2000 12-15 years fish IgE mediated 







- - - - - - - - - 
Kim (2011) Korea 2006-2007 0-12 months seafood IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Tyoe of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Oh (2004) Korea 2000 6-12 years seafood IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 12-15 years seafood IgE mediated 







- - - - - - - - - 













- - - - - - - - 













- - - - - - - - 













- - - - - - - - 













- - - - - - - - 













- - - - - - - - 




- - - - - - 17.3  
(15.1-19.8)  
n=1010 
- - - 
Wu (2012) Taiwan 2004 <3 years crustaceans 
(shrimp) 
IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 4-18 years crustaceans 
(shrimp) 
IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 >19 years crustaceans 
(shrimp) 
IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 <3 years crustceans 
(crab) 
IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 4-18 years crustceans 
(crab) 
IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 >19 years crustceans 
(crab) 
IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 <3 years fish IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506      138 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. The present document is published 
complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights 
of the authors. 
Study ID Country Year(s) of 
study  
Age group Allergen  Tyoe of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Wu (2012) Taiwan 2004 4-18 years fish IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 >19 years fish IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 




- - - - - - 25.1  
(22.4-27.9)  
n=1010 
- - - 
Wan (2012) Taiwan nr 6-8 years mollusc (clam) IgE mediated 
only 
- - - - - - 4.8  
(3.6-6.3)  
n=1010 
- - - 




- - - - - - 7.5  
(6.0-9.4)  
n=1010 
- - - 




- - - - - - 9.9  
(8.2-12)  
n=1010 
- - - 




- - - - - - 24.9  
(22.2-27.7)  
n=1010 
- - - 
Wan (2012) Taiwan nr 6-8 years mollusc (squid) IgE mediated 
only 
- - - - - - 2.3  
(1.5-3.5)  
n=1010 
- - - 
Wan (2012) Taiwan nr 6-8 years mollusc (squid) IgE mediated 
only 
- - - - - - 6.8  
(5.4-8.6)  
n=1010 
- - - 
Wu (2012) Taiwan 2004 <3 years Molluscs IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 4-18 years Molluscs IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 >19 years Molluscs IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Lao-araya 
(2012) 


























(0.6 - 2.5)  
n=656 
- - - - - - - - - 
Lao-araya 
(2012) 




























- - - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Tyoe of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Lao-araya 
(2012) 















Thailand nr 6 months - 
6years 





(0.1 - 1.2)  
n=656 
- - - - - - - - - 
Lao-araya 
(2012) 







- - - - - - - - - 
Lao-araya 
(2012) 







- - - - - - - - - 
Santadusit 
(2005) 









(0.1 - 1.5)  
n=656 







2006 6-9 years fish IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Vierk (2007) United States 2001 18 years + crustaceans IgE mediated 

















- - - - 5.2  
(nr)  
n=nr 
- - - - - 




- - - - 6.1  
(nr)  
n=2869 
- - - - 1.1  
(nr)  
n=nr 




- - - - 6.7  
(nr)  
n=1672 
- - - - 1.2  
(nr)  
n=nr 




- - - - 5.9  
(nr)  
n=1361 
- - - - 0.9  
(nr)  
n=nr 




- - - - 4.6  
(nr)  
n=1392 
- - - - 0.7  
(nr)  
n=nr 




- - - - 5.9  
(nr)  
n=8203 
- - - - 1  
(nr)  
n=nr 








- - - - - - - - 
Sicherer (2004) United States 2002 6-17 years fish Both IgE and 
non IgE 
mediated 
- 0.2  
(0.1-0.5)  
n=2610 
- - - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Tyoe of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Vierk (2007) United States 2001 18 years + fish IgE mediated 














United States nr 18 years+ fish IgE mediated 







- - - - - - - - - 








- - - - - - - - 








- - - - - - - - 








- - - - - - - - 













- - - - - - - - 
Gupta (2011) United States 2009-2010 0-2 years fish (fin fish) IgE mediated 
(no SPT or 
SIgE) 
- 0.3  
(0.1-0.4)  
n=5429 
- - - - - - - - 
Gupta (2011) United States 2009-2010 3-5 years fish (fin fish) IgE mediated 
(no SPT or 
SIgE) 
- 0.5  
(0.3-0.8)  
n=5910 
- - - - - - - - 
Gupta (2011) United States 2009-2010 6-10 years fish (fin fish) IgE mediated 
(no SPT or 
SIgE) 
- 0.5  
(0.3-0.7)  
n=9911 
- - - - - - - - 
Gupta (2011) United States 2009-2010 11-13 years fish (fin fish) IgE mediated 
(no SPT or 
SIgE) 
- 0.6  
(0.4-0.8)  
n=6716 
- - - - - - - - 
Gupta (2011) United States 2009-2010 14-17 years fish (fin fish) IgE mediated 
(no SPT or 
SIgE) 
- 0.6  
(0.4-0.9)  
n=10514 
- - - - - - - - 
Gupta (2011) United States 2009-2010 All ages fish (fin fish) IgE mediated 
(no SPT or 
SIgE) 
- 0.5  
(0.4-0.6)  
n=3339 
- - - - - - - - 
Gupta (2011) United States 2009-2010 0-2 years shellfish IgE mediated 
(no SPT or 
SIgE) 
- 0.5  
(0.3-0.8)  
n=5429 
- - - - - - - - 








- - - - - - - - 
Gupta (2011) United States 2009-2010 3-5 years shellfish IgE mediated 
(no SPT or 
SIgE) 
- 1.2  
(0.8-1.6)  
n=5910 
- - - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Tyoe of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Gupta (2011) United States 2009-2010 6-10 years shellfish IgE mediated 
(no SPT or 
SIgE) 
- 1.3  
(1.1-1.6)  
n=9911 
- - - - - - - - 








- - - - - - - - 
Gupta (2011) United States 2009-2010 11-13 years shellfish IgE mediated 
(no SPT or 
SIgE) 
- 1.7  
(1.3-2.1)  
n=6716 
- - - - - - - - 
Gupta (2011) United States 2009-2010 14-17 years shellfish IgE mediated 
(no SPT or 
SIgE) 
- 2  
(1.7-2.5)  
n=10514 
- - - - - - - - 
Vierk (2007) United States 2001 18 years + shellfish IgE mediated 














United States nr 18 years+ shellfish IgE mediated 







- - - - - - - - - 








- - - - - - - - 








- - - - - - - - 








- - - - - - - - 













- - - - - - - - 
Gupta (2011) United States 2009-2010 All ages shellfish IgE mediated 
only (no SPT 
or SIgE) 
- 1.4  
(1.2-1.5)  
n=3339 
- - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
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Table 1.18:   Fruits allergy prevalence in European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Osterballe 
(2005) 
Denmark 2000-2001 < 3 years fruit/ 
vegetables 
Both IgE and 
non-IgE 
mediated 










Denmark 2000-2001 3 years fruit/ 
vegetables 
Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0 
†
 









Denmark 2000-2001 3-22 years fruit/ 
vegetables 
Both IgE and 
non-IgE 
mediated 












Denmark 2000-2001 >22 years fruit/ 
vegetables 
Both IgE and 
non-IgE 
mediated 
- - - - - - - - 2.7 
†
 









Finland 1980-1981 3 years fruits (apple) Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 6 years fruits (apple) Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 1 year fruits (apple, 
pear, cherry, 
peach, banana) 
Both IgE and 
non-IgE 
mediated (no 









(0.1 - 1.1)  
n=853 
- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 2 years fruits (apple, 
pear, cherry, 
peach, banana) 
Both IgE and 
non-IgE 
mediated (no 









(0.0 - 0.9)  
n=852 
- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 3 years fruits (apple, 
pear, cherry, 
peach, banana) 
Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 4 years fruits (apple, 
pear, cherry, 
peach, banana) 
Both IgE and 
non-IgE 
mediated (no 









(0.7 - 2.5)  
n=819 
- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 1 year fruits (citrus) Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 1 year fruits (citrus) Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 2 years fruits (citrus) Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Pyrhonen 
(2009) 
Finland 2001-2009 2 years fruits (citrus) Both IgE and 
non-IgE 
mediated (no 









(0.0 - 0.6)  
n=852 
- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 3 years fruits (citrus) Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 3 years fruits (citrus) Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 4 years fruits (citrus) Both IgE and 
non-IgE 
mediated (no 









(0.7  - 2.5)  
n=819 
- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 6 years fruits (citrus) Both IgE and 
non-IgE 
mediated (no 










Finland 1980-1981 1 year fruits 
(strawberry) 
Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 2 years fruits 
(strawberry) 
Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 3 years fruits 
(strawberry) 
Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 6 years fruits 
(strawberry) 
Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Touraine 
(2002) 
France 2000-2001 5-17 years fruits Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Touraine 
(2002) 




Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Rance (2005) France 2002 2-14 years fruits (kiwi) Both IgE and 
non-IgE 
mediated (no 




(0.5 - 1. 3)  
n=2716 
- - - - - - - - - 
Touraine 
(2002) 








- - - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
SPT or SIgE) 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years fruits Both IgE and 
non-IgE 
mediated 






Germany 1999-2000 0-80+ years Fruits Both IgE and 
non-IgE 
mediated 
- - - - - - - - - 0.3  
(0.1-0.6)  
n=3156 










- - - - - - - - - 
Schafer (2001) Germany 1997-1998 25-74 years fruits (apple 
etc) 








- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years fruits (apple) Both IgE and 
non-IgE 
mediated 
- - - - - 4.2  
(3.6-4.8)  
n=4093 






Germany 1999-2000 0-80+ years fruits (apricot) Both IgE and 
non-IgE 
mediated 






Germany 1999-2000 0-80+ years fruits (cherry) Both IgE and 
non-IgE 
mediated 












- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years fruits (grape) Both IgE and 
non-IgE 
mediated 






Germany 1999-2000 0-80+ years fruits 
(nectarine) 
Both IgE and 
non-IgE 
mediated 




Schafer (2001) Germany 1997-1998 25-74 years fruits (peach 
etc) 








- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years fruits (peach) Both IgE and 
non-IgE 
mediated 






Germany 1999-2000 0-80+ years fruits (pear) Both IgE and 
non-IgE 
mediated 






Germany 1999-2000 0-80+ years fruits (plum) Both IgE and 
non-IgE 
mediated 






Greece 2007 7-13 years Fruits Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Bakos (2006) Hungary 2002-2004 20-69 years fruits (apple) IgE mediated 
only 










- - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years fruits (apple) IgE mediated 
only 










- - - - - 
Bakos (2006) Hungary 2002-2004 20-69 years fruits (banana) IgE mediated 
only 





- - - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years fruits (banana) IgE mediated 
only 





- - - - - - 
Bakos (2006) Hungary 2002-2004 20-69 years fruits (orange) IgE mediated 
only 
- - - - - - - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years fruits (orange) IgE mediated 
only 





- - - - - 
Kristjansson 
(1999) 








- - - - - - - - - 
Kristjansson 
(1999) 








- - - - - - - - - 
Kristjansson 
(1999) 








- - - - - - - - - 
Kristjansson 
(1999) 
Iceland 1994 18 months fruits 
(plum/cherry) 








- - - - - - - - - 
Eggesbo 
(1999) 






- - - - - - - - - 
Eggesbo 
(1999) 






- - - - - - - - - 
Eggesbo 
(1999) 






- - - - - - - - - 
Falcao (2004) Portugal nr >39 years fruits Both IgE and 
non-IgE 
mediated (no 










Spain nr 6-13 years fruits Both IgE and 
non-IgE 
mediated (no 




(19.9 -22.1)  
n=5163 
- - - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Kristjansson 
(1999) 








- - - - - - - - - 
Kristjansson 
(1999) 








- - - - - - - - - 
Ostblom 
(2008 a) 








- - - - - - - - - 
Kristjansson 
(1999) 








- - - - - - - - - 
Ostblom 
(2008 a) 








- - - - - - - - - 
Kristjansson 
(1999) 
Sweden 1994 18 months fruits 
(plum/cherry) 








- - - - - - - - - 
Ostblom 
(2008 a) 
Sweden 1999-2000 4 years fruits 
(stonefruit) 













1993- 1994 4-15 years fruits (apple) Both IgE and 
non-IgE (no 











1993- 1994 4-15 years fruits (banana) Both IgE and 
non-IgE (no 











1993- 1994 4-15 years fruits (orange) Both IgE and 
non-IgE (no 











1993- 1994 4-15 years fruits 
(strawberry) 
Both IgE and 
non-IgE (no 






- - - - - - - - - 
Gelincik 
(2008) 



























(0.0 - 0.4)  
n=2739 
- - - - 0.1 
†
 
(0 - 0.3)  
n=2739 
- - 0 
†
 





















Turkey 2010 10-11 years fruits (kiwi) IgE mediated 
only 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 





(0.1 - 0.6)  
n=2739 
- - - - 0.3 
†
 
(0.1 - 0.6)  
n=2739 
- - 0.1 
†
 





























Turkey 2010 10-11 years fruits (peach) IgE mediated 
only 
























Turkey nr 18 years + fruits (pear) Both Ige and 
non-IgE 
mediated 
















Turkey nr 18 years + fruits 
(strawberry) 





























(0 - 0.3)  
n=2739 
- - - - 0 
†
 
(0 - 0.2)  
n=2739 
- - 0 
†
 















- - - - - - - - - 
Venter (2006) United 
Kingdom 
2003-2004 6 years fruits (banana) Both IgE and 
non-IgE 
mediated 










Young (1994) United 
Kingdom 
nr nr fruits (citrus) Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
Young (1994) United 
Kingdom 
nr nr fruits (non 
citrus) 
Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
Venter (2008) United 
Kingdom 
2001-2005 1 year fruits 
(pineapple) 
Both IgE and 
non-IgE 
mediated 





Venter (2008) United 
Kingdom 
2001-2005 2 years fruits 
(pineapple) 
Both IgE and 
non-IgE 
mediated 





Venter (2008) United 
Kingdom 
2001-2005 3 years fruits 
(pineapple) 
Both IgE and 
non-IgE 
mediated 





Venter (2006) United 
Kingdom 
2003-2004 6 years fruits 
(strawberry) 








- - - - - - - - - 
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† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
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Table 1.19:   Fruits allergy prevalence in non-European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 








- - - - - - - - - 







- - - - - - - - - 
Soller (2012) Canada 2008-2009 <18 years fruits “likely” IgE 
mediated (no 




- - - - - - - - - 
Soller (2012) Canada 2008-2009 >18 years fruits “likely” IgE 
mediated (no 




- - - - - - - - - 
Chen (2011) China 2009 0-12 months fruits (orange) IgE mediated 
only 





- - - - - - 
Hu (2010) China 1999 0-24 months fruits (orange) IgE mediated 
only 





- - - - - - 
Hu (2010) China 2009 0-24 months fruits (orange) IgE mediated 
only 





- - - - - - 
Marrugo 
(2008) 
Colombia nr All ages fruit/ 
vegetables 
Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 





- - - - - - - - - 





- - - - - - - - - 







- - - - - - - - - 







- - - - - - - - - 
Leung (2009) Hong Kong 2006-2007 2-7 years fruits (orange/ 
banana) 
IgE mediated 



















(0.0 - 0.2)  
n=9070 
- - - 0 
†
 
(0 - 0.1)  
n=9070 
- - - - 
Kim (2011) Korea 2006-2007 0-12 months fruits IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Oh (2004) Korea 2000 6-12 years fruits IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 12-15 years fruits IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 6-12 years fruits (apple) IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 12-15 years fruits (apple) IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 6-12 years fruits (banana) IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 12-15 years fruits (banana) IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 6-12 years fruits (peach) IgE mediated 







- - - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Oh (2004) Korea 2000 12-15 years fruits (peach) IgE mediated 







- - - - - - - - - 
Wan (2012) Taiwan nr 6-8 years fruits (grape) IgE mediated 
only 
- - - - - - 0.7  
(0.3-1.5)  
n=1010 
- - - 
Wu (2012) Taiwan 2004 <3 years fruits (kiwi) IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 >19 years fruits (kiwi) IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 4-18 years fruits (kiwi) IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wan (2012) Taiwan nr 6-8 years fruits (litchi) IgE mediated 
only 
- - - - - - 3.4  
(2.4-4.7)  
n=1010 
- - - 
Wu (2012) Taiwan 2004 <3 years fruits (mango) IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 >19 years fruits (mango) IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 4-18 years fruits (mango) IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wan (2012) Taiwan nr 6-8 years fruits (melon) IgE mediated 
only 
- - - - - - 2.4  
(2.4-4.7)  
n=1010 







2006 6-9 years fruits IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Gupta (2011) United States 2009-2010 0-2 years fruits 
(strawberry) 
IgE mediated 
(no SPT or 
SIgE) 
- 0.5  
(0.3-0.7)  
n=5429 
- - - - - - - - 
Gupta (2011) United States 2009-2010 3-5 years fruits 
(strawberry) 
IgE mediated 
(no SPT or 
SIgE) 
- 0.5  
(0.3-0.8)  
n=5910 
- - - - - - - - 
Gupta (2011) United States 2009-2010 6-10 years fruits 
(strawberry) 
IgE mediated 
(no SPT or 
SIgE) 
- 0.4  
(0.3-0.5)  
n=9911 
- - - - - - - - 
Gupta (2011) United States 2009-2010 11-13 years fruits 
(strawberry) 
IgE mediated 
(no SPT or 
SIgE) 
- 0.4  
(0.3-0.6)  
n=6716 
- - - - - - - - 
Gupta (2011) United States 2009-2010 14-17 years fruits 
(strawberry) 
IgE mediated 
(no SPT or 
SIgE) 
- 0.4  
(0.3-0.6)  
n=10514 
- - - - - - - - 
Gupta (2011) United States 2009-2010 All ages fruits 
(strawberry) 
IgE mediated 
(no SPT or 
SIgE) 
- 0.4  
(0.4-0.5)  
n=3339 
- - - - - - - - 
Vierk (2007) United States 2001 18 years + fruit/ 
vegetables 
IgE mediated 












† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
 
Table 1.20:   Milk/Dairy allergy prevalence in European countries by age group 
Study ID Country Year(s) of 
study  
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Host (2002 Denmark 1985-2000 0-1 years cow‟s milk Both IgE and 
non-IgE 
mediated 




Eller (2009) Denmark 1999-2000 6 months cow‟s milk Both IgE and 
non-IgE 
mediated 




Eller (2009) Denmark 1999-2000 1 year cow‟s milk Both IgE and 
non-IgE 
mediated 




Host (2002 Denmark 1985-2000 1 year cow‟s milk Both IgE and 
non-IgE 
mediated 
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Study ID Country Year(s) of 
study  
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Eller (2009) Denmark 2000-2001 18 months cow‟s milk Both IgE and 
non-IgE 
mediated 




Host (2002) Denmark 1985-2000 2 years cow‟s milk Both IgE and 
non-IgE 
mediated 






Denmark 2000-2001 < 3 years cow‟s milk Both IgE and 
non-IgE 
mediated 






(0.1 - 5.6)  
n=111 
Eller (2009) Denmark 2001-2002 3 years cow‟s milk Both IgE and 
non-IgE 
mediated 




Host (2002) Denmark 1985-2000 3 years cow‟s milk Both IgE and 
non-IgE 
mediated 






Denmark 2000-2001 3 years cow‟s milk Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0.6 
†
 









Denmark 2000-2001 3-22 years cow‟s milk Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0.3 
†
 





(0 - 2.1)  
n=301 
Host (2002) Denmark 1985-2000 5 years cow‟s milk Both IgE and 
non-IgE 
mediated 




Eller (2009) Denmark 2004-2005 6 years cow‟s milk Both IgE and 
non-IgE 
mediated 




Host (2002) Denmark 1985-2000 10 years cow‟s milk Both IgE and 
non-IgE 
mediated 




Host (2002) Denmark 1985-2000 15 years cow‟s milk Both IgE and 
non-IgE 
mediated 












(2.3 - 4.8)  
n=843 





Denmark 2000-2001 >22 years cow‟s milk Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0.3 
†
 





(0.4 - 1.7)  
n=936 
Julge (2001) Estonia 1993-1999 6 months cow‟s milk IgE mediated 
only 






- - - - - 
Julge (2001) Estonia 1993-1999 1 year cow‟s milk IgE mediated 
only 






- - - - - 
Julge (2001) Estonia 1993-1999 2 years cow‟s milk IgE mediated 
only 






- - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Julge (2001) Estonia 1993-1999 5 years cow‟s milk IgE mediated 
only 
- - - - 23.2  
(nr)  
n=207 





1994-1996 0-34 months cow‟s milk Both IgE and 
non-IgE 
mediated (no 










Finland 1980-1981 1 year cow‟s milk Both IgE and 
non-IgE 
mediated ((no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 1 year cow‟s milk Both IgE and 
non-IgE 
mediated ((no 









(4.2 - 7.5)  
n=853 
- - - - - - - 
Kajosaari 
(1982) 






- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 2 years cow‟s milk Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 3 years cow‟s milk Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 3 years cow‟s milk Both IgE and 
non-IgE 
mediated (no 









(5.8 - 9.7)  
n=784 
- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 4 years cow‟s milk Both IgE and 
non-IgE 
mediated (no 









(4.5 - 7.9)  
n=819 
- - - - - - - 
Isolauri  
(2004) 
Finland nr 7 years (born 
1990) 






- - 9 
(4.2-16.4) 
n=100 
-  - - - 
Isolauri 
(2004) 
Finland nr 27 years (born 
1963-1966  






- - 4.4 
(1.2-10.8) 
n=100 
-  - - - 
Isolauri 
(2004) 
Finland nr 47 years (born 
1943-1946 






- - 1.0 
(0.03-5.5) 
n=100 
-  - - - 
Isolauri 
(2004) 
Finland nr 67 years (born 
1923-1926) 






- - 7.1 
(2.9-14.0) 
n=100 
-  - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Rance (2005) France 2002 2-14 years cow‟s milk Both IgE and 
non-IgE 
mediated ((no 




(0.7 - 1.6)  
n=2716 
- - - - - - - - - 
Touraine 
(2002) 
France 2000-2001 5-17 years cow‟s milk Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years cow‟s milk Both IgE and 
non_IgE 
mediated 
- - - - - 0.2  
(0.1-0.4)  
n=3156 






Germany 1999-2000 0-80+ years cow‟s milk Both IgE and 
non_IgE 
mediated 
- - - - - - - - - 0.2  
(0.1-0.5)  
n=3156 
Schafer (1999) Germany 1994 5-6 years cow‟s milk Both IgE and 
non_IgE 
mediated 





- - - - - - 













- - - - - - 
Krause (2002) Greenland 1998 5-18 years cow‟s milk IgE mediated 
only 





- - - - - 
Bakos (2006) Hungary 2002-2004 20-69 years cow‟s milk IgE mediated 
only 










- - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years cow‟s milk IgE mediated 
only 










- - - - - 
Bakos (2006) Hungary 2002-2004 20-69 years milk (casein) IgE mediated 
only 










- - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years milk (casein) IgE mediated 
only 










- - - - - 
Kristjansson 
(1999) 













- - - - 
Kilgallen 
(1996) 
Ireland nr 0-6 months cow‟s milk Both IgE and 
Non-IgE 
mediated(no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 6-12 months cow‟s milk Both IgE and 
Non-IgE 
mediated(no 






- - - - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Kilgallen 
(1996) 
Ireland nr 12-24 months cow‟s milk Both IgE and 
Non-IgE 
mediated(no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 24-36 months cow‟s milk Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 36-48 months cow‟s milk Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 0-6 months dairy products Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 6-12 months dairy products Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 12-24 months dairy products Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 24-36 months dairy products Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 36-48 months dairy products Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 0-6 months dairy products 
(yoghurt) 
Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 6-12 months dairy products 
(yoghurt) 
Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 12-24 months dairy products 
(yoghurt) 
Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 24-36 months dairy products 
(yoghurt) 
Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Kilgallen 
(1996) 
Ireland nr 36-48 months dairy products 
(yoghurt) 
Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Frongia (2005) Italy 2003 12-24 months cow‟s milk Both IgE and 
non-IgE 
mediated (no 
SPT or SIgE) 





- - - - - - - 
Ronchetti 
(2008) 
Italy 2005 - 2006 9 years cow‟s milk Both IgE and 
non-IgE 
mediated 












Italy 2005 - 2006 13 years cow‟s milk Both IgE and 
non-IgE 
mediated 


















- - - - - - - - - 
Eggesbo 
(1999) 






- - - - - - - - - 
Eggesbo 
(1999) 






- - - - - - - - - 
Ro (2012) Norway 2002-2006 2 years cow‟s milk IgE mediated 
only 
- - - 0.9 
†
 





(2.9 - 7.8)  
n=352 
- - - - - 
Falcao (2004) Portugal 2000 >39 years cow‟s milk Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Martinez-
Gimeno (2000) 
Spain nr 6-13 years cow‟s milk Both IgE and 
non-IgE 
mediated (no 




(19.9 - 22.1)  
n=5163 
- - - - - - - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Kristjansson 
(1999) 













- - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Ostblom  
(2008 b) 













- - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Ostblom  
(2008 a) 













- 1.8  
(1.3-2.4)  
n=2563 
- - - 
Ostblom  
(2008 b) 













- - - - - - - 
Bjornsson 
(1996) 
Sweden 1991-1992 20-44 years cow‟s milk IgE mediated 
only 





- - - - - 
Schrander The 
Netherlands 
Unclear 0-1 years cow‟s milk Both IgE and 
non-IgE 
mediated (no 
















1993- 1994 4-15 years cow‟s milk Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Mustafayev 
(2012) 
Turkey 2010 10-11 years cheese IgE mediated 
only 






Altintas (1995) Turkey 1992-1993 0-1 years cow‟s milk Both IgE and 
non-IgE 
mediated (no 
SPT or SIgE) 





- - - - - - - 
Kucukosmano
glu (2008 b) 
Turkey 2002-2003 8-18months cow‟s milk IgE mediated 
only 
- - - 0.6 
†
 
(0.2 - 1.4)  
n=1015 









Altintas (1995) Turkey 1992-1993 1-2 years cow‟s milk Both IgE and 
non-IgE 
mediated 





- - - - - - - 





(0.6 - 1.4)  
n=2739 
- - - - 0.4 
†
 
(0.2 - 0.7)  
n=2739 
- - 0.1 
†
 

















- - - - - - 
Gelincik 
(2008) 














Emmett (1999) United 
Kingdom 
1995-1996 15 + years cheese Both IgE and 
non-IgE 
mediated (no 







- - - - - - - - - 
Young (1994) United 
Kingdom 








- - - - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
SPT or Spes 
IgE) 
Venter (2008) United 
Kingdom 
2001-2005 1 year cow‟s milk Both IgE and 
non-IgE 
mediated 










Venter (2008) United 
Kingdom 
2001-2005 2 years cow‟s milk Both IgE and 
non-IgE 
mediated 










Venter (2008) United 
Kingdom 
2001-2005 3 years cow‟s milk Both IgE and 
non-IgE 
mediated 










Arshad (2001) United 
Kingdom 
1993-1994 4 years cow‟s milk IgE  only - - - 1.3 
†
 
(0.7 - 2.3)  
n=981 
- - - - - - 
Venter (2006) United 
Kingdom 








- - 0.4 
†
 
(0.1 -1.4)  
n=700 





Roberts (2005) United 
Kingdom 
1998-2000 7 years cow‟s milk IgE mediated - - - 0.2 
†
 
(0.1 - 0.6)  
n=2007 
- - - - - - 
Emmett (1999) United 
Kingdom 








- - - - - - - - - 
Young (1994) United 
Kingdom 








- - - - - - - - - 
Pereira (2005) United 
Kingdom 













- - - - - - 
Pereira (2005) United 
Kingdom 













- - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
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Table 1.21:   Milk/Dairy allergy prevalence in non-European countries by age group 
Study ID Country Year(s) of 
study  
Age group Allergen Types of food 
allergy 
 
Questionnaire-based methods Sensitisation 






















       95% Prevalence (CI) 





- 2.7  
(2.1-3.4)  
n= nr 
- 5.6  
(3.2-8.0)  
n=355 
- - - - - - 

















- - - - 
Woods (1998) Australia 1998 20-44years dairy 
products 








- - - - - - - - - - 
Soller (2012) Canada 2008-2009 <18 years cow‟s milk “likely” IgE 
mediated (no 




- - - - - - - - - - 
Soller (2012) Canada 2008-2009 >18 years cow‟s milk “likely” IgE 
mediated (no 




- - - - - - - - - - 
Gerrard (1973) Canada nr 6-36 months cow‟s milk Both IgE and 
non-IgE 
mediated (no 
SPT or SIgE) 





- - - - - - - - 
Chen (2011) China 2009 0-12 months cow‟s milk IgE mediated 
only 












Hu (2010) China 1999 0-24 months cow‟s milk IgE mediated 
only 












Hu (2010) China 2009 0-24 months cow‟s milk IgE mediated 
only 











Sai (2011) China 2008-2009 adults cow‟s milk IgG mediated 
only 





Chen (2012) China 
(Chongqing) 
2009-2010 0-2 years cow‟s milk Both IgE and 
non-IgE 
mediated 





Chen (2012) China 
(Hangzhou) 
2009-2010 0-2 years cow‟s milk Both IgE and 
non-IgE 
mediated 





Chen (2012) China (Zhuhai) 2009-2010 0-2 years cow‟s milk Both IgE and 
non-IgE 
mediated 







Colombia nr All ages cow‟s milk IgE and non-
IgE mediated 







- - - - - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen Types of food 
allergy 
 
Questionnaire-based methods Sensitisation 






















       95% Prevalence (CI) 





- - - - - - - - - - 
Leung (2009) Hong Kong 2006-2007 2-7 years cheese IgE mediated 












Leung (2009) Hong Kong 2006-2007 2-7 years cow‟s milk IgE mediated 












Dalal (2002) Israel nr 0-2years cow‟s milk IgE mediated 
only 
- - 0.4 
†
 
(0.3 -0.6)  
n=9070 





- - - - 











hx or SPT 
and pos 
challenge 
Kim (2011) Korea 2006-2007 0-12 months cow‟s milk IgE mediated 
only((no SPT 
or SIgE)) 





- - - - - - - 
Oh (2004) Korea 2000 6-12 years cow‟s milk IgE mediated 







- - - - - - - - - - 
Oh (2004) Korea 2000 12-15 years cow‟s milk IgE mediated 







- - - - - - - - - - 





- - - - - - - 14.5  
(12.4-16.8)  
n=1010 
- - - 
Wan (2012) Taiwan nr 6-8 years BLG IgE mediated 
only 
- - - - - - - 6.7  
(5.3-8.5)  
n=1010 
- - - 
Wan (2012) Taiwan nr 6-8 years cheese IgE mediated 
only 
- - - - - - - 6.2  
(4.9-8.0)  
n=1010 
- - - 
Wu (2012) Taiwan 2004 <3 years cow‟s milk IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 >19 years cow‟s milk IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 4-18 years cow‟s milk IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wan (2012) Taiwan nr 6-8 years milk IgE mediated - - - - - - - 13.3  - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen Types of food 
allergy 
 
Questionnaire-based methods Sensitisation 






















       95% Prevalence (CI) 
(casein) only (11.3-15.5)  
n=1010 
Wan (2012) Taiwan nr 6-8 years milk (goat) IgE mediated 
only 
- - - - - - - 10.7  
(8.9-12.8)  
n=1010 
- - - 
Santadusit 
(2005) 





(0.9 -3.1)  
n=656 
- - - - - - - - - - 
Lao-araya 
(2012) 



















2006 6-9 years cow‟s milk IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Gupta (2011) United States 2009-2010 0-2 years cow‟s milk IgE mediated 
only (no SPT 
or SIgE) 
- - 2  
(1.6-2.4)  
n=5429 
- - - - - - - - 




- - - - - 12.2  
(nr)  
n=nr 
- - - - - 
Kumar (2011) United States 2011 (yr pub) 6 months - 6 
yrs 
cow‟s milk IgE mediated 
only 





- - - - - 













Liu (2010) United States 2005-2006 1-5 years cow‟s milk IgE mediated 
only 
- - - - - 22  
(nr)  
n=909 
- - - - 1.8  
(nr)  
n=nr 
Keet (2012) United States 2005-2006 1-21 years cow‟s milk IgE mediated 
only 
- - - - - 11  
(nr)  
n=3550 
- - - - - 


























Gupta (2011) United States 2009-2010 3-5 years cow‟s milk IgE mediated 
(no SPT or 
SIgE) 
- - 2  
(1.7-2.5)  
n=5910 
- - - - - - - - 
Gupta (2011) United States 2009-2010 6-10 years cow‟s milk IgE mediated 
(no SPT or 
SIgE) 
- - 1.5  
(1.2-1.8)  
n=9911 
- - - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen Types of food 
allergy 
 
Questionnaire-based methods Sensitisation 






















       95% Prevalence (CI) 
Liu (2010) United States 2005-2006 6-19 years cow‟s milk IgE mediated 
only 
- - - - - 8.1  
(nr)  
n=2869 
- - - - 0.3  
(nr)  
n=nr 
Gupta (2011) United States 2009-2010 11-13 years cow‟s milk IgE mediated 
(no SPT or 
SIgE) 
- - 1.4  
(1.1-1.8)  
n=6716 
- - - - - - - - 
Gupta (2011) United States 2009-2010 14-17 years cow‟s milk IgE mediated 
(no SPT or 
SIgE) 
- - 1.6  
(1.3-1.9)  
n=10514 
- - - - - - - - 
Greenhawt 
(2009) 
United States nr 18 years+ cow‟s milk IgE mediated 







- - - - - - - - - - 
Liu (2010) United States 2005-2006 20-39 years cow‟s milk IgE mediated 
only 
- - - - - 3.2  
(nr)  
n=1672 
- - - - 0.2  
(nr)  
n=nr 
Liu (2010) United States 2005-2006 40-59 years cow‟s milk IgE mediated 
only 
- - - - - 4.9  
(nr)  
n=1361 
- - - - 0.5  
(nr)  
n=nr 
Liu (2010) United States 2005-2006 60+ years cow‟s milk IgE mediated 
only 
- - - - - 3.8  
(nr)  
n=1392 
- - - - 0.3  
(nr)  
n=nr 
Liu (2010) United States 2005-2006 All ages cow‟s milk IgE mediated 
only 
- - - - - 5.7  
(nr)  
n=8203 
- - - - 0.4  
(nr)  
n=nr 
Gupta (2011) United States 2009-2010 All ages cow‟s milk IgE mediated 
(no SPT or 
SIgE) 
- - 1.7  
(1.5-1.8)  
n=3339 
- - - - - - - - 
Vierk (2007) United States 2001 18 years + milk/dairy IgE mediated 












† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
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Table 1.22:   Mustard allergy prevalence in European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Touraine 
(2002) 
France 2000-2001 5-17 years mustard Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
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Table 1.23:   Peanut allergy prevalence in European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen) Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Osterballe 
(2005) 
Denmark 2000-2001 < 3 years peanut Both IgE and 
non-IgE 
mediated 












Denmark 2000-2001 >22 years peanut Both IgE and 
non IgE 
mediated 










Eller (2009) Denmark 1998-1999 3 months peanut Both Ige and 
non-IgE 
mediated 




Eller (2009) Denmark 1999-2000 6 months peanut Both Ige and 
non-IgE 
mediated 




Eller (2009) Denmark 1999-2000 9 months peanut Both Ige and 
non-IgE 
mediated 




Eller (2009) Denmark 1999-2000 1 year peanut Both Ige and 
non-IgE 
mediated 






Denmark 2000-2001 3 years peanut Both Ige and 
non-IgE 
mediated 










Eller (2009) Denmark 2001-2002 3 years peanut Both Ige and 
non-IgE 
mediated 






Denmark 2000-2001 3-22 years peanut Both Ige and 
non-IgE 
mediated 










Eller (2009) Denmark 2004-2005 6 years peanut Both Ige and 
non-IgE 
mediated 




Mortz (2005) Denmark 1995-1996 14 years peanut IgE mediated 
only 


























- - - - - - - - 0.6  
(0.2-1.4)  
n=843 
Rance (2005) France 2002 2-14 years peanut Both IgE and 
non-IgE 
mediated (no 




(0.5 - 1.2)  
n=2716 
- - - - - - - - - 
Touraine 
(2002) 
France 2000-2001 5-17 years peanut Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen) Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years peanut Both IgE and 
non-IgE 
mediated 
- - - - - 0.6 
(0.4-1.0)  
n=3156 
- - - - 













- - - - - - 
Krause (2002) Greenland 1998 5-18 years peanut IgE mediated 
only 





- - - - - 
Bakos (2006) Hungary 2002-2004 20-69 years peanut IgE mediated 
only 










- - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years peanut IgE mediated 
only 










- - - - - 
Kristjansson 
(1999) 













- - - - 
Ro (2012) Norway 2002-2006 2 years peanut IgE mediated 
only 










- - - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Kristjansson 
(1999) 













- - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Ostblom  
(2008 a) 
















- - - 
Ostblom  
(2008 b) 













- - - - - - - 
Bjornsson 
(1996) 
Sweden 1991-1992 20-44 years peanut IgE mediated 
only 





- - - - - 
Mustafayev 
(2012) 
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Study ID Country Year(s) of 
study 
Age group Allergen) Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Gelincik 
(2008) 
Turkey nr 18 years + peanut Both Ige and 
non-IgE 
mediated 





















- - - - 0.1 
†
 
(0 - 0.3)  
n=2739 
- - 0 
†
 
(0 - 0.2)  
n=2739 
- 
Emmett (1999) United 
Kingdom 








- - - - - - - - 
Venter (2008) United 
Kingdom 
2001-2005 1 year peanut Both Ige and 
non-IgE 
mediated 





- - - - - - 
Venter (2008) United 
Kingdom 
2001-2005 2 years peanut Both Ige and 
non-IgE 
mediated 





- - - - - - 
Venter (2008) United 
Kingdom 
2001-2005 3 years peanut Both Ige and 
non-IgE 
mediated 










Grundy (2002) United 
Kingdom 






















2003-2005 3-6 years peanut IgE mediated 
only 
- - - 2.8  
(1.8-3.8)  
n=1072 






Tariq (1996) United 
Kingdom 

















- - - - 
Lack (2003) United 
Kingdom 


















Venter (2006) United 
Kingdom 


















Roberts (2005) United 
Kingdom 
1998-2000 7 years peanut IgE mediated 
only 










2003 8 years peanut IgE mediated 
only 















Pereira (2005) United 
Kingdom 













- - - - - - 
Pereira (2005) United 
Kingdom 













- - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen) Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Emmett (1999) United 
Kingdom 













- - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
 
Table 1.24:   Peanut allergy prevalence in non-European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 














      95% Prevalence (CI) 
Osborne (2011) Australia 2007-2010 12-15 months peanut IgE mediated 
only 
- - - 6.4  
(5.5-7.3)  
n=2757 





















- - - - 
Ben-Shoshan 
(2010) 


















- - - - - - - 
Ben-Shoshan 
(2010) 


















- - - - - - - 
Kagan (2003) Canada 2000-2002 5-9 years peanut IgE mediated 
only 







Canada 2000-2002 7 year  peanut IgE mediated 
only 





Canada 2005-2007 7 year  peanut IgE mediated 
only 
- - - - - - - - - 1.62  
(1.31-1.98)  
n=nr 
Chen (2011) China 2009 0-12 months peanut IgE mediated 
only 





- - - - - - 
Hu (2010) China 1999 0-24 months peanut IgE mediated 
only 





- - - - - - 
Hu (2010) China 2009 0-24 months peanut IgE mediated 
only 





- - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 














      95% Prevalence (CI) 





- - - - - - - - - 
Leung (2009) Hong Kong 2006-2007 2-7 years peanut IgE mediated 

















(0.0 - 0.2)  
n=9070 
- - - 0 
†
 
(0.0 - 0.1)  
n=9070 
- - - - 
Oh (2004) Korea 2000 6-12 years peanut IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 12-15 years peanut IgE mediated 







- - - - - - - - - 













- - - - - - - - 













- - - - - - - - 













- - - - - - - - 
Wu (2012) Taiwan 2004 <3 years peanut IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 >19 years peanut IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 4-18 years peanut IgE mediated 
only (no SPT 
or SIgE) 












2006 6-9 years peanut IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Branum (2009) United States 2005-2006 < 18 years peanut IgE mediated 
only (not 
clearly defined) 
- - - - 9.3  
(nr)  
n=nr 
- - - - - 
Sicherer (1999) United States 1997 <18 years peanut IgE mediated 







- - - - - - - - 
Sicherer (1999) United States 1997 ≥18 years peanut IgE mediated 







- - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 














      95% Prevalence (CI) 
Sicherer (2003) United States 2002 ≥65 years peanut IgE mediated 







- - - - - - - - 
Sicherer (2010) United States 2008 ≥65 years peanut IgE mediated 
only (no SPT 
or SIgE) 
- 0.7  
(0.4-1.2)  
n=2481 
- - - - - - - - 
Gupta (2011) United States 2009-2010 0-2 years peanut IgE mediated 
(no SPT or 
SIgE) 
- 1.4  
(1.1-1.8)  
n=5429 
- - - - - - - - 













Sicherer (2003) United States 2002 0-5 years peanut IgE mediated 







- - - - - - - - 
Sicherer (2010) United States 2008 0-5 years peanut IgE mediated 







- - - - - - - - 
Kumar (2011) United States 2011  6 months - 6 
years 
peanut IgE mediated 
only 
- - - - 13.5  
(11.6-15.7)  
n=1104 
- - - - - 
Keet (2012) United States 2005-2006 1-21 years peanut IgE mediated 
only 
- - - - 10  
(nr)  
n=3550 
- - - - - 
Liu (2010) United States 2005-2006 1-5 years peanut IgE mediated 
only 
- - - - 7.1  
(nr)  
n=909 
- - - - 1.8  
(nr)  
n=nr 
Gupta (2011) United States 2009-2010 3-5 years peanut IgE mediated 
(no SPT or 
SIgE) 
- 2.8  
(2.3-3.4)  
n=5910 
- - - - - - - - 
Sicherer (2003) United States 2002 6-10 years peanut IgE mediated 







- - - - - - - - 
Sicherer (2010) United States 2008 6-10 years peanut IgE mediated 







- - - - - - - - 
Gupta (2011) United States 2009-2010 6-10 years peanut IgE mediated 
(no SPT or 
SIgE) 
- 1.9  
(1.6-2.3)  
n=9911 
- - - - - - - - 
Liu (2010) United States 2005-2006 6-19 years peanut IgE mediated 
only 
- - - - 10.7  
(nr)  
n=2869 
- - - - 2.7  
(nr)  
n=nr 
Gupta (2011) United States 2009-2010 11-13 years peanut IgE mediated 
(no SPT or 
SIgE) 
- 2.3  
(1.9-2.8)  
n=6716 
- - - - - - - - 
Sicherer (2003) United States 2002 11-17 years peanut IgE mediated 







- - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 














      95% Prevalence (CI) 
Sicherer (2010) United States 2008 11-17 years peanut IgE mediated 







- - - - - - - - 
Gupta (2011) United States 2009-2010 14-17 years peanut IgE mediated 
(no SPT or 
SIgE) 
- 1.7  
(1.4-2.1)  
n=10514 
- - - - - - - - 
Vierk (2007) United States 2001 18 years + peanut IgE mediated 














United States nr 18 years+ peanut IgE mediated 





- - - - - - - - - 
Sicherer (2003) United States 2002 18-20 years peanut IgE mediated 







- - - - - - - - 
Sicherer (2010) United States 2008 18-20 years peanut IgE mediated 







- - - - - - - - 
Liu (2010) United States 2005-2006 20-39 years peanut IgE mediated 
only 
- - - - 8.7  
(nr)  
n=1672 
- - - - 1  
(nr)  
n=nr 
Sicherer (2003) United States 2002 21-30 years peanut IgE mediated 







- - - - - - - - 
Sicherer (2010) United States 2008 21-30 years peanut IgE mediated 







- - - - - - - - 
Sicherer (2003) United States 2002 31-40 years peanut IgE mediated 







- - - - - - - - 
Sicherer (2010) United States 2008 31-40 years peanut IgE mediated 







- - - - - - - - 
Liu (2010) United States 2005-2006 40-59 years peanut IgE mediated 
only 
- - - - 6.5  
(nr)  
n=1361 
- - - - 1.1  
(nr)  
n=nr 
Sicherer (2003) United States 2002 41-50 years peanut IgE mediated 







- - - - - - - - 
Sicherer (2010) United States 2008 41-50 years peanut IgE mediated 







- - - - - - - - 
Sicherer (2003) United States 2002 51-60 years peanut IgE mediated 







- - - - - - - - 
Sicherer (2010) United States 2008 51-60 years peanut IgE mediated 







- - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 














      95% Prevalence (CI) 
Liu (2010) United States 2005-2006 60+ years peanut IgE mediated 
only 
- - - - 4.5  
(nr)  
n=1392 
- - - - 0.3  
(nr)  
n=nr 
Sicherer (2003) United States 2002 61-64 years peanut IgE mediated 







- - - - - - - - 
Sicherer (2010) United States 2008 61-64 years peanut IgE mediated 







- - - - - - - - 





- - - - - - 
Liu (2010) United States 2005-2006 All ages peanut IgE mediated 
only 
- - - - 7.6  
(nr)  
n=8203 
- - - - 1.3  
(nr)  
n=nr 
Gupta (2011) United States 2009-2010 All ages peanut IgE mediated 
(no SPT or 
SIgE) 
- 2  
(1.8-2.2)  
n=3339 
- - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
 
Table 1.25:   Sesame allergy prevalence in European countries by age group 
Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 














      95% Prevalence (CI) 
Touraine 
(2002) 
France 2000-2001 5-17 years sesame Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years sesame Both IgE and 
non-IgE 
mediated 
- - - - - 2.2 
(1.7-2.7)  
n=4093 
- - - - 
Bakos (2006) Hungary 2002-2004 60-97 years sesame IgE mediated 
only 





- - - - - 
Venter (2008) United 
Kingdom 
2001-2005 1 years sesame Both IgE and 
non IgE 
mediated 





- - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 














      95% Prevalence (CI) 
Venter (2008) United 
Kingdom 
2001-2005 2 years sesame Both IgE and 
non IgE 
mediated 





- - - - - - 
Venter (2008) United 
Kingdom 
2001-2005 3 years sesame Both IgE and 
non IgE 
mediated 










Venter (2006) United 
Kingdom 








- - 0.4 
†
 
(0.1 -1.4)  
n=700 





Roberts (2005) United 
Kingdom 
1998-2000 7 years sesame IgE mediated 
only 
- - - 0.1 
†
 
(0 - 0.5)  
n=2003 
- - - - - - 
Pereira (2005) United 
Kingdom 
2002-2003 11 years sesame Both IgE and 
non-IgE 
mediated 





- - - - - - 
Pereira (2005) United 
Kingdom 
2002-2003 15 years sesame Both IgE and 
non-IgE 
mediated 





- - - - - - 
Emmett (1999) United 
Kingdom 








- - - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
 
Table 1.26:  Sesame allergy prevalence in non-European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy 
Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Osborne (2011) Australia 2007-2010 12-15 months sesame IgE mediated 
only 
- - - 1.6  
(1.2-2.1)  
n=2695 






















- - - - - - - 
Ben-Shoshan 
(2010) 
















- - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen  Type of food 
allergy 
Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 





(0.1 - 0.3)  
n=9070 





- - - - 
Sicherer (2010) United States 2008 <18 years sesame IgE-  only (no 






- - - - - - - - 
Sicherer (2010) United States 2008 >18 years sesame IgE-  only (no 






- - - - - - - - 
Sicherer (2010) United States 2008 All ages sesame IgE-  only (no 






- - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
 
Table 1.27:   Soya allergy prevalence in European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















        95% Prevalence (CI) 
Osterballe 
(2005) 
Denmark 2000-2001 < 3 years soya Both IgE and 
non-IgE 
mediated 










Denmark 2000-2001 3 years soya Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0 
†
 









Denmark 2000-2001 3-22 years soya Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0  
(0 - 2)  
n=301 
0.3  










(0.2 - 1.5)  
n=843 





Denmark 2000-2001 >22 years soya Both IgE and 
non-IgE 
mediated 
- - - - - - - - 0 
†
 









Germany 1999-2000 0-80+ years soya Both IgE and 
non-IgE 
mediated 
- - - - - 0.9 
(0.6-1.3)  
n=3156 
- - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















        95% Prevalence (CI) 















- - - - - - 
Krause (2002) Greenland 1998 5-18 years soya IgE mediated 
only 





- - - - - 
Bakos (2006) Hungary 2002-2004 20-69 years soya IgE mediated 
only 










- - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years soya IgE mediated 
only 








- - - - - 
Kristjansson 
(1999) 













- - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Kristjansson 
(1999) 













- - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Ostblom  
(2008 b) 













- - - - - - - 
Ostblom  
(2008 a) 













- 1.6  
(1.1-2.1)  
n=2563 
- - - 
Ostblom  
(2008 b) 













- - - - - - - 
Bjornsson 
(1996) 
Sweden 1991-1992 20-44 years soya IgE mediated 
only 










1993- 1994 4-15 years soya Both IgE and 
non-IgE (no 






- - - - - - - - - 
Arshad (2001) United 
Kingdom 
1993-1994 4 years soya IgE mediated 
only 
- - - 0.3 
†
 
(0.1 - 1)  
n=981 
- - - - - - 
Roberts (2005) United 
Kingdom 
1998-2000 7 years soya IgE mediated 
only 
- - - 0.2 
†
 
(0 - 0.7)  
n=1173 
- - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















        95% Prevalence (CI) 
Emmett (1999) United 
Kingdom 








- - - - - - - - - 
Young (1994) United 
Kingdom 
nr All ages soya Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
 
Table 1.28:   Soya allergy prevalence in non-European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















        95% Prevalence (CI) 
Soller (2012) Canada 2008-2009 <18 years soya “likely” IgE 
mediated (no 




- - - - - - - - - 
Soller (2012) Canada 2008-2009 >18 years soya “likely” IgE 
mediated (no 




- - - - - - - - - 
Hu (2010) China 1999 0-24 months soya IgE mediated 
only 





- - - - - - 
Hu (2010) China 2009 0-24 months soya IgE mediated 
only 





- - - - - - 
Sai (2011) China 2008-2009 adults soya IgG mediated 
only 










- - - - - - - - - 





(0.0 - 0.2)  
n=9070 
- - - 0 
†
 
(0.0 - 0.1)  
n=9070 
- - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















        95% Prevalence (CI) 
Kim (2011) Korea 2006-2007 0-12 months soya IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Oh (2004) Korea 2000 6-12 years soya IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 12-15 years soya IgE mediated 







- - - - - - - - - 
Wu (2012) Taiwan 2004 <3 years soya IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 >19 years soya IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Wu (2012) Taiwan 2004 4-18 years soya IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Santadusit 
(2005) 
Thailand nr 6 months - 
6years 





(0.0 - 1.0)  
n=656 
- - - - - - - - - 
Gupta (2011) United States 2009-2010 0-2 years soya IgE mediated 
(no SPT or 
SIgE) 
- 0.3  
(0.2-0.4)  
n=5429 
- - - - - - - - 













Gupta (2011) United States 2009-2010 3-5 years soya IgE mediated 
(no SPT or 
SIgE) 
- 0.5  
(0.3-0.7)  
n=5910 
- - - - - - - - 
Gupta (2011) United States 2009-2010 6-10 years soya IgE mediated 
(no SPT or 
SIgE) 
- 0.3  
(0.2-0.5)  
n=9911 
- - - - - - - - 
Gupta (2011) United States 2009-2010 11-13 years soya IgE mediated 
(no SPT or 
SIgE) 
- 0.6  
(0.4-0.8)  
n=6716 
- - - - - - - - 
Gupta (2011) United States 2009-2010 14-17 years soya IgE mediated 
(no SPT or 
SIgE) 
- 0.3  
(0.2-0.4)  
n=10514 
- - - - - - - - 
Vierk (2007) United States 2001 18 years + soya IgE mediated 














United States nr 18 years+ soya IgE mediated 







- - - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















        95% Prevalence (CI) 
Gupta (2011) United States 2009-2010 All ages soya IgE mediated 
only (no SPT 
or SIgE) 
- 0.4  
(0.3-0.4)  
n=3339 
- - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
 
Table 1.29:   Tree nuts allergy prevalence in European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Kajosaari 
(1982) 
Finland 1980-1981 1 year unspecified 
nuts 
Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 1 year unspecified 
nuts 
Both IgE and 
non-IgE 
mediated (no 









(0 - 0.6)  
n=853 
- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 2 years unspecified 
nuts 
Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 2 years unspecified 
nuts 
Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 3 years unspecified 
nuts 
Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 3 years unspecified 
nuts 
Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 4 years unspecified 
nuts 
Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years tree nuts 
(hazelnut) 
Both IgE and 
non-IgE 
mediated 
- - - - - 5.9 
(5.1-6.8)  
n=3156 




Schafer (2001) Germany 1997-1998 25-74 years tree nuts 
(hazelnut) 
Both IgE and 
non-IgE 
mediated 





- - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years tree nuts 
(walnut) 
Both IgE and 
non-IgE 
mediated 
- - - - - 1.8  
(1.4-2.4)  
n=3156 




Schafer (2001) Germany 1997-1998 25-74 years unspecified 
nuts 








- - - - - - - - - 
Sakellariou 
(2008) 
Greece 2007 20-54 years unspecified 
nuts 
Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 




- - - - - - - - - - 









- - - - - 














- - - - - 














- - - - - 




- - - - - - - - - - 









- - - - - 
Kristjansson 
(1999) 
Iceland 1994 18 months tree nuts 
(almond) 













- - - - 
Kristjansson 
(1999) 
Iceland 1994 18 months unspecified 
nuts 













- - - - 
Eggesbo (1999) Norway 1993-1995 1 year unspecified 
nuts 






- - - - - - - - - 
Eggesbo (1999) Norway 1993-1995 18 months unspecified 
nuts 






- - - - - - - - - 
Eggesbo (1999) Norway 1993-1995 2 years unspecified 
nuts 






- - - - - - - - - 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Martinez-
Gimeno (2000) 
Spain nr 6-13 years unspecified 
nuts 
Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kristjansson 
(1999) 
Sweden 1994 18 months tree nuts 
(almond) 













- - - - 
Ostblom  
(2008 a) 
Sweden 1999-2000 4 years tree nuts 
(almond) 








- - - - - - - - - 
Kristjansson 
(1999) 
Sweden 1994 18 months unspecified 
nuts 


















1993- 1994 4-15 years unspecified 
nuts 
Both IgE and 
non-IgE (no 






- - - - - - - - - 
Mustafayev 
(2012) 




















Gelincik (2008) Turkey nr 18 years + tree nuts 
(hazelnut) 
Both Ige and 
non-IgE 
mediated 





















(0.1 - 0.6)  
n=2739 
- - - - 0.1 
†
 
(0 - 0.3)  
n=2739 
- - 0 
†
 














- - - - - - - - - 
Mustafayev 
(2012) 




















Gelincik (2008) Turkey nr 18 years + tree nuts 
(walnut) 
Both Ige and 
non-IgE 
mediated 













(0.0 - 0.4)  
n=2739 
- - - - 0.1 
†
 
(0 - 0.3)  
n=2739 
- - 0 
†
 
(0- 0.2)  
n=2739 
- 
Gelincik (2008) Turkey nr 18 years + unspecified 
nuts 








- - - - - - - - - 
Venter (2008) United 
Kingdom 
2001-2005 1 year tree nuts 
(almond) 
Both Ige and 
non-IgE 
mediated 





Venter (2008) United 
Kingdom 
2001-2005 2 years tree nuts 
(almond) 
Both Ige and 
non-IgE 
mediated 
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Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Venter (2008) United 
Kingdom 
2001-2005 3 years tree nuts 
(almond) 
Both Ige and 
non-IgE 
mediated 










Roberts (2005) United 
Kingdom 




- - - 0.5 
†
 
(0.2 - 0.9)  
n=1935 
- - - - - - 
Venter (2008) United 
Kingdom 
2001-2005 3 years tree nuts 
(brazil) 
Both Ige and 
non-IgE 
mediated 










Roberts (2005) United 
Kingdom 




- - - 0.5 
†
 
(0.3 - 1)  
n=1977 
- - - - - - 
Venter (2008) United 
Kingdom 
2001-2005 1 year tree nuts 
(cashew) 
Both Ige and 
non-IgE 
mediated 





Venter (2008) United 
Kingdom 
2001-2005 3 years tree nuts 
(cashew) 
Both Ige and 
non-IgE 
mediated 










Tariq (1996) United 
Kingdom 









- - - - 
Roberts (2005) United 
Kingdom 




- - - 0.4 
†
 
(0.2 - 0.8)  
n=1998 
- - - - - - 
Venter (2008) United 
Kingdom 
2001-2005 3 years tree nuts 
(hazelnut) 
Both Ige and 
non-IgE 
mediated 










Tariq (1996) United 
Kingdom 









- - - - 
Roberts (2005) United 
Kingdom 




- - - 0.1 
†
 
(0 - 0.5)  
n=2076 
- - - - - - 
Roberts (2005) United 
Kingdom 




- - - 0.2 
†
 
(0 - 0.5)  
n=1989 
- - - - - - 
Roberts (2005) United 
Kingdom 




- - - 0.5 
†
 
(0.3 - 1)  
n=1997 
- - - - - - 
Young (1994) United 
Kingdom 
nr All ages unspecified 
nuts 
Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
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Table 1.30:   Tree nuts allergy prevalence in non-European countries by age group 
Study ID Country Year(s) of 
study 
Age group Allergen Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 

















      95% Prevalence (CI) 
Woods (1998) Australia 1998 20-44years unspecified 
nuts 








- - - - - - - - - 





- - - - - - - - - 
Kim (2011) Korea 2006-2007 0-12 months unspecified 
nuts 
IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Shek (2010) Philippines 2007-2008 14-16 years unspecified 
nuts 













- - - - - - - - 
Shek (2010) Singapore 2007-2008 14-16 years unspecified 
nuts 













- - - - - - - - 
Shek (2010) Singapore 2007-2008 4-6 years unspecified 
nuts 













- - - - - - - - 




- - - - - - 2.2  
(1.4-3.3)  
n=1010 
- - - 









- - - - - - - - 
Sicherer (1999) United States 1997 <18 years unspecified 
nuts 
IgE-  only (no 






- - - - - - - - 
Sicherer (2003) United States 2002 <18 years unspecified 
nuts 
IgE-  only (no 






- - - - - - - - 
Sicherer (2010) United States 2008 > 18 years unspecified 
nuts 
IgE-  only (no 






- - - - - - - - 
Sicherer (2003) United States 2002 >18 years unspecified 
nuts 
IgE-  only (no 






- - - - - - - - 
Sicherer (1999) United States 1997 ≥18 years unspecified 
nuts 
IgE-  only (no 






- - - - - - - - 
 
† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
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Table 1.31:  All Other Foods allergy prevalence in European countries by age group 
Study ID Country Year(s)  study  Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Osterballe 
(2005) 
Denmark 2000-2001 < 3 years additives Both IgE and 
non IgE 
mediated 










Denmark 2000-2001 >22 years additives Both IgE and 
non IgE 
mediated 
- - - - - - - - 0.1 
†
 









Denmark 2000-2001 3 years additives Both IgE and 
non IgE 
mediated 
- - - - - - - - 0 
†
 









Denmark 2000-2001 3-22 years additives Both IgE and 
non IgE 
mediated 
- - - - - - - - 0 
†
 















(5.1 - 8.6)  
n=843 





Finland 1980-1981 1 year chocolate Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 2 years chocolate Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 3 years chocolate Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 6 years chocolate Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 1 year legumes Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 2 years legumes Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 3 years legumes Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 4 years legumes Both IgE and 
non-IgE 
mediated (no 









(0.8 - 2.6)  
n=819 
- - - - - - - 
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Study ID Country Year(s)  study  Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Pyrhonen 
(2009) 
Finland 2001-2009 1 year strawberry/chocol
ate/tomato 
Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 2 years strawberry/chocol
ate/tomato 
Both IgE and 
non-IgE 
mediated (no 









(0.1 - 1.1)  
n=852 
- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 3 years strawberry/chocol
ate/tomato 
Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Pyrhonen 
(2009) 
Finland 2001-2009 4 years strawberry/chocol
ate/tomato 
Both IgE and 
non-IgE 
mediated (no 











- - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 1 year tomato Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 2 years tomato Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 3 years tomato Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 6 years tomato Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 1 year vegetables (peas) Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 2 years vegetables (peas) Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 3 years vegetables (peas) Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
Kajosaari 
(1982) 
Finland 1980-1981 6 years vegetables (peas) Both IgE and 
non-IgE 
mediated (no 




- - - - - - - - - 
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Study ID Country Year(s)  study  Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Touraine 
(2002) 
France 2000-2001 5-17 years chocolate Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Touraine 
(2002) 
France 2000-2001 5-17 years garlic Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Touraine 
(2002) 
France 2000-2001 5-17 years honey Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Touraine 
(2002) 
France 2000-2001 5-17 years Latex- 
kiwi/melon/banan
a/chestnut 
Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Touraine 
(2002) 
France 2000-2001 5-17 years pork Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years additives Both IgE and 
non-IgE 
mediated 
- - - - - - - - - 0.3  
(0.1-0.5)  
n=3156 








- - - - - - - - - 
Schafer (2001) Germany 1997-1998 25-74 years alcohol (sparkling 
wine) 








- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years cacao Both IgE and 
non-IgE 
mediated 





Germany 1999-2000 0-80+ years carob Both IgE and 
non-IgE 
mediated 
- - - - - 0.9 
(0.6-1.3)  
n=3156 
- - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years carrageen Both IgE and 
non-IgE 
mediated 
- - - - - 0.2  
(0.1-0.4)  
n=3156 
- - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years guargum Both IgE and 
non-IgE 
mediated 
- - - - - 0.2  
(0.1-0.5)  
n=3156 
- - - - 








- - - - - - - - - 








- - - - - - - - - 
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Study ID Country Year(s)  study  Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years poppy seeds Both IgE and 
non-IgE 
mediated 
- - - - - 0.7  
(0.5-1.1)  
n=3156 
- - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years pork Both IgE and 
non-IgE 
mediated 
- - - - - 0.2  
(0.1-0.4)  
n=3156 
- - - - 
Schafer (2001) Germany 1997-1998 25-74 years pork Both IgE and 
non-IgE 
mediated 





- - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years potato Both IgE and 
non-IgE 
mediated 
- - - - - 4.9  
(4.2-5.7)  
n=3156 
- - - - 








- - - - - - - - - 








- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years vegetables Both IgE and 
non-IgE 
mediated 






Germany 1999-2000 0-80+ years vegetables Both IgE and 
non-IgE 
mediated 
- - - - - - - - - 0.3  
(0.1-0.6)  
n=3156 








- - - - - - - - - 
Zuberbier 
(2004) 
Germany 1999-2000 0-80+ years vegetables 
(carrot) 
Both IgE and 
non-IgE 
mediated 
- - - - - 3.6  
(2.9-4.3)  
n=3156 
- - - - 
Zannikos 
(2008) 
Greece 2007 7-13 years chocolate Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
Sakellariou 
(2008) 
Greece 2007 20-54 years chocolate Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Sakellariou 
(2008) 
Greece 2007 20-54 years meat Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Bakos (2006) Hungary 2002-2004 20-69 years potato IgE mediated 
only 










- - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years Potato IgE mediated 
only 










- - - - - 
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Study ID Country Year(s)  study  Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Bakos (2006) Hungary 2002-2004 20-69 years tomato IgE mediated 
only 
- - - - - - - - - - 
Bakos (2006) Hungary 2002-2004 60-97 years tomato IgE mediated 
only 





- - - - - 














- - - - - 














- - - - - 
Kristjansson 
(1999) 








- - - - - - - - - 
Kristjansson 
(1999) 








- - - - - - - - - 
Kristjansson 
(1999) 








- - - - - - - - - 
Kristjansson 
(1999) 
Iceland 1994 18 months vegetables 
(carrot) 








- - - - - - - - - 
Kristjansson 
(1999) 













- - - - 
Kilgallen 
(1996) 
Ireland nr 0-6 months additives Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 12-24 months additives Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 24-36 months additives Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 36-48 months additives Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 6-12 months additives Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
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Study ID Country Year(s)  study  Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Kilgallen 
(1996) 
Ireland nr 0-6 months colourings Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 12-24 months colourings Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 24-36 months colourings Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 36-48 months colourings Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 6-12 months colourings Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 0-6 months soft drinks Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 6-12 months soft drinks Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 12-24 months soft drinks Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 24-36 months soft drinks Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 36-48 months soft drinks Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 0-6 months sweets Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 6-12 months sweets Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
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Study ID Country Year(s)  study  Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Kilgallen 
(1996) 
Ireland nr 12-24 months sweets Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 24-36 months sweets Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kilgallen 
(1996) 
Ireland nr 36-48 months sweets Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Frongia (2005) Italy 2003 12-24 months tomato Both IgE and 
non-IgE 
mediated (no 
SPT or SIgE) 





- - - - - - - 
Ronchetti 
(2008) 
Italy 2005 - 2006 9 years tomato Both IgE and 
non-IgE 
mediated 












Italy 2005 - 2006 13 years tomato Both IgE and 
non-IgE 
mediated 


















- - - - - - - - - 
Eggesbo 
(1999) 






- - - - - - - - - 
Eggesbo 
(1999) 






- - - - - - - - - 
Eggesbo 
(1999) 






- - - - - - - - - 
Eggesbo 
(1999) 






- - - - - - - - - 
Eggesbo 
(1999) 






- - - - - - - - - 
Falcao (2004) Portugal nr >39 years Chocolate Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Falcao (2004) Portugal nr >39 years Legumes Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
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Study ID Country Year(s)  study  Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Falcao (2004) Portugal nr >39 years Meat Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Falcao (2004) Portugal nr >39 years Spices Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Martinez-
Gimeno (2000) 
Spain nr 6-13 years legumes Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Kristjansson 
(1999) 








- - - - - - - - - 
Kristjansson 
(1999) 








- - - - - - - - - 
Ostblom  
(2008 a) 








- - - - - - - - - 
Kristjansson 
(1999) 








- - - - - - - - - 
Kristjansson 
(1999) 
Sweden 1994 18 months vegetables 
(carrot) 








- - - - - - - - - 
Kristjansson 
(1999) 













- - - - 
Ostblom  
(2008 a) 













1993- 1994 4-15 years additives Both IgE and 
non-IgE (no 











1993- 1994 4-15 years chocolate Both IgE and 
non-IgE (no 











1993- 1994 4-15 years mayonnaise Both IgE and 
non-IgE (no 











1993- 1994 4-15 years pork Both IgE and 
non-IgE (no 






- - - - - - - - - 
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Study ID Country Year(s)  study  Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
























1993- 1994 4-15 years soft drinks Both IgE and 
non-IgE (no 











1993- 1994 4-15 years sugar Both IgE and 
non-IgE (no 











1993- 1994 4-15 years tomato Both IgE and 
non-IgE (no 






- - - - - - - - - 
Gelincik 
(2008) 
Turkey nr 18 years + additives Both Ige and 
non-IgE 
mediated 











(1 - 1.9)  
n=2739 
- - - - 0.3 
†
 
(0.2 - 0.7)  
n=2739 
- - 0.3 
†
 





Turkey 2010 10-11 years beef IgE mediated 
only 











(0.1 - 0.5)  
n=2739 
- - - - 0.1 
†
 
(0.1 - 0.4)  
n=2739 
- - 0 
†
 





Turkey nr 18 years + black pepper Both Ige and 
non-IgE 
mediated 
















- - - - - - - - - 





(0.1 - 0.5)  
n=2739 
- - - - 0.1 
†
 
(0 - 0.3)  
n=2739 
- - 0 
†
 



























(2.4 - 3.7)  
n=2739 
- - - - 0.5 
†
 
(0.3 - 0.8 )  
n=2739 
- - 0.1 
†
 





































- - - - - - - - - 
Gelincik 
(2008) 
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Study ID Country Year(s)  study  Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Gelincik 
(2008) 








- - - - - - - - - 
Gelincik 
(2008) 



















(0 - 0.3)  
n=2739 
- - - - 0 
†
 
(0 - 0.2)  
n=2739 
- - 0 
†
 





Turkey nr 18 years + Potato Both Ige and 
non-IgE 
mediated 








Turkey nr 18 years + Red chilli Both Ige and 
non-IgE 
mediated 
























Turkey 2010 10-11 years spinach IgE mediated 
only 








Turkey nr 18 years + Spinach Both Ige and 
non-IgE 
mediated 



















(0.1 - 0.6)  
n=2739 
- - - - 0.1 
†
 
(0 - 0.3)  
n=2739 
- - 0.0 
†
 





























Turkey nr 18 years + vegetables 
(carrot) 
Both Ige and 
non-IgE 
mediated 














Pereira (2005) United 
Kingdom 








- - - - - - - - - 
Pereira (2005) United 
Kingdom 








- - - - - - - - - 
Venter (2006) United 
Kingdom 



















Young (1994) United 
Kingdom 
nr All ages additives Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
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Study ID Country Year(s)  study  Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 



















      95% Prevalence (CI) 
Young (1994) United 
Kingdom 
nr All ages alcohol Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
Young (1994) United 
Kingdom 
nr All ages caffeine Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
Emmett (1999) United 
Kingdom 








- - - - - - - - - 
Young (1994) United 
Kingdom 
nr All ages chocolate Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
Young (1994) United 
Kingdom 
nr All ages meat Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
Emmett (1999) United 
Kingdom 








- - - - - - - - - 
Venter (2008) United 
Kingdom 
2001-2005 1 year salicylate Both IgE and 
non-IgE 
mediated 





Venter (2008) United 
Kingdom 
2001-2005 2 years salicylate Both IgE and 
non-IgE 
mediated 





Venter (2008) United 
Kingdom 
2001-2005 3 years salicylate Both IgE and 
non-IgE 
mediated 





Venter (2008) United 
Kingdom 
2001-2005 1 year tomato Both IgE and 
non-IgE 
mediated 





Venter (2008) United 
Kingdom 
2001-2005 2 years tomato Both IgE and 
non-IgE 
mediated 





Venter (2008) United 
Kingdom 
2001-2005 3 years tomato Both IgE and 
non-IgE 
mediated 





Young (1994) United 
Kingdom 
nr All ages tomato Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
Young (1994) United 
Kingdom 
nr All ages vegetables Both IgE and 
non IgE 
mediated (no 






- - - - - - - - - 
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Table 1.32:   All Other Foods allergy prevalence in non-European countries by age group 
Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 
Self-reported Clinical history Clinician-
diagnosed 










      95% Prevalence (CI) 








- - - - - - - - - 








- - - - - - - - - 
Woods (1998) Australia 1998 20-44years Fats/oils, butter, 
margarine/ cream/ 
salad dressing 








- - - - - - - - - 
Woods (1998) Australia 1998 20-44years herbs/spices/condi
ments/ garlic, chilli 








- - - - - - - - - 








- - - - - - - - - 








- - - - - - - - - 








- - - - - - - - - 
Woods (1998) Australia 1998 20-44years Monosodium 
glutamate 








- - - - - - - - - 








- - - - - - - - - 
Woods (1998) Australia 1998 20-44years Restaurant 
meals/take away 
meals 








- - - - - - - - - 








- - - - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 
Self-reported Clinical history Clinician-
diagnosed 










      95% Prevalence (CI) 








- - - - - - - - - 








- - - - - - - - - 








- - - - - - - - - 








- - - - - - - - - 
Soller (2012) Canada 2008-2009 <18 years vegetables “likely” IgE 
mediated (no 




- - - - - - - - - 
Soller (2012) Canada 2008-2009 >18 years vegetables “likely” IgE 
mediated (no 




- - - - - - - - - 
Sai (2011) China 2008-2009 adults Beef IgG mediated 
only 





Sai (2011) China 2008-2009 adults Chicken IgG mediated 
only 





Sai (2011) China 2008-2009 adults Mushroom IgG mediated 
only 





Sai (2011) China 2008-2009 adults Pork IgG mediated 
only 





Sai (2011) China 2008-2009 adults Rice IgG mediated 
only 





Sai (2011) China 2008-2009 adults Sweetcorn IgG mediated 
only 





Sai (2011) China 2008-2009 adults Tomato IgG mediated 
only 







Colombia Nr All ages additives Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 
Self-reported Clinical history Clinician-
diagnosed 










      95% Prevalence (CI) 
Marrugo 
(2008) 
Colombia Nr All ages alcohol Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 
Marrugo 
(2008) 
Colombia Nr All ages meat Both IgE and 
non-IgE 
mediated (no 






- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 
Self-reported Clinical history Clinician-
diagnosed 










      95% Prevalence (CI) 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 





- - - - - - - - - 
Leung (2009) Hong Kong 2006-2007 2-7 years Beef IgE mediated 












Leung (2009) Hong Kong 2006-2007 2-7 years Chocolate IgE mediated 












Leung (2009) Hong Kong 2006-2007 2-7 years Lamb IgE mediated 












Leung (2009) Hong Kong 2006-2007 2-7 years Tomato IgE mediated 
























- - 0.8  
(0.3-1.9)  
n=741 
- - - 





(0 - 0.1)  
n=9070 
- - - 0 
†
 
(0 - 0.1)  
n=9070 
- - - - 





(0 - 0.1)  
n=9070 
- - - 0 
†
 
(0 - 0.1)  
n=9070 
- - - - 





(0 - 0.1)  
n=9070 
- - - 0 
†
 
(0 - 0.1)  
n=9070 
- - - - 





(0 - 0.1)  
n=9070 
- - - 0 
†
 
(0 - 0.1)  
n=9070 
- - - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 
Self-reported Clinical history Clinician-
diagnosed 










      95% Prevalence (CI) 





(0 - 0.1)  
n=9070 
- - - 0 
†
 
(0 - 0.1)  
n=9070 
- - - - 
Oh (2004) Korea 2000 12-15 years Beef IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 6-12 years Beef IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 6-12 years Beef IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 12-15 years Buckwheat IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 6-12 years Buckwheat IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 12-15 years chicken IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 6-12 years chicken IgE mediated 







- - - - - - - - - 
Kim (2011) Korea 2006-2007 0-12 months perilla seeds IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Oh (2004) Korea 2000 12-15 years Pork IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 6-12 years Pork IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 12-15 years Tomato IgE mediated 







- - - - - - - - - 
Oh (2004) Korea 2000 6-12 years Tomato IgE mediated 







- - - - - - - - - 
Wan (2012) Taiwan nr 6-8 years bamboo shoot IgE mediated 
only 
- - - - - - 1.2  
(0.7-2.1)  
n=1010 
- - - 
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Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 
Self-reported Clinical history Clinician-
diagnosed 










      95% Prevalence (CI) 
Wan (2012) Taiwan nr 6-8 years cacao IgE mediated 
only 
- - - - - - 0.3  
(0.1-1.0)  
n=1010 
- - - 
Wan (2012) Taiwan nr 6-8 years garlic IgE mediated 
only 
- - - - - - 11.6  
(9.7-13.8)  
n=1010 
- - - 
Wan (2012) Taiwan nr 6-8 years onion IgE mediated 
only 
- - - - - - 1.6  
(0.9-2.6)  
n=1010 
- - - 
Lao-araya 
(2012) 







- - - - - - - - - 
Lao-araya 
(2012) 





































- - - - - - - - - 
Santadusit 
(2005) 
Thailand nr 6 months - 
6years 





(0.0 - 1.0)  
n=656 
- - - - - - - - - 
Lao-araya 
(2012) 







- - - - - - - - - 
Santadusit 
(2005) 
Thailand nr 6 months - 
6years 





(0.1 - 1.2)  
n=656 







2006 6-9 years vegetables IgE mediated 
only (no SPT 
or SIgE) 





- - - - - - - 
Vierk (2007) United States 2001 18 years + additives IgE mediated 

























Vierk (2007) United States 2001 18 years + Chocolate IgE mediated 
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Study ID Country Year(s) of 
study  
Age group Allergen  Type of food 
allergy Questionnaire-based methods Sensitisation 
Sensitisation with clinical 
history 
Food challenge with clinical 
history 
Other 
Self-reported Clinical history Clinician-
diagnosed 










      95% Prevalence (CI) 














† Percentage prevalence and/or confidence intervals calculated from raw data provided in the paper 
‡ Percentage prevalence inferred from graph provided (no raw data reported).  
# Data has been subject to correction or estimation by the authors (presented as reported in the paper). 
Note: Where confidence intervals are missing the data has either been inferred from a graph or they have not been provided by the paper and, in the absence of raw data, could not be calculated. 
University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506    200 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by 
the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. 
The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and 
the conclusions reached in the present document, without prejudice to the rights of the author(s). 
1.2.7. Time Trends 
There are only a few cases in which it is appropriate to compare prevalence rates across decades. In these 
instances, studies have adopted similar methodologies in similar age groups in the same country. It would 
not make sense to compare across countries, where diet changes significantly, and across methodologies 
as each one carries its own level of risk/bias.  
1.2.7.1. Celery  
There are no studies available which are appropriate to compare to show any time trends in sesame 
allergy. 
1.2.7.2. Cereals 
Two studies were conducted on the prevalence of cereal allergy in Finland, one in 1980 and the other 20 
years later in 2001. As similar methodologies were used comparisons can be made to reveal time trends 
in wheat allergy in 1 and 2 year old children. At 1 year of age, self-reported allergy to wheat in 1980 was 
estimated at 1% (95% CI: not reported) (Kajosaari 1982), this rose to 2.1 % (95% CI:1.3-3.4%) 
(Pyrhonen 2009) when studied in 2001. At 2 years of age, self-reported allergy to wheat was 1% (95% 
CI: not reported) (Kajosaari 1982), again doubling to 2% (95% CI: 1.2-3.2%) in 2001 (Pyrhonen 2009).  
 
Two further studies in the UK, both measuring sensitisation to wheat using skin prick tests, found 0.3% 
(95% CI:0.1-1.0) sensitisation in 4 year olds in the 1993 cohort (Arshad 2001) and 0% (95% CI: 0.0-0.1) 
in 3 year olds in the 2001 cohort (Venter 2008). Skin prick tests were conducted using the same allergens 
and the same research nurses. A study conducted in China, looked at sensitisation rates to wheat, as 
determined by a positive skin prick test in 1999 and 10 years later in 2009 in children aged 0-24 months. 
They found a 0.2% increase, from 0.3% (95% CI: 0.0-2.1%) (Hu 2010) in 1999 to 0.5 % (95% CI: 0.1-
2.1%) in 2009 (Hu 2010).  
1.2.7.3. Egg 
Two studies looking at egg allergy in Finland were carried out in 1980 and 2001, and as similar methods 
were utilised, we are able to compare the prevalence rates, At 1 year of age, 6% (95% CI: not reported) of 
parents reported an adverse reaction to egg in 1980, whereas in 2001 only 2.7% (95% CI: 1.8-4.1%) 
(Kajosaari 1982) parents reported a problem with egg. At 2 years of age, there was a 7% (95% CI: not 
reported) (Kajosaari 1982) self-reported prevalence of egg allergy in 1980 compared to 4% (95% CI: 2.8-
5.6%) (Pyrhonen 2009) prevalence found at the same age in 2001. At 3 years of age, 9% (95% CI: not 
reported) of parents reported an egg allergy in their children (Kajosaari 1982), this dropped to only 3.6% 
(95% CI:2.4-5.2%) reporting a problem in the same age group in 2001 (Pyrhonen 2009). 
  
In the UK, a study was conducted in 1995 which reported self-reported egg allergy at 15 years of age, this 
showed a 0.7% (95% CI: 0.6-0.8%) prevalence (Emmett 1999). When compared to a later study also in 
the UK with 15 year olds, self-reported egg allergy had risen to 3%. (95% CI: 2.0-4.6%) (Pereira 2005). 
Two further studies in the UK, both measuring sensitisation to egg using skin prick tests, found 0.8% 
(95% CI: 0.4-2.0) sensitisation in 4 year olds in a 1993 cohort (Arshad 2001) and 1.4% (95% CI:0.7-2.7) 
in 3 year olds in 2001 cohort (Venter 2008). In China, sensitisation to egg increased from 7.6% (95% CI: 
5.0-11.3%) in 0-24 month olds in 1999, to 16.2% (95% CI: 12.8-20.4%) in the same age group in 2009 
(Hu 2010). Of note, Osborne 2011 reports the highest challenge proven rate of egg allergy in young 
children worldwide (9%; 95% CI: 7.9-10.0) in a study conducted in Australia, however the challenges 
were performed using raw egg. 
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1.2.7.4. Fish and Shellfish 
The prevalence of self-reported allergy to fish in Finland in 1980 was 6% (95% CI: not reported) 
(Kajosaari 1982) which declined slightly when assessed in 2001 when it was reported to be 5% (95% CI: 
3.4-6.4%) (Pyrhonen 2009). In 1980 5% (95% CI: not reported) of parents reported that their child 
experienced an adverse reaction after consumption of fish (Kajosaari 1982), this declined to 3.6% (95% 
CI: 2.4-5.2%) in 2001 (Pyrhonen, 2009). Two further studies in the UK, both measuring sensitisation to 
cod using skin prick tests, found 0.7% (95% CI:0.3-2.0) sensitisation in 4 year olds in a 1993 cohort 
(Arshad 2001) and 0.5% (95% CI: 0.1-1.5) in 3 year olds in a 2001 cohort (Venter 2008). In China, 0-24 
month olds were skin prick tested, which resulted in 0% (95% CI: 0.0-1.6%) prevalence to shrimp in 
1999 and 0.3% (95% CI: 0.0-1.7%) in 2009 (Hu, 2010). Prevalence of sensitisation to fish was 0.3% 
(95% CI: 0.0-2.1%) in 1999 and 0.8 % (95% CI: 0.2-2.5%) in 2009 (Hu, 2010). 
1.2.7.5. Fruits 
At 1 year of age, self-reported allergy to citrus fruits was reported to be 8% (95% CI: not reported) in 
1980 (Kajosaari 1982) and 3.5% (95% CI: 2.4-5.1%) in 2001 (Pyrhonen 2009). At 2 years of age the 
prevalence rates were 9% (95% CI: not reported) in 1980 (Kajosaari 1982) and 7.2% (95% CI: 5.6-9.2%)    
in 2001 (Pyrhonen 2009). At 3 years of age the self-reported prevalence was 11% (95% CI: not reported) 
in 1980 (Kajosaari 1982) compared to 6.5% (95% CI: 4.9-8.5%) in 2001 (Pyrhonen 2009). In China, 
sensitisation to orange fell from 1% (95% CI: 0.3-3.1%) in 1999 to 0% (95% CI:0-1.2%) in 2009 (Hu 
2010).  
1.2.7.6. Milk/dairy 
Comparing cow‟s milk allergy in Finland in 1980 to 2001, self-reported rates were 2% (95% CI: not 
reported) at age 1, 5% (95% CI: not reported) at age 2 and 2% (95% CI: not reported) at age 3 in 1980 
(Kajosaari 1982). Rates in 2001 were somewhat higher; 5.4% (95%CI: 4.0-7.2%) at age 1, 6.8% (95% 
CI:5.2-8.6%) at age 2 and 5.9% (95% CI: 4.4-7.8%)  at age 3 (Pyrhonen 2009). Two further studies in the 
UK, both measuring sensitisation to milk using skin prick tests, found 1.3% (95% CI:0.7-2.3) 
sensitisation in 4 year olds in a 1993 cohort (Arshad 2001) and 0.5% (95% CI:0.1-1.5) in 3 year olds in a 
2001 cohort (Venter 2008). In China, cow‟s milk sensitivity diagnosed using skin prick tests in 0-24 
month olds almost doubled from 3.3 % (95% CI: 1.7-6.2%) in 1999 to 6.5% (95% CI: 4.4-9.6%) in 2009 
(Hu 2010). 
1.2.7.7. Mustard 
There was only one study found on mustard allergy and so no time trends can be assessed. 
1.2.7.8. Peanut  
Two cohorts of children (age 3–4 years) born on the Isle of Wight, were assessed for peanut allergy and 
the outcomes compared: Cohort A: Born in 1989; (Tarik) reviewed at 4 years of age (n = 2181). Cohort 
B: Born between 1994 and 1996; reviewed between 3 and 4 years of age (n = 1273). Peanut sensitization 
increased significantly from 1.3% in Cohort A to 3.3% (P = 0.003) in Cohort B (Grundy) before falling 
back to 2.0% in Cohort C (P = 0.145) (Venter 2008). Similarly, clinical peanut allergy increased 
significantly from 0.5% in Cohort A to 1.4% (P = 0.023) in Cohort B, with a subsequent fall to 1.2% in 
Cohort C (P = 0.850).  
1.2.7.9. Sesame 
There were limited studies on sesame allergy, with only two studies worldwide utilising food challenges, 
and both studies were done within the same decade so no time trends can be reported.  
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1.2.7.10. Soya 
One study in China looked at sensitisation to soya, reporting a 1% (95% CI: 0.3-3.1) prevalence in 0-24 
month olds in 1999, compared to 0.5% (95% CI: 0.1-2.1) in the same age group in 2009 (Hu 2010). In 
addition, in the United States Bock 1987 reported a rate of 2.7% (95% CI: 1.2-4.2) for self-reported soya 
allergy in 0-3 year olds in the 1980s, compared to Gupta 2011 who found a prevalence of 0.3% (95% CI: 
0.2-0.4) for 0-2 year olds in 2009 when assessing a convincing clinical history.  
1.2.7.11. Tree Nuts 
A study conducted in Finland in 1980 reported the prevalence of self-reported allergy to nuts 
(unspecified). It reported a 2% (95% CI: not reported) prevalence at age 1, 0% (95% CI: not reported) 
prevalence at age 2 and 2% (95% CI: not reported) prevalence at 3 years of age (Kajosaari 1982). A 
similar study also looking at self-reported allergy to nuts in Finland in 2001 found 0.8% (95% CI: 0.4-
1.8%) prevalence at 1 year of age, 2% (95% CI: 1.2-3.3%) at 2 years of age and 1.4% (95% CI: 0.7-
2.6%) prevalence at 3 years of age (Pyrhonen 2009). In the US, Sicherer 1999 and Sicherer 2010 reported 
allergy to nuts based on a convincing clinical history in 1997 and 2008 for children under the age of 18 
years and adults. In the children the prevalence of allergy to nuts was 0.2% (95% CI: 0.1-0.4%) in 1997 
(Sicherer 1999), which doubled to 0.4% (95% CI: 0.3-0.6%) almost 10 years later in 2008 (Sicherer 
2010). For adults, the same studies reported a prevalence rate of 1.6% (95% CI: 1.4-1.9%) prevalence in 
1997 (Sicherer 1999) which dropped to 1.0% (95% CI: 0.8-1.1%) prevalence in 2008 (Sicherer 2010). 
1.2.7.12. Other Foods 
A vast array of allergens was included in this group and so comparing across decades is challenging. 
However, prevalence rates of self-reported allergy in studies published before 2000 varied between 0% in 
allergens such as additives and colourings, sweets, chicken, soft drinks, pulses and vegetables (Killgallen 
1996; Kristjansson 1999; Emmett 1999). The highest self-reported prevalence was seen in tomato allergy 
at 11% (95% CI: not reported) (Kajosaari 1982). Studies published after 2000 report self-reported rates of 
allergy between 0.0% in tomato allergy (Oh 2004; Obeng 2011) and 14% in strawberry, chocolate, 
tomato, latex associated foods (kiwi, melon, banana, chestnut) (Pyrhonen 2009; Touraine 2002). 
1.2.8. Discussion 
In this systematic review we have focused on the 14 major allergens as identified by the EU including: 
milk, egg, wheat, fish, shellfish, molluscs, soya, peanut, tree nuts, sesame, mustard, lupin and celery. We 
have excluded sulphites from the systematic review as agreed with EFSA. Additionally, we have also 
looked at fruit, vegetable and other reported allergens. 
 
Celery 
Celery allergy is considered to be a big problem in mainland Europe. The main problem with studying 
the prevalence of celery allergy is that celery salt is considered much more allergenic than celery itself; 
none of the identified studies utilized celery salt in their food challenges. In fact, despite being considered 
as one of the major 14 food allergens, there appear to be only six studies reported on celery allergy. Two 
studies presented rates of self-reported allergy, three studies focused on SPT results and three reported on 
specific IgE levels. The best information we have on possible celery allergy is based on the data from 
Zuberbier 2004 indicating that 3.5% of the German population suffer from celery allergy based on SPT 
and a good clinical history and the data from Wan 2012 indicating that 1.8% of 6-8 year olds in Taiwan 
suffer from celery allergy based on serum IgE levels and a good clinical history. 
 
Cereals (Wheat) 
Wheat allergy prevalence based on food challenge is reported in three studies only. Osterballe 2004 
reported no wheat allergy in all ages in Denmark, Orhan 2009 found no wheat allergy in 6-9 year old 
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children in Turkey and Venter 2008 reported that 0.4% of 1 year olds, 0.3% of two year olds, 0.2% of 
three year olds, and 0.3% of six year olds suffer from wheat allergy in the UK. 
 
Egg 
Egg allergy is probably one of the most common allergies seen in early childhood and provides a clinical 
dilemma in terms of diagnosis and management due to the effect of heating on allergenicity as discussed 
in Objective 4a. A number of studies have looked at challenge-proven egg allergy in Europe.  As with 
peanut, the two main studies using a food challenge outcome are Osterballe 2005 (Denmark) and Venter 
2008 (United Kingdom). In young children (age 0-3 years) challenge-proven egg allergy prevalence rates 
have been found to be 1.8% (Osterballe 2005) in under 3‟s and at 2.9% at 3 years. Slightly lower rates are 
reported in the UK: 1.8% at 1 year, 1.3% at 2 year and 1% at 3 years (Venter 2008). 
 
In older children (>3 years)  rates based on food challenges were 0.7% (Eller 2009; Demark), 1% 
(Kajosaari 1982; Finland), 0.1% (Mustafayev 2012; Turkey), 1.9% (Orhan 2009; Turkey) and 0.3% 
(Venter 2006). In adults, challenge proven egg allergy data is from two studies only, showing no egg 
allergy in 22 year olds in Denmark (Osterballe 2005) and 0.1% of a whole population in Germany 
(Zuberbier 2004). 
 
In studies from the rest of the world, the prevalence of food-challenge proven egg allergy has been 
reported for Australia and China and only in young children. Osborne identified egg allergy rates of 9% 
in 12 – 15 month old children in Melbourne, Australia. This is much higher than rates reported in Europe 
and other countries in the rest of the world such as China. Egg allergy rates in China were reported to be 
2.5% in 0-12 month olds (Chen 2011), 2.9% in 0-24 month olds seen in 1999, and a much higher rate of 
5% in 0-24 month olds in 2009 (Hu 2010). Chen 2012 also reported rates of 4.4%, 4.2% and 3% in 0-2 
year olds in 2009-2010 in 3 different areas in China. 
 
Fish and Shellfish  
Challenge-proven data on the prevalence of fish allergies is surprisingly weak. In terms of fish (cod) 
allergy, the majority of data is derived from the UK cohort (Venter 2008), showing that 0.1% of one, two, 
three and six year olds suffered from a codfish allergy despite rates of sensitisation of between 0.3 – 1%. 
This information was echoed in Osterballe 2005 who found that none of the children under 3 years in 
their study had a fish allergy and only 0.6% of the adults studied had a challenge-proven allergy. 
Sensitisation rates for fish/cod were not available from this study. The only other adult study available, 
found that 0% of adults have a fish allergy in Turkey (Gelinicik 2008). In 6 year olds, 1% of a Finnish 
group studied showed the 6 year olds had a positive food challenge to fish (Kajosaari 1999). No fish 
allergy was found in the same age group in Turkey (Orhan 2009). 
 
In terms of shellfish allergy, only one study (Osterballe 2005) showed any challenge proven data finding 
a prevalence rate of 0% shellfish (prawn) allergy in young children and 1.1% in adults (Osterballe 2005). 
Mollusc allergy has only been investigated in four studies across Europe, three of which presented self-
reported allergy only. The rates of self-reported allergy were 0.5% to octopus for a group of 22 year olds 
in Denmark (Osterballe 2005), 0.4% to oyster in 5-7 year olds in France (Touraine 2002) and 0.5% to all 
molluscs in >39year olds in Spain (Falcáo 2004). Zuberbier 2004 reported a 0% prevalence of 
sensitisation to mollusc in all ages in Germany.  
 
Looking at the rest of the world, despite a large number of questionnaire-based studies indicating 
reported rates of 0.2% (Ben-Shoshan 2010) to 4.3% (Connett 2012) and sensitization rates of 0.3% to 
0.8%, only one study performed food challenges to fish reporting that 0.2% of 3-7 year olds in Thailand 
have a confirmed fish allergy (Lao-Araya 2012). Self-reported rates of shellfish allergy varied between 
0.1%-11.7%. Sensitization rates measured by SPT were between 0-3.7% and 4.6- 6.7% as measured by 
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SIgE testing.  However only one study reported on shellfish allergy prevalence based on SPT plus a good 
clinical history and found that 17.3% of 6-8 year olds in Taiwan have a shellfish allergy (Wan 2012). 
 
Data on mollusc allergy is even more sparse, with Lao-Araya showing that 0.2% of 3 -7 years olds in 
Thailand self-report problems to eating molluscs, Wu 2012 report clinician diagnosed mollusc allergy 
ranging from 0.1% in under 3 year olds to 1.5% in adults in Taiwan. Wan 2012 indicates very high 
sensitisation rates in the same country, based on SPT and a good clinical history ranging from 2.3% 
(squid) to 25.1% (abalone) in children. Importantly, there were no studies conducted worldwide that used 
food challenges to confirm the prevalence of mollusc allergy in children or adults. The majority of studies 
identified on fish and shellfish allergy reported prevalence rates of IgE-mediated and non-IgE mediated 
allergy collectively. However 22 studies reported IgE-mediated allergy only, using sensitisation rates and 
a convincing history of IgE- associated symptoms following ingestion of fish or shellfish to confirm this 
type of allergic reaction. 
 
Fruit 
A large variety of fruits have been studied including: a mixture of fruit and vegetables, apple, 
citrus/orange fruits, strawberry, kiwi, pear, apricot, cherry, grape, nectarine, peach, plum, banana, and 
pineapple. Those studied in the rest of the world but not in Europe included: pawpaw, mango and melon, 
litchi, “fruit juice”, “dried fruit”. Adverse reactions to cherry, plum and apricot were reported in Europe 
but not in the rest of the world. Considering the debates surrounding the use DBPCFC in diagnosing fruit 
allergies a surprisingly large number were conducted, questioning the allergenicity of the challenge food. 
The potential for adverse reactions to be linked to oral allergy syndrome or latex allergy and possible 
cross-reactions were not mentioned either. 
 
Milk  
One of the main problems with reporting the prevalence of milk allergy is that many studies have failed 
to distinguish between IgE and non-IgE mediated cow‟s milk allergy. The latter has also been incorrectly 
referred to as milk intolerance prior to 2004. Finally, due to the time to onset of symptoms, non-IgE 
mediated cow‟s milk allergy may be missed in many cases if food challenges were only performed over 
one day rather than at least 3-4 days. 
 
Studies indicated the prevalence of food-challenge proven milk allergy in the EU as 0.9% in under 3 year 
olds (Osterballe 2005; Denmark) and 1.6% in 3 year olds (Osterballe 2005; Denmark). Also in Denmark, 
prevalence rates of 0.4% in 6 month olds,  0.6% in 9 month olds, 1.1% in 18 month olds, 0.8% in 1 year 
olds, 0.7% in 3 year olds and 0% in 6 year olds have been reported (Eller 2009). Similar prevalence rates 
have been found in the UK: 2.4% in 1 year olds, 1.2% in two year olds and 0.4% in 3 year olds (Venter 
2008). Only two studies looked at milk allergies in older children which found 0.1% challenge proven 
milk allergy in 6 -9 year olds in Turkey (Orhan 2009) and 0.8% in 6 year olds in the UK (Venter 2008). 
 
In adults only three studies looked at challenge-proven milk allergy reporting prevalence rates of 0.8% in 
over 22 year olds in Denmark (Osterballe 2005), 0% in adults in Turkey (Gelincik 2008) and 0.2% in a 
whole population in Germany (Zuberbier 2004). Looking at the rest of the world, milk allergy prevalence 
in children younger than 3 years ranged from 1.3% (Chen 2009) to 5% (Bock 1987). In older children 
only one study, conducted in Taiwan, reported challenge-proven milk allergy and found none of the 
children to be milk allergic (Loa-araya 2012). There are no studies looking at the prevalence of milk 
allergy in the rest of the world. 
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Mustard 
The prevalence of mustard allergy has been examined by a single study, which presented self-report data 
only, finding that 3% of teenagers in France self report problems with mustard (Touraine 2002). No other 
studies on the prevalence of mustard allergy could be found in the literature. Hence, there are huge gaps 
in our knowledge of the prevalence of mustard allergy, notably the prevalence of mustard allergy 
confirmed by food challenge. 
 
Peanut 
Peanut allergy is probably the most discussed allergen in the world and, due to the severity of the 
reactions, most of the studies investigating immunotherapy to foods have focused on peanut allergy. The 
prevalence of peanut allergy has been studied widely in the EU and the rest of world with using varied 
methodologies. In Europe, the landmark studies have included those conducted by Osterballe et al. 
(Denmark), Venter et al. (UK),  Hourihane et al. (UK) and Nicolau et al. (UK). These studies provide 
valuable data on the prevalence of challenge-proven peanut allergy in young children with the highest 
rate reported as 1.8% in a group of 3-6 year olds in the UK (Hourihane 2007). In older children, Nicolau 
et al. (UK) reported a prevalence of 1.9% challenge-proven peanut allergy in 8 year olds (Nicolau 2009). 
The only data on challenge proven peanut allergy in adults in Europe is from Osterballe et al. showing 
that 1.2% of adults in Denmark suffer from peanut allergy (Osterballe 2005). 
 
Studies investigating peanut allergy in the rest of the world has been dominated to some extent by 
questionnaire based studies in the US and Canada. In terms of challenge-proven peanut allergy, Osborne 
et al. (2011; Australia) found the highest prevalence (2.9%) in 12-15 month olds. Using a complex 
definition of peanut allergy, which included food challenges in some participants, Ben-Shoshan 2010 
(Canada) reported a prevalence of 1.6% in 7 year olds in 2005; a slight increase from that reported for 7 
year olds in 2000-2002 (1.3%). In the same country, Kagan 2003 reported prevalence for peanut allergy 
of 1.5% in 5-9 year olds using similar definitions to that of Ben-Shoshan 2010. The geographical 
disparities in allergies to individual foods is highlighted by the findings of Dalal 2002 who did not 
diagnose any peanut allergy in a group of 0-2 year olds in Israel. 
 
Sesame 
The prevalence of self-reported sesame allergy ranged between 0 - 1.5% (Touraine 2002; Emmett 1999), 
with only one study in Europe reporting challenge-proven sesame allergy. This study found the 
prevalence to be 0.6% in 3 year olds and 0.1% in 6 year olds (Venter 2006; Venter 2008). Sensitisation 
rates varied between 0.1 – 1.4%. In the rest of the world, the prevalence of self-reported sesame allergy 
ranged between 0.1 – 0.2%, although data was only available for Canada (Ben-Shoshan 2010). 
Sensitisation rates determined by SPT and the prevalence of challenge-proven sesame allergy was 
reported by only one study, which found that 1.6% of 12-15 month olds in Australia are sensitized to 
sesame and 0.7% (95% CI: 0.4-1.0) had challenge-proven sesame allergy (Osborne 2011). Despite the 
finding of a study conducted in Israel that there was no challenge-proven peanut allergy in a study group 
of 0-2 year olds, 0.2% of the study group did have challenge-proven sesame allergy (Dalal 2002). 
 
Soya 
Soya allergy is often mentioned in relation to cow‟s milk allergy IN infants and it is estimated that up to 
60% of children with gastro-intestinal milk allergy may suffer from co-existing soya allergy. This figure 
is much lower in children with IgE-mediated allergy. Soya milk as an alternative for children with cow‟s 
milk allergy is also often debated. However, despite all the hype surrounding soya and possible soya 
allergy only one study conducted in Europe and another conducted in the US report challenge-proven 
allergy to soya. Osterballe 2005 found no soya allergy in a group of under 3 year olds from Denmark 
although Bock 1987 found that 0.8% of children in the same age group in the United States had soya 
allergies (Bock 1987). In addition, Osterballe 2005 also reported that 0.4% of 3 year olds and 0.3% of 
adults in Denmark suffer from a soya allergy. 
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Tree nuts 
Many studies looking into tree nut allergy disappointingly did not specify the type of nuts being studied. 
Self-reported tree nut allergy to unspecified nuts however ranged from between 0.2 – 4.7% (Obeng 2011; 
Shek 2010). The studies that reported prevalence based on a challenge-proven diagnosis to specific tree 
nuts focused on hazelnut, walnut, almond, cashew nut and pistachio. These studies indicate that 2.2% of 
the German population suffer from a hazelnut allergy (Zuberbier 2004), as do 0.1% of the adult Turkish 
population and 0-1% of older children in Turkey (Orhan 2009; Mustayev 2012; Gelincik 2008), and 0.1% 
of 3 year old children in the UK (Venter 2008). Walnut allergy based on food challenges is reported in 
1% of the German population (Zuberbier 2004) as well as 0.1% of Turkish adults and 0-0.4% of older 
children in Turkey (Orhan 2009; Mustayev 2012; Gelincik 2008). Food challenge proven almond and 
cashew nut allergy was reported by only one study (Venter 2008) in 0.2% and 0.1% of 3 year olds in the 
United Kingdom respectively. None of the studies in the rest of the world report challenge-proven tree 




Numerous foods have been reported in the literature to cause adverse reactions in individuals in both 
Europe and throughout the world. The majority of studies utilised self-reported methods for calculating 
prevalence. Before the year 2000 studies reported prevalence rates ranging from 0% to 11%, which 
increased to 14% in studies published after 2000. This suggests a minimum of a 3% increase in reported 
levels of prevalence. This could be due to the increased knowledge and awareness of allergy worldwide 
and also the expanding availability of different foods. However, compared to other allergens, there was a 
lack of studies adopting the gold standard of diagnosis which incorporates both open and double-blind 
placebo-controlled food challenges. This is the most effective way to determine prevalences of food 
allergy.  
 
Therefore in summary, it is surprising to find such paucity of information on the prevalence of food 
allergy, although the published literature does give us a good indicating of the scale of the problem. The 
lack of information may be explained by the cost incurred of performing large scale epidemiological 
studies and the difficulties in performing food challenges, particularly DBPCFC. It is hoped that the 
evidence base will be enriched once the Europrevall studies funded by the EU are published. 
Emerging allergens 
This section presents a summary and analysis of the data gathered on allergens other than: milk/dairy, 
eggs, cereals, peanuts, nuts, celery, crustaceans, fish, molluscs, soy, lupin, mustard and sesame that have 
either increased in prevalence or have been highlighted as there was a significant reported prevalence in 
at least one country in Europe.  
The prevalence of allergy to citrus fruits was found in this review to be relatively high for self-reported 
allergy with values between 3.2 to 11% being reported from a range of countries including Finland, 
Germany, Iceland, Sweden and the United Kingdom. Fewer studies reported challenge results and these 
tended to give a lower prevalence of 2% and under. Allergy to citrus is often reported as resulting in mild 
symptoms however there are reports of severe reactions including anaphylaxis. Those at risk of these 
more severe reactions are possible those with allergy to the lipid transfer proteins (Ebo, Ahrazem, Lopez-
Torrejon, Bridts, Salcedo and Stevens; 2007).  
Kiwi allergy has been reported in the wider literature as being one of the more common causes of allergy 
to fruit. We found that this food was not reported as a separate item by the majority of included studies.  
The data we could extract indicated self-report in France of 0.8% and open food challenge in Turkey at 
0.1 %. Although it is thought that many people with allergy to kiwi fruit experience mild symptoms, there 
are reports of more severe reactions including anaphylaxis recently reviewed by Lucas (2003).  
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The prevalence of positive skin prick tests to tomato was relatively high in Italy Ronchette (2008) 3.1%.  
Those that used more robust methods such as food challenge gave much lower values, the highest being 
in Turkey, Gelincik (2008) with 0.1% for those over 18, and other studies indicating less than 01%,   
Orhan (2009) and Venter (2006).   
Additives as a group were highlighted in a number of studies countries. Self-reported allergy could be 
quite high at 6.6 % Osterballe (2005), and 3.4 % in the United Kingdom   Pereira (2005), however on 
challenge the figures were lower at less than 0.1%.  
Cocoa allergy was reported in a number of countries, Orhan (2009) supplied the self-reported, skin prick 
test with history and challenge findings with the later indicating a 0.1% prevalence. That this could cause 
symptoms in 0.1% was concurred by Zurberbier (2004) and Gelincik (2008) . There are very few reports 
of allergic reactions to cocoa in the wider literature and no reports on anaphylaxis.   
Wan (2012) carried out skin prick tests on those who reported a positive history of garlic allergy and 
relatively high prevalence at 11.6% for children in Taiwan for children. The same study showed 
relatively high for onion and bamboo shoot.  In European studies self-reported allergy to garlic was lower 
at only 1.5% in France, Touraine (2002), 0.1% in Turkey Gelincik (2008). For all other allergens the self-
reported rates are higher than challenge findings and so we would expect very garlic allergy rates Europe 
according to our data. The wider literature does include reports of allergy to garlic including anaphylaxis,  
(Pérez-pimiento, Santaolalla, De Paz, Fernández-parra, Domínguez-lázaro, and Moneo; 1999). 
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1.4. List of Excluded Studies 
Below is a table of studies excluded from the review and their reasons for exclusion. These have been 
selected on the basis that they might be expected to have been included in the review (e.g. they have been 
included in previous systematic reviews), but did not meet the eligibility criteria (Table 1.12). 
Table 1.33:   Studies excluded from the systematic review 
Short Title Title  Reason for exclusion 
Aardoom 
(1997) 
Food intolerance (food hypersensitivity) and chronic 
complaints in children: the parents' perception 





Prevalence of food allergy in asthmatic patients Sample, all had asthma 
 
Altman (1996) Public perception of food allergy Duplicate 
 
Avila (2002) Hypersensitivity detected by skin tests to food in 
allergic patients in the Hospital Infantil de Mexico 
Federico Gomez 





Prevalence and risk factors of latex sensitization in 
an unselected pediatric population 
No separated data for each allergen 
 
Biagini (2004) Evaluation of the prevalence of antiwheat-, anti-
flour dust, and anti-alpha-amylase specific IgE 
antibodies in US blood donors 





Allergic diathesis in infants in the first year of life  Topic 
 
Garcia (2003) Incidence of allergy to cow's milk protein in the first 
year of life and its effect on consumption of 
hydrolyzed formulae 
Sample, all had suspected cow‟s milk 
allergy 
 
Gislason (2000) Allergy and intolerance to food in an Icelandic urban 
population 20-44 years of age 
Sample, enriched with participants 
with asthma 
Hill (1997) The frequency of food allergy in Australia and Asia Sample inappropriate  (Limited to 
children of atopic parents only) 
Hossny (2011) Peanut sensitization in a group of allergic Egyptian 
children 
Inappropriate sample (allergic patients 
only) 
Host (1990) A prospective study of cow milk allergy in Danish 
infants during the first 3 years of life. Clinical course 
in relation to clinical and immunological type of 
hypersensitivity reaction 
Linked to Host 2002 
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Short Title Title  Reason for exclusion 
Isolauri (2004) The allergy epidemic extends beyond the past few 
decades 
Excluded in error for extraction 
 
Jansen (1994) Prevalence of food allergy and intolerance in the 
adult Dutch population 








Kanny (2001) Population study of food allergy in France Data not provided by individual 
allergen 
Keiding, (1997) Asthma, allergy and other types of hypersensitivity 
in Denmark: and the development 
Unable to locate article 
 
Levin (2011) Associations between asthma and bronchial hyper-
responsiveness with allergy and atopy phenotypes in 
urban black South African teenagers 
Topic, mainly concerning allergy to 
inhalant allergens 
 
Lunet (2005) Self-reported food and drug allergy in Maputo, 
Mozambique 
Reports allergy to foods collectively 
i.e not per allergen 
Marklund 
(2004) 
Health-related quality of life among adolescents 
with allergy-like conditions - with emphasis on food 
hypersensitivity 





Health-related quality of life in food hypersensitive 
schoolchildren and their families: parents‟ 
perceptions 
 Sample, not cross section of 
community 
 
Ouahidi (2010) The effect of thermic and acid treatment on the 
allergenicity of peanut proteins among the 
population of the region of Fes-Meknes in Morocco 




Prevalence of food allergy and its relationship to 
asthma and allergic rhinitis in schoolchildren 
Topic not suitable 
 
Ramos (1993) Hypersensitivity to common allergens in the central 





Epidemiological characteristics of patients with food 
allergy assisted at Regional Center of Allergies and 
Clinical Immunology of Monterrey 
Sample, all had allergy 
Roehr (2004) Food allergy and non-allergic food hypersensitivity 
in children and adolescents 




Cow's milk protein intolerance in infants under 1 
year of age: a prospective epidemiological study 
Included for extraction 
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Short Title Title  Reason for exclusion 
Takahashi 
(1998) 
Buckwheat allergy in 90,000 school children in 
Yokohama 
Incidence rather than prevalence 
 
Tariq (2000) Egg allergy in infancy predicts respiratory allergic 
disease by 4 years of age 









Venter (2006) Incidence of parentally reported and clinically 
diagnosed food hypersensitivity in the first year of 
life 




Analysis of the sensitization profile towards 
allergens in central Africa 
Sample all participants had allergy 
Woods (2001) International prevalences of reported food allergies 
and intolerances. Comparisons arising from the 
European Community Respiratory Health Survey 
(ECRHS) 1991-1994 
Australian data presented in Woods 
2002 and no separated data for 
individual countries for specific 
allergens. 
Woods (2002) Prevalence of food allergies in young adults and 
their relationship to asthma, nasal allergies, and 
eczema 
 Inappropriate sample (the sample has 
been enriched from a group reporting 
asthma-like symptoms) 
 
1.5. Additional references 
Ebo DG, Ahrazem O, Lopez-Torrejon G, Bridts CH, Salcedo G and Stevens WJ, 2013. Anaphylaxis from 
Mandarin (Citrus reticulata): Identification of Potential Responsible Allergens. International Archives 
of Allergy and Immunology, 144, 39-43. 
Lucas JSA, Lewis SA and Hourihane JOB, 2003. Kiwi fruit allergy: A review. 14, 420-428. 
Pérez-pimiento A, Santaolalla M, De Paz S, Fernández-parra B, Domínguez-lázaro AR and Moneo I, 
1999. Anaphylactic reaction to young garlic. Allergy, 54, 626-629. 
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2. THE EFFECT OF FOOD PROCESSING ON THE ALLERGENICITY IN RELATION TO EACH OF THE 
FOLLOWING FOOD ALLERGENS: MILK/DAIRY, EGGS, CEREALS, BUCKWHEAT, PEANUTS, 
NUTS, CELERY, CRUSTACEANS, FISH, MOLLUSCS, SOY, LUPIN, MUSTARD AND SESAME?  
(OBJECTIVE 4A) 
2.1. Introduction 
2.1.1. Assessing allergenicity of the processed food 
Guidelines indicate that double blind placebo controlled food challenges are the method of choice 
assessing allergenicity of foods and diagnosis of allergy for those with immediate and delayed type 
reactions in Europe (Bindslev-Jensen et al., 2004; Fiocchi et al., 2010) and the United States of America 
(Boyce et al., 2010). However open challenges can be used for specific situations (Bindslev-Jensen, et al., 
2004) and have been shown to have reasonable negative predictive values (Venter, 2007). In food 
challenges participants are challenged with increasing doses of the food and once symptoms are 
experienced the challenge halted. Allergenicity of that food for an individual may be expressed as the 
dose eliciting a reaction, or the dose combined with the type of symptoms experienced (Hourihane et al., 
2005) (Nowak-Wegrzyn et al., 2009) but there are no agreed standards for doing this.  
Skin prick tests with food allergens and measurement of specific IgE in serum without clinical history or 
challenge results have been shown to have poor accuracy for diagnosis of food allergy (Fiocchi et al., 
2002; Järvinen & Sicherer, 2012), and these tests do not indicate accurately enough the intensity of 
reaction on food challenge or the threshold dose that could elicit symptoms (Hourihane, et al., 2005) 
(Osterballe & Bindslev-Jensen, 2003). In addition these tests are not appropriate for non IgE mediated 
allergy (Fiocchi et al., 2010).    
Therefore changes in the allergenicity of the processed foods have been assessed using evidence from 
studies comparing open or blind challenge data, studies comparing ability to bind specific IgE or ability 
to provoke a positive skin prick test will not be included in this review. This review presents details of the 
challenge procedure for quality assessment and comparability. 
2.1.2. Participants 
The participants involved with challenge studies are key to the quality of the research; hence one of the 
quality criteria for assessing the studies was whether the participants are representative of those with food 
allergy. A random sample would reduce the risk of bias. As person specific factors affect symptoms 
experienced by individuals on exposure to a particular food it is of paramount importance that the 
population studies were described in detail so that the generalisability of the findings to specific 
populations could be assessed. 
2.1.3. Food processing methods 
A wide range of methods were assessed. We have distinguished between studies of laboratory prepared 
foods and those using commercially available or kitchen prepared foods that could be less reliable but 
more relevant to real world situations. 
2.2. Materials and Methods 
2.2.1. Literature search strategy 
The following databases were searched from Web of Science (1970-November 2012), BIOSIS Citation 
Index (1969-November 2012), BIOSIS reviews (1969-2008), Medline (1950-November 2012), Pubmed 
(-November 2012), using the search terms shown (Table 2.1). No limits were used. 
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Table 2.1:   Search strategy in Web of Knowledge. Each group was combined with the terms within a 
group were linked with „or‟ and the groups were linked with „and‟ 
Topics Search terms Web of Knowledge Search terms (Including  
appropriate MeSH terms) 
PubMed 
 
Group 1. Food 
 
Milk and dairy milk OR butter or cream or dairy or cheese 
or yoghurt or petit filous or casein or whey 
or lacto Infant NEAR/2 formula 
milk[Tiab] OR milk[MeSH Terms] OR 
lactose[MeSH Terms] OR 
lactose[Tiab] OR dairy[Tiab] OR 
butter[Tiab] OR cream[Tiab] OR 
“infant formula”[Tiab] OR 
cheese[Tiab] OR yoghurt[Tiab] OR 
“petit filous”[Tiab] OR casein[Tiab] 
OR whey[Tiab] 
Egg Egg egg[Tiab] OR eggs[Tiab] 
Cereals Cereal or gluten or wheat or rye or barley 
or oats or spelt or kamut 
cereals[Tiab] OR glutens[MeSH 
Terms] OR glutens[Tiab] OR 
gluten[Tiab] OR wheat[Tiab] OR 
rye[Tiab] OR barley[ Tiab] OR oats [ 
Tiab] OR oat[Tiab] OR spelt[ Tiab] OR 
kamut[Tiab] 
Peanuts peanut or arachis peanut[Tiab] OR arachis[Tiab] 
Nuts nut  or arachis or cashew or brasil or 
almond or hazel or walnut or pecan or 
macadamia or pistachio or filbert 
nuts[MeSH Terms] OR nuts[Tiab] OR 
nut[Tiab] OR almond[Tiab] OR 
almonds[Tiab] OR hazelnut[ Tiab] OR 
hazelnuts[Tiab] OR walnut[Tiab] OR 
walnuts[Tiab] OR cashew[Tiab] OR 
cashews[Tiab] OR pecan[Tiab] OR 
pecans[Tiab] OR macadamia[Tiab] OR 
macadamias[Tiab] OR pistachio[Tiab] 
OR pistachios[Tiab] OR 
beechnut[Tiab] OR beechnuts[Tiab] 
OR filbert[Tiab] OR filberts[Tiab] 
Celery Celery celery[tiab] 
Crustaceans crustacea OR crustacean OR crustaceans 
OR crab OR crabs OR lobster OR lobsters 
OR shrimp OR shrimps OR prawn OR 
prawns OR crayfish OR shellfish OR 
langoustine OR langoustines 
crustacea[MeSH Terms] OR 
crustacea[Tiab] OR crustacean[Tiab] 
OR crustaceans[Tiab] OR crab[Tiab] 
OR crabs[Tiab] OR lobster[Tiab] OR 
lobsters[Tiab] OR shrimp[Tiab] OR 
shrimps[Tiab] OR prawn[Tiab] OR 
prawns[Tiab] OR crayfish[Tiab] OR 
shellfish[MeSH Terms] OR 
shellfish[Tiab] OR langoustine[Tiab] 
OR langoustines[Tiab] 
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Topics Search terms Web of Knowledge Search terms (Including  
appropriate MeSH terms) 
PubMed 
    Fish fish OR pollock OR carp OR cod OR 
mackerel OR salmon OR tuna OR shark 
OR “sea bass” OR swordfish OR hake OR 
sole OR megrim OR sardine OR sardines 
OR halibut OR anchovy OR anchovies OR 
catfish OR trout 
fishes[MeSH Terms] OR fish[Tiab] OR 
pollock[Tiab] OR carp[Tiab] OR 
cod[Tiab] OR mackerel[Tiab] OR 
salmon[Tiab] OR tuna[Tiab] OR 
shark[tiab] OR “sea bass”[tiab] OR 
swordfish[tiab] OR hake[tiab] OR 
sole[tiab] OR megrim[tiab] OR 
sardine[tiab] OR sardines[tiab] OR 
halibut[tiab] OR anchovy[tiab] OR 
anchovies[tiab] OR catfish[tiab] OR 
trout[tiab] 
mollusca[MeSH Terms] OR 
mollusc[Tiab] OR molluscs[Tiab] OR 
oyster[Tiab] OR oysters[Tiab] OR snail 
[Tiab] OR snails[Tiab] OR squid[Tiab] 
OR mussel[Tiab] OR mussels[Tiab] 
OR clam[Tiab] OR clams[Tiab] OR 
abalone[tiab] OR octopus[tiab] OR 
scallop[tiab] OR scallops[tiab] 
Soy Soy* soy[Tiab] OR soybeans[MeSH Terms] 
OR soybean[Tiab] OR soybeans[Tiab] 
OR soya[Tiab] 
Lupin LUPINUS-ALBUS, Lupin* lupinus[MeSH Terms] OR lupin[Tiab] 
Mustard Mustard "mustard plant"[MeSH Terms] OR 
mustard[Tiab] 
Sesame Sesame* sesamum[MeSH Terms] OR 
"sesame"[Tiab] 
 
Group 2. Food Challenge 
 
Open food challenge  (Food or oral or  open or mucosal or 
ingestion) near/2 Challenge 
Challenge*[tiab ]  
Double blind placebo 
controlled food 
challenge 
((food or oral or mucosal or ingestion) 
near/2 challenge*) OR (DBPC) 
DBPC*[tiab] “double blind placebo 
controlled” 
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Topics Search terms Web of Knowledge Search terms (Including  
appropriate MeSH terms) 
PubMed 
 
Group 3.  Food processing 
 








treatment) treatment in 
powder production e.g.  
coffee, other  heating 
treatments (ohmic) and 
chemical peeling of 
fruit (lipid transfer 
protein in skin). 
(heat* or cook* or roast* or fry* or 
pasteuri* or boil) or (heavy near/2 salting) 
or dying or microwav* OR ferment* or 
smoking or drying or (UV NEAR/2 
treatment) or lyme or ohmic OR (chemical 
near/4 peeling )) or Hydrostatic pressure or 
(food near/1 process*) or (food near/1 
process*) or (digest*) or (hydrol*) or 
filtration 
Heat*[tiab ] OR cook*[tiab ] OR roast* 
[tiab ] OR fry*[tiab ] OR pasteuri*[tiab 
] OR boil[tiab ] OR 
Hydrolysis [tiab ] OR digestion [tiab ] 
OR enzymatic treatment [tiab ] OR 
fermented [tiab ] OR 
Hydrostatic pressure[tiab ] OR food 
process* [tiab ] OR  “heavy salting”  
[tiab ] OR dying  [tiab ] OR microwav* 
[tiab ] OR ferment* [tiab ] OR smoking 
[tiab ] OR drying [tiab ] OR UV  [tiab ] 
OR lyme [tiab ] OR ohmic [tiab ] OR 
“chemical peeling”[tiab ]  
Filtration/specific 
product related 
(wine OR beer OR clarif*) wine [tiab ] OR beer [tiab ]  Or clarify* 
[tiab]    
 
2.2.1.1. Selection procedure 
All titles and abstracts were imported to Endnote and duplicates removed. One reviewer, SK, screened 
the titles and abstracts to remove studies not relevant to the objective.  The full texts were obtained for 
the remaining studies; a second screen by SK then removed studies that were not relevant to the research 
question and the reasons identified.  
2.2.1.2. Types of studies 
We included any study that reported on the effect of food processing on the allergenicity of the named 
foods, a wide range of sampling designs were acceptable including those involving people from:  
 a random sample from a cross-section of a community or clinic population. 
 a non-random sample  from a cross-section of a community or clinic population. 
 convenience or self or clinician selected volunteers with food allergy. 
Studies that used the following designs were included: 
 cross-over with challenge with a comparison form of the food against another test form of the 
food or a test from that has a different intensity of treatment, for example oven treatment at 
200
o
C at 30 minutes versus 300
 o
C for 1 hour. Studies with random or non-random order of cross 
over were included.  
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 Random or non random between group comparisons in which a group with proven allergy (with 
positive challenge) to the food are allocated to exposure to a comparison form of the food or a 
test form of the food using random or non random methods. Each participant being exposed to 
either the comparison or test form of the food only. For example infants with allergy to cow milk 
being allocated to partially hydrolysed or fully hydrolysed cow milk formula.  
 Non-comparison studies were included only if those being challenged had a recent diagnosis of 
allergy to that food using a valid method that included food challenge. We did not include non 
comparison studies where the participants did not have a recent positive food challenge result to 
the comparison food.  
2.2.1.3. Type of participants 
We included studies whose participants were either adults or children (residing in any country) with 
gastro intestinal food allergies such as eosinophilic esophagitis, eosinophilic gastroenteritis, food protein 
induced allergic proctocolitis, food protein induced enterocolitis syndrome, oral allergy syndrome, those 
with cutaneous reactions to foods such as acute urticaria, angiodema, atopic dermatitis, allergic contact 
dermatitis, contact urticaria, and respiratory symptoms (Boyce et al, 2010) with a positive diagnosis using 
recognized procedures such as of a history of symptoms and a positive serum specific IgE or skin prick 
test to the relevant food (any foods containing milk/dairy, eggs, cereals, peanuts, nuts, celery, 
crustaceans, fish, molluscs, soy, lupin, mustard and sesame), or a positive food challenge (Boyce et al 
2010).   
2.2.1.4. Methods of food processing 
We included studies comparing different types of processing (e.g. frying, boiling, dry oven, sterilisation, 
pasteurisation, enzyme degradation or heating and/or pressure; mechanical concentration or fractionation; 
chemical treatment including action of enzymes) or different intensities (e.g. duration or temperature) of 
processing methods or processing methods compared to the raw or native product. The full list is 
included in the group 3 terms of the search strategy (Table 2.1). 
2.2.1.5. Types of outcome measure 
The review included studies that assessed allergenicity of the food determined by observation of: 
 Type and intensity of symptoms (self reported or clinician assessed) 
 Dose to elicit a reaction 
 Combination of the above 
on contact with or ingestion of the food product within a clinic or office setting, using open or double 
blind placebo controlled challenge by participants with the relevant food allergy (see definition above).   
2.2.2. Extraction of data 
Data on the methods of recruiting participants, description of participants, diagnosis, food processing 
methods, challenge procedures and allergenicity of the foods was collected, by SK.  A second reviewer 
checked that the data extraction and interpretation was accurate, and any differences resolved by 
discussion. Data was collected and stored in EPPI-Reviewer 4 software (Social Science Research Unit at 
the Institute of Education, University of London, UK). 
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2.2.3. Assessing the quality of studies 
We assessed the quality of the studies using the following categories: 
1. Quality of diagnosis of food allergy for the study participants 
2. Sampling procedure 
3. How representative the sample is likely to be if people with severe allergy 
4. Challenge procedure, i.e. is it accurate for the individual food 
5. Comparison of challenge findings between processed foods 
The methods for doing this quality assessment are outlined in Table 2.2.  
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Table 2.2:   The method for assessing the quality of the included studies 
Criteria Very low risk 
of bias 
Low risk of  
bias 
High risk of 
bias 
Unclear 










IgE &/or SPT) (if 
appropriate)  
Sensitisation 

















the sample is likely 
to be if people with 
severe allergy 
NA random sampling 







procedure, i.e. is it 
accurate for each 








and taste tested 
masking recipe 








forms of processed 
foods or raw foods 
NA Individual 
challenges had 









high risk of bias, 
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2.2.4. Analysis of Data 
We classified the two or more forms of the food used in the challenge as comparison or test, if there was 
more than one test food these were labeled sequentially. Normally the form of the food that was used to 
select participants was considered to be the comparison food e.g. „we recruited people with allergy to raw 
peanut‟, comparison food= raw peanut.  In studies that were not specific about whether the selection 
criteria was allergy was to processed or unprocessed forms of the food we selected the least processed 
food form as the comparison e.g. „we recruited people with egg allergy and then challenged to 
extensively heated and raw egg (comparison =raw egg, test =extensively heated egg). For dichotomous 
data such as percentage demonstrating a positive challenge if possible we presented the findings as Odds 
Ratio or Risk Ratio. For continuous data such as the minimum dose to elicit symptoms we presented the 
findings as mean difference. 
2.3. Results 
2.3.1. Results of Search 
After removal of duplicates 1040 references were retrieved of these 86 were potentially eligible after full 
text screening (Figure 2.1).  The types of studies excluded at this stage were listed as those without 
human participants, not involving food allergy, did not involve one of the listed foods, and studies where 
there was no comparison of different processing methods on the allergenicity of the foods (Figure 2.1).  
Within the „other‟ category studies were excluded because data was not available for individual foods or 
the study involved only one or two cases. 
The studies excluded after full text screening are show (Section 2.5 List of  excluded studies),  common 
reasons for exclusion at this stage were that participants were only challenged to one form of the food and 
that the majority of challenges were negative, therefore current food allergy could not be confirmed.  
Other groups of excluded studies were those investigated immune reactivity and not challenge findings, 
being represented by studies that investigated how IgE binding to food proteins within ELISA, or western 
blotting are altered by different processing methods. Studies investigating primary prevention of allergy 
by introduction of special infant milk formulas were also excluded at this stage as they were beyond the 
remit of this review. 
We attempted to find studies investigating the effect of using egg or milk as fining agents within the wine 
making industry. However we were unable to find studies that included egg and milk allergic participants 
who were confirmed with oral food challenges and who also underwent challenges with the wine 
products.  
Although a large number of studies are carried out on peanut allergy we could not find studies that 
challenged participants with two forms of peanut, for example raw and roasted, however we did find one 
study that investigated the allergenicity of crude or refined peanut oil. 
We included 25 studies and they are detailed in the following section. 
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Figure 2.2.:  PRISMA flow diagram, ending with included studies, and number included for each food, Full text 








Records identified through 
web of Knowledge 


























identified through other 
sources 
(n =  10 ) 
Records after duplicates removed  
(n = 1040) 
Included Studies 
(n = 25) 
Records identified 
through Pubmed 
(n =478 ) 
Not included: title and 
abstract screen (n =954) 
not human research       (331) 
not food allergy              (63) 
no challenge              (89) 
no food comparison        (441) 
comparison not on list    (12) 
review               (10) 
duplicate              (9) 
could not obtain full text(1) 
other                                    (5) 
 Included from title and abstract 
screen (n = 86) 
OBTAINED FULL TEXT 
(study may have reported more than 
one allergen) 
cereal   (2) 
celery  (3) 
egg  (22)  
egg or milk  
(in wine or beer)  ( 9) 
Hazelnut  (2) 
milk  (41) 
peanut  (6) 
seafood  (8) 




Full-text articles not 
included * (n=61) 
not allergy     (14) 
Not food processing(31) 
Not challenged      (19) 
primary prevention  (5) 
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2.3.2. Description of Studies 
The studies included investigated the allergenicity of the following reported allergens celery (1), wheat 
(1), egg (6), hazelnut (2), milk and dairy (14), peanut oil (1) these studies are listed in food order (Table 
2.3).  Studies tended to focus on the effect of heat, commonly, boiling, roasting or baking. The exceptions 
were the studies investigating hydrolysis and fractioning of milk for infant milk formulas, Ammar (1999), 
Burks (2008), Caffarelli (2002), Giampietro (2001), Kaczmarski (2005), Niggemann (2008), Ragno 
(1993), Rugo (1992), Sampson (1991) and one study investigating the effect of maturation time for 
cheese production for those with allergy to the additive lysozyme (from egg), Marseglia (2012) or milk 
allergens Alessandri (2012).  
The majority of studies utilized a cross-over design with each participant underwent challenge to two 
forms of the food. The order in which the participants were allocated to the challenge with each type of 
food was determined randomly for only a small proportion of studies and these investigated milk, 
Giampietro (2001), Host (1988), Ragno (1993), Sampson (1991) and one peanut oil, Hourihane (1997). A 
random order of challenge reduces the risk of bias for the study, as those that are challenge positive to 
one form of food could refuse challenge with the second form of food, or one type of food is perceived as 
being more allergenic than another.  
The remaining cross-over studies used a non-random order, usually because the participants were 
challenged to the food considered least allergenic first as exemplified by Nowak-Wegrzyn (2008). Within 
this study participants were challenged with heated milk, only those that were challenge negative then 
went on to have the challenge with un-heated milk. A similar study was carried out with egg, Lemon-
Mule (2008), where challenges were first carried out to baked eggs and again only those that tolerated 
this challenge went on to be challenged with regular egg (scrambled or cooked in French toast). The 
authors designed these studies to investigate whether a diet including extensively heated egg or milk 
could lead to increased tolerance rather than the effect of processing on allergenicity.  
In one study, a large group of participants was challenged to raw hazelnut first and then a subset 
challenged to the roasted product. This study was considered as a between group comparison as the 
paired cross-over data was not available Worm (2009). The selection procedure for this subset was not 
clear and so the group receiving challenge with the roasted product could have been naturally more or 
less sensitive to hazelnut protein than the main group. 
 
Table 2.3:   Summary of description of studies (alphabetical order by food) 
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Europe, Niguarda Ca 
Granda Hospital, Milan, 
Italy;  Milan University 
Hospital, Milan, Italy;  
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Those responding to a 











The details of the study participants are presented in study author order for easy reference (Table 2.4). All 
studies of egg and milk were carried out with children (Table 2.4), perhaps reflecting the higher 
prevalence within these age groups. Studies involving adults were carried out for celery Ballmer-Weber 
(2002), for wheat Scibilia (2006), and a mixed population for milk, Hansen (2003), Nowak-Wegrzyn 
(2008) and, Ragno (1993), and for peanuts, Hourihane (1997). 
We made the decision to include only those individuals who were challenge positive to one or more of 
the forms of the food. Therefore, we excluded the data from those who were challenge negative to both 
forms of the food.  So for example using this rule we excluded from our analysis in the study by Nowak-
Wegrzyn (2008) on milk 9 of the 100 participants, for the by Boyano Martinez on reactivity to egg we 
excluded 17 of 56 participants and for the study on peanut oil , by Hourihane (1997) we excluded two of 
the 62 potential participants. 
Of the 25 studies, 20 included participants with either skin prick test or specific IgE sensitivity to the 
allergen, in addition to the food challenge findings. Studies did not tend to include a high proportion of 
participants with severe allergy, although many did enroll at least one person with a history of 
anaphylaxis and within one study, Komata (2009), 49% of participants had a history of anaphylaxis.   
Table 2.4:   Participants included in the studies (alphabetical order by study author) 
Study ID Food Type of 
Allergy 
Sensitisation History of 
Symptoms 





























































15 days –3 
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Study ID Food Type of 
Allergy 
Sensitisation History of 
Symptoms 
Challenge  Country Sex Age Range 





specific IgE  
Not reported 
Failure to thrive 
 















































































































































































CAP- raw or 
roasted.  SPT 
Prick to prick- 
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Study ID Food Type of 
Allergy 
Sensitisation History of 
Symptoms 
Challenge  Country Sex Age Range 

















































































range 1 - 
28 months  

















































































































SPT Yes, but not 
described 





























7.5 y range  
0.5 - 21 y  
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Study ID Food Type of 
Allergy 
Sensitisation History of 
Symptoms 
Challenge  Country Sex Age Range 
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2.3.4. Processing methods 
The summary of the processing methods are shown (Table 2.5), in study author order. Many of the 
methods used are relevant to commercial and home cooking such as baking milk within a muffin. For the 
comparison food we listed the form of the food that we considered being least processed. In most cases, 
this was listed by the authors as being the more allergenic form as exemplified by raw egg, compared to 
egg baked within a cake.  The study authors reported wet weight or volume rather than standardizing 
challenges by dry weight or protein concentration.  
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Table 2.5:   Method of processing comparison and test food. Wet weight indicates the weight of the processed or unprocessed food was used without adjusting for the 
moisture or protein content (alphabetical order by author). 












Test brand and 
supplier 

















































Wet weight or 
volume 
200 ml Cow's 
milk = 13.3 g 
PR 
Ammar (1999) Hydrolysed 






















Ando (2008) Raw 
Prepared by 
Laboratory prepared 
Raw liquid egg white 












Liquid egg white, 90 
˚C for 60 min, 

















20 g raw added to 
the drink (1 ml of 
drink contains 0.144 
g raw celery) 
Test 1 
Baked, 110 ˚C for 
15 min.  Small 
additional open 
challenge of samples 
cooked for 7.45, 
13.12, 23.64, 76.07 

















Wet weight or 
volume 
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Test brand and 
supplier 
































Wet weight or 
volume 
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volume 
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Test brand and 
supplier 
Test variety Test  
quantified by 
Test 4 












































Wet weight or 
volume 
 

























Wet weight or 
volume 
 











































Roasted, salted peanuts  KP Foods, 
Leicester 
Not reported Nuts Test 1 
Refined peanut oil 
 
Random batches of 
oil supplied by the 
Seed Crushers' and 
Unclear Wet weight 
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Test brand and 
supplier 
Test variety Test  
quantified by 
Test 2 























Bebilon Pepti 1 or 
2, Nutricia 
 Wet weight or 
volume 
 








Muffin with 1.3 g of 
milk protein. Baked 
at 350 ˚C for 30 
min. Also Baked 
cheese within a 
Pizza  
Prepared by 
prepared in house 
Unclear Unclear Wet weight 
Komata (2009) Pasteurised 
 
Unclear Unclear Volume Test 1 
Extensively heated 

















Egg not clear if raw or 
cooked 
 
Not reported Not reported Volume Test 1 
Cheese 




Granda Padano 24 
month matured 












Not reported Volume 
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Test brand and 
supplier 
Test variety Test  
quantified by 
filtered whey 
 Test 2 
Amino acid based  
 
Test 2 






















Non-fat Wet weight 




  Wet weight 
 















Nidina HA, Nestle 
 Wet weight or 
volume 
 











Casein hydrolysate  
Test 2 
Casein hydrolysate  
 
Test 3 
Whey hydrolysate  
 
Test 4 







































 Wet weight or 
volume 
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Test brand and 
supplier 


















No details on how 











Urisu (1997) Raw 
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2.3.5. Challenge procedure 
The challenge procedures are summarised (Table 2.6). In those studies that carried out a DBPCFC the 
method of masking and the procedure for randomisation was not clearly reported in many of the studies. 
Although many studies reported the method of masking and the recipe, they did not report whether this 
was taste tested. The method of generating the random sequence, the ratio of active to placebo challenge 
and the way in which the sequence was concealed from the participants and the study personnel  during 
the challenge and while the symptoms were assessed was not described in the majority of studies. We 
attempted to record how the study authors dealt with positive reactions to placebo; however in the 
majority of instances this was not reported.  If the test food challenge procedure differed significantly for 
the comparison food then this was shown (Table 2.7).  
 
Studies that reported their challenge methods in detail include Alessandri (2012 b), Hansen (2003) and 
Sampson (1991). 
 
Table 2.6:   Challenge procedure for comparison food (study author order) 


























0.1, 0.5, 2, 10, 50 ml  
up to 1 egg 
equivalent to 6 g egg 
protein 




Positive response  
local non-objective restricted 
to area in contact with 
allergen, oral allergy syndrome 
or isolated digestive 
complaints, systemic objective, 
e.g. urticaria, asthma, or 
anaphylaxis 
Dose response 
within 6 hours of the first dose 













0.05, 0.15, 0.3, 1, 3, 
10, 30, 50, 100, 195 
ml 
Time delay: 20 min 
Positive response 
Handling of positive placebo 
Not reported 










 1, 5, 80 ml  




Any reaction also any delayed 
reaction 
Handling of positive placebo 
Not reported 








Unclear Unclear 0.1 ml, 1 ml, 10 ml 
and then the 
remainder of the egg 
white 
Time delay: 30 min 
Positive response 
Continued until objective 
symptoms developed or entire 
challenge dose ingested. 
 
Handling of positive placebo 
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0.7 g, 28.5 g 
Time delay: Unclear 
Method 
Ingestion 
Positive response  
Oral allergy syndrome, 
dyspnoea, rhinitis, 





Handling of positive placebo 


















1/8  , 1/4 and 1/2 of 






















 Positive response 
 














Time delay: 20 min 
Method 
Ingestion 
A positive response 



















0.2, 2, 20, 50 and 
150 ml 





gastrointestinal, rhinitis and 
erythema and itch. 
Handling of positive placebo 
Not reported 





















Copenhagen 10 g, 
Zurich 18.2 g 
Method 
Ingestion 
Positive response  






na na labial challenge, 
followed by ¼ ½ 1 
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Doses Outcome description 
Method 
Ingestion 
Host (1988) Yes   
a milk 












5, 10, 20, 40, 80, up 
to 160 ml 





a) the child displayed 
definitive allergic reactions in-
keeping with the child‟s 
history of CMA. b) The 
provoked symptoms 
disappeared after withdrawal 
of the milk preparation in 
question or c) coincidental 

















0.1, 1, 3, 10, 30, 50, 
100 ml according to 
age 
Time delay: unclear 
Method 
Ingestion 
Positive response. If infants 
did not show a positive 
response they were fed the 
milk for up to 2 weeks. 






























na na Not reported 























Yes DBPCFC Yes Unclear 0.1,0.3, 1.0, 3.0, 






Handling of positive placebo 
Not described 
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Positive response  
Objective symptoms 















A drop of the inner 
lower lip then 5 ml 
then 100ml. 
Time delay 









Handling of positive placebo 
Not described 
Rugo (1992) Yes 
Milk/dairy 
eliminatio











 0.2ml - 1ml - 2ml - 








Challenges were stopped once 
symptoms occurred or at 
highest dose. Immediate and 



















Up to 10 g in 100ml 
of formula in a 
period of 60 - 90 
minutes. Each 
challenge was 
initiated with 5ml 
formula. 
Time delay 
15 minutes  
Positive response 
 
Handling of positive placebo 
No positive reactions to 
placebo 



















schedule: 100 mg, 
600 mg, 1.6 g, 3.1 g, 





Positive response  
 
Dose response 
Handling of positive placebo 
No positive reactions to 
placebo 





























1.0–2.5–5.0– 10.0 g. 
Time delay 
15 min 
Positive response % 
Dose response 
Single amount of HN eliciting 
symptoms 
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Table 2.7:   Challenge procedures for test food (alphabetical order by author) if different to 
comparison food 





















na na 0.003, 0.01, 0.02,  
0.07, 0.2, 0.7, 2.0, 
3.03, 6.07, 13.0 g 






Ammar (1999) Unclear Open 
challenge 
carried out 
na na Method 
Ingestion 





















by open feeding for 




Extended over 7d 
 
Convincing reaction 
Positive reactions to 













up the foods for 
challenge 
labial challenge, 
followed by ¼ ½ 1 












   0.5, 1, 2, 4, 8, 14.5 g 
time delay between 








Yes Unclear Allocated to either 
amino acid or 









Na na Method 
Ingestion 
¼ portions muffin (1.3 
g milk protein) over 
1h. If no symptoms 




Positive response  
Objective symptoms 
University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506 245 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by 
the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. 
The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and 
the conclusions reached in the present document, without prejudice to the rights of the authors. 



























Up to 10 g in 100ml 
of Nutramigen in a 
period of 60 - 90 min. 
Each challenge was 
initiated with 5ml 
formula. 
Time delay 



















schedule: 100 mg, 
600 mg, 1.6 g, 3.1 g, 







Positive response  
 
Dose response 
Handling of positive 
placebo 
No positive reactions 
to placebo 















1.0–2.5–5.0– 10.0 g 
doses initiation dose 
dependent on 
response to raw 
Time delay between 
doses:15 min 
Challenge halted 
when: Not stated 





2.3.6. Study design 
The study designs are shown (Table 2.8). Within a number of studies that used a cross over design the 
order of receiving the different types of foods was fixed, studies with this fixed order can be grouped into 
two categories: 
 participants received the form of the food thought to the least allergenic first (either open or by 
DBPCFC). If a participant demonstrated symptoms they were not challenged to the second food. 
This was because a positive response was assumed and further challenge thought unethical; 
 participants were challenged with the form thought to be more allergenic first to confirm food 
allergy, only those that were challenge positive had the second challenge with the processed food 
e.g.  Niggemann (2008), first challenged the infants to pasteurized milk (using DBPCFC) and 
subsequently carried out a randomised cross over study comparing two processed formulas to test 
allergenicity and the effect on growth. 
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Table 2.8:   Study design and outcome assessment (alphabetical order by author) 
Study ID Overarching design Order of challenge comparison/test  Outcome results 
Alessandri 
(2012 b) 
Cross over non random 
 
Not random 
Time delay between different foods, 
given on  separate days 
Challenge carried out first with boiled 
egg those that were positive were not 






Cross over non random Not random, milk given first Any reaction 
Ammar (1999) Cross over non random 
 
Not random, all challenged with 
hydrolysate after a diet of Neocate 
Any reaction  
Ando (2008) Cross over non random 
 
Not random, heated egg challenge 
carried out first, those that were negative 
were challenged to raw egg, those 
positive to heated egg were not 
challenged to raw egg as they were 















Cross over non random 
 
Not random 
Cooked egg white given first for 45 
participants, only those negative to 
cooked egg were challenge with raw. 
Another 10 were challenged with raw 
only, as they stated they tolerated 
cooked egg. 
Any reaction  
Burks (2008) Cross over non random 
(study 2 only) 
Not random Any reaction 
Caffarelli 
(2002) 





Cross over random Random Any reaction 
Hansen (2003) Cross over non random 
 
Not random 
Zurich: raw challenge first, time delay 
between different foods was one year  
Copenhagen: random, time delay 




Host (1988) Cross over random 
 
Random Any reaction 
Dose of reaction 
Hourihane 
(1997) 
Cross over non-random 
 
 
Cross over random 
Non random 
Crude and refines oil first then roasted 
peanut 
Random 
„random order determined by a member 




Dose of reaction 
Kaczmarski 
(2005) 
Cross over non random 
 
Not random 
Low lactose cow‟s milk first, however 
not clear on order of EHC or EHW 
Any reaction 
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Study ID Overarching design Order of challenge comparison/test  Outcome results 
Kim (2011) Cross over non random 
 
Not random 




Komata (2009) Cross over non random 
 
Not random, Unheated milk given first 





Cross over non random 
 
Not random, extensively heated egg was 
given first, however time delay between 
different foods was not reported 
Any reaction 
 
Dose of reaction 
Marseglia 
(2012) 
Cross over non random 
 
Time delay between different foods 
Egg challenge was done previous year. 





Cross over non random All challenged with pasteurised milk first  
then given extensively hydrolysed or 






Cross over non random 
 
None random, assumed same day. Any reaction.  
Ragno (1993) Cross over random Random Any reaction 
Rugo (1992) Cross over non random 
 
Not random, comparison food given first 
 
Any reaction.   
Sampson 
(1991) 
Cross over random Random Any reaction 
Scibilia (2006) Cross over non random Unclear Any reaction 
Urisu (1997) Cross over non random 
 
Not random.  Ovomucoid depleted, 
heated then raw 
Any reaction 
 
Worm (2009) Between group 
comparison non random 
 
Not random.  All (90) were challenged 
to raw given first, a non-random subset 
(20) were challenged to roasted.  
Any reaction 
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2.3.7. The Quality of studies 
The quality of diagnosis for most studies   
Table 2.9:    Quality of Studies (alphabetical order by author) 
Study ID Diagnosis* Challenge order 
comp/test* 




Very low risk of bias 
 
High risk of bias High risk of bias 
Specially selected for 
being negative to the 
test food 




Very low risk of bias High risk of bias High risk of bias High risk of bias 
Ammar 
(1999) 
Low risk of bias 
 
High risk of bias High risk of bias 
Specially selected for 
being positive to 
comparison food 
High risk of bias  
 
Ando (2008) Low risk of bias 
 
High risk of bias High risk of bias 
Specially selected for 




High risk of bias 
Ballmer-
Weber (2002) 




Low risk of bias High risk of bias High risk of bias High risk of bias 
Burks (2008) Very low risk of bias High risk of bias High risk of bias Unclear risk of bias 
Caffarelli 
(20020  
Low risk of bias High risk of bias High risk of bias High risk of bias 
Giampietro 
(2001) 
Low risk of bias Low risk of bias High risk of bias High risk of bias 
Hansen 
(2003) 
Very low risk of bias High risk of bias Unclear High risk of bias 
Host (1988) Low risk of bias Low risk of bias High risk of bias High risk of bias 
Hourihane 
(1997) 
Low risk of bias Low risk of bias 
(between oils) 
High risk of bias High risk of bias 
Kaczmarski 
(2005) 
Low risk of bias High risk of bias High risk of bias High risk of bias 
Kim (2011) Low risk of bias 
 
High risk of bias High risk of bias 
Specially selected for 
being negative to the 
test food 




Low risk of bias 
 
High risk of bias 
 
Low risk of bias 
 





Low risk of bias High risk of bias High risk of bias High risk of bias 
Marseglia 
(2012) 
Low risk of bias High risk of bias High risk of bias High risk of bias 
Niggeman 
(2008) 




Low risk of bias High risk of bias High risk of bias High risk of bias 
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Study ID Diagnosis* Challenge order 
comp/test* 
Sampling* Severe allergy 
represented* 
Ragno (1993) Low risk of bias High risk of bias High risk of bias High risk of bias 
Rugo (1992) Low risk of bias High risk of bias High risk of bias High risk of bias 
Sampson 
(1991) 
Very low risk of bias Low risk of bias High risk of bias High risk of bias 
Scibilia 
(2006) 
Low risk of bias Unclear High risk of bias High risk of bias 
Urisu (1997) Low risk of bias High risk of bias High risk of bias High risk of bias 
Worm (2009) Low risk of bias High risk of bias Unclear 
 
High risk of bias 
For the method of assessing the quality of studies see Table 2.2 
 
2.3.8. Findings on effect of processing on allergenicity 
The table below (Table 2.10) shows the findings for all studies in food order. The percentage of 
participants tested showing a positive response are shown together with the threshold dose that elicited a 
reaction if provided.  We excluded data from participants that were challenge negative to both 
comparison and test food. In the majority of cases, the least processed food provided the greater response 
rate i.e. was the more allergenic.  
2.3.8.1. Celery 
The one study that investigated celery, Ballmer-Weber (2002), demonstrated that for approximately half 
of those who reacted to raw celery challenges were negative for celery cooked at 100 
o
C for 15 minutes 
(Table 2.10).  In the four cases that reacted to both raw and cooked celery the threshold dose was 
increased by heating in all cases. The trend seems to be decrease but not elimination in allergenicity with 
heat, however the small sample size and the non-representative sample make it difficult to generalise the 
findings to the wider population. Of the five tested, all reacted to the celery spice, three of these had 
negative responses to the cooked celery. 
2.3.8.2. Cows‟ milk 
We included four studies, a total of 121 participants, in which challenges were performed to amino acid 
based formulas with infants who were challenge positive to cow‟s milk, Alessandri (2012 a), Ammar 
(1999), Burks (2008), Caffarelli (2002), Niggemann (2008), (Table 2.10).  All participants were negative 
except for two, in Caffarelli (2002), who were skin prick test and specific IgE negative to the formula and 
developed eczema more than 12 hours after the challenge. 
Of the included studies, five, Caffarelli (2002), Kaczmarski (2005), Ragno (1993), Rugo (1992), and 
Sampson (1991) investigated hydrolysed casein formulas in a total of 119 participants, who were 
challenge positive to cows‟ milk.  Studies showed that between zero to 35 % of the sample populations, a 
total of 20 participants were challenge positive to the hydrolysed casein formulas. In the study showing 
the highest reactivity (17/48), the inclusion criteria was atopic eczema or dermatitis and the challenge 
positive showed symptoms such as dermatitis, gastrointestinal or irritability and the challenge was carried 
out over a prolonged period. 
Of the included studies, six investigated hydrolysed whey based formulas Caffarelli (2002), Giampietro 
(2001), Kaczmarski (2005), Niggemann (2008), Ragno (1993), Rugo (1992) in a total of 156 children 
who were proven cow‟s milk allergic by challenge. The proportion positive to whey derived formulas 
ranged from zero to nearly 35%. The formula providing the greatest reduction in allergenicity was the 
extensively hydrolysed, ultra filtered formula, tested by Niggemann (2008), and formulas giving the 
higher proportion of reactive infants were for the partially hydrolysed formulas, 36% Giampietro (2001) 
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and 25% Caffarelli (2002). In Caffarelli (2002), the same participants were exposed to hydrolysed whey 
and extensively hydrolysed casein giving percentage responders of 25 and 5% respectively. 
Only one study Host (1988) investigated pasteurization, and there was limited evidence (5 participants) 
that there was no effect on allergenicity. Kim (2011), Komata (2009) and Nowak-Wegrzyn (2008) studied 
the effect of heating on milk allergy. They showed that a proportion of those allergic to pasteurized milk 
are tolerant to heated or baked milk. However, Kim (2011) and Nowak-Wegrzyn (2008) selected for 
those who thought they had developed tolerance to baked milk and they still found positive challenge 
result (26% and 36% respectively). These participants did not go on to be challenged with uncooked milk, 
as a positive response was assumed. The selection criteria of Kim (2011) and Nowak-Wegrzyn (2008) 
make it impossible for us to generalize the findings a wider population. A much higher percentage 
(94.7%) of participants in the study by Komata (2009) reacted to heated milk. These participants were 
selected as they were hospitalized and a relatively high proportion (48.6%) had reported anaphylaxis to 
milk.  
One study Alessandri (2012) looked at the effect of cheese making (Parmigiano-Reggiano) on the 
allergenicity of cow‟s milk. Of the 50 participants that had positive challenges to cows‟ milk, only 42% 
reacted to the matured hard cheese. The study authors analysis of specific IgE binding in vitro indicated 
that the partial breakdown of casein in the cheese making process could account for the decrease in 
reactivity by participants in the challenge. Beta-lacto globulin was unaffected by the cheese making 
process. Those found to be tolerant in challenge were advised not to avoid Parmigiano-Reggiano cheese, 
and after a two year follow up no adverse events were recorded. 
2.3.8.3. Egg 
The effect of heating on egg allergy was studies by Alessandri (2012 b), Ando (2008), Boyano Martinez 
(2001), Lemon-mule (2008) and Urisu (1997) in a total of 146 participants (Table 2.10). Between 10.6 % 
and 57.6 % of egg challenge positive participants reacted to extensively heated egg. In the lowest 
percentage study,  Lemon-Mule (2008), study participants who had reported recent reactions to heated 
egg were excluded from the study, so this is a biased estimate.  One study, Urisu (1997) additionally 
investigated ovomucoid-depleted egg and found that of the 36 participants that were egg challenge 
positive, only 2.6% reacted to the heated ovomucoid depleted egg compared to 44.7% that reacted to the 
heated egg. 
The effect of cheese processing on the allergenicity of egg lysozyme was tested by one study, Marseglia 
(2012) in 21 participants, in which cheese matured for 24 months was found to be less allergenic than 12 
month matured cheese. 
2.3.8.4. Tree nuts 
There were only two studies that used challenge to investigate heat on tree nuts and they both studies 
hazelnut Hansen (2003) and Worm (2009). Both found that roasting reduced allergenicity in terms of the 
percentage responding (29.4 and 85% respectively) and in addition roasting seemed to increase the 
threshold dose to elicit a reaction (Table 2.10). 
2.3.8.5. Wheat 
One study, Scibilia (2006), looked at boiling wheat in 10 participants and found no reduction in 
allergenicity (Table 2.10) 
2.3.8.6. Peanut 
No studies were found that compared the challenge responses to peanut processed using different 
methods. The studies on allergenicity of different peanut preparations investigated IgE binding or other in 
vitro methods.    We also searched for studies that looked at challenges with peanut oil in those with 
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proven peanut allergy. One study, Hourihane (1993) investigated whether people with allergy to peanut 
would react to crude peanut oil. In this study 10% of those tested had positive challenge results to the 
crude peanut oil (Table 2.10) and non to the refined peanut oil.  
 
Table 2.10:   Allergenicity of processed foods (alphabetical order by food) 
Paper ID Food Number showing positive response Threshold dose 
Mean (±SD) 







Celery Raw   
9/9 (100 %) 
 
Raw 
10/10 (100%) § 




6/11 (54.5%) § 
Raw   (all) 
n =10;   
9.0 (±13.4) g 
Raw   (paired) 
n =4;   
0.7 (±0.0) g 
Heated (all) 
 n=6;   
6.8 (±13.6) g 
Heated (paired) 
 n=4;   
9.5 (±14.4) g 
  Raw   
5/5 (100 %) 
Raw 
10/10 (100%) § 
Spice   
5/5 (100 %) 
Spice 





Cows‟ milk Pasteurised   
 
 




 21/50 (42 %) 
  




 30/30 (100 %) 
Amino acid based  
(Neocate) 
 0/30 (0 %) 
  




5/5 (100 %) 
Amino acid based 
(Neocate) 






Pasteurised   
20/20 (100 %) 
Amino acid based 






















































2/20 (10 %) 
  










0/8 (0 %) 
  
University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506 252 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by 
the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. 
The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and 
the conclusions reached in the present document, without prejudice to the rights of the authors. 
Paper ID Food Number showing positive response Threshold dose 
Mean (±SD) 



































Pasteurised   
 
 











   
 













31/31 (100 %) 
Whey extensively 
hydrolysed 
(Nutrilon Pepti)  
































Low Lactose  
(Bebilon) 
 











































 9/20 (45 %) 
  




8/8 (100 %) 
Whey hydrolysed 
(Alfare)  
2/8 (25 %) 
  




8/8 (100 %) 
Whey hydrolysate 
(Beba HA)  
5/8 (62.5 %) 
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Paper ID Food Number showing positive response Threshold dose 
Mean (±SD) 









8/8 (100 %) 
Whey hydrolysate 
(Ultrafiltered) 
4/8 (50 %) 
  
Host 1988 Cows‟ 
milk-heat 
Raw 
 5/5 (100 %) 
Pasteurised  
5/5 (100 %) 
Raw   n =5;  41g 
( ±38.9g) 
Pasteurised  n=5;  
23g (±29.4g) 




5/5 (100 %) 
Homogenised & 
pasteurised 
 5/5 (100 %) 
Raw   n =5;  41g 
( ±38.9g) 
Homogenised & 
pasteurised  n=5;  
27g (±29.4g) 






88/88 (100 %) 
Baked  
0/65 (0 %) 
 
Baked  # 





















64/64 (100 %) 
Heated  
 0/41 (0 %) 
 
Heated # 
  23/64 (35.9 %) 
  
Alessandri 
(2012 b) egg 
Egg Raw   
14/14 (100 %) 
 
Raw # 
  33/33 (100 %) 
Boiled   
0/14 (0 %)  
 
Boiled # 
  19/33 (57.6 %) 
  
Ando (2008) Egg Raw   
29/29 (100 %) 
 
Raw  # 
67/67 (100 %) 
Heated   
0/29 (0 %)  
 
Heated # 





Egg Raw  
20/20 (100 %) 
Heated  
0/20 (0 %) 
  
  Raw # 
38/38 (100 %) 
Heated # 




Egg Regular    
27/27 (100 %) 
Regular   
 66/66 (100 %) 
Ext. heated   
0/27 (0 %) 
Ext.heated  2 
7/66 (10.6 %) 
  
Urisu (1997) Egg Raw 
















Regular   
  
21/21 (100 %) 
Cheese (12 month 
matured)  
5/21 (23.8 %) 
  
  Regular    
 
21/21 (100 %) 
Cheese (24 month 
matured)  
1/21 (4.8 %) 
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Paper ID Food Number showing positive response Threshold dose 
Mean (±SD) 





Hansen 2003 Hazelnut Raw  
17/17 (100 %) 
Roasted 




Hazelnut Raw  
82/90 (91.1 %) 
Roasted 
 17/20 (85 %) 
Raw   n =82; 
median 0.1g  
range 0.01-2.0 g 
Roasted  n=17;  
median 0.23 g 
range 0.01-10 g 
Scibilia 
(2006) 
Wheat Raw  
11/11 (100 %) 
Boiled  
11/11 (100 %) 
Raw   n =10;  
12.1 g (±11.6g) 
Boiled  n=10;  
10.6 g (±10.5g) 
Hourihane 
(1993) 





#  for this row of data the positive challenge response to the „raw or comparison‟ food was assumed to be positive if participants 
had a positive response to the cooked form of the food. 
§  in this study challenge data for both foods was available for only 9 participants, for the remaining participants only one 
challenge was carried out. 
2.4. Discussion and Conclusions 
The included studies were of high quality for the criterion of methods used to diagnose allergy with most 
studies considered at least low risk of bias for diagnosis as they carried out double blind challenges or 
open challenges with positive specific IgE. In contrast nearly all studies were considered high risk of bias 
for sampling. This was because the study reports did not provide a sampling strategy that would ensure 
that the samples were an accurate reflection of the allergic population as a whole, or accurately 
represented those with severe allergies. However random sampling from the allergic population would be 
costly and difficult. The health risks of taking part in such research, and undergoing repeated challenges 
makes random sampling from the wider food allergic population contentious. For participants the health 
risks may not out way the potential benefits of being more informed about their own allergies and those 
who had experienced severe reactions in the past may have been reluctant to take part. However the lack 
of robust evidence with large study populations for foods sold specifically as being allergen reduced, such 
as the hydrolysed infant milk formulas, does not support evidence-based decision making.    
 Those studies that included participants with positive specific IgE and a clinical history found that some 
individuals did not react to any form of the food. This is not surprising as the positive predictive value for 
these tests or a combination of tests is not 100%. Both skin tests and specific IgE tests have low positive 
predictive values (Cianferoni, Garrett, Naimi, Khullar and Spergel; 2012). If possible we excluded cases 
that were not proven food allergic by challenge for this review.   
There was evidence that heat reduced the allergenicity for egg, milk, celery and hazelnut. However, the 
reduction varies for individual people and for the different foods. 
The research studies included highlight that a number of people allergic to uncooked or lightly cooked 
milk or egg develop tolerance to the baked product, and that this is maintained after long term 
consumption. The proportion of the allergic population that this applies to is not clear as the sampling 
strategies selected for those who suspected that they were tolerant to baked products. However, the 
research does confirm that there is a subpopulation in whom challenge with cooked milk or egg could 
reduce unnecessary dietary restrictions.   One study, Urisu (1997), additionally investigated ovomucoid 
depleted cooked egg and found there was a further reduction in the number of people having a positive 
challenge. This could be a potentially useful innovation however further testing would be required. 
One small single study investigated the reactivity to cooked celery, Ballmer-Weber (2002). Although 
allergenicity was reduced a large proportion remained reactive to cooked celery, even if heated for over 
70 minutes at 100 oC.  However it is not clear from this study if there would be any long term effect of 
introducing cooked celery into the diet of these tolerant individuals. The positive responses to celery spice 
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by even those who were challenge negative to raw celery make it essential that food labelling is clear.  
More research should be conducted on the effect of the cooking process on celery spice, to establish of 
the allergenicity in this form can also be reduced by the cooking process. Specific IgE to crude extract or 
purified proteins of celery did not show promise for predicting tolerance to heated celery, Ballmer-Weber 
(2002).  
Roasting reduced the allergenicity to hazelnut for some people, Hanson (2003) Worm (2009), however 
within the later study 85% remained reactive. Those with a history of anaphylaxis to hazelnut have been 
shown to have specific IgE for a 9 kd lipid transfer protein that is heat stable  (Pastorello, Vieths, 
Pravettoni, Farioli, Trambaioli et al, 2002). The presence of this very heat stable allergen/s could explain 
the persistence of reactivity even after roasting.  Although there were no studies included comparing 
challenge with roasted compared to raw peanut there is strong evidence in the wider literature that roasted 
peanut remains allergenic, and that the major allergens remain stable and may even have enhanced 
allergenicity in vitro after extensive heating due to the Maillard reaction (Paschke, 2009; Maleki, Chung,  
Champagne and Raufman, 2000).  Refined peanut oil contains only trace quantities of protein and was 
found not to cause reactions in those tested, Hourihane (1993), however there were a small proportion 
(10%) who showed mild symptoms to the crude oil preparation.  
The one study that investigated wheat showed that boiling did not reduce allergenicity and this finding is 
perhaps due to cereals also containing lipid transfer proteins (Pastorello, Pompei, Pravettoni, Farioli, 
Calamari, Scibilia, and Ortolani, 2003). 
Processing to reduce allergenicity of infant formulas has been investigated in a number of studies.  All of 
the studies were relatively small.  We excluded a number of studies as the infants did not have cows‟ milk 
allergy confirmed by oral challenge. Overall there was a reduction in the number of infants showing a 
positive response to hydrolysed formulas compared to standard cows‟ milk formula. There is a need for 
studies to follow guidelines on testing these formulas (Muraro, 2011). 
In conclusion the evidence suggests allergenicity of foods can be altered by food processing. However, 
although there are trends for certain foods such as extensive heat for egg, milk, celery  and to some extent 
hazelnut reducing allergenicity this reduction will not be experienced by all people with that allergy. The 
studies we reviewed were small and were not representative of the wider allergic population. More high 
quality research is required to determine if certain types of processing increase allergenicity, especially 
for foods where this is suggested by the in vitro research evidence, for example peanut. It would be useful 
to identify groups of people more likely to tolerate certain types of processed foods, so that more specific 
diagnostic challenges can be accessed and lead to individualised management strategies. 
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3. WHAT NEW ANALYTICAL METHODS ARE AVAILABLE TO ANALYSE/DETECT THE FOLLOWING 
FOOD ALLERGENS IN PROCESSED FOODS: MILK/DAIRY, EGGS, CEREALS, BUCKWHEAT, 
PEANUTS, NUTS, CELERY, CRUSTACEANS, FISH, MOLLUSCS, SOY, LUPINE, MUSTARD AND 
SESAME? (OBJECTIVE 4B) 
3.1. Search Strategy 
We searched the databases presented in section1.1.1, using the search terms outlined in Table 3.1, words 
within groups linked by OR and between groups liked with AND. In addition we asked experts within the 
field for published studies (to be completed). The following databases were searched from Web of 
Science (1970-November 2012), BIOSIS Citation Index (1969-November 2012), BIOSIS reviews (1969-
2008), Medline (1950-November 2012), Pubmed (- November 2012), using the search terms shown 
(Table 3.1). No limits were used. The included studies were limited to those published after 2004. 
Table 3.1:  Search terms for identifying assays that detect allergenic foods 
Topics Search terms Web of Knowledge Search terms  Pubmed 
 
Group 1. Food web of Knowledge 
 
Milk and dairy milk OR butter or cream or dairy or 
cheese or yoghurt or petit filous or 
casein or whey or lacto Infant NEAR/2 
formula 
milk[Tiab] OR milk[MeSH Terms] OR 
lactose[MeSH Terms] OR lactose[Tiab] OR 
dairy[Tiab] OR butter[Tiab] OR cream[Tiab] OR 
“infant formula”[Tiab] OR cheese[Tiab] OR 
yoghurt[Tiab] OR “petit filous”[Tiab] OR 
casein[Tiab] OR whey[Tiab] 
Egg Egg egg[Tiab] OR eggs[Tiab] 
Cereals Cereal or gluten or wheat or rye or 
barley or oats or spelt or kamut 
cereals[MeSH Terms] OR cereal[Tiab] OR 
cereals[Tiab] OR glutens[MeSH Terms] OR 
glutens[Tiab] OR gluten[Tiab] OR wheat[Tiab] 
OR rye[Tiab] OR barley[ Tiab] OR oats [ Tiab] 
OR oat[Tiab] OR spelt[ Tiab] OR kamut[Tiab] 
Buckwheat Buckwheat Buckwheat,  
Peanuts nut or arachis peanut[Tiab] OR arachis[Tiab] 
Nuts nut  or arachis or cashew or brazil 
brasil or almond or hazel or walnut or 
pecan or macadamia or pistachio or 
filbert  
nuts[MeSH Terms] OR nuts[Tiab] OR nut[Tiab] 
OR almond[Tiab] OR almonds[Tiab] OR 
hazelnut[ Tiab] OR hazelnuts[Tiab] OR 
walnut[Tiab] OR walnuts[Tiab] OR 
cashew[Tiab] OR cashews[Tiab] OR 
pecan[Tiab] OR pecans[Tiab] OR 
macadamia[Tiab] OR macadamias[Tiab] OR 
pistachio[Tiab] OR pistachios[Tiab] OR 
beechnut[Tiab] OR beechnuts[Tiab] OR 
filbert[Tiab] OR filberts[Tiab] 
Celery Celery celery[tiab] 
Crustaceans crustacea OR crustacean OR 
crustaceans OR crab OR crabs OR 
lobster OR lobsters OR shrimp OR 
crustacea[MeSH Terms] OR crustacea[Tiab] OR 
crustacean[Tiab] OR crustaceans[Tiab] OR 
crab[Tiab] OR crabs[Tiab] OR lobster[Tiab] OR 
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Topics Search terms Web of Knowledge Search terms  Pubmed 
shrimps OR prawn OR prawns OR 
crayfish OR shellfish OR langoustine 
OR langoustines 
lobsters[Tiab] OR shrimp[Tiab] OR 
shrimps[Tiab] OR prawn[Tiab] OR 
prawns[Tiab] OR crayfish[Tiab] OR 
shellfish[MeSH Terms] OR shellfish[Tiab] OR 
langoustine[Tiab] OR langoustines[Tiab] 
 Fish,   fish OR pollock OR carp OR cod OR 
mackerel OR salmon OR tuna OR 
shark OR “sea bass” OR swordfish OR 
hake OR sole OR megrim OR sardine 
OR sardines OR halibut OR anchovy 
OR anchovies OR catfish OR trout 
fishes[MeSH Terms] OR fish[Tiab] OR 
pollock[Tiab] OR carp[Tiab] OR cod[Tiab] OR 
mackerel[Tiab] OR salmon[Tiab] OR tuna[Tiab] 
OR shark[tiab] OR “sea bass”[tiab] OR 
swordfish[tiab] OR hake[tiab] OR sole[tiab] OR 
megrim[tiab] OR sardine[tiab] OR sardines[tiab] 
OR halibut[tiab] OR anchovy[tiab] OR 
anchovies[tiab] OR catfish[tiab] OR trout[tiab] 
mollusca[MeSH Terms] OR mollusc[Tiab] OR 
molluscs[Tiab] OR oyster[Tiab] OR 
oysters[Tiab] OR snail [Tiab] OR snails[Tiab] 
OR squid[Tiab] OR mussel[Tiab] OR 
mussels[Tiab] OR clam[Tiab] OR clams[Tiab] 
OR abalone[tiab] OR octopus[tiab] OR 
scallop[tiab] OR scallops[tiab] 
Mollusces mollusc OR molluscs OR oyster OR 
oysters OR snail  OR snails OR squid 
OR mussel OR mussels OR clam OR 
clams OR abalone OR octopus OR 
scallop OR scallops 
mollusca[MeSH Terms] OR mollusc[Tiab] OR 
molluscs[Tiab] OR oyster[Tiab] OR 
oysters[Tiab] OR snail [Tiab] OR snails[Tiab] 
OR squid[Tiab] OR mussel[Tiab] OR 
mussels[Tiab] OR clam[Tiab] OR clams[Tiab] 
OR abalone[tiab] OR octopus[tiab] OR 
scallop[tiab] OR scallops[tiab] 
Soy Soy soy[Tiab] OR soybeans[MeSH Terms] OR 
soybean[Tiab] OR soybeans[Tiab] OR 
soya[Tiab] 
Lupin LUPINUS-ALBUS, Lupine lupinus[MeSH Terms] OR lupin*[Tiab] 
Mustard Mustard "mustard plant"[MeSH Terms] OR 
mustard[Tiab] 
Sesame Sesame sesamum[MeSH Terms] OR "sesame"[Tiab] 
 




Allerg [ OR Antigen* OR Epitope* OR 
IgE OR protein 
Allerg [ OR Antigen* OR Epitope* OR IgE OR 
protein 
 





(heat* or cook* or roast* or fry* or 
pasteuri* or boil) or (heavy near/2 
salting) or dying or microwav* OR 
ferment* or smoking or drying or (UV 
Heat*[tiab ] OR cook*[tiab ] OR roast* [tiab] 
OR fry*[tiab ] OR pasteuri*[tiab ] OR boil[tiab ] 
OR 
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NEAR/2 treatment) or lyme or ohmic 
OR (chemical near/4 peeling ) or 
Hydrostatic pressure or (food near/1 
process*) or ("food proces*") or 
(digest*) or (hydrol*) or filtration 
Hydrolysis [tiab ] OR digestion [tiab ] OR 
enzymatic treatment [tiab ] OR fermented [tiab ] 
OR 
Hydrostatic pressure[tiab ] OR food process* 
[tiab ] OR  “heavy salting”  [tiab ] OR dying  
[tiab ] OR microwav* [tiab ] OR ferment* [tiab ] 
OR smoking [tiab ] OR drying [tiab ] OR UV  
[tiab ] OR lyme [tiab ] OR ohmic [tiab ] OR 
“chemical peeling”[tiab ] 
Product related (wine OR beer OR clarif*) wine [tiab ] OR beer [tiab ]  Or clarify* [tiab] 
 
Group 6 Assay quality 
 
 (Sensitivity near/10 specificity) or 
(detection near/2 limit) or (receiver 
near/1 operator) or (limit near/2 
detection) or limit near/2 quantification 
 
 
Group 7 Assay/test 
 
 spectrometry or PCR or polymerase 
near/1 chain OR Immuno near/1 assay 
OR Competitive near/1 lateral OR 
Bioreceptor* OR Dog* OR canine* 
OR Sens* OR ELISA or RIA or 
biosensor* 
spectrometry [tiab ] OR PCR[tiab ] OR 
polymerase chain [tiab ] OR 
„Immuno assay‟  [tiab ] OR „Competitive lateral 
flow‟ [tiab ] OR Bioreceptor*[tiab ] OR 
Dog*[tiab ] OR canine*[tiab ] OR Sens*[tiab ] 
OR Detection limit*[tiab ] OR „Receiver 
operator curve‟ [tiab ] OR ELISA [tiab ], RIA 
[tiab ], CAP  [tiab ] , biosensor* [tiab] 
3.1.1. Selection criteria 
All titles and abstracts were imported to Endnote and duplicates removed. One reviewer, SK, screened the 
titles and abstracts to remove studies not relevant to the objective. The full texts were obtained for the 
remaining studies; a second screen by SK then removed studies that were not relevant to the research 
question and the reasons identified.  
3.1.1.1. Types of studies 
We set out to include studies investigating extraction and detection of the food/proteins in a food matrix 
of relevance to the real world setting.  Studies investigating food matrixes spiked with allergen were 
included, and those using samples taken from „field‟ samples (manufactured, laboratory processed or 
home produced). 
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3.1.1.2.  Types of detection methods 
All methods of detection that quantify the specific food or allergenic proteins within the food source or 
indicate that the allergen is present or absent.  It was anticipated that mass spectrometry, polymerase 
chain reaction, immunoassay, Molditoff would be included in the review; however there was no exclusion 
criteria on the type of assay.  
3.1.1.3. Types of outcome measure 
The review included studies that assessed quality of studies as laid out by the International Committee for 
Harmonisation Topic Q 2 (R1) Validation of Analytical Procedures. For spiked samples we were 
interested in measures of validity and reliability of assays: specificity, linearity, range, accuracy, 
precision, detection limit, quantification limit, robustness, system suitability testing. We were interested 
in showing values for the extraction method and the assay in combination, in which case these were 
labelled „sampling‟, or of the assay alone and these are labelled „assay‟, e.g. assay limit of quantification, 
or sample limit of quantification. For studies of „field samples‟, that is samples taken from kitchens or 
from commercial sources with unknown quantities the assays were compared with the best available 
assay either using continuous or binary data (e.g. cut off for allergen present or absent).  
3.1.2. Extraction of data 
The following data was collected:  food allergen assessed, method of detection, test mechanism for 
example protein detection, antigen or epitope detection using immunoassay, detection of DNA, 
allergenicity using food challenge, type of study, comparison of reference test against an index test or 
percentage retrieval if spiked sample, the name of the test, the commercial company and address.  
3.1.3. Assessment of methodological quality of included studies  
The quality of the studies have been assessed for the range of food processing techniques used. We 
divided studies into those investigating the analytical quality of the assays and those investigating the 
effectiveness of the assays for „field‟ samples.  Assays investigating the analytical quality were assessed 
according to the adapted criteria from the International Committee for Harmonisation Topic Q 2 (R1) 
Validation of Analytical Procedures and by adapting the scoring system for assessing diagnostic tests 
QUADAS (Whiting et al., 2003).  Criteria used are outlined in the following Table 3.2.  
Table 3.2:  Quality assessment of studies 
Criteria Low risk of bias High risk of bias Unclear 
Spiking procedure Likely to incorporate allergen 
into the matrix e.g. tempered 
chocolate 
Method unlikely to incorporate 
allergen into matrix e.g. mixing 
powdered allergen with 
powdered matrix 
Not reported 
Spiking or extract used for 
standard curve 
Standardised source, or 
source clearly identified 
Not standardised Not reported 
Sampling/extraction Each replicate involves 
separate extraction and 
sampling 
One sample made into separate 
aliquots  
Not reported 
‘Field’ sampling Random sample, or all 
samples from a representative 
source of food. 
Non random sample, or all from 
an isolated source 
Not reported 
Assessment of data Blind or methodology  for 
measurement or calculation 
technique rigorous and 
objective 
Not blind and methodology not 
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3.1.4. Data synthesis and presentation  
Tables will present for each allergen and each processing method the range of the limit of detection and 
quantification for each analytical technique with the corresponding extraction technique.  
3.2. Results 
The search strategy yielded 1475 studies after removal of duplications. The initial screening of title and 
abstract removed 1351 studies. Of those excluded a large proportion were about the development of 
laboratory diagnostic for allergy, detection of parasite eggs, and a range of other biological substances 
these studies were excluded under the heading, „not detecting listed foods‟. Some studies were review 
articles and so were listed under „not contain primary data‟ and there were a group of studies that did not 
investigate detection within a suitable food related matrix. 
Full text screening was carried out on 124 studies, yielding 84 included studies and excluding 40 studies. 
The reasons for exclusion were grouped under six headings. One: that there was no data for accuracy i.e. 
percentage recovery from spiked food samples, or comparison with the results from another assay with 
known accuracy, and there was no data for the limit of detection of the assay for a suitable food matrix. 
Two: although there may be data on assay validation, this did not include recovery or sensitivity of 
detecting the allergenic compound within a suitable food matrix. Three: the data was not in a suitable 
format and we could not calculate the percentage recovery or identify the limit of detection.  Four: the 
study showed data that was presented within another study or the study was a duplicate. Five: the assay 
was developed to assess if a food was contaminated with food from another specifies for example goat‟s 
milk adulterated with cheaper bovine cow‟s milk and Six: the study was published prior to 2004. The 
studies excluded at the full text stage are shown (Section 3.5). 
3.2.1. Almond  
We included two studies, one evaluating  ELISA and  one PCR for detecting almond in cakes, 
confectionary and cereals (Table 3.3), Garber (2010a) used almond sources from  a local shop whereas 
Roeder (2011) sourced their almond extract for the spiking experiments from a research institute (Table 
3.4). Garber (2010) tested three commercial ELISAs, Veratox, Ridascreen and ELISA systems showing 
that the limit of detection ranged between 3-9 µg/g for extraction and measurement of the almond 
proteins in food matrices such as cake, oatmeal, chocolate and muffins.  The real-time PCR tested by 
Roeder (2011) gave a limit of detection of 5 mg/kg
-1 
or 50 µg/g (Table 3.5).  
 
Table 3.3:   Almond: characteristics of included studies 
Study ID Assay 
developed to 
detect  
Food matrix tested Spiking experiments or field 
samples tested and source of spike 





























Source of spike 
Whole unroasted almonds with seed 
coat from Institut Fur 
Produktqualitat (Berlin, Germany) 
PCR 
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Table 3.4:   Almond: description of assay 





Veratox (Neogen Corporation, Lansing, MI, USA); 
 
Test 2 
Ridascreen Fast (R-Biopharm Inc, Marshal, MI, USA), 
Test 3 














Table 3.5:   Almond: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 











almond crude 1 ELISA, 
Veratox 
cake     9 µg/g     
Garber 
2010 
almond crude 1 ELISA, 
Veratox 
cereals     4 µg/g     
Garber 
2010 
almond crude 1 ELISA, 
Veratox 
chocolate     4.2 µg/g     
Garber 
2010 
almond crude 2 ELISA, 
RIDASCR
EEN 
cake     7 µg/g     
Garber 
2010 
almond crude 2 ELISA, 
RIDASCR
EEN 
cereals     2.5 µg/g     
Garber 
2010 
almond crude 2 ELISA, 
RIDASCR
EEN 
chocolate     3 µg/g     
Garber 
2010 
almond crude 3 ELISA 
Systems 
cake     7 µg/g     
Garber 
2010 
almond crude 3 ELISA 
Systems 
cereals     4.3 µg/g     
Garber 
2010 
almond crude 3 ELISA 
Systems 
chocolate     5 µg/g     
Roeder 
2011 
almond nsLTP 1 Real time 
PCR 
chocolate     50 µg/g
 
     
Roeder 
2011 
almond nsLTP 1 Real time 
PCR 
cookie     50 µg/g     
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3.2.2. Brazil nut 
The type of assay and the foods spiked with Brazil nut extract of the three included studies are shown 
(Table 3.6 and 3.7). The ELISA investigated by Ben Rejab (2005) provided similar sensitivity, 1 ppm 
(equivalent to 1 µg/g), as the PCR assay described by Roeder (2010) for brazil nut added to chocolate. 
Roeder (2010) tested the assay for a wider range of products including cookie, dough and cereals and in 
all cases the allergen could be detected at concentrations as low as 5 µg/g. Sharma (2009) investigated 
percentage recovery for their in house ELISA and found good recoveries   down to 10 µg/g. However 
there was overestimation particularly for wheat flour (Table 3.8), Sharma (2009) found that the lowest 
recovery was from dark chocolate µg/g, perhaps due to Brazil nut chocolate complexes that were 
insoluble in the extraction buffer. Although blank samples of most foods gave negligible readings, apart 
from cinnamon, the recoveries for wheat flour and cookie were over 100%, which indicate that there was 
an interaction between the food matrix and the Brazil but proteins that altered the antibody protein 
binding giving higher than expected results.  Both the ELISAs were developed to detect the crude protein 
mix, whereas the PCR was directed against the gene for the major Brazil nut allergen.  
 
Table 3.6:  Brazil nut: characteristics of included studies 
Study ID Assay 
developed to 
detect  
Food matrix tested Spiking experiments or field 
samples tested and source of spike 









Roasted defatted peanuts and nuts 
extracted, dialysed 
Source of spike 
Not reported 
Standardisation 
Made up to 1mg/ml
-1
 protein 














Range of cereals, 
chocolate bars, 




Source of spike 
Brazil nuts heat treated for drying 











Flour, Wheat flour 
Spiked 
 
Source of spike 
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Table 3.7:  Brazil nut: description of assay 













Brazil nut Test 1 















Table 3.8:  Brazil nut: accuracy and limit of detection and quantification 
Study ID Specific 
protein 












  1 ELISA chocolate 
dark 
    1 µg/g 
   
    
Roeder 
2010 
Ber e 1 gene 1 Real time 
PCR 
chocolate     5 µg/g     
Roeder 
2010 
Ber e 1 gene 1 Real time 
PCR 
cookie     5 µg/g     
Roeder 
2010 
Ber e 1 gene 1 Real time 
PCR 
dough     5 µg/g     
Sharma 
2009 
Protein 1 ELISA cereals 10-100 µg/g 105-119         
Sharma 
2009 
Protein 1 ELISA chocolate 
dark 
10-100 µg/g 90-95         
Sharma 
2009 
Protein 1 ELISA cookie 10-100 µg/g 123-130         
Sharma 
2009 
Protein 1 ELISA wheat flour 10-100 µg/g 150-189         
 
3.2.3. Buckwheat 
We included three studies that investigated the validation of assays for detecting buckwheat within a 
variety of foods including noodles and cake. All three tests were immunoassays directed against crude 
extracts, two ELISA and one a dipstick test (Table 3.9 and Table 3.10). The  ELISAs produced by  
Morinaga Institute of Biological Science and the commercial ELISA, FASTKIT,  tested by Akiyama 
(2004a) in an experiment where  cake samples were spiked with between 5 and 20 ng/ml of buckwheat, 
gave between 89 and 94 % recoveries. However this recovery was reduced for snacks and noodles spiked 
with buckwheat (Table 3.11). The in-house ELISA developed and tested by Panda (2010) provided a limit 
of detection of 2 ppm (2 µg/g) for spiked noodles or cake. The same authors investigated the ELISA-
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Systems kit and this was found to be not as sensitive with a limit of detection of 100 µg/g.  The IC 
dipstick, in addition to being easy to use and not requiring specialised equipment to develop the test, gave 
sensitivity down to 5 µg/g in a range of products, Morishita (2006) (Table 3.11). 
 
Table 3.9:  Buckwheat: characteristics of included studies 





Spiking experiments or field samples 
tested and source of spike 













Source of spike 
FASMAC 
Standardisation 
Protein measured using BCA protein assay 




































Source of spike 
Buckwheat flour ( Hodgsons Mill, 




Table 3.10:  Buckwheat: description of assay 






Buckwheat ELISA (MORINAGA Institute of 
Biological Science)  
Test 2 
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Study ID Allergen Assay details Additional information 
 








Table 3.11:  Buckwheat: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 












buckwheat crude 1 ELISA 
MORINAGA 
buffer     1 ng/ml 1 ng/ml 
Akiyama 
2004a 
buckwheat crude 1 ELISA 
MORINAGA 
cake 5-20 ng/ml 62-102         
Akiyama 
2004a 
buckwheat crude 1 ELISA 
MORINAGA 
noodles 5-20 ng/ml 43-56         
Akiyama 
2004a 
buckwheat crude 1 ELISA 
MORINAGA 
snack 5-20 ng/ml 50-54         
Akiyama 
2004a 
buckwheat crude 2 ELISA, 
FASTKIT 
buffer     1 ng/ml 4 ng/ml 
Akiyama 
2004a 
buckwheat crude 2 ELISA, 
FASTKIT 
cake 5-20 ng/ml 89-94         
Akiyama 
2004a 
buckwheat crude 2 ELISA, 
FASTKIT 
noodles 5-20 ng/ml 76-94         
Akiyama 
2004a 
buckwheat crude 2 ELISA, 
FASTKIT 
snack 5-20 ng/ml 63-64         
Morishita 
2006 
buckwheat crude 1 IC - dipstick chicken 
meatball or 
burger 
    5 µg/g     
Morishita 
2006 
buckwheat crude 1 IC - dipstick cookie     5 µg/g     
Morishita 
2006 
buckwheat crude 1 IC - dipstick Dumplings 
fried/ 
steamed 
    5 µg/g     
Morishita 
2006 
buckwheat crude 1 IC - dipstick jelly     5 µg/g     
Morishita 
2006 
buckwheat crude 1 IC - dipstick Pickles in 
Vinegar/soy 
    5 µg/g     
Morishita 
2006 
buckwheat crude 1 IC - dipstick Potato salad     5 µg/g     
Morishita 
2006 
buckwheat crude 1 IC - dipstick sauce     5 µg/g     
Panda 2010 buckwheat crude 1 ELISA cake 3-1000 µg/g 58-69 2 µg/g 2 µg/g 
Panda 2010 buckwheat crude 1 ELISA noodles 3-1000 µg/g 83-108 2 µg/g 2 µg/g 
Panda 2010 buckwheat crude 2 ELISA-
Systems 
noodles 3-1000 µg/g 0-95 100 µg/g     
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3.2.4. Cashew 
Four studies investigated detection systems for cashew. The ELISA assays provided good sensitivity and 
good recovery from a wide range of spiked products such as ice-cream, pesto, and chocolate, Geskin 
(2011), Ben Rejeb (2005). The PCR assay tested by Brezezinski (2006) did not improve the limit of 
detection giving only 100 µg/g limit of detection for with a cookie food matrix. 
 
Ehlert (2002) developed and validated a multi-target method for the simultaneous detection of a range of 
allergens food matrices. The Ligation-dependent probe amplification assay is based on PCR and enables 
several different allergens to be tested in one tube.  The limit of detection of this test for cashew was 
estimated at 5 mg/kg
-1 
equivalent to 50 µg/g for detecting pesto sauce spiked with cashew proteins.  
Table 3.12:   Cashew: characteristics of included studies 
Study ID Assay developed 
to detect  
Food matrix 
tested 
Spiking experiments or field 
samples tested and source of 
spike 









Roasted defatted peanuts and nuts 
extracted, dialysed 
Source of spike 
Not reported 
Standardisation 
Made up to 1mg/ml
-1
 protein 





























Source of spike 
Nut materials, sesame seeds, 
ingredients of self-prepared DNA 
plant and animal materials used to 
test the specificity of the method 
and spike  samples of chocolate, 
were obtained from the Bavarian 
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Table 3.13:  Cashew: description of assay 























Ligation dependent probe amplification (LPA)  
Test 2 
Cashew real time PCR  
Test 3 
Hazelnut and peanut: ELISA Ridascreen 
Test 1 
LPA for simultaneous 
detection of DNA from 
different foods 
Test 2 
PCR, In house  
Test 3 
ELISA, commercial,  R-











Polyclonal capture antibody 
Sandwich,  In-house 
 
Table 3.14:   Cashew: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 












cashew  Crude 1 ELISA chocolate 
dark 
    1 µg/g     
Brezezinski 
2006 
cashew cashew 2S 
albumin 
1 PCR cookie     10
0 
µg/g     
Ehlert 2009 cashew DNA 1 LPA pesto   50 µg/g     
Ehlert 2009 cashew DNA 2 PCR real 
time 
pesto   20 µg/g     




1-1000 µg/g 100-110         
Geskin 2011 cashew crude 1 ELISA 
sheep 
cookie 1-100 µg/g 75-99         
Geskin 2011 cashew crude 1 ELISA 
sheep 
ice cream 1-102 µg/g 111-128         
Gesking 2011 cashew crude 1 ELISA 
sheep 
buffer   0.
11 
µg/g 0.46 µg/g 
Gesking 2011 cashew crude 2 ELISA goat buffer   0.
11 
µg/g 0.46 µg/g 
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3.2.5. Celery 
Three studies investigated detection of celery allergen in foods (Table 3.15 and Table 3.16) and one 
looked at ELISA. Wang (2011) and two looked at PCR Coisson (2010) and Wu (2010). Wang (2011) 
investigated an in house ELISA system, and recovery data was carried out at one concentration only 
10µg/g.  Good recovery was observed in a range of powdered foods. This recovery rate may not be 
maintained if more complex matrices such as dough were used.   The PCR assay sensitivities varied from 
0.1%, Wu (2010) to 5 % w/w, Coisson (2010) when meatball samples were spiked with the allergen. The 
PCR assay sensitivity was reduced by heating of the food matrix but this was still acceptable at 1 % w/w, 
Wu (2010) (Table 3.17). 
Table 3.15:  Celery: characteristics of included studies 
Study ID Allergen Assay 
developed to 
detect  
Food matrix tested Spiking experiments or 
field samples tested and 
source of spike 





















Source of spike 
A. graveolens L (celery 
leaves). Samples 
purchased from 











Api g  1.01 
corn powder 
wheat powder 
Rice, rice powder 
soy powder 
Spiked 
Source of spike 
Apium graveolens 
bought from local market 
ELISA 
 
















Source of spike 
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Table 3.16:  Celery: description of assay 
Study ID Allergen Assay details Additional information 
Coisson 
(2010) 
Celery Test 1 

















Wu (2010) Celery 
 
Test 1 






Table 3.17:  Celery: accuracy and limit of detection and quantification 
Study ID Specific 
protein 












DNA 1 PCR meatball or 
burger 
    5 % w/w     
Wang 2011 Api g 1.01 1 ELISA buffer     5.6 µg/g     
Wang 2011 Api g 1.01 1 ELISA corn powder 10 µg/g 102         
Wang 2011 Api g 1.01 1 ELISA rice powder 10 µg/g 100         
Wang 2011 Api g 1.01 1 ELISA soy powder 10 µg/g 83         
Wang 2011 Api g 1.01 1 ELISA wheat flour 10 µg/g 115         
Wang 2011 Heated 
Api g 1.01 
1 ELISA Heated/ 
buffer 
    5.7 µg/g     








    0.1 % w/w     










    1 % w/w     
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3.2.6. Cereals 
Five included studies investigated detection of wheat or gluten allergens and the key characteristics and 
the type of assay are shown (Table 3.18 and Table 3.19) ELISA, immune assay dip sticks and mass 
spectrometry were tested. Akiyama (2004) and Mena (2012) investigated ELISA. The FASTKIT ELISA 
was tested by Akiyama 2004, at relatively low concentration of allergens and although this ELISA gave 
recovery rates of less than 50% it provided a limit of detection down to 1 ng/ml, the Gliadin test kit gave 
similar or slightly better recovery rates. Mena (2012) with the ELISA R5 system, found that there was 
good recovery of gluten from a range of foods such as biscuit, bread, cereals, however in products 
containing chocolate there was very poor recovery perhaps due to interaction of tannins with the proteins. 
Mena (2012) developed a modified extraction procedure and this solved the problem enabling yields of 
nearly 100% when chocolate samples were spiked with 55 µg/g of gluten. The authors were using a 
commercial extraction system UPEX, such extraction systems could lead to increased reproducibility 
providing there is strict quality control.   
 
The other type of immunoassay investigates were the test strips, EZ Gluten, which gave good sensitivity 
of 5 µg/g in rice, dog food, beer and cooked dough, and a dipstick system, Morishita 2006 that provided a 
good limit of detection of 5 µg/g Morishita 2006.  
 
One study developed and validated mass spectrometry for gluten, investigating a range of sequences, 
Sealey-Voyksner 2010. This assay provided good recovery rates, 69-112 percent, of more than at very 
low concentrations of allergen (Table 3.20).  
 
Table 3.18:   Cereals: characteristics of included studies 
Study ID Allergen Assay 
developed to 
detect  
Food matrix tested Spiking experiments or 
field samples tested and 






















Source of spike 
Wheat: provided by 

















Source of spike 
National Institute of 
Standards and Technology 
SRM 1567a wheat flour, and 
a commercial bleached all-













cereals, Bread, Cake, 
Chips, Cookie, 
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Study ID Allergen Assay 
developed to 
detect  
Food matrix tested Spiking experiments or 
field samples tested and 
source of spike 
Type of 
assays tested 
wide range of 



































Corn flour and wheat 
Spiked 






Table 3.19:   Cereals: description of assay 






Wheat protein ELISA kit (Gliadin kit)  
Test 2 







EZ Gluten assay 
Immunoassay 
Test strips (manufacturer states 
10 ppm limit of detection) 
Mena 
(2012) 
Gluten Test 1 
ELISA R5 UPEX 
Test 2 
ELISA R5 Modified UPEX 
ELISA 
Polyclonal capture antibody 





Wheat Test 1 
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Table 3.20:  Cereals: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 












wheat Gliadin 1 ELISA cereals 5-20 ng/ml 53-65         
Akiyama 
2004 
wheat Gliadin 1 ELISA fish paste 5-20 ng/ml 56-59         
Akiyama 
2004 
wheat Gliadin 1 ELISA pasta sauce 5-20 ng/ml 62-65         
Akiyama 
2004 
wheat Gliadin 1 ELISA sauce 5-20 ng/ml 35-44         
Akiyama 
2004 



































sausage 5-20 ng/ml 41-45 1 ng/ml 5 ng/ml 
Allred 
2012 
gluten Crude 1 EZ  Gluten beer     5 ppm     
Allred 
2012 
gluten Crude 1 EZ  Gluten dog food     5 ppm     
Allred 
2012 
gluten Crude 1 EZ  Gluten dough 
cooked 
    5 ppm     
Allred 
2012 
gluten Crude 1 EZ  Gluten rice     5 ppm     
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
baby food 55µg/g (one 
conc.) 
101         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
biscuit 55µg/g (one 
conc.) 
105         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
bread 55µg/g (one 
conc.) 
104         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
cake 55µg/g (one 
conc.) 
25         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
cereals 55µg/g (one 
conc.) 
102         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
chips 5 µg/g 5one 
conc.) 
1.3         





55 ppm (one 
conc.) 
41         
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Study ID Allergen Specific 
protein 

















8         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
cold meat 55µg/g (one 
conc.) 
94         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
cooked ham 55µg/g (one 
conc.) 
103         







21         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
custard 55µg/g (one 
conc.) 
95         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
flour 55µg/g (one 
conc.) 
109         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
jam 55µg/g (one 
conc.) 
32         







94         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
paprika 55µg/g (one 
conc.) 
99         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
pepper 55µg/g (one 
conc.) 
44         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
pizza dough 55µg/g (one 
conc.) 
107         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
pudding 55µg/g (one 
conc.) 
108         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
sausage 55µg/g (one 
conc.) 
106         
Mena 2012 gluten Gliadins 1 ELISA 
UPEX 
extraction 
snack 55µg/g (one 
conc.) 
92         




biscuit 55µg/g (one 
conc.) 
99         




cake 55µg/g (one 
conc.) 
98         








101         
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Study ID Allergen Specific 
protein 


















102         




jam 55µg/g (one 
conc.) 
102         




pepper 55µg/g (one 
conc.) 
122         
Morishita 
2006 
wheat crude 1 IC - dipstick chicken 
meatball or 
burger 
    5 µg/g     
Morishita 
2006 
wheat crude 1 IC - dipstick cookie           
Morishita 
2006 
wheat crude 1 IC - dipstick Dumplings 
fried/ 
steamed 
          
Morishita 
2006 
wheat crude 1 IC - dipstick jelly     5 µg/g     
Morishita 
2006 
wheat crude 1 IC - dipstick Pickles in 
Vinegar/ 
soy 
    5 µg/g     
Morishita 
2006 
wheat crude 1 IC - dipstick Potato salad     5 µg/g     
Morishita 
2006 






1 Mass Spec corn 0.06-60 
pg/mg 







1 Mass Spec corn 0.06-60 
pg/mg 







1 Mass Spec corn 0.06-60 
pg/mg 






1 Mass Spec corn 0.06-60 
pg/mg 




gluten PQQSPF 1 Mass Spec corn 0.06-60 
pg/mg 






1 Mass Spec corn flour 10-1000 
pg/mg 







1 Mass Spec corn flour 10-1000 
pg/mg 







1 Mass Spec corn flour 10-1000 
pg/mg 
93-103 14   50   
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Study ID Allergen Specific 
protein 















1 Mass Spec corn flour 10-1000 
pg/mg 







1 Mass Spec corn flour 10-1000 
pg/mg 




gluten PQQSPF 1 Mass Spec corn flour 10-1000 
pg/mg 






1 Mass Spec wheat 0.06-60 
pg/mg 







1 Mass Spec wheat 0.06-60 
pg/mg 







1 Mass Spec wheat 0.06-60 
pg/mg 






1 Mass Spec wheat 0.06-60 
pg/mg 







1 Mass Spec wheat 0.06-60 
pg/mg 




gluten PQQSPF 1 Mass Spec wheat 0.06-60 
pg/mg 
69-108         
Mass Spec= Mass spectrometry 
 
3.2.7. Egg 
Ovomucoid, the major allergen (Gal d1) is less abundant in the egg white than ovalbumin which is also a 
major allergen (Gal d2) and the most abundant protein in egg white. Other major allergens in egg white 
are ovotransferrin and lysozyme. The latter is of particular interest as hen‟s egg lysozyme can be used in  
wine production and cheese making.  Alphalivetin Gal d 5 is present in the egg yolk.  Within this review 
studies developing or validating assay to detect crude extract, ovalbumin, ovomucoid or lysozyme were 
found and included. 
Six studies investigating assays or egg proteins were included in the review, the assays included ELISA 
(in-house and commercial), time-of-flight mass spectrometry and dipstick techniques (Table 3.21). 
Akiyama (2003) compared three ELISAs using bread, cereals and sauces as the food matrix. The two 
ELISA kits developed by the Morinaga Institute of Biological Sciences detected ovalbumin and 
ovomucoid  and provided good recovery (in most cases more than 80%) for samples spiked with 5-20 
ng/ml, and the limit of detection in a sausage mixture was 4 ng/ml (0.001 µg/ml). Khuda 2012b also 
found good recovery from dark chocolate, but very poor recovery from sugar cookie at just 15%. 
However, it should be noted that none of the assays tested by Khuda demonstrated good recoveries from 
the sugar cookie mix.  The FASTKIT ELISA tested by Akiyama (2003) did not perform as well as the 
Morinaga system, giving recoveries of less than 50% for sausage spiked with egg. The Veratox ELISA 
was tested by Khuda (2012b) where recoveries were very high, more than 200% from dark chocolate but 
as mentioned before poor from sugar cookie at less than 10%. The ELISA-BIOKITS was less effective 
than the other assays for dark chocolate, and similarly poor for the sugar cookie mixture, Khuda (2012 b). 
Shon (2010) developed an in-house ELISA against ovomucoid and achieved acceptable recoveries from 
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sausage and milk substitute when spiked with 10 µg/g.  Lacorn (2011), used an in-house sandwich ELISA 
to detect egg powder or cooked egg powder in wine and achieved recoveries of 76-110% and a limit of 
detection of 0.27 µg/ml.   
The IC – dipstick provided a limit of detection of 5 µg/g in a wide range of foods, Morishita (2006), and 
had the advantage of ease of use.  Schneider (2010a) developed a method for mass spectrometry that 
achieved a limit of detection of 5 µg/g for lysozyme in cheese. 
Table 3.21:   Egg: characteristics of included studies 
Study ID Assay developed 
to detect  
Food matrix tested Spiking experiments or field 
















Dose of spike 5-20ng/mL 
Source of spike 
Egg (Nippon Meat Packers, Inc), fresh 












Source of spike 
Spray-dried egg yolk solids (Hershey 




(2012a) egg  
Crude extract 
Spray dried egg 
powder 
 
Dark Chocolate Source of spike 
Spray dried egg powder-NIST RM 
8445 (National Institute of Standards 









Cookie Source of spike 
Spray dried whole egg powder, NIST 
RM 8445 (National Institute of 









Spiked and source 
Spray dried whole egg powder 
(National Institute of standards and 
Technology,) Whole egg and white: 
Henningsen Foods (Omaha, NE) 
Cooked egg white: prepared in house. 
Food grade liquid egg white (Eifix 
Eiweiss, Wiesenhof, Germany)  
Standardisation 
Total protein: whole egg 48± 1 %, 
Durmas method. Egg white powder: P-
11 protein content  83.8 % (Kjehldahl 
determination), cooked egg white: 
protein, using BCA ( 2.8 mg/ml) Food 

















hic test kits 
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Study ID Assay developed 
to detect  
Food matrix tested Spiking experiments or field 
samples tested and source of spike 
Type of 
assays tested 
Potato Salad, Sauce 
Tomato, Soup 






















Source of spike 
Cheese samples (Manchego, Grana 
Padano, Parmigiano Reggiano and 
hard cheese mixtures) were purchased 













Source of spike 





















Source of spike 
whole egg powder and egg white 





Table 3.22:   Egg: description of assay 






Egg protein ovalbumin ELISA kit (Morinaga Institute 
of Biological Sciences) 
Test 2 
 Egg protein ovomucoid ELISA kit (Morinaga 
Institute of Biological Sciences) 
Test 3 





















RIDASCREEN FAST peanut, egg, and casein from R- 
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Study ID Allergen Assay details Additional information 
Veratox peanut, egg, and total milk allergen 
quantitative test kits from Neogen (NE) Corp. 
(Lansing, MI, USA) 
Test 3 
Morinaga (MO) peanut, egg, and milk (casein and 
BLG) protein ELISA kits (Crystal Chem, Downers 
Grove, IL, USA) 
Test 4 
Tepnel (TE) BIOKITS peanut, egg, casein, and BLG 
assay kits (Neogen Corp.) 
Test 5 
ELISA Systems (ES) peanut, egg, casein, and BLG 







RIDASCREEN FAST peanut, egg, and casein from R- 
Biopharm (RB, Washington, MO, USA) 
Test 2 
Veratox peanut, egg, and total milk allergen 
quantitative test kits from Neogen (NE) Corp. 
(Lansing, MI, USA) 
Test 3 
Morinaga (MO) peanut, egg, and milk (casein and 
BLG) protein ELISA kits (Crystal Chem, Downers 
Grove, IL, USA) 
Test 4 
Tepnel (TE) BIOKITS peanut, egg, casein, and BLG 
assay kits (Neogen Corp.) 
Test 5 
ELISA Systems (ES) peanut, egg, casein, and BLG 
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Table 3.23:   Egg: accuracy and limit of detection and quantification 
Study ID Specific 
protein 












Ovalbumin 1 ELISA 
Morinaga 
bread 5-20 ng/ml 81-86         
Akiyama 
2003 
Ovalbumin 1 ELISA 
Morinaga 
cereals 5-20 ng/ml 85-87         
Akiyama 
2003 
Ovalbumin 1 ELISA 
Morinaga 
cookie 5-20 ng/ml 90-101         
Akiyama 
2003 
Ovalbumin 1 ELISA 
Morinaga 
sauce 5-20 ng/ml 71-82         
Akiyama 
2003 
Ovalbumin 1 ELISA 
Morinaga 
sausage 5-20 ng/ml 92-105 4 ng/ml       8 ng/ml 
Akiyama 
2003 
Ovomucoid 2 ELISA 
Morinaga 
bread 5-20 ng/ml 88-107         
Akiyama 
2003 
Ovomucoid 2 ELISA 
Morinaga 
cereals 5-20 ng/ml 89-108         
Akiyama 
2003 
Ovomucoid 2 ELISA 
Morinaga 
cookie 5-20 ng/ml 104-167         
Akiyama 
2003 
Ovomucoid 2 ELISA 
Morinaga 
sauce 5-20 ng/ml 57-65         
Akiyama 
2003 
Ovomucoid 2 ELISA 
Morinaga 



































cereals 5-20 ng/ml 42-43     
Khuda 
2012a 
crude 1 ELISA, 
RIDASCRE





255         
Khuda 
2012a 






283         
Khuda 
2012a 






76         
Khuda 
2012a 






58         
Khuda 
2012a 






66         
Khuda 
2012b 
crude 1 ELISA, 
RIDASCRE
EN FAST  
sugar cookie linear 
regression 
10         
Khuda 
2012b 
crude 2 ELISA, 
Veratox  
sugar cookie linear 
regression 
9         
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Study ID Specific 
protein 












crude 3 ELISA, 
Morinaga 
sugar cookie linear 
regression 
15         
Khuda 
2012b 
crude 4 ELISA, 
BIOKITS 
sugar cookie linear 
regression 
4         
Khuda 
2012b 
crude 5 ELISA 
Systems  
sugar cookie linear 
regression 















1 ELISA wine 1.5-13.5 µg 
/ml 
87-109 0.27 µg /ml     0.5 mg/L 
Morishita 
2006 
crude 1 IC - dipstick chicken 
meatball or 
burger 
    5 µg/g     
Morishita 
2006 
crude 1 IC - dipstick cookie     5 µg/g     
Morishita 
2006 
crude 1 IC - dipstick Dumplings 
fried/steame
d 
    5 µg/g     
Morishita 
2006 
crude 1 IC - dipstick jelly     5 µg/g     
Morishita 
2006 
crude 1 IC - dipstick Pickles in 
Vinegar/soy 
    5 µg/g     
Morishita 
2006 
crude 1 IC - dipstick Potato salad     5 µg/g     
Morishita 
2006 






cheese     5 µg/g     
Schneider 
2010b 
lysozyme 1 ELISA cheese 50-400 
mg/kg 
87-94 2.73 ng/ml     




74         
Shon 2010 ovomucoid 1 ELISA in house 
sausage 
5-30mg/kg 66         




129         
 
3.2.8. Fish and Shellfish 
The majority of assays for fish and shellfish in foods were developed to detect parvalbumin the major fish 
allergen or tropomyosin the main allergen for a wide range of shellfish (Table 3.24). Both these allergenic 
proteins are relatively heat stable. The assays investigated included ELISA and PCR (Table 3.25). The 
majority of food matrices tested were liquids such as soups, and in the findings indicated that for most 
assays there was relatively good recovery (Table 3.26) 
 Cai (2013) developed and tested a parvalbumin ELISA over a wide range of concentrations 10-1000 
ng/ml and demonstrated  good recovery rates of 70-140%. Faeste (2008) developed their own  in-house  
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ELISA that gave a limit of detection of 0.01 µg/g, however they did not present the recovery rates. 
Shibahara (2013b) also developed and validated an ELISA to parvalbumin showing acceptable recoveries 
for matrices such as meatballs and potato products when were with 10 ppm (10 µg/g). 
Shibahara (2007) developed an ELISA for detecting shrimp and crab tropomyosin and although the limit 
of detection for different food matrices was not presented, the study demonstrated that for foods spiked 
with as little as  10ppm (10 µg /g) the percentage recovery ranged from 64-82%. Fuller (2007) showed 
similar sensitivity for an in-house ELISA to detect tropomyosin and Wener (2007) showed good recovery 
rates when samples were spiked with as little as 1 µg/ml and the limit of detection was as low as 0.2 
µg/ml in certain foods.  
One by study by Taguchi (2011) investigated PCR to detect the DNA of crab, and this assay showed a 
limit of detection in a similar region of 10 µg/g. This PCR had the advantage that it can discriminate 
between shrimp and crab unlike the two commercial LISA kits that it was tested against (Table 3.25).  
Table 3.24:   Fish and Shellfish: characteristics of included studies 
Study ID Allergen Assay 
developed to 
detect  
Food matrix tested Spiking experiments or 
field samples tested and 
source of spike 
Type of 
assays tested 
Cai (2013) Fish 




Tofu and mushroom 
Spiked 
Source of spike 













































Ocean Pie, Quiche 
Rice: pilau rice 
Sauce, Soy sauce, 
lemon and dill 
sauce, Spread: tuna 





Source of spike 



















Source of spike 
Extracted from freeze-













Rice: rice gruel 
Spiked 
Field 
Source of spike 
Five species of fish: 
Japanese eel Anguilla 
ELISA 
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Study ID Allergen Assay 
developed to 
detect  
Food matrix tested Spiking experiments or 
field samples tested and 
source of spike 
Type of 
assays tested 
Soup: vegetable and 
chicken soup 
japonica, horse mackerel 
Trachurus japonicus, 
crimson sea bream 
Evynnis japonica, pacific 
mackerel S.japonicus and 























27 commercial food 
products,  purchased 
from local stores 
Spiked 
Field 
Source of spike 
Markets in Tokyo and 
Chiba, Japan, or provided 































   
 
Table 3.25:  Fish and Shellfish: description of assay 
Study ID Allergen Assay details Additional information 



















Crustaceans Test 1 
ELISA 
ELISA 
Polyclonal capture antibody 





Crustaceans Test 1 
ELISA 
ELISA 
Monoclonal capture antibody 
Polyclonal detection antibody 
University of Portsmouth  Prevalence of food allergy in Europe 
 
EFSA supporting publication 2013:EN-506 289 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by 
the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender procedure. 
The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and 
the conclusions reached in the present document, without prejudice to the rights of the authors. 









Polyclonal capture antibody 









EIA crustacean 'Nissui' ELISA 
Test 2 
crustacean kit 'Maruha'  ELISA 
Test 3 
Shrimp PCR  
Test 4 
Crab PCR In-house 
Test 1 
Nissui Pharmaceutical Co., Ltd., 
Toshima-ku, Tokyo 
Test 2 









ELISA  ELISA  
Polyclonal capture antibody 





Table 3.26:   Fish and Shellfish: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 
















        
Cai 2013 silver carp   parvalbumin 1 ELISA 
In-house 









































soy sauce     0.01 µg/g 0.02 µg/g 
Fuller 2007 crustaceans tropomyosin 1 ELISA 
In-house 
buffer nr nr 1 µg/g   




7.5 ppm 67-86      




7.5 ppm 99-140      
Fuller 2007 crustaceans tropomyosin 1 ELISA 
In-house 
pie/ quiche 7.5 ppm 41-112      
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Study ID Allergen Specific 
protein 










Fuller 2007 crustaceans tropomyosin 1 ELISA 
In-house 
pie/ quiche 7.5 ppm 74-84      
Fuller 2007 crustaceans tropomyosin 1 ELISA 
In-house 
rice 7.5 ppm 76-117      
Fuller 2007 crustaceans tropomyosin 1 ELISA 
In-house 
sauce 7.5 ppm 85-124      
Fuller 2007 crustaceans tropomyosin 1 ELISA 
In-house 
soy sauce 7.5 ppm 76-87      
Fuller 2007 crustaceans tropomyosin 1 ELISA 
In-house 
spread 7.5 ppm 117-143      
Shibahara 
2007 
crustaceans tropomyosin 1 ELISA 
In-house 
buffer     0.4 ng/ml 1.2 ng/ml 
Shibahara 
2007 
crustaceans tropomyosin 1 ELISA 
In-house 
croquette 2,10,16 ppm 88-103         
Shibahara 
2007 





2,10,16 ppm 94-105         
Shibahara 
2007 
crustaceans tropomyosin 1 ELISA 
In-house 
sauce 2,10,16 ppm 94-104         
Shibahara 
2013b 
fish parvalbumin 1 ELISA 
In-house 
buffer     0.23 ng/ml 0.7 µg/g 
Shibahara 
2013b 





10 ppm 73.5         
Shibahara 
2013b 





10 ppm 81.8         
Shibahara 
2013b 





10 ppm 63.6         
Shibahara 
2013b 




            
Shibahara 
2013b 




10 ppm 78.8         
Shibahara 
2013b 
fish parvalbumin 1 ELISA 
In-house 
soup 10 ppm 78.7         
Taguchi  
2011 
crustaceans DNA -shrimp 3 shrimp PCR miso   10 µg/g    
Taguchi  
2011 
crustaceans DNA -shrimp 3 shrimp PCR soup   10 µg/g    
Taguchi  
2011 
crustaceans DNA -shrimp 3 shrimp PCR soup   10 µg/g   
Taguchi  
2011 
crustaceans DNA -crab 4 crab-PCR miso     10 µg/g     
Taguchi  
2011 
crustaceans DNA -crab 4 crab-PCR soup     10 µg/g     
Taguchi  
2011 
crustaceans DNA -crab 4 crab-PCR soup     10 µg/g     
Taguchi 
2011 
crustaceans DNA -shrimp 3 shrimp PCR chicken 
meatball or 
burger 
  10 µg/g   
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Study ID Allergen Specific 
protein 












crustaceans DNA -shrimp 3 shrimp PCR croquette   10 µg/g   
Taguchi 
2011 
crustaceans DNA -shrimp 3 shrimp PCR range of 
products 
        
Taguchi 
2011 
crustaceans DNA -shrimp 3 shrimp PCR rice gruel/ 
porridge 
  10 µg/g   
Taguchi 
2011 
crustaceans DNA -crab 4 crab-PCR chicken 
meatball or 
burger 
    10 µg/g     
Taguchi 
2011 
crustaceans DNA -crab 4 crab-PCR croquette     10 µg/g     
Taguchi 
2011 
crustaceans DNA -crab 4 crab-PCR range of 
products 
            
Taguchi 
2011 
crustaceans DNA -crab 4 crab-PCR rice gruel/ 
porridge 
    10 µg/g     
Werner 
2007 
crustaceans tropomyosin 1 ELISA 
In-house 
fish 1-100 µg/ml 68-83 0.3 µg/g     
Werner 
2007 
crustaceans tropomyosin 1 ELISA 
In-house 
mayonnaise 1-100 µg/ml 102-120 0.2 µg/g     
Werner 
2007 
crustaceans tropomyosin 1 ELISA 
In-house 
sauce 1-100 µg/ml 79-94 0.3 µg/g     
Werner 
2007 
crustaceans tropomyosin 1 ELISA 
In-house 
surimi 1-100 µg/ml 66-88 0.9 µg/g     
 
3.2.9. Hazelnut 
A range of immunoassays including dipstick tests and real-time PCR assays were validated by the studies 
included within this review and the food matrices used included chocolate, cereals and cookies  (Table 
3.27). Commercial and in-house tests were investigated (Table 3.28). Most of the assays investigated 
could detect to below 10 ppm (10 µg/g) in a range of samples, including milk chocolate (Table 3.29). 
 
Akkerdaas (2004), Ben Rejeb (2003), Ben Rejeb (2005h), Blais (2001), Cucu (2012), Drs (2004), 
Holzhauser (1999) developed and validated in-house ELISAs. All provided a limit of detection as low as 
or lower than 1 µg/g with recoveries of over 50%. 
 
Commercial assays tested included Veratox, Garber (2010),  ELISA systems, Garber 2010)   Ridascreen, 
Ehlert (2009), Garber (2010), Piknova (2008) with a limit of detection between 1 and 6 µg/g The 
exception was Ridascreen tested by Ehlert (2009) that gave a limit of detection of 10 mg/kg
-1
, equivalent 
to 100 µg/g. All assays were directed against crude extracts rather than purified proteins. 
 
Ehlert (2009) developed and validated a ligation-dependent probe amplification system for simultaneous 
detection of DNA from a number of allergenic foods.  The limit of detection in food matrices such as 
chocolate and cookies was 10 mg/kg
-1
 that equates to 100 µg/g. Faeste (2006) developed a time-resolved 
fluoro-imunoassay and this had reasonable recoveries of between 5-123 % for matrices spiked with 1-150 
mg/kg (1-150 µg/g). 
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Table 3.27:   Hazelnut: characteristics of included studies 





Spiking experiments or 
field samples tested and 
source of spike 














Source of spike 


















Source of spike 
Roasted hazelnuts from a 
local store  
Standardisation 
Total protein content 












Roasted defatted peanuts 
and nuts extracted, 
dialysed 
Source of spike 
Not reported 
Standardisation 
Made up to 1mg/ml
-1
 
protein content measured 



















Source of spike 
Shelled raw hazelnuts 
ground and defatted salted 
and centrifuged. 
Standardisation 
Total protein 35 mg/ml 




























Both before and 
after cooking 
Spiked 
Source of spike 
9 different brands of 
hazelnut (8 raw, 1 

































Source of spike 
Nut materials, sesame 
seeds, ingredients of self-
prepared DNA plant and 
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Spiking experiments or 
field samples tested and 
source of spike 
Type of assays 
tested 
 test the specificity of the 
method and spike  
samples of chocolate, 
were obtained from the 


















Source of spike 
Raw Mina hazelnuts 
(Iran) 
Standardisation 
Raw nuts were 
homogenised, suspended 
in buffer, vortexed, 
centrifuged and filtered 
through glass wool. Total 
protein content was 
determined using the 
Lowrey method, and 
protein standard solution 







































Source of spike 
Piemonte and Nocciole 
Ordu, provided by Dr G 
Malgarini, Sorematx, 
Arlon-Schoppach, 
Belgium. toasted.  
Standardisation 
soluble protein was 
















nuts, nougat, milk 
products 
Source of spike 
Hazelnuts of the variety 
Nocciole Ordu (Turkey) 
both native and toasted at 
140
 o
C for 30 min, were 




food products were 
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Spiking experiments or 
field samples tested and 
source of spike 




















Source of spike 
Roasted hazelnut samples 


























Source of spike 
Five cultivars from 




























peanut or hazelnut 
Spiked 
Field 





Table 3.28:   Hazelnut: description of assay 
Study ID Allergen Assay details Additional information 
Akkerdaas 
(2004) 
Hazelnut Test 1 
ELISA 
ELISA 
Polyclonal capture antibody 

















Polyclonal detection antibody 
Competitive inhibition 
In-house 






Polyclonal capture antibody 
Polyclonal detection antibody 
Sandwich 
In-house 
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Study ID Allergen Assay details Additional information 





Nested real-time PCR 
PCR 





Polyclonal detection antibody 
Competitive inhibition 
In-house 













Ligation dependent probe amplification 
Test 2 
Hazelnut and peanut: real-time PCR Surefood 
allergen kit (Congen Biotechnology GmbH, 
Berlin, Germany) cashew real time PCR In 
house  
Test 3 
Hazelnut and peanut: ELISA Ridascreen (R-























Veratox (Neogen Corporation, Lansing, MI, 
USA); 
Test 2 
Ridascreen Fast (R-Biopharm Inc, Marshal, MI, 
USA), 
Test 3 
Elisa systems(bioMerieux Industry (Hazelwood, 
MO, USA) 











Polyclonal capture antibody 














Polyclonal capture antibody 






SureFood-Allergen Hazelnut test 
(Congen Biotechnology, No. 
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Real-time PCR hsp 1 
Test 2 
ELISA RidaScreen FAST Hazelnut (R-















Polyclonal capture antibody 
Polyclonal detector antibody.  
In-house 
 
Table 3.29:   Hazelnut: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 












hazelnut Crude pepsin 
stable 
1 ELISA buffer     0.7 ng/ml     
Akkerdaas 
2004 
hazelnut Crude pepsin 
stable 
1 ELISA chocolate 
milk 
0.5 -100  
µg/g 
53-120 0.5  µg/g     
Akkerdaas 
2004 
hazelnut Crude pepsin 
stable 
1 ELISA range of 
products 





1 ELISA breakfast 
cereal 





1 ELISA chocolate 
dark 





1 ELISA chocolate 
milk 










1 ELISA ice cream 1-10 µg/g 78-83         
Ben Rejeb 
2005 
hazelnut   1 ELISA chocolate 
dark 
    1 ppm     




    0.25 ppm     
Blais 2001 hazelnut Crude 1 EIA 
(ELISA) 
Cake     0.12 ppm     




    0.25 ppm     
Blais 2001 hazelnut Crude 1 EIA 
(ELISA) 
cookie     0.5 ppm     
Blais 2001 hazelnut Crude 1 EIA 
(ELISA) 
ice cream     0.25 ppm     
Blais 2001 hazelnut Crude 1 EIA 
(ELISA) 
muesli     0.5 ppm     
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Study ID Allergen Specific 
protein 










Blais 2001 hazelnut Crude 1 EIA 
(ELISA) 
snack cereal     1 ppm     
Blais 2001 hazelnut Crude 1 EIA 
(ELISA) 
snack cereal     0.5 ppm     
Costa 2012 hazelnut hsp 1 1 Real time 
PCR 
Pasta Nr nr 100 mg/kg    100 mg/kg 
Costa 2012 hazelnut hsp 1 2 Nested Real 
time PCR 
Pasta     50 mg/kg     50 mg/kg 




Nr nr nr   nr   
Cucu 2012 hazelnut crude 1 ELISA cookie 30-100  
µg/g 
10 - 20         
Cucu 2012 hazelnut crude 1 ELISA cookie 
(spiked after 
baking) 
3-25  µg/g 73-107         
Drs 2004 hazelnut crude 1 ELISA cookie   128 10 µg/L
-1
     30 µg/L-1 
Ehlert 2009 hazelnut DNA 1 LPA chocolate Nr nr 5 mg/kg
-1
     
Ehlert 2009 hazelnut DNA 1 LPA walnut 
cookies 
Nr nr 100 mg/kg
-1
     
Ehlert 2009 hazelnut DNA 2 PCR real 
time 
chocolate   10 mg/kg
-1
     




  10 mg/kg
-1
     
Ehlert 2009 hazelnut crude 3 ELISA 
Ridascreen 
chocolate   10 mg/kg
-1
     




  1 mg/kg
-1





1  Fluoro-IA cereals 1-150 
mg/kg 





1 Fluoro-IA cereals 1-150 
mg/kg 














1 Fluoro-IA cookie 1-150 
mg/kg 




hazelnut crude 1 ELISA, 
Veratox 




hazelnut crude 1 ELISA, 
Veratox 




hazelnut crude 1 ELISA, 
Veratox 




hazelnut crude 2 ELISA, 
RIDASCRE
EN 
Cake     2 µg/g     
Garber 
2010 
hazelnut crude 2 ELISA, 
RIDASCRE
cereals     2 µg/g     
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Study ID Allergen Specific 
protein 














hazelnut crude 2 ELISA, 
RIDASCRE
EN 




hazelnut crude 3 ELISA 
Systems 




hazelnut crude 3 ELISA 
Systems 




hazelnut crude 3 ELISA 
Systems 
chocolate     8 µg/g     
Holzhauser 
1999 
hazelnut crude 1 ELISA almond     1.1 ppm 1.4 ppm 
Holzhauser 
1999 
hazelnut crude 1 ELISA cashew     4.5 ppm 6.9 ppm 
Holzhauser 
1999 
hazelnut crude 1 ELISA chocolate 0.001 - 10 
% 
103-132         
Holzhauser 
1999 
hazelnut crude 1 ELISA chocolate 
milk 
0.001 - 10 
% 
83-118 0.07 ppm 0.13 ppm 
Holzhauser 
1999 
hazelnut crude 1 ELISA chocolate 
milk 
    0.11 ppm 0.19 ppm 
Holzhauser 
1999 
hazelnut crude 1 ELISA cookie 0.001 - 10 
% 
90-127         
Holzhauser 
1999 
hazelnut crude 1 ELISA crisps/ Thai 
cracker 
    0.09 ppm 0.14 ppm 
Holzhauser 
1999 
hazelnut crude 1 ELISA ice cream     0.07 ppm 0.12 ppm 
Holzhauser 
1999 
hazelnut crude 1 ELISA popcorn     0.43 ppm 0.67 ppm 
Holzhauser 
1999 
hazelnut crude 1 ELISA pumpkin 
seed 
    10.3 ppm 14.1 ppm 
Holzhauser 
1999 
hazelnut crude 1 ELISA range of 
products 
            
Holzhauser 
1999 
hazelnut crude 1 ELISA snack cereal 0.001 – 
10%  
67-127         
Holzhauser 
1999 
hazelnut crude 1 ELISA snack cereal     0.05 ppm 0.05 ppm 
Holzhauser 
1999 
hazelnut crude 1 ELISA walnut     5.5 ppm 6.9 ppm 
Kiening 
2005 
hazelnut crude 1 ELISA cereals 1-10 mg/kg 95-101         
Kiening 
2005 
hazelnut crude 1 ELISA chocolate 
dark 
1-10 mg/kg 86-94         
Kiening 
2005 
hazelnut crude 1 ELISA chocolate 
milk 
1-10 mg/kg 0-115         
Kiening 
2005 
hazelnut crude 1 ELISA cookie 1-10 mg/kg 95-127         
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Study ID Allergen Specific 
protein 












hazelnut crude 1 ELISA ice cream 1-10 mg/kg 93-111         
Piknova 
2008 
hazelnut   2 ELISA 
(Ridascreen) 
dough   0.01 % w/w    
Piknova 
2008 








We had findings from three studies that investigated ELISA and PCR in food matrixes such as bread, 
cakes and sausage meat. The assays all provided a limit of detection of approximately 1 ppm equivalent 
to 1µg/g with good recoveries when spiked with between 1 and 1000µg/g of lupine. The ELISA assays, 
Holden (2005), Holden (2007), and Kaw (2008) were developed in-house and were directed against crude 
antigens rather than specific allergens. All the studies presented limit of detection and percentage 
recovery and this was as low as 1 µg/g with the Holden (2005) assay detecting down to 0.1µg/g in 
sausage or pastry matrices.  
Demmel (2011) tested a real time PCR assay in pizza, flour and dough and demonstrated a consistent 
limit of detection of 0.1µg/g of Lupine flour. However the percentage recovery was not presented. 
 
Table 3.30:   Lupine: characteristics of included studies 





Spiking experiments or field 













Source of spike 
Sweet lupine flour from L 
angustifolius, (Chemical and 
Veterinarian Research Institute 









Source of spike 



















Source of spike 
Processed proteins from L. 
albus seeds, in the form of 
tofu-like product 
(Lopino;Lupina, Visbek, 
Germany) native proteins from 
L.angustifolius seeds, in the 
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Spiking experiments or field 















Source of spike 
purchased from a local grocery 
store 
Standardisation 
protein concentration was 





Table 3.31:   Lupine: description of assay 
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Table 3.32:  Lupine: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 












lupine crude 1 PCR real 
time 
dough   0.1 µg/g    
Demmel 
2011 
lupine crude 1 PCR real 
time 
flour   0.1 µg/g    
Demmel 
2011 




  0.1 µg/g    
Holden 
2005 
lupine crude 1 ELISA bread 1-1000 µg/g 80-116 0.2 µg/g    
Holden 
2005 
lupine crude 1 ELISA chocolate 
spread 
1-1000 µg/g 61-84 0.4 µg/g    
Holden 
2005 
lupine crude 1 ELISA pasta 1-1000 µg/g 88-116 0.1 µg/g    
Holden 
2005 
lupine crude 1 ELISA sausage 
vegetarian 
1-1000 µg/g 60-64 0.1 µg/g    
Holden 
2007 
lopino crude 1 ELISA pAb-
mAb 
bread 1-1000 µg/g 85-150        
Holden 
2007 
lupine crude 1 ELISA pAb-
mAb 
bread 1-1000 µg/g 44-88         
Kaw 2008 lupine crude 1 ELISA muffin 
(corn) 
1-1000 ppm 91-118 1 µg/g     
Kaw 2008 lupine crude 1 ELISA sausage 1-1000 ppm 97-117 1 µg/g     
 
3.2.11. Milk 
A range of assays were investigated including commercial and in house ELISAs, direct automated optical 
biosensor , mass spectrometry and dipsticks in a range of food matrices such as pasta sauce, sausage, 
cereals, biscuits, sorbet, dark chocolate and wine (Table 3.33). The assays tended to be directed against 
specific components of milk for example casein, kappa-casein and beta-lactoglobulin and these 
correspond to the major allergenic proteins (Table 3.34). 
The in- house ELISA developed by  Hefle (2004) was directed against casein and gave a limit of 
detection of 0.5 ppm equivalent to 0.5 µg/g in the food matrices ice-cream and dark chocolate.    
The commercial ELISA kit FASTKIT tested by Akiyama (2002)  (Table 3.35) gave between 5-95 percent 
recoveries for detecting casein and beta-lactoglobulin in food matrices spiked with as little as 5 ng/ml, 
these recoveries varied considerable in different foods matrices. Recovery was under 40% for casein in 
various sauces whereas the cereals, cookies and sausage mix gave better recoveries.  The same FASTKIT 
directed against beta-lactoglobulin  gave more consistent recoveries, 49-95% in the same range of foods. 
The FASTKIT directed against crude milk extract gave poorer recoveries of between 24-48%. 
Presumable this later assay was directed against a range of milk proteins including beta-lactoglobulin and 
caseins.  
The RIDASCREEN ELISA for detecting casein tested by Khuda (2012a) gave very poor recovery in dark 
chocolate, this study was of high quality and the researchers ensured that they attempted to recover the 
milk proteins from tempered chocolate. The same RIDASCREEN assays for detecting casein and beta-
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lactoglobulin gave negligible recoveries from sugar cookie mixture, Khuda (2012b). However none of the 
assays tested in this study showed good recovery from the sugar cookie matrix. 
 The Veratox ELISA for casein tested by Khuda (2012a) gave excellent recovery from dark chocolate at 
122%, and like the previous assay poor recovery from sugar cookie at 7%.   
The ELISA ICP-MS for casein, was shown to have a limit of detection of 0.5µg/g in dark chocolate and 
ice cream matrices by Hefle (2004), the percent recovery was not shown. 
The ELISA BIOKIT showed recoveries of only 2% from dark chocolate for beta-lactoglobulin but better 
at 50% for casein, Khuda (2012a). As mentioned in the previous paragraphs recovery from sugar cookie 
was poor at 0%, (Khuda 2012b). 
The ELISA Systems kits gave recoveries of 50 and 40% for casein and beta-lactoglobulin respectively 
from chocolate, Khuda (2012a), and again negligible recoveries of 6% or less from sugar cookie, Khuda 
(2012b).  
A novel, direct automated optical biosensor (Biacore 3000) was tested with a monoclonal antibody 
specific for cows‟ milk kappa-casein contaminating sheep or goats‟ milk, Haasnoot (2004).  This 
specificity may not be useful for allergen testing as human IgE tends to show cross reactivity with caseins 
from different species. The assay limit of detection was given as 0.7% - 0.08 w/w which converts to  700-
800µg/g for detecting bovine proteins in sheep and goat milk. This validation experiment while being 
suitable for species contamination was not suitable for allergy testing. 
Morishita (2006) developed and tested an IC - dipstick method that provided a good limit of detection 
5µg/g in a range of foods. This assay has the advantage over the ELISA systems that complex laboratory 
systems and equipment are not required.  
Monaci (2008) developed and tested a detection system using mass spectrometry to detect the milk 
protein alpha lactalbumin. This gave recoveries of 73-79% for fruit juice spiked with as little as 5µg/ml.  
 
Table 3.33:   Milk: characteristics of included studies 
Study ID Allergen Assay 
developed to 
detect  
Food matrix tested Spiking experiments or 
field samples tested and 




















Dose of spike 5-20 ng/mL 
Source of spike 
Milk: provided by Nippon 
Meat Packers, Inc. Fresh 















Cake, biscuit and 
crisps 
Field 
Source of spike 
















Ewes and goats milk 
 
Spiked 
Source of spike 
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Study ID Allergen Assay 
developed to 
detect  
Food matrix tested Spiking experiments or 
field samples tested and 






reconstituting a bovine 
skimmed milk powder (1g 

































Dark Chocolate Source of spike 
Non-fat dry milk-NIST 
SRM 1549 (National 















Source of spike 
Non-fat dry milk-NIST 
SRM 1549 (National 


















Source of spike 
Non-fat dry milk, NIST 
SRM 1549 (National 


















fruit, guava, grape, 





Source of spike 
LG A, LG B (purity 92%) 
and x-LA (purity 98%) 
and formic acid, (98-100% 
purity grade) (FA) (Sigma-












































ic test kits 
Dip stick 
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Study ID Allergen Assay 
developed to 
detect  
Food matrix tested Spiking experiments or 
field samples tested and 
source of spike 
Type of 
assays tested 
















Source of spike 
Local retail market 
ELISA  kit 
Mass 
spectrometry 
Table 3.34:  Milk: description of assay 






Milk protein Casein ELISA kit  
Test 2 
Milk protein beta-Lactoglobulin ELISA kit 
Test 3 










Electrochemical  Immunosensor, (Dropsens, Inc, 
Spain) 
Test 2 
beta-lactoglobulin ELISA, ELISA systems 







electrodes (Dropsens, Inc, 









direct automated optical biosensor (Biacore 3000) 
Mab 6A10 
Test 2 
direct automated optical biosensor (Biacore 3000) 
Mab 4G10 
Test 3 
inhibition automated optical biosensor (Biacore 
3000) Mab 6A10 
Test 4 
inhibition automated optical biosensor (Biacore 













Polyclonal capture antibody 








RIDASCREEN FAST peanut, egg, and casein from 
Test 1,2 and 3 
ELISA 
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Study ID Allergen Assay details Additional information 
milk  R- Biopharm (RB, Washington, MO, USA) 
Test 2 
Veratox peanut, egg, and total milk allergen 
quantitative test kits from Neogen (NE) Corp. 
(Lansing, MI, USA) 
Test 3 
Morinaga (MO) peanut, egg, and milk (casein and 
BLG) protein ELISA kits (Crystal Chem, Downers 
Grove, IL, USA) 
Test 4 
Tepnel (TE) BIOKITS peanut, egg, casein, and BLG 
assay kits (Neogen Corp.) 
Test 5 
ELISA Systems (ES) peanut, egg, casein, and BLG 









RIDASCREEN FAST peanut, egg, and casein from 
R- Biopharm (RB, Washington, MO, USA) 
Test 2 
Veratox peanut, egg, and total milk allergen 
quantitative test kits from Neogen (NE) Corp. 
(Lansing, MI, USA) 
Test 3 
Morinaga (MO) peanut, egg, and milk (casein and 
BLG) protein ELISA kits (Crystal Chem, Downers 
Grove, IL, USA) 
Test 4 
Tepnel (TE) BIOKITS peanut, egg, casein, and BLG 
assay kits (Neogen Corp.) 
Test 5 
ELISA Systems (ES) peanut, egg, casein, and BLG 
residue kits (BioMerieux, Durham, NC, USA) 
ELISA 









Mass spectrometry  xLA 
Test 2 
Mass spectrometry  LGA 
Test 3 












Ultima triple quadrupole mass 
spectrometer 
HPLC coupled with single-




 Immuno-chromatographic test kits- Dip stick Immunoassay 






 VERATOX  kit ELISA 
Test 2 
Mass spectrometry 
Time of flight-mass spectrometry 
Test 1 
Neogen, Lansing, MI 
Test 2 
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Table 3.35:  Milk: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 












milk Casein 1 ELISA 
FASTKIT 
cereals 5-20 ng/ml 63-65         
Akiyama 
2004 
milk Casein 1 ELISA 
FASTKIT 
cookie 5-20 ng/ml 82-91         
Akiyama 
2004 
milk Casein 1 ELISA, 
FASTKIT 
pasta sauce 5-20 ng/ml 34-35         
Akiyama 
2004 
milk Casein 1 ELISA, 
FASTKIT 
sauce 5-20 ng/ml 5-8.         
Akiyama 
2004 
milk Casein 1 ELISA, 
FASTKIT 



































sausage 5-20 ng/ml 74-95 1 ng/ml 5 ng/ml 
Akiyama 
2004 




cereals 5-10 ng/ml 23-25         
Akiyama 
2004 




cookie 5-10 ng/ml 34-41         
Akiyama 
2004 




pasta sauce 5-10 ng/ml 27-40         
Akiyama 
2004 




sauce 5-10 ng/ml 41-43         
Akiyama 
2004 




sausage 5-10 ng/ml 41-48         
Haasnoot 
2004 
milk kappa-casein 1 Biosensor 
direct Mab 
6A10 
milk (goat or 
sheep) 
0.25-2 % 80-108 0.07 % w/w 
 
    
Haasnoot 
2004 
milk kappa-casein 2 Biosensor 
direct Mab 
4G10 
milk (goat or 
sheep) 
0.25-2 % 84-110 0.06 % w/w     
Haasnoot 
2004 
milk kappa-casein 2 Biosensor 
direct Mab 
4G10 
milk (goat or 
sheep) 
0.25-2 % 77-112 0.08 % w/w     
Haasnoot 
2004 
milk kappa-casein 3 Biosensor 
direct Mab 
6A10 
milk (goat or 
sheep) 
0.25-2 % 77-112 0.08 % w/w     




    0.5 ppm     
Hefle 2004 milk casein 1 ELISA, ICP-
MS 
ice cream     0.5 ppm     
Khuda 
2012a 
milk casein 1 ELISA, 
RIDASCRE





2         
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Study ID Allergen Specific 
protein 


















122         
Khuda 
2012a 






69         
Khuda 
2012a 






357         
Khuda 
2012a 






54         
Khuda 
2012a 






2         
Khuda 
2012a 






50         
Khuda 
2012a 






44         
Khuda 
2012b 
milk casein 1 ELISA, 
RIDASCRE
EN FAST  
sugar cookie linear 
regression 
0         
Khuda 
2012b 
milk BLG 1 ELISA, 
RIDASCRE
EN FAST  
sugar cookie linear 
regression 
0         
Khuda 
2012b 
milk casein 2 ELISA, 
Veratox  
sugar cookie linear 
regression 
7         
Khuda 
2012b 
milk casein 3 ELISA, 
Morinaga 
sugar cookie linear 
regression 
4         
Khuda 
2012b 
milk BLG 3 ELISA, 
Morinaga 
sugar cookie linear 
regression 
12         
Khuda 
2012b 
milk casein 4 ELISA, 
BIOKITS 
sugar cookie linear 
regression 
3         
Khuda 
2012b 
milk BLG 4 ELISA, 
BIOKITS 
sugar cookie linear 
regression 
0         
Khuda 
2012b 
milk casein 5 ELISA 
Systems  
sugar cookie linear 
regression 
6         
Khuda 
2012b 
milk BLG 5 ELISA 
Systems  
sugar cookie linear 
regression 
1         
Monaci 
2008 
milk alpha LA 1 Mass 
Spectrometric 
fruit juice 5-20 µg/ml 73-79         
Monaci 
2008 
milk LGA 2 Mass 
Spectrometric 
fruit juice   68-74         
Monaci 
2008 
milk LGB 3 Mass 
Spectrometric 
fruit juice   75-78         
Monaci 
2011 
milk casein 1 LC-MS white wine 10-1000 
µg/ml-1 
  39 µg/mL
-1
     
Morishita 
2006 
milk crude 1 IC - dipstick chicken 
meatball  
or burger 
    5 µg/g     
Morishita 
2006 
milk crude 1 IC - dipstick cookie     5 µg/g     
Morishita 
2006 
milk crude 1 IC - dipstick Dumplings 
fried/ 
steamed 
    5 µg/g     
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Study ID Allergen Specific 
protein 












milk crude 1 IC - dipstick jelly     5 µg/g     
Morishita 
2006 
milk crude 1 IC - dipstick Pickles in 
Vinegar/soy 
    5 µg/g     
Morishita 
2006 
milk crude 1 IC - dipstick Potato salad     5 µg/g     
Morishita 
2006 
milk crude 1 IC - dipstick sauce     5 µg/g     
Weber 
2006 




    5 ppm     
3.2.12. Peanut 
Twenty studies investigated detection systems for peanut, perhaps as a result of the severity of symptoms 
reported by people with peanut allergy. 
An in-house ELISA was developed and tested by Akiyama (2004b) and performed with similar 
sensitivity as the commercial FASTKIT, providing recoveries of  50-182% with spiked concentrations as 
low as 5 ng/ml. The matrix with the lowest recovery was chocolate with 50-54%. Deng (2012) developed 
an assay for peanut agglutinin and found recoveries in chocolate were variable depending on the 
concentration of the spike. Ehlert (2009) developed and tested an in-house ELISA and showed a limit of 
detection of between 5 and 100 mg/kg
-1  
equivalent to 50-1000µg/g .  Khuda (2012b), tested the Morinaga 
ELISA in a sugar cookie matrix and found that recoveries were low at 12%. Kiening developed and tested 
an ELISA against crude peanut extract and when cereals, cookies, ice-cream or chocolate were spiked 
achieved recoveries of 87-123%. Yeung (1996) developed a similarly effective assay and extraction 
system for snacks, oils and sauces spiked with 2.5-20µg/g peanut extract.  
 Commercial ELISA systems were evaluated in a number of studies. The FASKIT ELISA gave good 
recoveries in the region of 65-97 % when butter, chocolate, pasta sauces were spiked with between 2-
20ng/ml. RIDASCREEN gave good recoveries with dark chocolate but poor recoveries, 11 % from sugar 
cookie, Khuda (2012a), Park (2005) did not show recovery but did indicate that the limit of detection was 
5 µg/g for chocolate, cereals, cookie and ice-cream.   BIOKITS gave under 10%  recovery for dark 
chocolate and  sugar cookie Khuda (2012a). The Veratox  ELISA gave limited recoveries from spiked 
chocolate, 30%, Khuda (2012a), poor from sugar cookie, 15%. Park (2005) did not give the recovery, but 
did show a limit of detection of 5µg/g for chocolate, cereals, cookie and ice-cream. Some companies and 
researchers have developed systems to increase the sensitivity of the ELISA system further. Speroni 
(2010) evaluated an ELISA system incorporating  antibody coated magnetic micro particles, for the 
detection of the peanut allergens Ara h 3,4. This assay had a limit of detection of 0.8µg/g when cereals 
were spiked with peanut flour and a good recoveries, 80-95%.  
Mass spectrometry and Electrospray mass spectrometry provided limit of detections for as low as 0.1µg/g 
in chocolate cereal snacks, Careri (2007b), these methods have the advantage that they can be directed 
against a range of peanut proteins, however the use will be limited as the equipment involved is 
expensive. The Ligation dependent probe amplification (LPA) tested by Ehlert (2009) did not give good 
limit of detection for cookie as a matrix at 5  mg/kg
-1
  (equivalent to 50µg/g) and gave a very poor limit of 
detection from walnut mixtures spiked with peanut.  PCR evaluated by Ehlert (2009) sowed a similar 




The IC-dipstick tested by Morishita (2006) gave consistent limit of detection of 5µg/g, and had the 
advantage of ease of use and did not require specialist equipment.     
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Table 3.36:   Peanut: characteristics of included studies 





Spiking experiments or 
field samples tested and 















Source of spike 
Morinaga Institute of 
Biological Science, Virginia 
Peanuts 
Standardisation 
Protein measured BCA 
protein assay kit and adjusted 
















Roasted defatted peanuts and 
nuts extracted, dialysed 
Source of spike 
Not reported 
Standardisation 
Made up to 1mg/ml-1 protein 
















Source of spike 
Leibniz-Centre for Medicine 
and Biosciences at the 











Ara h 2 and Ara 
h 3/4 
Breakfast cereals 
Rice crispy/cacao  
 
Spiked 
Source of spike 













Ara h, 2, 3 
 
Chocolate snack Spiked 
Field 
Source of spike 
Ara h2 was purified from 
toasted peanuts, Ara h 1 and 
Ara h3/4 were provided by 
the Leibniz Centre for 
Medicine and Biosciences at 























 Range of 
products and  
peanut oil without 
Spiked 
Field 
Source of spike 
Peanut agglutinin, (Sigma, 
St. Louis, MO, USA) 
ELISA 
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Spiking experiments or 
field samples tested and 
source of spike 
Type of 
assays tested 















Source of spike 
Nut materials, sesame seeds, 
ingredients of self-prepared 
DNA plant and animal 
materials used to test the 
specificity of the method and 
spike  samples of chocolate, 
were obtained from the 














or gene  






Pastry or dough 
 
Spiked. 
Source of spike 
Biscuit prepared by Central 
Science Laboratory Food 
Analysis Proficiency 
Assessment Scheme, spiked 













Source of spike 
light-roasted peanut flour, 
12% fat light roast, product 
521271, lot 109FA (Golden 

















Spray dried whole egg 
powder NIST RM 8445 
(NIST), non-fat milk 
powder, and light-roasted 
peanut flour, 12% fat light 
roast, product 521271, lot 
109FA  
Source of spike 
Peanut (Golden Peanut Co., 






















Standard peanut butter as 
peanut reference material 
(SRM 2387) National 




Source of spike 
Standard peanut butter (SRM 
2387) (National Institute of 
ELISA 
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Spiking experiments or 
field samples tested and 
source of spike 
Type of 
assays tested 
Standards and Technology, 






















ic test kits 
Dip stick 
 










Source of spike 
Peanut butter (National 
Institute for Standards and 
Technology (NIST); 
Gaithersburg, MD), Standard 





























and a group of 















peptide or gene 






Source of spike 
Oil-roasted Virginia peanuts 
















Source of spike 
Roasted peanuts purchased at 
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Spiking experiments or 
field samples tested and 
























































Source of spike 
raw peanuts purchased from 






















Source of spike 
3 peanut preparations 
(roasted, raw, denatured, 
unfolded raw peanuts) 





Table 3.37:   Peanut: description of assay 






Peanut protein ELISA Kit (Morinaga Institute of 
Biological Science) 
Test 2 
















Polyclonal detection antibody 
Competitive inhibition 
In-house 
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mass spectrometry using both 







Time of flight mass spectrometry (LC-ESI-Q-TOF) 
Test 2 
Liquid chromatography-triple quadruple mass 
spectrometry LC-QqQ-MS-MS 
Test 1 








Europium (Eu)-tagged inductively coupled plasma 




ionization tandem mass spectrometry (LC/ESI-
MS/MS) with a triple quadrupole mass analyzer. 
Ara h 3/4 
Test 3 
Electroliquid chromatography/electrospray 
ionization tandem mass spectrometry (LC/ESI-
MS/MS) with a triple quadrupole mass analyzer. 









Polyclonal capture antibody 





Peanut Test 1 
Ligation dependent probe amplification 
Test 2 
Hazelnut and peanut: real-time PCR Surefood 
allergen kit (Congen Biotechnology GmbH, Berlin, 
Germany) cashew real time PCR In house  
Test 3 
Hazelnut and peanut: ELISA Ridascreen (R-

















RIDASCREEN FAST peanut, egg, and casein from 
R- Biopharm (RB, Washington, MO, USA) Peanut 
protein including Ara h1 
Test 2 
Veratox peanut, egg, and total milk allergen 
quantitative test kits from Neogen (NE) Corp. 
(Lansing, MI, USA) 
Test 3 
Morinaga (MO) peanut, egg, and milk (casein and 
BLG) protein ELISA kits (Crystal Chem, Downers 
Grove, IL, USA) 
Test 4 
Tepnel (TE) BIOKITS peanut, egg, casein, and 
BLG assay kits (Neogen Corp.) 
ELISA 
Polyclonal capture antibody 
Polyclonal detection antibody 
Commercial company 
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Study ID Allergen Assay details Additional information 
Test 5 
ELISA Systems (ES) peanut, egg, casein, and BLG 











Monoclonal capture antibody 
mouse Y70 
Polyclonal detection antibody 



















Veratox Assay for peanut 
Test 2 
RIDASCREEN Assay for peanut 
Test 3 
BioKits Assay for peanut 
Test 1 
ELISA, commercial, Neogen  
Test 2 
ELISA, commercial,  R-
Biopharm RIDASCREEN FAST 
Peanut  
Test 3  













 ELISA, Monoclonal capture 
antibody mAb 2C12,  
Monoclonal detection antibody 
mAB 2F7, in-house. 
Test 2 
ELISA, commercial, Neogen 









Monoclonal capture antibody 








Protein A-Pn-b ELISA Veratox Quantitative peanut 
allergen test 
Test 2 
MP-NH2-PAMAM G 1.5-Pn-b ELISA 
ELISA format based on antibody 
coated magnetic micro particles. 
The immune support are coated 












Polyclonal capture antibody 












Polyclonal capture antibody 
Polyclonal detection antibody 
Sandwich 
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Polyclonal capture antibody 





Table 3.38:   Peanut: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 












peanut crude 1 ELISA biscuit 5-20 ng/ml 74-76         
Akiyama 
2004b 
peanut crude 1 ELISA buffer 5-20 ng/ml        2 ng/ml      8 ng/ml 
Akiyama 
2004b 
peanut crude 1 ELISA butter 5-20 ng/ml 68-70         
Akiyama 
2004b 
peanut crude 1 ELISA chocolate 5-20 ng/ml 50-54         
Akiyama 
2004 b 
peanut crude 1 ELISA sauce 5-20 ng/ml 66-68         
Akiyama 
2004b 
peanut crude 2 ELISA, 
FASTKIT 
biscuit 5-20 ng/ml 122-182         
Akiyama 
2004b 
peanut crude 2 ELISA, 
FASTKIT 
buffer    2.5 ng/ml 5 ng/ml 
Akiyama 
2004b 
peanut crude 2 ELISA, 
FASTKIT 
butter 5-20 ng/ml 65-70         
Akiyama 
2004 b 
peanut crude 2 ELISA, 
FASTKIT 
chocolate 5-20 ng/ml 72-82         
Akiyama 
2004b 
peanut crude 2 ELISA, 
FASTKIT 
sauce 5-20 ng/ml 79-97         
Ben Rejeb 
2005 
peanut   1 ELISA chocolate 
dark 
    1 ppm    
Careri 
2007a 




cereals     2 mg/kg
-1
   
Careri 
2007b 





        
Careri 
2007b 







    1 µg/g
-1
 3.7 µg/g-1 
Careri 
2007b 






    5 µg/g
-1
 14 µg/g-1 
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Study ID Allergen Specific 
protein 


















5  µg/g-1 86 2.2 µg/g
-1
 5 µg/g-1 
Careri 
2008a 
peanut  Ara h 3 2 Electrospray 




    1 µg/g
-1
 3.7 µg/g-1 
Careri 
2008a 
peanut  Ara h 2 3 Electrospray 




    5 µg/g
-1
 14 µg/g-1 




milk 1-60 ng/mL 0- 69         
Ehlert 2009 peanut DNA 1 LPA chocolate nr nr 5 mg/kg
-1
     
Ehlert 2009 peanut DNA 1 LPA cookie   5 mg/kg
-1
     
Ehlert 2009 peanut DNA 1 LPA walnut 
cookies 
  1000 mg/kg
-1
     
Ehlert 2009 peanut DNA 2 PCR real 
time 
chocolate   5 mg/kg
-1
     
Ehlert 2009 peanut DNA 2 PCR real 
time 
cookie   0.5 mg/kg
-1
     




  1 mg/kg
-1
     
Ehlert 2009 peanut crude 3 ELISA chocolate   5 mg/kg
-1
     
Ehlert 2009 peanut crude 3 ELISA cookie   5 mg/kg
-1
     
Ehlert 2009 peanut crude 3 ELISA walnut 
cookies 
  100 mg/kg
-1
     
Hird 2003 peanut Ara h2 1 PCR real 
time 
biscuit   2 ppm > 2 ppm 
Khuda 
2012a 
peanut crude 1 ELISA, 
RIDASCRE





73         
Khuda 
2012a 






35         
Khuda 
2012a 






11         
Khuda 
2012a 






3         
Khuda 
2012a 






29         
Khuda 
2012b 
peanut crude 1 ELISA, 
RIDASCRE
EN FAST  
sugar cookie linear 
regression 
11         
Khuda 
2012b 
peanut crude 2 ELISA, 
Veratox  
sugar cookie linear 
regression 
15         
Khuda 
2012b 
peanut crude 3 ELISA, 
Morinaga 
sugar cookie linear 
regression 
12         
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Study ID Allergen Specific 
protein 












peanut crude 4 ELISA, 
BIOKITS 
sugar cookie linear 
regression 
0         
Khuda 
2012b 
peanut crude 5 ELISA 
Systems  
sugar cookie linear 
regression 
2         
Kiening 
2005 
peanut crude 1 ELISA cereals 1-10 mg/kg 105-117         
Kiening 
2005 
peanut crude 1 ELISA chocolate 
dark 
1-10 mg/kg 87-101         
Kiening 
2005 
peanut crude 1 ELISA chocolate 
milk 
1-10 mg/kg 113-123         
Kiening 
2005 
peanut crude 1 ELISA cookie 1-10 mg/kg 92-107         
Kiening 
2005 
peanut crude 1 ELISA ice cream 1-10 mg/kg 94-110         
Morishita 
2006 
peanut crude 1 IC - dipstick chicken 
meatball or 
burger 
    5 µg/g     
Morishita 
2006 
peanut crude 1 IC - dipstick cookie     5 µg/g     
Morishita 
2006 
peanut crude 1 IC - dipstick Dumplings 
fried/steame
d 
    5 µg/g     
Morishita 
2006 
peanut crude 1 IC - dipstick jelly     5 µg/g     
Morishita 
2006 
peanut crude 1 IC - dipstick Pickles in 
Vinegar/soy 
    5 µg/g     
Morishita 
2006 
peanut crude 1 IC - dipstick Potato salad     5 µg/g     
Morishita 
2006 
peanut crude 1 IC - dipstick sauce     5 µg/g     
Park 2005 peanut crude 1 ELISA 
Veratox 
cereals     5 µg/g     
Park 2005 peanut crude 1 ELISA 
Veratox 
chocolate     5 µg/g     
Park 2005 peanut crude 1 ELISA 
Veratox 
cookie     5 µg/g     
Park 2005 peanut crude 1 ELISA 
Veratox 
ice cream     5 µg/g     
Park 2005 peanut crude 2 ELISA 
RIDASCRE
EN 
cereals     5 µg/g     
Park 2005 peanut crude 2 ELISA 
RIDASCRE
EN 
chocolate     5 µg/g     
Park 2005 peanut crude 2 ELISA 
RIDASCRE
EN 
cookie     5 µg/g     
Park 2005 peanut crude 2 ELISA 
RIDASCRE
EN 
ice cream     5 µg/g     
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Study ID Allergen Specific 
protein 










Park 2005 peanut crude 3 ELISA 
BioKits 
cereals     5 µg/g     
Park 2005 peanut crude 3 ELISA 
BioKits 
chocolate     5 µg/g     
Park 2005 peanut crude 3 ELISA 
BioKits 
cookie     5 µg/g     
Park 2005 peanut crude 3 ELISA 
BioKits 
ice cream     5 µg/g     
Pomes 
2003 




0-0     
Pomes 
2003 




7-100     
Pomes 
2003 




54-94     
Pomes 
2003 




      
Pomes 
2004 
peanut Ara h 1 1 ELISA chocolate     0.16 % w/w     
Speroni 
2010 
peanut Ara h3/4 1 ELISA biscuit             
Speroni 
2010 
peanut Ara h 3/4 1 protein A-
Pn-b ELISA 
biscuit 5-15 mg/kg 93-94 0.8 mg/kg 2.4 mg/kg 
Speroni 
2010 




biscuit 5-15 mg/kg 114 0.8 mg/kg 2.4 mg/kg 
Speroni 
2010 
peanut Ara h3/4 1 ELISA breakfast 
cereal 
            
Speroni 
2010 
peanut Ara h 3/4 1 protein A-
Pn-b ELISA 
cereals 5-15 mg/kg 80-95 0.8 mg/kg 2.4 mg/kg 
Speroni 
2010 




cereals 5-15 mg/kg 84 0.8 mg/kg 2.4 mg/kg 
Stephan 
2004 
peanut Crude 1 ELISA chocolate 
milk 
10-200 ppm 64-111         
Stephan 
2004 
peanut Crude 1 ELISA milk 10-200 ppm 81-142         
Wen  
2005a 
peanut Ara h1 1 LFA chocolate     158 µg/g     
Yeung 
1996 
peanut crude 1 ELISA chocolate 2.5-20 µg/g 83-88         
Yeung 
1996 
peanut crude 1 ELISA cookie 2.5-20 µg/g 62-75         
Yeung 
1996 
peanut crude 1 ELISA crisps/  
Thai cracker 
2.5-20 µg/g 53-100         
Yeung 
1996 
peanut crude 1 ELISA ice cream 2.5-20 µg/g 45-81         
Yeung 
1996 
peanut crude 1 ELISA oil 2.5-20 µg/g 71-84         
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Study ID Allergen Specific 
protein 












peanut crude 1 ELISA sauce 2.5-20 µg/g 84-92         
Yeung 
1996 
peanut crude 1 ELISA snack 2.5-20 µg/g 66-80         
Yeung 
1996 
peanut crude 1 ELISA snack 2.5-20 µg/g 80-95         
Yman 2006 peanut crude 1 RIE chocolate     70 µg/g     
Yman 2006 peanut crude 2 SPR 
immunoassay 
chocolate     1 µg/g     
Yman 2006 peanut crude 3 Ridascreen chocolate     1 µg/g     
Yman 2006 peanut crude 4 BioKit 
(Tepnal 
BioSystems) 
chocolate     1 µg/g     
 
3.2.13. Sesame 
ELISA and one PCR method were assessed in the included studies for detecting sesame in matrices such 
as wheat cracker, cookie, muesli, crisp toast and bread (Table 3.39).  
There were two studies evaluating in-house ELISAs. Hussain (2010) showed good recoveries from bread, 
cookies and snacks when spiked at a relatively high concentration of 24-200 µg/g. Redle (2010) showed 
similar results for their in-house ELISA.    
There was only one study that evaluated PCR, Coisson (2010), and this was directed against the DNA for 
sesame mannitol dehydrogenase (Table 3.40). The limit of detection was given as 10% w/w for sausage 
meat samples spiked with sesame, which is equivalent to 10,0000µg/g (Table 3.41).   
Table 3.39:   Sesame: characteristics of included studies 
Study ID Allergen Assay developed 
to detect  
Food matrix tested Spiking experiments or 
field samples tested and 


















Source of spike 
S. indicum (sesame seeds) 
and A. graveolens L 
(celery leaves). Samples 
purchased from 
















crisp toast 1, crisp 
Spiked 
Field 
Source of spike 
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Study ID Allergen Assay developed 
to detect  
Food matrix tested Spiking experiments or 
field samples tested and 
source of spike 
Type of 
assays tested 








sesame balls, crisp 
flakes, sesame flakes, 
cookies, crisp toast, 
sesame oil, biscuits, 
crackers, muesli, 
cereal 
assessed using Bradford 
assay 
 





whole grain bread, 
whole wheat bread, 
crisp toast 
Cookie 





crisp toast, snacks 
Spiked 
Field 
Source of spike 
White peeled, unpeeled, 
and black sesame seeds 






Table 3.40:   Sesame: description of assay 






PCR with multiplex 
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Table 3.41:   Sesame: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 












sesame DNA 1   meatball  
or burger 
PCR nr 10 % w/w     
Husain 
2010 
sesame crude 1 ELISA bread 25-200 µg/g 70-85         
Husain 
2010 
sesame crude 1 ELISA cookie 25-200 µg/g           
Husain 
2010 
sesame crude 1 ELISA Crisp toast 25-200 µg/g 92-103         
Husain 
2010 
sesame crude 1 ELISA muesli 0.001-1% 80-300         
Husain 
2010 
sesame crude 1 ELISA snack 25-200 µg/g 76-126         
Husain 
2010 
sesame crude 1 ELISA Wheat 
cracker 
0.001-1 % 80-300         
Redl 2010 sesame Crude 1 ELISA Crisp toast 25-200 µg/g 89-145 5 
 
µg/L     
Redl 2010 sesame Crude 1 ELISA snack 25-200 µg/g 48-108 3 µg/L 
 
    
Redl 2010 sesame Crude 1 ELISA white bread 25-200 µg/g 85-120         
Redl 2010 sesame seeds 1 ELISA Whole wheat 
cookies 
0.001-0.5 % 80-200         
Redl 2010 sesame Crude 1 ELISA Whole-
wheat bread 




There were seven recent studies investigating assays for soy proteins (Table 3.42).  The assays studies 
include ELISA and  PCR (Table 3.43) and the findings for limit of detection (Table 3.44) highlight that 
there are assay available that can  to less than 5µg/ml.  
Cuco (2012) compared their in-house ELISA to the commercial kit, KTI-ELISA. While there were good 
recoveries for cookie as a matrix, 83-118%  for both assays the cookie mixtures spiked before baking had 
poor recoveries at only 0-32% recovery. This is an important finding for any products that could become 
contaminated with heat stable allergenic foods. Ma (2010) developed an ELISA against the major 
allergenic proteins of soy, glycinin. This assay detected the allergen in processed soy products spiked 
with glycinin and found recoveries of between 96-103%.  
L'Hocine (2007) evaluated the Tepnal and ELISA systems kits and found the limits of detection in milk 
was good at 1 and 0.1µg/ml respectively.      
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Food matrix tested Spiking experiments or field 














Source of spike 
Alpro (Wevelgem, Belgium) 
and Cargill (Mechelen, 
Belgium). A mixture of equal 























































Source of spike 
Commercial soy flour (SF), 
soyprotein concentrate (SPC), 
and soy protein isolate (SPI) 
provided by “Aliments Newly 
Weds” (Boucherville, Que., 
Canada). Commercial soy 
protein hydrolysate (SPH) 
purchased from “Aliments 
UFL” (Boucherville, Que., 
Canada). Texturized soy protein 















such as seed, meal 
and fermented paste 
 
Spiked 
Source of spike 
Crude extracts of glycinin 
(Professor Shuntang Guo of 
China Agricultural University) 
further purified by the 
researchers 
Standardisation 

















Source of spike 
ELISA 
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Food matrix tested Spiking experiments or field 















The soybeans (Glycine max 
var.Enrei, Haruyutaka, 
Nattosyoryu and Toyomusume) 
(Kinki University)  were used to 
make defatted soybean powder 
(DSP) 
Standardisation 
DSP in the model processed 
foods was calculated, taking 
into account the protein content 
of the DSP and the change in 
weight of the model processed 
foods during their preparation.  
Field 
Purchased at local supermarkets 
(Ibaraki, Japan) in 2006 
 
Table 3.43:  Soy: description of assay 








































Tepnel Biosystems kit (Tepnel Biosystems Ltd., 
Flintshire, U.K.) 
Test 2 
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Study ID Allergen Assay details Additional information 














Table 3.44:  Soy: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 










Cucu 2012 soy crude 1 ELISA cookie 21-84  µg/g 1.5-24         





94-115         
Cucu 2012 soy KTI 2 KTI ELISA cookie 21-84  µg/g 0-32         





83-118         
Espineira 
2009 
soy crude 1 PCR real 
time 
fish     0.05 % w/w     
Espineira 
2009 
soy DNA 1 PCR real 
time 
flour     100 mg/kg     
Espineira 
2009 
soy crude 2 End-point 
PCR 
fish     0.06
25 
% w/w     
Espineira 
2009 
soy DNA 2 End-point 
PCR 
flour     10 mg/kg     
Hei soy beta-
conglycinin 







        
L'Hocine 
2007 






1 µg/ml 3 µg/ml 
L'Hocine 
2007 






0.01 µg/ml 0.23 µg/ml 
Ma 2010 soy glycinin 1 ELISA Extracted 
soybean 
meal 
10-40 µg/ml 96-99         
Ma 2010 soy glycinin 1 ELISA Extruded 
soybean 
meal 
10-40 µg/ml 98-103         
Ma 2010 soy glycinin 1 ELISA Fermented 
soybean 
paste 
10-40 µg/ml 97-105         
Ma 2010 soy glycinin 1 ELISA Roasted full 
fat soybean 
10-40 µg/ml 97-102         
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Study ID Allergen Specific 
protein 










Ma 2010 soy glycinin 1 ELISA Soybean 
protein 
concentrate 
1-4 µg/ml 95-103         




102-103         
Morishita 
2008 
soy glycinin 1 ELISA buffer 10 µg/g 
(one conc. 
only) 
  0.19 µg/ml 0.38 µg/ml 
Morishita 
2008 
soy glycinin 1 ELISA croquette 10 µg/g 
(one conc. 
only) 
92.8         
Morishita 
2008 





97.6         
Morishita 
2008 
soy glycinin 1 ELISA sauce 10 µg/g 
(one conc. 
only) 
89.7         
Morishita 
2008 
soy glycinin 1 ELISA sausage 10 µg/g 
(one conc. 
only) 
87.7         
Morishita 
2008 
soy glycinin 1 ELISA soup 10 µg/g 
(one conc. 
only) 
98.7         
 
3.2.15. Walnut 
Assays that detected walnut proteins in a range of foods such as biscuit, cake, chocolate, cashew pesto, 
cereals, cakes and flour (Table 3.45) were included in this review. The assays investigated included 
ELISA and PCR (Table 3.46). Doi (2008) used roasted walnut flour as the spike for a wide range of foods 
(Table 3.45), the results were shown for only one concentration of spike, and this was at 10µg/g (Table 
3.47). In all foods matrices tested the recovery was good at 83-123 %. A study by Niemann (2009) 
showed the development and validation of an in-house ELISA that for chocolate demonstrated good 
recovery at 95-100% and a limit of detection of 1ppm or 1µg/g. 
The study by Wang (2009) evaluated a real time PCR in a wheat matrix. The limit of detection was 
shown to be 0.001% w/w which equates to 1 µg/g. So this assay shows similar findings to the ELISA 
tests. 
Table 3.45:   Walnut: characteristics of included studies 
Study ID Allergen Assay 
developed to 
detect  
Food matrix tested Spiking experiments or field 























Source of spike 
Defatted walnut powder 
(Chandler, Haward and 
Chinese Walnut) ( Tabata Inc, 
Chiba, Japan and Mitsuboshi 
Boeki Ltd, Kobe, Japan) all 
ELISA 
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Study ID Allergen Assay 
developed to 
detect  
Food matrix tested Spiking experiments or field 








such as chocolate 
and biscuits 
were roasted 120 
o
















Source of spike 
Several brands of English 
walnuts and black walnuts, 

















Source of spike 
Juglans regia bought from 





Table 3.46:  Walnut: Description of Assay 
Study ID Allergen Assay details Additional information 




















Ligation dependent probe amplification 
Test 2 
Hazelnut and peanut: real-time PCR Surefood allergen 
kit (Congen Biotechnology GmbH, Berlin, Germany) 
cashew real time PCR In house  
Test 3 
Hazelnut and peanut: ELISA Ridascreen (R-Biopharm 
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Table 3.47:  Walnut: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 










Doi 2008 walnut soluble 
protein 
1 ELISA biscuit 10  µg/g 83         
Doi 2008 walnut soluble 
protein 
1 ELISA bread 10  µg/g 123         
Doi 2008 walnut soluble 
protein 
1 ELISA cake 10  µg/g 100         
Doi 2008 walnut soluble 
protein 
1 ELISA chicken 
meatball or 
burger 
10 µg/g 120         
Doi 2008 walnut soluble 
protein 
1 ELISA jelly 10 µg/g 102         
Doi 2008 walnut soluble 
protein 
1 ELISA juice 10 µg/g 101         
Doi 2008 walnut soluble 
protein 
1 ELISA rice gruel/ 
porridge 
10 µg/g 115         
Niemann 
2009 
walnut crude 1 ELISA cake 1-100ppm not clear         
Niemann 
2009 
walnut crude 1 ELISA cereals 1-100ppm not clear         
Niemann 
2009 
walnut crude 1 ELISA chocolate 1-100ppm 95-104 0.5 ppm 1 ppm 
Niemann 
2009 
walnut crude 1 ELISA cookie 1-100ppm not clear         
Wang 2009 walnut crude 1 Real-Time 
PCR 
wheat flour     0.001 % w/w     
 
3.2.16. Other 
There were two studies that looked at allergenic foods not listed in the previous categories, the foods 
detected were the tree nuts macadamia and pecan and mustard (Table 3.48). Lee (2008) evaluated an 
ELISA to detect mustard, the antibodies were directed against whole/crude mustard proteins (Table 3.49). 
Sausage was spiked with between 1 and 1000 ppm and gave good recoveries of between 80-107% (Table 
3.50). The same study evaluated a commercial ELISA Systems kit, and this achieved only 13-20% 
recovery under the same conditions.   
The Ligation dependent probe amplification gave a very poor limit of detection of 1000 mg/kg
-1 
(100 µg/g), for both macadamia and pecan in a walnut cookie matrix, Ehlert (2009) (Table 3.50).  
Table 3.48:   Other: characteristics of included studies 
Study ID Allergen Assay 
developed to 
detect  
Food matrix tested Spiking experiments or field 



















Source of spike 
Nut materials, sesame seeds, 
ingredients of self-prepared 
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Study ID Allergen Assay 
developed to 
detect  
Food matrix tested Spiking experiments or field 








materials used to test the 
specificity of the method and 
spike  samples of chocolate, 
were obtained from the 






















Source of spike 
Nut materials, sesame seeds, 
ingredients of self-prepared 
DNA plant and animal 
materials used to test the 
specificity of the method and 
spike  samples of chocolate, 
were obtained from the 




















baked beans, salad 













Table 3.49:   Other: Description of Assay 






Ligation dependent probe amplification 
Test 2 
Hazelnut and peanut: real-time PCR Surefood 
allergen kit (Congen Biotechnology GmbH, Berlin, 
Germany) cashew real time PCR In house  
Test 3 
Hazelnut and peanut: ELISA Ridascreen (R-

















Polyclonal capture using 
rabbit or sheep antibody 
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Table 3.50:  Other: accuracy and limit of detection and quantification 
Study ID Allergen Specific 
protein 










Ehlert 2009 macadamia DNA 1 LPA walnut 
cookies 
    1000 mg/kg
-1
     
Lee 2008 mustard crude 1 ELISA sausage 1-1000 ppm 80-107         
Lee 2008 mustard crude 2 ELISA 
systems 
sausage 1-1000 ppm 12.6-20.0         
Ehlert 2009 pecan DNA 1 LPA walnut 
cookies 
nr nr 1000 mg/kg
-1
     
 
3.2.17. Quality of studies 
The quality of the included studies was assessed using predetermined criteria as outlined in the methods 
section (Table 3.2). For some food matrix types it would seem that the allergen spike was not mixed with 
the food in a way that would reflect real world situations. For example grinding up foods that were 
already cooked to make a powder and then mixing with the powdered allergen extract. These studies were 
therefore marked as a risk of bias for the spiking procedure. A few of the studies used standardised 
extracts from a trusted source and they received a low risk of bias grading for this item. While nearly all 
studies indicated that they repeated the assay procedure, only a few of the studies showed their findings 
for repeat spiking and extraction processes and these were graded as low risk of bias for this item. (Table 
3.51) 
Table 3.51:  Quality of the included studies 
Short Title Spiking procedure Source of extract for spike Extraction repeated 
Akiyama 
(2003) 
High risk of bias 
 
Low risk of bias 
 




High risk of bias 
 




High risk of bias 
 




Low risk of bias 
 
High risk of bias High risk of bias 
 
Allred (2012) Low risk of bias Low risk of bias High risk of bias 
Ben (2003) Unclear risk of bias Low risk of bias Unclear risk of bias 
Blais (2001) High risk of bias 
 
Low risk of bias High risk of bias 
Brzezinski 
(2006) 
High risk of bias 
 
High risk of bias High risk of bias 
Ben Rejeb 
(2003) 
High risk of bias 
 
High risk of bias 
 
Unclear risk of bias 
Ben Rejeb High risk of bias Unclear risk of bias Unclear risk of bias 
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Short Title Spiking procedure Source of extract for spike Extraction repeated 
(2005)    
Brzezinski 
(2007) 
High risk of bias 
 
High risk of bias Low risk of bias 
Careri (2007a) Unclear risk of bias Low risk of bias Unclear risk of bias 
Careri (2007b)  Spiked or field 
Unclear risk of bias 
High risk of bias 
 
Unclear risk of bias 
Careri (2008) Unclear risk of bias Unclear risk of bias High risk of bias 
Coisson (2010) Low risk of bias Low risk of bias High risk of bias 
Costa (2012) High risk of Bias Low risk of bias High risk of bias 
Cucu (2012) Low risk of bias Low risk of bias Unclear risk of bias 
Cucu (2012) Low risk of bias High risk of bias Unclear risk of bias 
Demmel 
(2011) 
Low risk of bias Unclear risk of bias Low risk of bias 
Deng (2012) Low risk of bias Unclear risk of bias Low risk of bias 
Cai  Unclear risk of bias High risk of bias Unclear risk of bias 
Doi (2008) Unclear risk of bias Unclear risk of bias Low risk of bias 
Drs (2004) Unclear risk of bias Unclear risk of bias Unclear risk of bias 
Ehlert (2009) Low risk of bias Low risk of bias Unclear risk of bias 
Eissa (2012) Unclear risk of bias Unclear risk of bias Unclear risk of bias 
Espineira 
(2010) 
Unclear risk of bias Unclear risk of bias Unclear risk of bias 
Faeste (2006) High risk of Bias Low risk of bias Low risk of bias 
Faeste (2008) Low risk of bias High risk of bias Unclear risk of bias 
Fuller (2006) Unclear risk of bias High risk of bias High risk of bias 
Garber (2010a) 
almond 
Low risk of bias 
 
High risk of bias 
 
Unclear risk of bias 
Garber (2010b) 
hazelnut 
Low risk of bias 
 
High risk of bias 
 
Unclear risk of bias 
Gaskin (2011) Low risk of bias High risk of bias Low risk of bias 
Haasnoot 
(2004) 
Unclear risk of bias High risk of bias Unclear risk of bias 
Hefle (2001) Low risk of bias High risk of bias High risk of bias 
Hefle (2004) Low risk of bias Unclear risk of bias Low risk of bias 
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Short Title Spiking procedure Source of extract for spike Extraction repeated 
Hei (2012) Unclear risk of bias Unclear risk of bias Unclear risk of bias 
Hird (2003) Low risk of bias Low risk of bias Unclear risk of bias 
Holden (2005) High risk of Bias Low risk of bias Low risk of bias 
Holden (2007) Low risk of bias High risk of bias Unclear risk of bias 
Holzhauser 
(1999) 
Unclear risk of bias Low risk of bias Unclear risk of bias 
Holzhauser 
(2002) 
Unclear risk of bias Unclear risk of bias Unclear risk of bias 
Husain (2010) Unclear risk of bias Low risk of bias Unclear risk of bias 
Kaw (2008) Low risk of bias Low risk of bias Unclear risk of bias 
Khuda (2012a) 
egg  
Low risk of bias Low risk of bias Low risk of bias 
Khuda (2012a) 
milk 
Low risk of bias Low risk of bias Low risk of bias 
Khuda (2012b) 
Peanut 
Low risk of bias 
 
Low risk of bias 
 




Low risk of bias 
 
Low risk of bias 
 




Low risk of bias Low risk of bias Low risk of bias 
Khuda (21012 
b) milk 
Low risk of bias 
 
Low risk of bias Low risk of bias 
Kiening (2005) High risk of bias Low risk of bias Unclear risk of bias 
Lacorn (2011) Low risk of bias Low risk of bias Low risk of bias 
Lee (2008) Low risk of bias Unclear risk of bias Unclear risk of bias 
L'Hocine 
(2007) 
Unclear risk of bias Unclear risk of bias Unclear risk of bias 
Ma (2010) High risk of bias Low risk of bias Low risk of bias 
Mena (2012) Unclear risk of bias Unclear risk of bias Unclear risk of bias 
Monaci (2008) Unclear risk of bias Unclear risk of bias Low risk of bias 
Monaci (2011) Low risk of bias Unclear risk of bias Unclear risk of bias 
Morishita 
(2006) 
Unclear risk of bias Unclear risk of bias Unclear risk of bias 
Morishita 
(2008) 
Low risk of bias Low risk of bias High risk of bias 
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Short Title Spiking procedure Source of extract for spike Extraction repeated 
Niemann 
(2009) 
Low risk of bias High risk of bias Unclear risk of bias 
Panda (2010) Low risk of bias Unclear risk of bias Unclear risk of bias 
Park (2005) Low Risk of bias Low risk of Bias Low risk of bias 
Piknova (2008) Low Risk of bias High risk of Bias Unclear risk of bias 
Pomes (2003) High Risk of Bias High risk of Bias Unclear risk of bias 
Pomes (2004) Unclear risk of bias High risk of Bias Unclear risk of Bias 
Redl (2010) Low Risk of bias High risk of Bias Unclear risk of bias 
Roeder (2010) Low risk of bias High risk of bias Low risk of bias 
Roeder (2011) Low risk of bias Low risk of bias Unclear risk of bias 
Roux (2001) High risk of bias High risk of bias High risk of bias 
Schneider 
(2010a) 
High risk of bias 
 
High risk of bias 
 
Unclear risk of bias 
Schneider 
(2010b) 
High risk of bias 
 
Unclear risk of bias 
 




High risk of bias 
 
Unclear risk of bias Unclear risk of bias 
Sharma (2009) Unclear risk of bias High risk of bias Unclear risk of bias 
Shibahara 
(2007) 
High risk of bias High risk of bias Unclear risk of bias 
Shibahara 
(2013b) 
Unclear risk of bias High risk of bias Low risk of bias 
Shon (2010) Unclear risk of bias Unclear risk of bias Unclear risk of bias 
Speroni (2010) Unclear risk of bias High risk of bias Unclear risk of bias 
Stephan (2002) Unclear risk of bias Unclear risk of bias Unclear risk of bias 
Stephan (2004) Unclear risk of bias 
 
Source of spike 
Source 
Not reported 
Unclear risk of bias 
Taguchi (2011) Unclear risk of bias High risk of bias Unclear risk of bias 
Wang (2009) Low risk of bias High risk of bias High risk of bias 
Wang (2011) Low risk of bias High risk of bias Low risk of bias 
Weber (2006) Unclear risk of bias High risk of bias Unclear risk of bias 
Wen (2005a) Unclear risk of bias High risk of bias Unclear risk of bias 
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Short Title Spiking procedure Source of extract for spike Extraction repeated 
Werner (2007) Unclear risk of bias Unclear risk of bias High risk of bias 
Wu (2010) Unclear risk of bias High risk of bias High risk of bias 
Yeung (1996) Unclear risk of bias High risk of bias Unclear risk of bias 
Yeung (1997) Unclear risk of bias Unclear risk of bias Unclear risk of bias 
 
3.3. Discussion and Conclusions 
This review revealed that there are a large number of studies that have investigated the effectiveness of 
assays for detecting allergens in foods since 2004. There was variability in the types of experiments 
carried out, the format and statistical analysis of the data presented and in specific techniques such as the 
method of spiking and in the source of extracts used to validate the assay in the studies retrieved for this 
review. In a large proportion of studies there was a potential high risk of bias for at least one item. There 
are a range of criteria that could be used to validate assays and ensure that there is consistent quality 
control across institutions. We focused on the accuracy as determined by the percentage recovery of a 
spiked sample and the limit of detection of each allergen within a suitable food matrix; this is just one 
aspect of quality control. 
The range of quality criteria that should be assessed in the validation of any assay to detect a chemical or 
biologically active compound and these are outlined by the International Conference on Harmonisation of 
Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (1995). However 
these guidelines require adaptation for the specific requirements of detecting allergens in foods. There are 
a number of standards and guidelines produced throughout the world to facilitate this.  Within Europe 
there are two standards that apply to the detection of allergens in foods EN 15633-1: 2009 for 
immunoassays and EN 15634-1: 2009, for molecular biological, these standards are produced and 
published by the European Committee for Standardization (2013). In Japan official detection assays were 
adopted by the government and the method used to validate this assays published (Akiyama, Imai and 
Ebisawa; 2011). In addition to assay quality criteria those developing and using the tests must be aware of 
current research and guidelines on the types of foods found to be allergenic and the quantities could 
potentially cause symptoms. The Codex Alimentarius Commission, established by Food and Agriculture 
Organization of the United Nations and the World Health Organization develops harmonised international 
food standards, guidelines and codes of practice and so should be a useful source for this type of 
information.  
Before funding or adopting an assay and extraction procedure  it is recommended that all key quality and 
validation data are reviewed in accordance with the relevant standards and that each laboratory carry out 
their own validation experiments to assess the performance of the assay within their specific context.   
The results section within this review show the percentage recovery and the limit of detection and 
quantification for each assay when different food matrices were spiked with the allergenic food. This 
information is grouped by allergen.  It was apparent that for many of the allergenic foods there were 
assays that could detect down to 1 µg/g. Data was available for the following allergenic foods: almond, 
Brazil nut, Buckwheat, cashew nut, celery, egg, fish and shell fish, hazelnut, lupine, milk, mustard, 
peanut, pecan, sesame, soy and  walnut.  
The immunoassays generally gave a similar limit of detection as the PCR assays. Although PCR is 
extremely sensitive for detecting tiny quantities of DNA we were reporting the ability to detect 
contamination with crude preparations of the allergenic foods for example peanut flour, rather than 
extracts of peanut DNA.  
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The individual findings can be found in the results sections however there are several points to consider 
when looking at these findings as a whole. These include: 
 The limit of detection reported by some of these studies showed that the values reported by 
manufacturers are not always achieved in practice. Limits of detection for the allergen extracted 
from a similar food to the intended use are essential. 
 The food matrix contaminated with an allergenic food is highly likely to affect the performance 
of the extraction processes and limit of detection of the assay. Chocolate in particular could mask 
the allergen, and decrease the percentage recovery and increase the limit of detection. Users 
should ensure that the assay is validated for the specific food matrix. 
 Consideration should be made as to whether users need to know the limit of detection for a 
specific protein, for example a food additive such as lysozyme or presence of any protein from 
the allergenic food.  
 Processing, for example baking, can reduce the percentage recovery and increase the limit of 
detection. If the contamination could  have occurred prior to processing then the validation 
experiments should include this processing step. 
 Internationally agreed standards for the allergenic food source used in the spiking experiments the 
concentration of specific proteins will vary, and this in turn will lead to differences in the 
measured limit of detection by ppm or weight/weight. 
3.4. List of Included Studies 
Akiyama H, Isuzugawa K, Harikai N, Watanabe H, Iijima K, Yamakawa H, Mizuguchi Y, Yoshikawa R, 
Yamamoto M, Sato H, Watai M, Arakawa F, Ogasawara T, Nishihara R, Kato H, Yamauchi A, 
Takahata Y, Morimatsu F, Mamegoshi S, Muraoka S, Honjoh T, Watanabe T, Wakui C, Imamura T, 
Toyoda M and Maitani T, 2003. Inter-laboratory evaluation studies of notified ELISA methods for 
allergic substances (Egg). Journal of the Food Hygienic Society of Japan, 44, 213-219. 
Akiyama H, Nakamura K, Harikai N, Watanabe H, Iijima K, Yamakawa H, Mizuguchi Y, Yoshikawa R, 
Yamamoto M, Sato H, Watai M, Arakawa F, Ogasawara T, Nishihara R, Kato H, Yamauchi A, 
Takahata Y, Morimatsu F, Mamegoshi S, Muraoka S, Honjoh T, Watanabe T, Sakata K, Imamura T, 
Toyoda M, Matsuda R and Maitani T, 2004. Inter-laboratory evaluation studies for establishment of 
notified ELISA methods for allergic substances (Buckwheat). Journal of the Food Hygienic Society of 
Japan, 45, 313-318. 
Akiyama H, Nakamura K, Harikai N, Watanabe H, Ijima K, Yamakawa H, Mizuguchi Y, Yoshikawa R, 
Yamamoto M, Sato H, Watai M, Arakawa F, Ogasawara T, Nishihara R, Kato H, Yamauchi A, 
Takahata Y, Morimatsu F, Mamegoshi S, Muraoka S, Honjoh T, Watanabe T, Sakata K, Imamura T, 
Toyoda M, Matsuda R and Maitani T, 2004. Inter-laboratory evaluation studies for establishment of 
notified ELISA methods for allergic substances (peanuts). Shokuhin Eiseigaku Zasshi, 45, 325-331. 
Akiyama H, Isuzugawa K, Harikai N, Watanabe H, Iijima K, Yamakawa H, Mizuguchi Y, Yoshikawa R, 
Yamamoto M, Sato H, Watai M, Arakawa F, Ogasawara T, Nishihara R, Kato H, Yamauchi A, 
Takahata Y, Morimatsu F, Mamegoshi S, Muraoka S, Honjoh T, Watanabe T, Sakata K, Imamura T, 
Toyoda M, Matsuda R and Maitani T, 2004. Inter-laboratory evaluation studies for development of 
notified ELISA methods for allergic substances (milk). Journal of the Food Hygienic Society of Japan, 
45, 120-127. 
Akiyama H, Isuzugawa K, Harikai N, Watanabe H, Iijima K, Yamakawa H, Mizuguchi Y, Yoshikawa R, 
Yamamoto M, Sato H, Watai M, Arakawa F, Ogasawara T, Nishihara R, Kato H, Yamauchi A, 
Takahata Y, Morimatsu F, Mamegoshi S, Muraoka S, Honjoh T, Watanabe T, Sakata K, Imamura T, 
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ABBREVIATIONS 
DBPCFC  Double blind placebo controlled food challenge 
HN  Hazelnut 
IgE   Immunoglobulin -E 
OAS  Oral allergy syndrome 
OFC  Open Food Challenge 
PCR  Polymerase Chain Reaction 
PBS  Phosphate Buffered Saline 
SPT  Skin Prick Test 
   
 
 
